data_2n5a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n5a _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 14.4 m -72.71 145.0 47.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.653 0.739 . . . . 0.0 112.68 -168.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.48 139.47 30.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.237 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 11' ' ' PHE . 5.9 m-85 -85.11 170.54 12.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.772 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 54.1 mttm -121.62 -39.24 2.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -148.56 -179.07 6.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.55 -27.92 69.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 m -60.01 -45.37 93.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.2 mp0 -57.99 -42.69 85.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.52 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.682 ' O ' HG12 ' A' ' 15' ' ' ILE . 13.5 t80 -60.4 -54.63 43.26 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.51 -39.12 79.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.684 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -61.65 -47.07 87.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.706 0.288 . . . . 0.0 110.565 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.71 72.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.471 . . . . 0.0 110.379 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.682 HG12 ' O ' ' A' ' 11' ' ' PHE . 10.4 mm -65.21 -40.37 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.38 2.21 9.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.297 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -73.95 139.62 45.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.711 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.33 40.46 0.56 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.315 0.578 . . . . 0.0 110.823 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 2.3 pttp -153.54 163.11 40.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.884 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' A' ' 84' ' ' VAL . 1.9 tm? -69.54 113.82 7.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.029 0.442 . . . . 0.0 110.995 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 4.4 p -110.01 118.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.957 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.559 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -110.23 119.66 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 109.85 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 11' ' ' PHE . 58.0 t -102.59 127.41 56.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.243 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -87.86 97.01 10.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.443 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -107.15 110.36 22.43 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.092 0.472 . . . . 0.0 110.818 -176.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 26.3 p90 -145.31 -171.54 3.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.092 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 57' ' ' VAL . . . -136.25 136.69 40.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.415 HG23 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -61.02 -24.12 65.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -88.69 -10.44 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.275 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' HG3' ' A' ' 72' ' ' MET . 44.2 t -77.44 158.39 30.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.034 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.1 -76.57 0.6 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.217 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 6.3 Cg_exo -74.39 14.77 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.187 2.591 . . . . 0.0 113.757 -173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.4 p -59.92 -34.95 73.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.882 0.848 . . . . 0.0 109.916 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -70.29 -8.0 46.87 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.423 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 24.1 ttt -84.44 -28.99 26.47 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.098 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.607 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 1.4 mp -77.5 -25.73 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -54.32 -64.98 1.46 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 94.8 Cg_endo -82.46 -30.55 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 121.192 1.261 . . . . 0.0 114.133 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.57 ' SD ' ' HB1' ' A' ' 90' ' ' ALA . 1.5 ttp -67.44 -42.8 82.53 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 118.508 0.595 . . . . 0.0 109.905 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.626 ' CD1' HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -73.31 -37.35 51.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.432 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.9 -38.52 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.658 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 56.8 mttp -65.36 -31.37 72.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.107 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.9 m-30 -55.65 -62.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.703 0.287 . . . . 0.0 110.268 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -73.84 -14.05 61.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.678 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 tt0 -60.32 -33.4 72.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.4 -47.96 8.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 175.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.2 p90 -128.68 86.4 57.68 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.158 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 -0.68 8.95 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.475 2.116 . . . . 0.0 112.252 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -67.47 -13.35 61.96 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.17 17.27 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.2 m-20 -91.8 126.42 36.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.254 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -102.27 114.16 28.07 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.493 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 3' ' ' THR . 98.6 m-85 -139.89 152.65 46.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.06 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.7 pttp -148.98 153.46 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.849 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.777 HD23 ' CZ ' ' A' ' 25' ' ' PHE . 8.0 tt -159.14 146.44 17.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.1 m-20 -99.68 125.23 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' CE1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -65.21 -22.72 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.07 -35.65 73.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.454 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.67 -43.53 11.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.964 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 46.0 mt -131.77 89.98 2.77 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.559 0.695 . . . . 0.0 112.445 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.06 -33.78 39.78 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.246 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.53 -30.13 68.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.151 0.501 . . . . 0.0 110.03 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.545 HG12 HD22 ' A' ' 67' ' ' ASN . 89.2 t -62.89 -50.23 80.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -46.76 -42.42 16.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.191 0.519 . . . . 0.0 111.406 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.04 -34.72 69.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.631 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 16.0 tptt -61.1 -26.44 67.66 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.545 HD22 HG12 ' A' ' 63' ' ' VAL . 9.1 m-20 -105.09 -10.89 16.87 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.187 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 43.1 mt-10 80.17 26.68 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.391 1.057 . . . . 0.0 111.271 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -104.72 110.71 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.687 0.756 . . . . 0.0 111.241 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -114.0 -34.66 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.54 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.65 159.65 26.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.872 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.451 ' HG3' ' SG ' ' A' ' 30' ' ' CYS . 20.3 ptp -151.17 140.84 14.06 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.906 0.384 . . . . 0.0 110.958 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.524 ' CG ' HD12 ' A' ' 36' ' ' ILE . 72.2 Cg_endo -80.83 150.47 79.1 Favored 'Cis proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.726 -1.781 . . . . 0.0 113.154 -2.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -120.79 145.93 47.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.229 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' A' ' 40' ' ' ILE . 3.6 mp -120.76 123.47 42.75 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 174.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 mt -122.5 112.72 18.37 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.841 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.559 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 4.0 mp -94.46 134.8 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.54 ' CG ' HD12 ' A' ' 15' ' ' ILE . 52.0 m-85 -133.45 156.73 47.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.406 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.42 122.75 19.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.47 167.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 t30 60.78 41.49 14.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.661 0.743 . . . . 0.0 111.352 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 86.16 -4.32 86.12 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.272 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -121.86 161.61 22.45 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 25.1 tt0 -66.92 178.75 1.28 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -150.59 -28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.047 162.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -154.81 146.39 23.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 112.073 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -135.14 115.33 13.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.665 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.06 141.54 45.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -121.62 48.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.152 0.501 . . . . 0.0 110.743 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.35 129.2 1.18 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.309 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -62.63 108.21 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.122 0.487 . . . . 0.0 112.114 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.54 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.98 90.32 32.55 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -33.07 -63.15 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.659 3.573 . . . . 0.0 115.074 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 -46.02 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.969 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 91' ' ' ASN . 29.5 mm -87.36 -34.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.271 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 31.9 tttt -59.83 -37.87 80.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.595 0.712 . . . . 0.0 109.121 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.75 -30.27 69.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.466 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -56.59 8.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.441 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.0 mm -51.07 -41.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.223 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.74 70.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.36 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -78.98 -21.04 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.979 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.787 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 52' ' ' PHE . 96.1 t . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.482 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.6 m -83.04 139.18 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 112.447 -170.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.602 ' OE1' ' HA ' ' A' ' 55' ' ' LEU . 8.4 tp-100 -90.56 138.91 31.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.097 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.677 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 16.0 m-85 -95.69 161.4 14.05 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.613 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.8 ptpp? -134.37 -3.72 2.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.315 170.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -141.94 158.86 43.27 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.939 0.399 . . . . 0.0 111.322 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 63' ' ' VAL . . . -71.21 -27.94 63.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.097 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -57.61 -46.4 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.344 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.677 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.1 mt-10 -55.41 -43.27 75.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.984 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.665 ' CE2' HG13 ' A' ' 23' ' ' VAL . 28.8 t80 -60.55 -58.41 8.6 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.36 -37.39 80.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.259 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -59.41 -43.22 93.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.892 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.02 -33.73 74.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.475 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 11' ' ' PHE . 15.2 mm -63.01 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.279 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.93 -1.3 16.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.693 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 8.3 tt0 -72.31 141.32 48.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.791 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.32 48.16 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.501 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 5.3 ptpp? -157.9 -179.88 8.55 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.461 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.7 tm? -73.8 123.11 23.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 109.885 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.9 t -102.2 117.9 48.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.231 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -97.06 103.0 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 11' ' ' PHE . 38.4 t -105.34 124.17 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.973 0.892 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -102.17 96.76 7.2 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.733 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.7 m-85 -101.0 128.62 46.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.778 0.799 . . . . 0.0 111.908 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 25.7 p90 -152.95 178.47 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.113 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.5 138.92 51.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.738 0.304 . . . . 0.0 110.277 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 p -66.19 -18.87 65.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.473 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -86.44 -10.75 53.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.59 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.16 152.75 24.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.597 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.59 -61.87 1.67 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.953 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.35 3.28 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.094 2.529 . . . . 0.0 113.872 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 29.0 p -60.43 -32.42 71.35 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.603 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.6 tptm -68.2 -11.88 60.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.801 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.677 ' SD ' ' HB1' ' A' ' 90' ' ' ALA . 24.0 ttt -79.43 -28.11 41.71 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.556 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -76.21 -22.73 15.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.616 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 34' ' ' LYS . . . -53.57 -68.25 0.49 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.474 172.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 78.9 Cg_endo -84.11 -32.04 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 CA-C-N 120.941 1.372 . . . . 0.0 114.43 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.546 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -64.97 -48.55 73.61 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.374 0.534 . . . . 0.0 109.71 -176.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.599 HD12 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -68.19 -37.9 78.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.045 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.14 -26.52 67.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 109.499 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 50.2 tptt -77.13 -30.85 55.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.948 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.659 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 18.1 m-30 -52.65 -64.55 0.78 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.012 0.434 . . . . 0.0 109.872 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.4 m -80.03 -13.2 59.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.216 -173.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.0 -35.99 80.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.15 -39.39 14.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.212 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 10.4 p90 -131.77 90.87 35.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 111.937 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 1.87 6.12 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.792 2.328 . . . . 0.0 112.652 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.31 -23.25 67.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.542 . . . . 0.0 111.257 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.4 157.95 16.42 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.04 138.42 31.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.358 0.599 . . . . 0.0 111.23 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -110.78 115.91 30.37 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.234 -171.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.482 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 92.1 m-85 -138.89 154.25 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 111.843 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 53.1 mttm -140.93 155.86 46.19 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.99 0.916 . . . . 0.0 109.972 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.664 HD23 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.03 147.49 16.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.937 0.398 . . . . 0.0 111.024 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.3 t0 -96.7 118.85 34.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.015 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 26' ' ' TYR . 21.7 t -66.12 -28.57 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.172 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.46 -25.47 65.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.93 -42.06 9.27 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.309 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.7 mm? -122.45 76.18 1.31 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.272 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.41 -40.72 91.47 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.027 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.78 -31.56 71.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.907 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 85.3 t -61.73 -52.55 59.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.132 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 69' ' ' VAL . . . -51.33 -39.33 56.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 111.075 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.71 -33.14 72.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.417 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -22.12 66.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.969 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.585 ' HB2' HG11 ' A' ' 69' ' ' VAL . 8.9 m-20 -109.79 -11.54 14.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 -173.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 80.28 27.28 0.29 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.439 1.087 . . . . 0.0 111.381 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.585 HG11 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -106.36 126.11 62.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.957 0.408 . . . . 0.0 110.375 173.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -139.85 5.52 2.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.08 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.46 ' HG2' ' CB ' ' A' ' 27' ' ' ALA . 2.4 mpt? -124.31 121.39 26.05 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.032 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HB2' HG12 ' A' ' 36' ' ' ILE . 40.3 Cg_endo -90.5 162.53 32.46 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.983 -1.257 . . . . 0.0 113.162 -1.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 m -136.89 131.93 33.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.325 0.583 . . . . 0.0 111.176 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 95' ' ' ILE . 4.1 mp -101.93 125.25 48.57 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.47 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.633 HD23 ' CE1' ' A' ' 78' ' ' PHE . 2.1 mt -118.61 113.2 20.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.149 0.5 . . . . 0.0 110.437 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.8 mp -97.19 133.32 41.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.633 ' CE1' HD23 ' A' ' 76' ' ' LEU . 55.1 m-85 -130.67 158.2 40.7 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.578 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -140.93 125.26 17.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 48.09 51.85 14.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.131 0.972 . . . . 0.0 113.508 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' HG21 ' A' ' 15' ' ' ILE . . . 76.67 3.19 78.46 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.653 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -119.03 160.93 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.23 -179.31 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -151.51 -34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 164.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -167.85 149.96 5.57 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.569 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 17.8 pttm -144.54 131.36 20.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.439 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.87 123.76 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.09 55.85 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.244 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.11 128.28 0.94 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 35' ' ' MET . . . -61.11 115.98 4.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.92 90.33 32.3 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.8 Cg_exo -25.13 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 125.256 3.971 . . . . 0.0 115.68 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.96 -28.42 35.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.15 -0.344 . . . . 0.0 111.833 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.1 83.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 HG22 HD21 ' A' ' 75' ' ' LEU . 41.0 mm -82.54 -31.0 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.818 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 33.4 mtmt -61.2 -40.07 92.55 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -64.7 -30.29 71.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.16 173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -52.54 45.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.469 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 4.2 mm -51.96 -41.09 30.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.56 -31.46 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.286 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.72 66.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.605 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -86.25 -20.79 27.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.59 177.283 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 41' ' ' GLU . 74.5 t . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.547 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.0 m -81.77 145.54 30.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.086 -172.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -92.37 124.62 36.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 9.0 m-85 -84.58 157.31 21.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 21.6 pttm -135.16 -3.27 2.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.239 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -140.83 164.9 28.98 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.153 0.501 . . . . 0.0 111.792 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . . . -76.47 -31.85 58.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.284 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 m -59.28 -42.94 92.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.656 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.601 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 24.2 mt-10 -53.66 -45.61 70.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.741 ' CE2' HG13 ' A' ' 23' ' ' VAL . 12.3 t80 -56.84 -59.49 4.96 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.244 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -60.72 -27.83 68.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.766 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -64.42 -44.59 90.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.051 0.453 . . . . 0.0 110.055 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.15 -20.2 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.887 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 11' ' ' PHE . 17.9 mm -77.9 -38.35 24.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.109 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.59 14.59 2.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -99.18 163.37 12.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.955 0.407 . . . . 0.0 111.05 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.62 36.47 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.075 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.5 173.67 12.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.921 0.391 . . . . 0.0 110.916 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.5 tm? -79.37 126.12 30.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.331 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.68 128.23 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.35 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.38 102.96 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.741 HG13 ' CE2' ' A' ' 11' ' ' PHE . 41.6 t -96.98 129.61 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.595 0.712 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -111.62 97.46 6.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.131 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.494 ' CD2' HG11 ' A' ' 69' ' ' VAL . 3.4 m-85 -103.23 137.24 41.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.571 0.7 . . . . 0.0 112.058 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 22.6 p90 -156.48 -171.37 3.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.688 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.63 135.1 32.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 p -69.3 -19.47 63.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.981 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -84.14 -14.77 49.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.01 0.434 . . . . 0.0 110.319 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 49.7 t -88.7 141.73 28.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.855 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.03 -60.85 5.31 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.83 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 41.1 Cg_endo -67.55 8.86 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.117 2.545 . . . . 0.0 114.766 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -60.52 -30.49 69.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.81 0.814 . . . . 0.0 109.958 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.661 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 19.7 ptmt -67.25 -9.6 42.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.646 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.422 ' HE2' ' HG3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -81.24 -34.57 32.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.68 -24.66 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.674 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -57.04 -65.89 1.5 Allowed Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.978 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.5 Cg_endo -84.32 -30.58 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.692 1.594 . . . . 0.0 113.545 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -67.26 -39.74 86.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 109.804 -176.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -75.07 -39.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.137 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 33.0 mt-10 -63.13 -32.02 73.31 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 173.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 39' ' ' MET . 27.3 ttpp -64.41 -41.06 96.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.284 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.1 m-85 -53.65 -63.23 1.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.949 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -76.4 -13.54 60.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.278 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.42 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.03 -41.07 13.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.29 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.533 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.6 p90 -133.8 90.81 26.56 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.28 0.562 . . . . 0.0 112.179 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.81 1.4 5.81 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.691 2.261 . . . . 0.0 112.584 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -63.15 -19.9 64.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.123 0.487 . . . . 0.0 110.694 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.13 153.26 19.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.73 143.39 26.59 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.914 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.2 p90 -111.84 116.05 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.309 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.547 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 90.6 m-85 -141.76 137.85 31.9 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 120.987 0.423 . . . . 0.0 112.12 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 31.1 mtmt -123.19 153.36 40.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.465 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 60' ' ' LEU . 8.8 tt -161.17 144.42 12.82 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.6 p-10 -100.52 129.63 46.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.082 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 26' ' ' TYR . 3.8 p -72.67 -16.63 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.488 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -57.93 -43.54 86.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.991 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -88.89 -42.32 11.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.0 mm? -111.9 76.45 0.98 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.276 0.56 . . . . 0.0 112.01 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 57' ' ' VAL . . . -67.34 -47.23 64.65 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.413 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.36 -30.95 70.84 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 111.177 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 89.5 t -65.53 -54.14 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.9 70.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 111.187 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.48 -30.22 69.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -66.96 -23.53 65.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.536 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.557 ' HB2' HG13 ' A' ' 69' ' ' VAL . 58.1 m-20 -106.63 -12.58 15.53 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.868 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 26.5 tt0 80.46 22.27 0.43 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.308 1.005 . . . . 0.0 110.938 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.25 124.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 121.818 -0.551 . . . . 0.0 109.834 173.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 m -131.63 -25.48 2.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.477 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.1 159.68 14.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -128.26 142.69 45.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 121.069 0.461 . . . . 0.0 111.434 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -82.23 166.39 70.63 Favored 'Cis proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.289 -1.546 . . . . 0.0 112.009 -9.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 m -140.8 136.64 32.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.539 . . . . 0.0 111.023 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 95' ' ' ILE . 4.8 mp -112.18 136.45 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.445 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 78' ' ' PHE . 4.7 mt -128.8 115.94 18.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.121 0.486 . . . . 0.0 110.856 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.67 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -99.3 129.31 45.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.055 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.468 ' CG ' HD12 ' A' ' 15' ' ' ILE . 54.0 m-85 -130.15 151.32 50.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.593 0.235 . . . . 0.0 110.788 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 56.0 tttp -132.96 124.57 28.02 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.1 p30 44.8 50.37 8.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 84.03 -4.98 81.58 Favored Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.589 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -119.97 160.85 21.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.18 179.94 0.87 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -152.68 -24.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.601 164.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -170.99 157.63 5.35 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 111.436 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.21 133.91 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.428 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.23 144.05 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 88' ' ' VAL . 9.0 p -117.1 49.04 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 122.218 1.008 . . . . 0.0 109.897 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.02 130.5 1.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.275 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' HB1' ' CD1' ' A' ' 36' ' ' ILE . . . -60.59 111.88 1.78 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -118.57 91.12 41.12 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.334 175.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 46.7 Cg_exo -31.69 -65.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.922 3.748 . . . . 0.0 115.359 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.65 -45.45 11.69 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.05 -30.59 71.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.3 mt -85.95 -31.61 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.308 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 15.4 ttpp -59.83 -38.77 82.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -64.4 -34.61 78.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.857 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -64.67 -60.78 2.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -50.73 -30.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.582 0.551 . . . . 0.0 110.802 -176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.5 -20.86 39.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.771 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.71 -32.11 17.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.67 ' ND2' HD22 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -92.19 -12.07 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.907 -178.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.942 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 4.8 m -65.03 145.03 56.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.775 -168.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -96.71 123.88 40.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.807 -175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 12.5 m-85 -84.63 158.95 20.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.235 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -128.65 -27.25 2.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.007 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 29.6 p -127.54 162.8 25.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.409 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.09 -26.72 62.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.13 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.508 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.0 mt-10 -58.1 -41.43 83.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.522 172.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.638 ' CE2' HG13 ' A' ' 23' ' ' VAL . 31.8 t80 -57.36 -59.72 4.72 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -56.36 -40.75 75.05 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.722 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -42.5 82.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.665 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 -36.27 71.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.364 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.7 mm -61.89 -40.73 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.8 2.24 8.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.257 -172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.85 143.15 44.02 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.56 34.43 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.563 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 172.31 13.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.153 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.545 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -68.49 123.08 19.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.488 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.6 t -103.2 114.28 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -93.64 103.61 14.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.638 HG13 ' CE2' ' A' ' 11' ' ' PHE . 56.1 t -105.61 124.65 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.787 0.803 . . . . 0.0 111.256 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -103.43 98.37 8.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.933 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CE2' HD21 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.5 121.59 44.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.482 0.658 . . . . 0.0 111.698 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 28.3 p90 -147.98 169.6 19.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.213 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.7 49.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -23.28 55.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -87.29 -10.17 53.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.518 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.13 158.83 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.758 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.62 -74.22 0.44 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.611 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 5.9 Cg_exo -77.91 25.66 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.315 2.677 . . . . 0.0 114.078 -171.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 p -65.65 -35.67 81.46 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.011 0.91 . . . . 0.0 109.566 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -68.31 -8.01 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.993 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -36.2 30.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.613 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.31 -25.58 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.864 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -55.36 -66.2 1.12 Allowed Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.738 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 90.0 Cg_endo -82.47 -30.05 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.263 1.309 . . . . 0.0 114.251 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.523 ' HE3' ' HA ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -66.13 -44.97 82.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.606 0.639 . . . . 0.0 109.463 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.614 HD11 ' CB ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -71.64 -37.57 63.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.219 -178.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.52 -33.19 75.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.809 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 5.0 tppp? -67.46 -34.97 78.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.331 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 20.5 m-30 -49.59 -62.99 1.24 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.267 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -76.55 -14.34 60.02 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.016 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.39 -33.09 70.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.568 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.74 -45.52 10.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.567 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.3 p90 -130.49 86.67 52.54 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.143 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.4 -1.79 10.25 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.446 2.097 . . . . 0.0 112.168 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -9.98 45.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.481 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.8 16.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -92.75 135.83 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.125 0.488 . . . . 0.0 111.234 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -113.66 116.55 29.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.235 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -140.47 151.25 44.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.928 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -148.77 158.24 44.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.609 HD21 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.04 146.75 16.04 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 177.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.3 m-20 -95.83 118.33 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.183 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.574 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -67.74 -16.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.43 . . . . 0.0 110.895 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.58 -40.17 96.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.03 -42.76 14.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.195 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.441 ' HB2' HD22 ' A' ' 55' ' ' LEU . 2.8 mm? -127.15 73.02 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 111.555 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.84 -36.89 87.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.17 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.11 -38.83 73.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 110.866 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.469 HG12 HD22 ' A' ' 67' ' ' ASN . 95.4 t -63.66 -51.21 72.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.035 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.82 -39.06 62.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.884 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 30.1 mm-40 -69.27 -33.33 73.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.366 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 12.3 tptt -62.37 -30.05 70.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.815 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.583 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -102.71 -7.5 21.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.674 -170.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 45.1 mt-10 79.08 24.95 0.49 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.047 0.842 . . . . 0.0 111.043 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -100.68 112.09 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.231 0.538 . . . . 0.0 110.103 175.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.5 t -124.78 -20.83 4.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.28 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.574 ' CE ' HG21 ' A' ' 57' ' ' VAL . 19.9 mmt -129.36 121.55 20.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.056 -174.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 73.4 Cg_endo -88.01 167.71 40.26 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.005 -1.248 . . . . 0.0 113.018 -3.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 10.7 m -136.58 138.16 40.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.686 0.755 . . . . 0.0 111.555 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -109.02 127.79 54.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.569 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.561 HD22 ' CE1' ' A' ' 78' ' ' PHE . 3.1 mt -121.5 113.6 20.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.112 0.482 . . . . 0.0 110.632 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.638 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -98.83 131.59 44.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.139 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.561 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.1 m-85 -129.69 158.34 39.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.465 0.174 . . . . 0.0 110.586 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -141.25 123.76 15.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p30 48.07 54.02 10.76 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 15' ' ' ILE . . . 79.62 -1.6 76.89 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.48 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -127.62 161.33 29.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.3 tt0 -65.55 179.43 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.06 0.457 . . . . 0.0 110.907 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -151.03 -28.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 163.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -168.63 152.68 5.73 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.539 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.81 129.58 17.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.866 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.17 129.89 60.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.545 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.94 50.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.018 0.437 . . . . 0.0 111.503 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.49 128.47 0.99 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.251 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -60.33 114.42 2.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.507 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.12 90.21 32.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.68 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 74.1 Cg_exo -21.93 -83.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 1 C-N-CA 125.512 4.141 . . . . 0.0 115.595 -171.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 96' ' ' LYS . . . -83.87 -30.51 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -173.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.66 77.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.36 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.507 HG12 ' HB3' ' A' ' 91' ' ' ASN . 34.7 mm -83.39 -29.85 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.798 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 37.3 mtpt -59.31 -39.25 82.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -66.63 -33.03 74.76 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.516 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -61.71 -60.78 3.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.52 -36.56 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 123.831 0.707 . . . . 0.0 110.683 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.55 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.831 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -37.12 14.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.296 0.57 . . . . 0.0 109.991 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.638 ' ND2' HD22 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -85.42 -11.65 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.522 174.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 52' ' ' PHE . 52.8 t . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.557 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 11.2 m -71.82 144.64 49.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 0.0 112.525 -169.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -90.86 121.51 32.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.232 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 11' ' ' PHE . 3.7 m-85 -69.75 168.5 14.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 0.0 110.418 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 16.7 mtpp -127.86 -36.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.019 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -144.6 179.28 7.39 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.51 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.74 68.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -57.48 -48.5 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.787 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -55.02 -43.04 73.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.729 174.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.704 ' CE2' HG12 ' A' ' 23' ' ' VAL . 15.5 t80 -58.03 -60.08 4.29 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.7 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.01 -38.87 76.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.803 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -60.36 -47.83 84.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.695 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.24 75.0 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.844 0.354 . . . . 0.0 110.402 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 11' ' ' PHE . 14.3 mm -59.67 -36.81 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.308 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 14.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -83.14 153.73 24.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.65 0.262 . . . . 0.0 110.537 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -87.99 39.34 0.89 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.478 0.656 . . . . 0.0 110.36 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 17.7 ptpt -152.61 -179.8 7.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.051 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 99' ' ' ILE . 2.0 tm? -76.35 121.63 23.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.629 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 15' ' ' ILE . 1.1 t -96.21 116.19 37.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.051 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.41 103.16 14.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.704 HG12 ' CE2' ' A' ' 11' ' ' PHE . 43.4 t -104.93 126.53 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.592 0.71 . . . . 0.0 111.285 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -105.66 101.16 10.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.847 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.6 m-85 -104.69 121.64 44.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 42.1 p90 -151.4 162.64 40.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.525 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -111.7 132.31 54.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -62.0 -24.55 67.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.687 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -84.27 -17.13 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.823 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.39 152.45 39.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.342 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.89 -75.56 0.48 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.348 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 20.85 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.156 2.571 . . . . 0.0 114.226 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.4 p -65.74 -28.57 69.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.903 0.858 . . . . 0.0 109.345 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 22.5 pttp -68.33 -8.45 39.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.501 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.597 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 25.0 ttt -84.92 -25.56 27.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.148 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.644 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -79.99 -24.7 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.306 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.557 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.39 -63.57 2.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.633 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.6 Cg_endo -83.91 -34.47 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.084 1.856 . . . . 0.0 114.045 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.532 ' SD ' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -66.25 -42.99 87.81 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.426 0.631 . . . . 0.0 109.681 -176.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -73.51 -36.82 48.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.883 -178.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.43 -30.49 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.035 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 51.1 tttp -75.78 -28.91 58.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.524 -176.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.2 m-85 -56.59 -57.87 10.5 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.4 p -76.5 -13.75 60.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.496 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 34.1 tt0 -60.79 -31.9 71.27 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.34 -47.04 8.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.095 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.6 p90 -129.6 90.06 44.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.099 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -1.09 9.61 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.266 1.977 . . . . 0.0 112.174 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -10.62 51.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.964 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 154.63 18.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.1 m-20 -91.61 126.34 36.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' HB2' HG23 ' A' ' 2' ' ' VAL . 1.2 p90 -101.86 116.21 32.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.177 -174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.58 152.48 46.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.988 0.423 . . . . 0.0 111.029 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . 63.5 pttt -148.91 160.92 42.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.611 HD23 ' CE2' ' A' ' 25' ' ' PHE . 8.4 tt -157.58 151.19 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 18.6 t0 -97.86 119.1 35.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.62 -26.99 42.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.809 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.19 -35.59 80.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.373 0.606 . . . . 0.0 109.98 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.53 -42.46 20.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.498 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -135.09 84.01 2.07 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.91 -33.76 54.42 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.553 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.28 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 67' ' ' ASN . 79.6 t -63.74 -51.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.911 173.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -51.41 -39.69 57.76 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 110.76 176.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 75.9 mt-30 -69.97 -32.56 70.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.588 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -20.73 66.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.877 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.586 ' HB2' HG12 ' A' ' 69' ' ' VAL . 15.4 m-20 -110.71 -8.75 14.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.482 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 25.7 tt0 80.69 25.85 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.102 0.876 . . . . 0.0 110.883 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -105.92 107.81 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.333 0.587 . . . . 0.0 110.668 174.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -116.76 -24.52 7.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.138 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.12 157.76 26.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.3 ptp -151.3 137.4 11.19 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.269 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.516 ' CG ' HD11 ' A' ' 36' ' ' ILE . 58.0 Cg_endo -77.88 155.82 94.87 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.768 -1.763 . . . . 0.0 113.021 -3.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.5 m -134.73 142.87 46.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.442 0.639 . . . . 0.0 111.339 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 HD22 HG22 ' A' ' 95' ' ' ILE . 4.0 mp -114.24 129.36 56.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.768 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.576 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 mt -122.21 117.17 25.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 0.0 110.999 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.474 HD22 ' HB1' ' A' ' 85' ' ' ALA . 1.8 mp -101.06 129.45 46.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.102 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.576 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.6 m-85 -127.79 161.39 29.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 4.6 ttpm? -143.55 115.45 8.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.008 168.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 64.26 55.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.762 0.791 . . . . 0.0 111.205 172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.39 2.66 60.04 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.488 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 8.5 ptpp? -133.44 160.97 35.84 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 31.6 tt0 -64.99 177.63 0.96 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 110.856 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -148.84 -35.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 160.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 77' ' ' LEU . . . -162.99 152.96 15.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.51 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 42.3 pttt -147.61 127.16 13.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.168 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.66 134.22 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.278 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.9 52.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.234 0.54 . . . . 0.0 110.782 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.28 129.46 1.25 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.073 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.597 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -64.69 103.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.734 0.302 . . . . 0.0 111.601 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -117.49 88.89 30.42 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.032 175.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -35.37 -67.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.496 3.464 . . . . 0.0 115.272 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 -32.16 48.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.24 63.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.163 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.565 ' O ' HG12 ' A' ' 99' ' ' ILE . 40.3 mm -87.56 -34.4 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.23 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.681 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 55.0 tttt -59.48 -35.06 73.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -72.89 -31.22 64.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -68.75 -52.76 27.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.5 mm -54.43 -37.51 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.337 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.112 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -44.51 34.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.832 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.6 m-80 -79.03 -16.95 56.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.654 -172.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.628 177.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.497 ' CG1' ' HG3' ' A' ' 54' ' ' LYS . 95.2 t . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 21.3 m -81.53 144.53 31.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.513 -170.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -90.13 135.83 33.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.122 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.707 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 8.9 m-30 -88.37 167.88 13.13 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 170.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 55.7 pttt -134.67 -20.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.206 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -145.49 174.69 10.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' CA ' HG22 ' A' ' 63' ' ' VAL . . . -70.8 -27.48 63.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -59.27 -43.8 92.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.304 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 42.9 mm-40 -55.35 -46.62 76.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.382 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.666 ' CE2' HG13 ' A' ' 23' ' ' VAL . 16.6 t80 -59.24 -57.73 11.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.695 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.59 -40.98 93.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.828 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -62.02 -40.09 94.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.192 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.628 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.78 -42.58 90.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.648 175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 11' ' ' PHE . 4.9 mm -60.2 -40.33 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.97 7.65 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.433 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 24.3 mt-30 -83.95 148.66 26.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.53 44.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HZ1' ' HB3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -144.26 167.87 21.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.089 177.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.3 tm? -78.88 117.58 20.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 14' ' ' ALA . 41.1 t -108.36 122.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.227 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 28.9 t -106.59 112.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.666 HG13 ' CE2' ' A' ' 11' ' ' PHE . 54.6 t -100.14 121.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.641 0.734 . . . . 0.0 110.87 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . . . -85.26 96.61 9.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -96.84 126.03 41.7 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.966 0.413 . . . . 0.0 110.077 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.402 ' O ' HG13 ' A' ' 57' ' ' VAL . 8.6 p90 -149.8 -175.28 4.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.573 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -132.76 130.04 39.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.637 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -65.55 -19.47 65.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.959 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -84.98 -13.5 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.174 0.511 . . . . 0.0 110.552 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.647 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.2 t -90.48 136.56 32.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.37 7.67 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 113.532 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.647 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.3 Cg_exo -61.33 3.59 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.103 2.535 . . . . 0.0 114.145 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.1 t -59.03 -29.88 67.6 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.737 0.779 . . . . 0.0 110.429 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -67.97 -8.99 41.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.306 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -38.13 44.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.639 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.05 -25.46 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.861 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -55.65 -65.69 1.38 Allowed Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.891 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 73.2 Cg_endo -83.55 -26.87 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.72 1.613 . . . . 0.0 114.378 -175.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.506 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.3 tmm? -72.72 -37.45 67.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.291 0.567 . . . . 0.0 109.753 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.6 mt -79.85 -33.34 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.659 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.53 -29.05 70.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -72.79 -38.77 67.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.823 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.57 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -57.12 -49.63 75.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.5 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 95.8 p -85.39 -13.97 47.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.56 -27.98 69.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -89.68 -40.7 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.12 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 11.5 p90 -138.85 93.11 10.8 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 112.431 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.44 2.37 2.9 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.451 2.1 . . . . 0.0 112.107 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.06 -23.74 67.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.48 157.58 16.7 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.3 135.75 33.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.904 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.5 p90 -111.52 115.46 29.24 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.249 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 3' ' ' THR . 95.8 m-85 -140.66 156.74 46.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.716 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 43.4 mtmt -137.52 149.21 46.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.155 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.589 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 8.8 tt -157.87 148.81 21.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.034 0.445 . . . . 0.0 110.745 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 5.3 t0 -104.38 123.35 47.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.479 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.8 p -70.29 -24.39 25.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.061 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.62 -23.96 65.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.532 0.682 . . . . 0.0 109.694 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -99.12 -42.49 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.507 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.609 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -120.22 76.16 1.15 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.276 0.56 . . . . 0.0 112.163 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.81 62.67 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.85 -25.58 65.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.914 0.388 . . . . 0.0 110.797 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 51.5 t -68.68 -50.33 56.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.62 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -52.82 -22.84 5.85 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -86.26 -27.3 24.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -75.39 -26.5 58.48 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.107 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.62 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.5 p30 -110.13 -12.6 14.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 29.3 tt0 79.84 17.35 0.75 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.85 0.718 . . . . 0.0 112.635 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -89.55 130.89 38.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 121.567 -0.708 . . . . 0.0 110.639 173.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -123.94 -27.34 3.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.98 166.36 11.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.535 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.479 ' CE ' HG11 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -148.09 141.71 15.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.84 0.353 . . . . 0.0 110.951 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.89 150.29 78.55 Favored 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.836 -1.735 . . . . 0.0 112.635 -2.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -132.46 136.93 47.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.552 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD22 ' HE2' ' A' ' 39' ' ' MET . 4.3 mp -107.83 123.26 48.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -116.06 116.43 27.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.573 0.701 . . . . 0.0 109.876 175.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 HD23 ' HB1' ' A' ' 85' ' ' ALA . 2.2 mp -95.75 128.46 42.65 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.504 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.672 ' CE1' HD22 ' A' ' 76' ' ' LEU . 58.9 m-85 -125.96 153.26 44.55 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.493 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -135.87 125.39 25.13 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 46.8 53.82 9.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.223 1.009 . . . . 0.0 113.49 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' HG21 ' A' ' 15' ' ' ILE . . . 73.8 5.4 69.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.528 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -120.08 161.12 21.51 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 84' ' ' VAL . 27.0 tt0 -71.58 179.89 2.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.451 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -153.86 -33.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 164.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -167.58 149.76 5.78 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.423 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -146.82 127.86 14.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.032 0.444 . . . . 0.0 110.54 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 95' ' ' ILE . 4.2 m -132.44 139.42 50.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -101.69 48.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.255 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.33 131.58 1.71 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.317 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -69.72 108.13 3.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.474 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -117.28 89.75 32.06 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 12.2 Cg_exo -28.53 -67.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.79 3.66 . . . . 0.0 115.588 -171.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.9 21.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.74 71.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.739 0.304 . . . . 0.0 111.32 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.3 mm -72.62 -49.24 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.673 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mtmp? -63.46 -28.59 70.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -38.38 68.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.038 173.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.72 68.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.498 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.61 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 4.2 mm -52.73 -39.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.711 -178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.7 -19.85 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.175 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.9 -38.08 23.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.254 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' ND2' HD22 ' A' ' 77' ' ' LEU . 58.1 m-80 -83.95 -21.16 31.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.448 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.894 178.17 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 52' ' ' PHE . 43.7 t . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.628 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 1.4 m -60.48 144.42 51.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.414 -168.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -101.52 117.43 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.224 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.4 m-85 -71.07 167.58 18.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.138 0.494 . . . . 0.0 111.755 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -125.38 -41.31 2.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.924 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -138.5 -179.96 6.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 111.443 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.435 ' N ' HG21 ' A' ' 63' ' ' VAL . . . -67.86 -25.5 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.978 0.418 . . . . 0.0 110.186 175.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -61.2 -46.83 88.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -54.96 -42.74 72.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.448 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.738 ' CE2' HG12 ' A' ' 23' ' ' VAL . 17.6 t80 -57.37 -58.88 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.01 -36.35 74.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -63.54 -41.46 98.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.845 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.21 -35.54 78.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.037 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.1 mm -62.26 -39.16 83.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.052 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.06 0.97 9.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -75.5 143.58 42.45 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.73 40.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 0.0 110.986 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.19 167.44 22.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.381 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.7 tm? -70.1 126.42 29.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 15' ' ' ILE . 2.0 t -106.07 120.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.2 104.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' CE2' ' A' ' 11' ' ' PHE . 39.4 t -102.72 127.18 56.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.663 0.744 . . . . 0.0 111.083 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.574 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -105.33 98.17 7.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.125 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 55' ' ' LEU . 3.3 m-85 -103.21 123.97 47.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.417 ' O ' HG11 ' A' ' 57' ' ' VAL . 48.9 p90 -152.92 179.02 9.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.398 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.455 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -129.92 135.97 48.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.652 0.263 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.625 HG21 ' OD2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -63.96 -22.04 66.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.38 -13.26 52.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.562 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 52.9 t -81.99 148.79 28.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.706 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.39 -65.98 1.98 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.525 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 13.1 Cg_exo -71.8 18.52 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.24 2.627 . . . . 0.0 114.23 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -67.44 -29.24 68.66 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.048 0.927 . . . . 0.0 109.44 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 99.2 mttt -68.08 -7.36 28.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.133 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -38.33 58.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.22 -25.47 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.044 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -55.45 -65.8 1.3 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.976 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 96.2 Cg_endo -82.46 -29.75 1.36 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.456 1.437 . . . . 0.0 114.299 -173.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.534 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -66.3 -44.9 82.14 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.36 0.6 . . . . 0.0 109.456 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -69.55 -37.5 74.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.22 -179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 40.8 mt-10 -62.83 -31.99 73.1 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.065 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.53 -32.74 70.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.69 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 16.8 m-30 -52.44 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -76.07 -13.4 60.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.263 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -60.55 -39.57 88.41 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -79.05 -47.61 15.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.611 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.5 p90 -133.06 89.9 32.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.214 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.28 2.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.503 2.135 . . . . 0.0 112.661 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -24.74 67.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.304 0.573 . . . . 0.0 110.716 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.48 153.29 20.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.352 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.92 150.17 21.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.162 -175.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.532 ' HB2' HG21 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -118.33 115.96 25.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.969 -172.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.628 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.9 m-85 -141.8 149.51 40.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 111.635 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 36.9 mtmt -131.03 160.78 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.932 0.893 . . . . 0.0 110.1 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD23 ' CE2' ' A' ' 25' ' ' PHE . 9.0 tt -159.8 147.8 17.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.625 ' OD2' HG21 ' A' ' 28' ' ' THR . 0.4 OUTLIER -98.89 117.99 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.131 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -71.83 -17.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 0.0 110.376 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.02 -31.99 69.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 60' ' ' LEU . 37.2 tt0 -87.69 -42.77 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.024 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.4 mm? -124.22 80.63 1.85 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.0 -39.77 93.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.701 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.83 -33.98 76.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 67' ' ' ASN . 86.6 t -65.56 -49.53 77.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.095 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -50.7 -39.26 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.713 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.6 mm100 -69.24 -38.11 78.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.12 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -59.46 -24.96 63.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.475 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.54 ' HB2' HG12 ' A' ' 69' ' ' VAL . 8.7 m-20 -109.47 -8.02 15.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 122.278 -0.264 . . . . 0.0 111.366 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.2 mt-10 79.21 27.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.997 0.811 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -106.22 109.84 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.4 0.619 . . . . 0.0 110.481 175.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.0 m -117.41 -34.51 4.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.182 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.07 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.624 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 19.6 ptp -151.79 149.27 23.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.959 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.3 Cg_endo -79.63 150.82 84.38 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.525 -1.864 . . . . 0.0 112.422 -4.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.1 m -126.05 140.21 52.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.595 0.712 . . . . 0.0 111.784 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.99 124.65 52.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.436 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.626 HD23 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -116.32 118.74 33.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.462 . . . . 0.0 110.57 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 85' ' ' ALA . 2.4 mp -99.72 131.84 45.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.279 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 76' ' ' LEU . 60.3 m-85 -131.23 160.31 35.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.558 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -144.69 131.19 19.83 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.85 52.88 11.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 78.45 1.6 82.39 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.46 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -125.46 160.31 29.78 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 28.1 tt0 -66.57 -178.36 0.69 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.12 -31.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.647 162.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -164.0 154.43 15.23 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.918 0.39 . . . . 0.0 111.736 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -145.69 126.53 14.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 m -133.65 142.74 40.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.669 0.271 . . . . 0.0 110.521 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.23 43.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.963 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.48 121.9 0.82 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.119 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.554 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -59.63 109.59 0.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.952 0.406 . . . . 0.0 111.566 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.14 90.66 34.24 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.2 Cg_exo -26.26 -79.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.826 3.684 . . . . 0.0 115.288 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.91 -35.31 43.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.81 76.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.417 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.7 mm -86.15 -31.61 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.633 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 22.4 mtmm -63.05 -32.93 74.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.704 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -69.96 -32.86 71.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.035 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.55 48.56 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.089 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.531 ' CG1' ' HH ' ' A' ' 47' ' ' TYR . 4.1 mm -54.26 -38.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.453 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.77 60.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.097 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.98 -38.14 32.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.437 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 ' ND2' HD23 ' A' ' 77' ' ' LEU . 52.5 m-80 -86.67 -14.58 42.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.269 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.73 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.001 0.429 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.651 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 2.7 m -72.47 146.14 47.08 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -167.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -93.54 139.06 31.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.954 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 11' ' ' PHE . 11.5 m-85 -103.67 154.87 19.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.029 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 25.3 pttm -133.85 -3.35 2.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.205 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -143.22 164.11 31.08 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -56.93 -47.66 80.11 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -53.5 -44.95 69.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.603 ' O ' HG12 ' A' ' 15' ' ' ILE . 17.0 t80 -58.89 -57.25 13.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.7 -34.86 78.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.757 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -62.35 -40.35 96.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.678 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.61 -20.78 63.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.466 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 11' ' ' PHE . 12.5 mm -82.58 -36.49 13.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.335 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 12.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -101.09 148.2 25.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 120.817 0.342 . . . . 0.0 110.313 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.73 66.22 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.619 0.723 . . . . 0.0 110.747 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -154.03 174.59 14.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.44 117.16 24.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.158 0.504 . . . . 0.0 109.846 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.3 t -102.23 128.43 54.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.2 t -115.78 108.79 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 11' ' ' PHE . 14.5 t -106.31 129.58 59.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.706 0.765 . . . . 0.0 110.885 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -98.68 100.17 11.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.081 -175.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' A' ' 55' ' ' LEU . 2.1 m-85 -105.89 108.88 20.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.492 0.663 . . . . 0.0 111.945 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.4 p90 -131.76 -174.51 3.44 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.532 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.97 139.91 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.892 0.377 . . . . 0.0 110.404 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -20.28 62.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.709 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -88.7 -15.75 34.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.36 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 33' ' ' CYS . 16.3 p -90.92 150.25 21.57 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.2 -46.99 9.55 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.912 -0.585 . . . . 0.0 114.321 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 42.0 Cg_endo -67.11 5.08 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.578 2.186 . . . . 0.0 114.307 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 24.4 p -61.98 -34.1 75.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.457 0.646 . . . . 0.0 110.383 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.4 -8.66 42.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.402 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.531 ' CG ' ' HB1' ' A' ' 90' ' ' ALA . 16.9 tpt -79.7 -33.34 41.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -79.95 -26.75 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.049 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -52.05 -62.04 3.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.269 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 42' ' ' LYS . 83.9 Cg_endo -80.39 -41.2 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 120.152 1.09 . . . . 0.0 113.706 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.473 ' HE2' ' CB ' ' A' ' 90' ' ' ALA . 2.8 tmm? -62.04 -36.21 80.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.246 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -82.17 -35.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.288 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -64.57 -23.43 67.26 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.189 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 27.0 mtpp -85.56 -26.05 26.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -60.69 -42.07 96.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.965 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -15.43 49.35 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 122.054 -0.404 . . . . 0.0 111.008 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 24.0 tt0 -56.53 -39.18 72.94 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.22 -50.23 8.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.908 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.584 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 14.3 p90 -134.13 91.02 24.46 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.252 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.99 0.78 8.48 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.885 1.723 . . . . 0.0 111.195 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -9.66 29.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.779 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.84 161.15 13.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.18 130.76 37.81 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HB2' HG21 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -114.96 116.32 28.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.053 -172.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.651 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 88.2 m-85 -140.57 151.34 44.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.526 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 19.5 pttm -148.64 152.44 36.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.15 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 60' ' ' LEU . 6.7 tt -160.33 152.44 20.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.757 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.7 p-10 -99.77 128.54 45.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 111.263 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -72.42 -12.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.082 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.49 -48.6 72.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.025 0.441 . . . . 0.0 109.926 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -80.12 -41.56 25.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.832 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.7 mm? -116.04 71.81 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.142 0.496 . . . . 0.0 112.249 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -75.15 -36.09 46.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.966 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.98 -30.58 71.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.403 0.621 . . . . 0.0 110.79 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 60.7 t -68.99 -52.55 32.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.6 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.91 -40.9 58.08 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.23 0.331 . . . . 0.0 111.238 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 71.6 mt-30 -69.66 -32.04 70.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.8 tptt -62.98 -27.95 69.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.729 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.602 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -103.94 -10.11 18.39 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.3 tt0 80.99 19.49 0.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.201 0.938 . . . . 0.0 111.029 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -96.44 118.66 43.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 121.804 -0.56 . . . . 0.0 110.145 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 m -117.32 -31.33 5.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.618 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.11 163.87 13.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.269 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -144.51 138.51 14.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.609 ' CG ' HD13 ' A' ' 36' ' ' ILE . 59.3 Cg_endo -83.39 152.18 69.03 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.741 -1.775 . . . . 0.0 113.024 -0.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.7 m -131.56 135.03 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.681 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.432 HD22 HD12 ' A' ' 40' ' ' ILE . 4.1 mp -104.9 129.93 53.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.533 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.586 HD21 ' CE2' ' A' ' 78' ' ' PHE . 1.3 mt -120.64 115.67 23.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.011 0.434 . . . . 0.0 110.92 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 2.1 mp -98.81 133.15 43.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CE2' HD21 ' A' ' 76' ' ' LEU . 47.9 m-85 -130.85 153.91 48.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.571 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 4.1 tppp? -132.68 118.15 18.75 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.571 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 8.8 p30 43.78 55.74 4.96 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.255 1.022 . . . . 0.0 113.735 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 80.34 -5.63 63.08 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.601 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.97 160.08 16.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.19 178.52 4.39 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -149.23 -34.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 163.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -167.01 157.17 11.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.465 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 pttt -152.03 134.71 15.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 t -132.1 124.5 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.343 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.09 52.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.203 0.525 . . . . 0.0 111.27 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.34 126.83 0.85 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.824 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -63.4 121.44 13.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.435 0.636 . . . . 0.0 111.558 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -117.24 90.69 34.76 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.999 176.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 51.1 Cg_exo -21.37 -75.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.377 4.051 . . . . 0.0 115.926 -171.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.0 -34.44 24.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.72 -29.58 70.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.433 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 99' ' ' ILE . 37.9 mm -73.35 -43.69 56.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.067 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 87.4 mttt -64.26 -24.83 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.634 0.73 . . . . 0.0 109.806 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -84.09 -29.04 27.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.676 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.13 -54.35 31.27 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.98 0.419 . . . . 0.0 110.207 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.572 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.8 mm -50.89 -39.79 19.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.646 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.94 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.383 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.18 41.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' ND2' HD22 ' A' ' 77' ' ' LEU . 47.5 m-80 -96.55 -15.34 21.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.968 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.791 177.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 52' ' ' PHE . 62.4 t . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 23.4 m -90.24 131.62 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.649 0.738 . . . . 0.0 112.555 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.457 ' OE1' ' HG3' ' A' ' 54' ' ' LYS . 8.5 mm100 -69.01 137.54 53.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.939 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -83.26 170.5 14.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.798 169.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.538 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 3.7 mtpm? -122.7 -41.38 2.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -140.67 179.28 6.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.873 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -66.09 -27.84 68.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.513 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -59.45 -46.99 87.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -53.13 -44.2 67.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.369 172.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.734 ' O ' HG12 ' A' ' 15' ' ' ILE . 14.8 t80 -59.84 -60.91 3.07 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.85 -39.78 65.91 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.939 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -64.29 -44.8 90.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.4 75.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.144 0.497 . . . . 0.0 110.312 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 11' ' ' PHE . 13.6 mm -63.49 -38.13 81.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.55 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.55 6.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.449 ' HB3' ' CD ' ' A' ' 19' ' ' LYS . 25.4 mt-30 -83.69 141.95 31.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.539 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 32.23 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 111.966 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.75 178.98 6.7 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -74.58 122.32 22.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.5 t -101.15 111.2 30.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -93.54 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 176.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.637 HG12 ' CE2' ' A' ' 11' ' ' PHE . 57.1 t -103.54 123.78 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.86 0.838 . . . . 0.0 111.188 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.649 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -95.98 96.63 9.02 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.215 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -99.29 130.63 45.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.8 p90 -157.49 -171.77 3.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.908 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -142.1 139.29 32.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -15.25 62.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -87.58 -12.74 44.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.014 0.435 . . . . 0.0 110.619 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.0 t -83.24 149.91 26.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.025 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.71 -67.89 1.58 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.791 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 41.7 Cg_endo -69.21 12.8 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.099 2.533 . . . . 0.0 114.356 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 26.5 p -63.94 -32.71 74.34 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.087 0.946 . . . . 0.0 109.879 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.652 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 44.2 mtmt -69.16 -8.86 49.43 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.009 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.45 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.31 -33.11 49.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -76.22 -24.55 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.814 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.584 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -55.77 -65.37 1.54 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.587 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.2 Cg_endo -82.91 -35.62 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.606 1.537 . . . . 0.0 113.238 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.51 ' HE3' ' HA ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.41 -40.16 95.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.623 0.725 . . . . 0.0 109.936 -175.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.12 -38.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.754 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 44.5 mt-10 -65.28 -29.57 70.35 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.525 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 13.1 mmmm -66.92 -40.2 87.57 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.444 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.0 m-30 -52.51 -62.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.781 0.324 . . . . 0.0 111.207 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.8 p -77.16 -13.29 59.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.731 0.301 . . . . 0.0 111.368 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.7 -39.68 85.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -81.84 -42.67 19.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.044 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.5 p90 -130.0 89.82 44.42 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 111.927 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.39 0.74 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.189 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -64.96 -12.11 46.14 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.207 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.32 147.13 26.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.903 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.509 ' HB2' HG23 ' A' ' 2' ' ' VAL . 2.3 p90 -91.51 116.09 28.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.142 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 3' ' ' THR . 94.9 m-85 -141.19 155.17 46.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HG3' ' OE1' ' A' ' 4' ' ' GLN . 19.3 ptmt -149.29 151.86 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.871 -172.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD23 ' HB2' ' A' ' 60' ' ' LEU . 10.1 tt -159.55 148.34 17.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.746 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.6 p-10 -101.65 120.75 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.221 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG11 ' CE ' ' A' ' 72' ' ' MET . 3.6 p -67.13 -16.75 21.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.611 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.85 -49.14 63.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.291 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -90.77 -42.98 10.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.819 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -105.33 73.65 1.05 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.548 0.689 . . . . 0.0 111.866 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -69.61 -43.64 67.29 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.135 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 3.7 p30 -67.63 -20.9 65.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 0.0 110.797 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 HD22 ' A' ' 67' ' ' ASN . 96.1 t -69.75 -51.98 35.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 69' ' ' VAL . . . -51.31 -40.44 59.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.343 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.2 pt20 -68.31 -36.12 78.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.088 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.26 -28.67 68.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.777 176.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.587 ' HB2' HG13 ' A' ' 69' ' ' VAL . 39.7 m-20 -102.77 -13.12 17.16 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.281 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 5.4 tp10 80.08 19.88 0.59 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.467 1.104 . . . . 0.0 111.067 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -95.09 119.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.187 0.518 . . . . 0.0 109.757 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -134.45 8.21 3.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.402 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.53 153.69 38.88 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.462 ' CE ' HG11 ' A' ' 57' ' ' VAL . 2.2 mpt? -129.8 130.68 23.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.915 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HB2' HG12 ' A' ' 36' ' ' ILE . 60.2 Cg_endo -86.14 165.76 51.87 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.247 -1.564 . . . . 0.0 112.377 -5.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.1 m -141.56 128.91 21.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.508 0.671 . . . . 0.0 111.09 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.457 HD23 HG23 ' A' ' 95' ' ' ILE . 4.1 mp -97.68 123.51 41.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.044 173.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.9 mt -115.9 113.79 23.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.317 0.58 . . . . 0.0 110.742 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.495 HD22 ' HB2' ' A' ' 85' ' ' ALA . 2.1 mp -99.24 127.53 45.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.04 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE1' HD22 ' A' ' 76' ' ' LEU . 48.8 m-85 -128.08 159.14 36.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.546 0.212 . . . . 0.0 111.219 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -143.81 135.8 26.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p30 49.54 41.57 21.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.183 0.993 . . . . 0.0 113.319 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.457 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 83.39 1.49 90.29 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.576 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -122.67 161.09 24.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.5 tt0 -68.88 179.61 1.76 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 118.404 0.547 . . . . 0.0 109.77 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -149.11 -28.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.497 162.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.495 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -163.95 152.64 13.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.098 0.475 . . . . 0.0 111.61 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -142.92 120.11 11.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.311 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.6 128.6 63.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.831 0.348 . . . . 0.0 110.978 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -99.8 52.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.126 0.488 . . . . 0.0 110.957 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.57 124.86 0.89 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.291 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -65.62 102.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.925 0.49 . . . . 0.0 112.131 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.43 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.0 89.52 34.64 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.176 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 29.5 Cg_exo -32.82 -66.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.326 3.351 . . . . 0.0 115.378 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.47 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.29 68.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.67 0.271 . . . . 0.0 111.69 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.531 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.3 mm -87.66 -33.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.083 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -61.55 -32.27 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.457 0.646 . . . . 0.0 109.512 170.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -71.59 -32.84 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.17 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.3 -52.27 48.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.123 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -53.36 -36.9 27.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -30.98 60.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.098 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.86 -37.41 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.499 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -86.83 -20.15 27.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.267 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.086 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 52' ' ' PHE . 83.4 t . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.464 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.5 m -74.14 144.8 44.73 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -170.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 55' ' ' LEU . 20.9 tp60 -101.16 122.71 44.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.657 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.643 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.2 m-85 -84.46 160.13 20.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.652 173.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -135.44 -1.76 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 166.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.0 p -140.46 159.82 41.35 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -72.97 -28.72 62.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.37 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.62 -42.87 93.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -54.67 -44.2 73.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.716 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.643 ' O ' HG12 ' A' ' 15' ' ' ILE . 18.5 t80 -57.53 -60.68 3.3 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -55.12 -40.62 70.72 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.708 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.8 t -58.77 -45.49 89.66 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.944 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.72 76.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.5 mm -65.97 -36.09 76.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.553 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 12.73 0.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -88.11 150.84 23.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.681 0.277 . . . . 0.0 110.585 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.52 36.9 0.49 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 110.766 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 79' ' ' LYS . 19.6 ptpt -137.3 177.49 7.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' A' ' 102' ' ' ASN . 2.2 tm? -82.38 118.49 23.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.0 t -102.78 119.99 51.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.832 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 31.2 t -107.13 106.79 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.595 HG13 ' CE2' ' A' ' 11' ' ' PHE . 11.9 t -101.76 123.79 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.94 0.876 . . . . 0.0 110.643 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -95.39 97.61 9.95 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.106 -174.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.63 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.2 m-85 -102.57 126.67 49.71 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.552 0.692 . . . . 0.0 111.866 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.63 174.85 12.97 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . . . -125.64 124.5 41.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.57 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -19.48 65.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.106 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -90.76 -6.98 53.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 54.1 t -93.29 152.42 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.559 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.21 -72.01 0.74 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.668 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 59.8 Cg_endo -76.39 31.58 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.904 2.402 . . . . 0.0 114.512 -172.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.19 -34.74 75.4 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.914 0.864 . . . . 0.0 110.114 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -68.1 -7.28 28.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.984 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.521 ' CG ' ' HB1' ' A' ' 90' ' ' ALA . 17.0 tpt -75.89 -35.2 59.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 109.067 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.645 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -80.19 -25.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.017 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -52.79 -63.04 2.58 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.764 176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 95.7 Cg_endo -82.23 -34.98 0.38 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.035 1.156 . . . . 0.0 113.652 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.459 ' HE3' ' CB ' ' A' ' 90' ' ' ALA . 3.2 tmm? -65.03 -37.89 89.07 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.187 0.518 . . . . 0.0 110.017 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -78.98 -36.26 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.798 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -63.94 -26.16 68.46 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.936 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 94.2 mttt -80.03 -34.92 37.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.5 p90 -55.51 -48.56 74.44 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.229 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 79.0 p -85.37 -14.4 46.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.51 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.42 -38.69 69.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.579 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -90.61 -37.93 13.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.399 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.582 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 12.3 p90 -132.72 90.7 31.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.683 . . . . 0.0 112.835 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.23 0.08 6.53 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.728 2.286 . . . . 0.0 112.645 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -14.88 62.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.977 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.7 154.83 18.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.54 127.79 37.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.874 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.506 ' HB2' HG23 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -100.78 116.11 31.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.233 -173.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.1 m-85 -138.23 150.94 47.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.655 0.264 . . . . 0.0 111.353 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 33.6 mtmt -134.38 158.5 43.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.755 0.822 . . . . 0.0 110.233 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.63 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.3 tt -160.43 141.61 12.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 110.79 170.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.85 117.24 29.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG23 ' HE1' ' A' ' 72' ' ' MET . 1.9 m -65.87 -19.08 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.491 0.663 . . . . 0.0 109.672 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.83 -38.31 78.4 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.059 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -96.38 -38.79 9.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.806 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.7 mm? -121.1 76.11 1.2 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.095 0.474 . . . . 0.0 111.682 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.5 78.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.259 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.25 -35.54 80.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.156 0.503 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 62.1 t -64.59 -48.71 83.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.23 -39.49 60.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.195 0.522 . . . . 0.0 110.773 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -74.86 -29.3 60.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.522 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.585 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -62.37 -27.49 69.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.052 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.585 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 30.1 m-20 -104.38 -13.1 16.22 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.315 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 39.7 mt-10 80.63 31.23 0.18 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.532 1.145 . . . . 0.0 111.045 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -107.94 107.71 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.552 . . . . 0.0 110.113 170.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 m -115.31 -10.59 12.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.758 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.46 142.33 36.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.487 ' HE1' HG23 ' A' ' 57' ' ' VAL . 2.0 mpt? -130.87 140.99 40.35 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.74 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 36' ' ' ILE . 58.9 Cg_endo -81.1 163.75 78.96 Favored 'Cis proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.858 -1.726 . . . . 0.0 113.305 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.6 m -148.78 138.22 21.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.043 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD23 ' HE1' ' A' ' 39' ' ' MET . 4.2 mp -106.56 130.28 54.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.305 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.654 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -120.41 114.07 21.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.016 0.436 . . . . 0.0 110.39 175.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.634 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -97.0 133.35 41.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.654 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.0 m-85 -130.31 152.85 49.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.8 tppp? -127.08 110.11 12.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.404 168.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.9 t30 57.44 56.46 5.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 111.788 167.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 72.86 12.27 78.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.731 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -131.42 159.23 38.63 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 178.22 4.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.48 -32.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 164.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.418 ' HB2' HD23 ' A' ' 77' ' ' LEU . . . -167.98 154.54 7.71 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.508 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.99 134.15 19.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.174 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.79 122.12 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.173 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.39 55.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.134 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.78 135.42 2.0 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.645 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -67.76 122.6 18.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.091 0.472 . . . . 0.0 111.523 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -117.73 90.29 35.59 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 29.2 Cg_exo -21.03 -78.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.639 4.226 . . . . 0.0 116.102 -169.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.78 -31.64 25.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . . . -63.53 -32.01 73.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.69 0.281 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.549 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.6 mm -71.35 -43.73 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.175 175.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 27.1 mmtp -61.8 -35.16 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -69.25 -37.51 77.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.459 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.6 -61.18 2.8 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -48.3 -35.3 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.956 0.785 . . . . 0.0 110.756 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.25 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.977 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -31.96 17.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 110.287 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.634 ' ND2' HD22 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -91.67 -13.75 31.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.728 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.86 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.8 t . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.601 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 6.8 m -70.52 145.4 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.6 mm-40 -87.39 139.08 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.534 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.649 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.0 m-85 -102.52 148.08 25.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -129.54 1.41 5.01 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.663 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 24.0 p -142.13 156.59 45.37 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.991 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.971 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -58.32 -41.95 85.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.663 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.649 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mt-10 -56.15 -48.29 76.56 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.279 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.727 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.1 t80 -55.07 -57.98 9.52 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.12 -33.26 68.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.488 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -65.13 -49.73 68.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.54 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.72 75.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 11' ' ' PHE . 15.6 mm -62.94 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.827 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 13.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.532 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -89.52 147.08 24.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.848 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.58 52.44 1.88 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.251 0.548 . . . . 0.0 112.145 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 51' ' ' ASP . 18.8 ptpt -154.86 178.49 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.0 tm? -76.59 118.86 19.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -102.78 124.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.806 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 17.2 t -113.74 111.13 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 11' ' ' PHE . 11.6 t -108.29 129.08 63.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.827 0.822 . . . . 0.0 110.95 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.668 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -97.04 101.11 12.62 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.905 -175.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE2' HD21 ' A' ' 55' ' ' LEU . 2.7 m-85 -108.48 115.65 30.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.332 0.587 . . . . 0.0 111.673 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 37.5 p90 -139.98 175.33 9.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.801 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.8 131.39 53.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.705 0.288 . . . . 0.0 110.572 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -26.99 69.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.419 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -81.34 -8.83 59.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.416 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.7 t -87.71 159.02 18.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.859 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.66 -67.2 1.46 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.344 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 39.8 Cg_endo -68.11 10.92 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.247 2.632 . . . . 0.0 114.219 -175.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.2 p -61.88 -34.52 76.16 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 21.8 ptmt -67.71 -8.62 36.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.666 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 21.2 ttt -82.55 -27.3 31.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.702 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -77.23 -25.16 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.064 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.83 -64.6 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.848 173.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.8 Cg_endo -82.95 -30.47 0.94 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 120.765 1.309 . . . . 0.0 114.411 -175.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.401 ' HE2' HD21 ' A' ' 75' ' ' LEU . 3.6 tmm? -70.45 -33.94 71.87 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.455 0.645 . . . . 0.0 109.767 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -83.63 -34.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.932 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 37.7 mt-10 -65.64 -21.6 66.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.274 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 55.1 tttm -79.87 -36.0 37.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.886 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.4 p90 -58.87 -46.36 87.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.183 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.3 p -85.26 -14.67 45.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.476 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 6.8 tp10 -60.67 -31.67 70.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.35 -50.1 9.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.723 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.583 ' O ' ' HD1' ' A' ' 47' ' ' TYR . 3.9 p90 -134.79 92.8 18.68 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.732 0.777 . . . . 0.0 112.923 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.9 -0.26 5.97 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.198 1.932 . . . . 0.0 112.338 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -67.11 -16.87 64.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.774 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.92 152.01 20.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -91.53 140.1 30.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.337 -175.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -113.21 115.18 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.947 -172.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.601 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -139.03 147.85 42.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.626 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.514 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 21.4 pttm -145.52 153.58 41.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.833 -174.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.637 HD21 ' CE2' ' A' ' 25' ' ' PHE . 8.0 tt -159.78 146.84 16.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.78 0.324 . . . . 0.0 110.687 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.2 m-20 -92.84 121.91 34.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.46 HG22 ' CE ' ' A' ' 72' ' ' MET . 1.3 m -68.31 -16.6 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.248 0.547 . . . . 0.0 110.04 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.79 -39.55 91.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -79.21 -41.96 27.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 60.7 mt -136.96 83.58 2.01 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.449 0.642 . . . . 0.0 111.865 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -72.55 -38.04 57.84 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.499 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.13 -27.21 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.395 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 91.1 t -67.47 -55.8 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.573 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -49.86 -41.15 44.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 111.14 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -69.2 -31.48 70.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.264 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 8.0 tptt -63.94 -25.78 68.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.31 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.59 ' HB2' HG13 ' A' ' 69' ' ' VAL . 14.8 m-20 -102.97 -12.91 17.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 17.9 tp10 80.78 28.36 0.21 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.505 1.128 . . . . 0.0 110.645 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -106.58 116.41 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.248 0.546 . . . . 0.0 110.011 170.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -117.47 -30.94 5.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.22 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.46 13.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.173 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.46 ' CE ' HG22 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -150.0 143.5 16.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 111.016 -179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.581 ' CG ' HD12 ' A' ' 36' ' ' ILE . 58.5 Cg_endo -80.04 149.74 80.84 Favored 'Cis proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.445 -1.898 . . . . 0.0 113.036 -3.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -130.48 138.35 50.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.218 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 39' ' ' MET . 4.1 mp -108.98 130.5 55.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.515 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.546 HD21 ' CE2' ' A' ' 78' ' ' PHE . 3.1 mt -119.6 116.13 25.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.188 0.518 . . . . 0.0 110.825 176.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -99.08 128.33 45.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.915 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.546 ' CE2' HD21 ' A' ' 76' ' ' LEU . 62.3 m-85 -131.13 155.9 46.19 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.941 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.545 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 40.3 ttmt -134.97 125.47 26.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.545 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.4 p-10 43.67 56.47 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 78.27 -1.66 69.5 Favored Glycine 0 CA--C 1.51 -0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.653 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -118.94 160.09 22.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HA ' ' CD1' ' A' ' 78' ' ' PHE . 28.6 tt0 -72.94 179.12 3.87 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -153.25 -32.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.657 163.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.42 157.37 7.31 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.893 0.377 . . . . 0.0 111.954 177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 132.07 15.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.339 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 95' ' ' ILE . 55.2 t -133.27 132.32 58.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.308 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.67 50.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.075 0.464 . . . . 0.0 111.574 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.49 134.88 1.82 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.666 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -65.18 112.85 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.275 0.56 . . . . 0.0 111.421 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.97 90.2 32.11 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.426 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 32.8 Cg_exo -28.79 -68.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.933 3.755 . . . . 0.0 115.147 -170.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.21 -40.07 18.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -64.78 -30.44 71.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.406 HD13 HG11 ' A' ' 87' ' ' VAL . 25.9 mm -74.59 -51.49 22.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.999 0.428 . . . . 0.0 110.226 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 9.9 mtmp? -64.36 -23.3 67.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -82.98 -25.83 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.47 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.73 12.53 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.531 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 11.6 mt -50.36 -43.61 22.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.551 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.8 74.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.004 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.384 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -82.77 -17.66 43.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.373 176.165 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.5 t . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -72.23 144.16 48.56 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -90.65 135.85 33.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.656 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 7.6 m-85 -82.64 170.02 15.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.359 0.6 . . . . 0.0 110.773 172.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 36.8 mttp -129.71 -27.16 2.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.21 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 26.2 p -147.48 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -69.95 -26.42 64.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.93 -43.11 99.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.673 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.8 mm-40 -52.74 -45.56 67.06 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.673 ' O ' HG12 ' A' ' 15' ' ' ILE . 20.5 t80 -60.08 -62.48 1.84 Allowed 'General case' 0 N--CA 1.458 -0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.055 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.32 -37.35 74.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.112 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -61.34 -45.95 92.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.691 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.09 82.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 110.21 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 11' ' ' PHE . 10.5 mm -64.16 -37.08 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.627 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 1.79 4.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.382 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 26.2 mt-30 -78.31 136.9 37.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.983 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 26.3 t0 -81.61 46.55 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.995 0.902 . . . . 0.0 110.285 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 19.8 ptpt -131.38 179.43 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.312 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 99' ' ' ILE . 1.9 tm? -83.43 113.95 21.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 3.5 t -104.51 121.33 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.88 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.7 t -108.8 114.95 48.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 11' ' ' PHE . 21.9 t -107.68 129.25 62.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -98.23 100.96 12.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.663 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CE2' HD21 ' A' ' 55' ' ' LEU . 2.2 m-85 -103.66 120.86 41.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.499 0.666 . . . . 0.0 111.585 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 39.6 p90 -152.23 161.24 42.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.769 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -113.5 133.55 55.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.664 0.268 . . . . 0.0 110.34 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.5 p -65.96 -21.54 66.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.418 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -77.83 -18.28 56.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.053 0.454 . . . . 0.0 110.387 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 48.1 t -82.38 147.06 29.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 -177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.58 -64.08 2.34 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.331 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 43.8 Cg_endo -68.06 10.5 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.284 2.656 . . . . 0.0 114.743 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 27.6 p -66.28 -24.79 66.62 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.833 0.825 . . . . 0.0 110.033 177.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.9 mttp -61.96 -20.64 64.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.94 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.451 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -68.16 -37.89 81.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 109.488 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 0.8 OUTLIER -74.36 -25.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.06 -65.87 0.98 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.145 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.6 Cg_endo -83.26 -31.73 0.61 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 CA-C-N 121.066 1.416 . . . . 0.0 114.298 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.46 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.4 tmm? -67.96 -34.75 77.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.499 0.666 . . . . 0.0 109.68 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -82.18 -37.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.28 -179.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 2' ' ' VAL . 36.3 mt-10 -64.56 -23.25 67.2 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.666 171.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -77.93 -36.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.995 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -58.61 -41.85 86.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.995 -179.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.18 -16.92 41.69 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.961 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.52 -27.24 68.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.02 -47.45 8.11 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.306 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.594 ' OH ' ' HB ' ' A' ' 99' ' ' ILE . 8.0 p90 -137.48 93.15 12.87 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 121.645 0.736 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.66 2.52 3.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.235 1.956 . . . . 0.0 111.662 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.04 -23.27 67.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.171 179.042 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.13 154.52 18.36 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.9 123.68 34.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.225 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.7 p90 -96.05 116.35 28.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 99.2 m-85 -139.75 151.7 46.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.321 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . 63.9 pttt -149.13 161.88 41.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 -175.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD21 ' CE2' ' A' ' 25' ' ' PHE . 7.9 tt -159.23 145.3 16.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.227 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t0 -90.98 116.47 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.077 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.48 -23.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -68.03 -34.37 76.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.342 0.591 . . . . 0.0 109.739 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -78.89 -42.01 28.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.056 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 91.1 mt -136.3 78.48 1.71 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.537 0.684 . . . . 0.0 111.971 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -69.03 -32.69 73.34 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.455 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.44 -36.9 81.68 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.085 0.469 . . . . 0.0 110.984 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 HD22 ' A' ' 67' ' ' ASN . 93.0 t -64.19 -49.01 83.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.892 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' VAL . . . -52.06 -38.27 56.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 25.3 mt-30 -70.5 -34.21 72.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.415 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 2.7 tptp -61.76 -25.86 67.72 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.188 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.587 ' HB2' HG13 ' A' ' 69' ' ' VAL . 17.1 m-20 -106.94 -13.05 15.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.272 -0.267 . . . . 0.0 111.627 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 13.3 tp10 79.82 31.26 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.378 1.049 . . . . 0.0 110.906 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.16 114.98 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.135 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.6 t -120.3 -19.12 7.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.891 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.64 156.58 16.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.731 0.301 . . . . 0.0 110.756 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -126.66 127.95 24.39 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.418 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HB2' HG12 ' A' ' 36' ' ' ILE . 17.8 Cg_endo -89.26 164.4 37.8 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.605 -0.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.3 m -141.47 131.8 25.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.604 . . . . 0.0 111.302 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.8 mp -102.34 135.78 43.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.474 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.7 HD22 ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -125.17 113.43 17.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.271 0.558 . . . . 0.0 110.58 172.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 85' ' ' ALA . 3.8 mp -93.95 130.05 40.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.7 ' CE2' HD22 ' A' ' 76' ' ' LEU . 43.4 m-85 -128.64 154.86 45.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.745 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 58.2 tttm -134.05 125.58 28.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.21 166.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 3.7 p-10 46.58 49.05 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.343 1.057 . . . . 0.0 113.553 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 81.53 -1.78 84.62 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.837 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HE2' HD22 ' A' ' 80' ' ' ASN . 37.8 mtmt -115.11 160.12 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -71.82 179.76 3.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.86 -32.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.478 163.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -171.67 140.58 1.35 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.05 136.17 41.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.81 123.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 m -88.34 58.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.12 137.42 2.2 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.969 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -68.46 118.76 11.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.04 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.03 89.93 31.52 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 89.8 Cg_exo -22.67 -80.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 1 C-N-CA 125.449 4.1 . . . . 0.0 115.537 -169.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 92' ' ' PRO . . . -84.09 -27.94 27.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.77 78.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.085 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.35 -46.32 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.1 mttt -64.0 -23.15 67.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.855 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.53 -33.64 36.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.521 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -67.46 -52.98 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.594 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.19 -42.22 25.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.571 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.13 63.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -36.45 57.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.492 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.3 m-80 -83.76 -21.91 32.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.842 178.417 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 40' ' ' ILE . 94.0 t . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.1 m -80.02 144.29 33.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.967 -171.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.9 tp-100 -93.3 136.79 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.168 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 8.6 m-85 -83.59 170.01 14.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.715 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 42.6 mtpt -123.55 -40.6 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.527 176.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -142.48 179.95 6.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' HG11 ' A' ' 63' ' ' VAL . . . -66.46 -25.76 66.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.652 0.263 . . . . 0.0 110.393 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -58.02 -49.99 74.96 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 6' ' ' LYS . 1.6 mp0 -55.16 -41.69 72.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.692 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.655 ' CE2' HG12 ' A' ' 23' ' ' VAL . 27.0 t80 -61.17 -59.76 4.81 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.61 -35.81 75.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.547 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -61.5 -45.03 95.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -32.7 74.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 110.342 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 11' ' ' PHE . 10.1 mm -63.54 -39.26 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 5.76 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.442 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.77 140.83 39.5 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.63 38.57 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.382 0.611 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -145.22 176.29 9.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.95 122.45 22.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.2 t -100.54 111.24 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.047 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.42 103.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.655 HG12 ' CE2' ' A' ' 11' ' ' PHE . 60.1 t -104.88 119.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.867 0.842 . . . . 0.0 111.166 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -97.05 96.79 8.72 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.74 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.8 m-85 -99.99 113.69 26.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.471 0.653 . . . . 0.0 111.791 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -140.27 163.8 31.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.616 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -115.84 134.54 54.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.5 p -60.67 -26.13 66.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.671 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -78.58 -15.47 58.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.418 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 44.7 t -80.7 144.38 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.071 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.47 -67.63 1.9 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.274 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 66.0 Cg_endo -74.22 20.73 0.4 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.942 2.428 . . . . 0.0 114.321 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.0 p -68.02 -27.92 66.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.839 0.828 . . . . 0.0 109.556 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.6 pttt -68.25 -7.65 32.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.041 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.449 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -79.67 -35.91 38.48 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.647 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.2 mp -75.49 -25.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.039 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -57.31 -61.55 6.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.809 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 88.0 Cg_endo -83.41 -30.67 0.78 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.417 1.412 . . . . 0.0 114.219 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.552 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 ttp -66.15 -50.41 64.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.67 0.668 . . . . 0.0 109.199 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -65.56 -37.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.228 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 26.6 tt0 -69.02 -27.81 66.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.2 0.524 . . . . 0.0 110.057 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -74.84 -29.05 60.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.052 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.552 ' CE1' ' HG2' ' A' ' 39' ' ' MET . 18.7 m-30 -51.49 -64.0 0.95 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 110.245 175.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 60.5 p -79.27 -14.11 59.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.1 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -58.38 -35.77 72.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -83.15 -47.97 11.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.2 p90 -129.3 91.34 42.0 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.204 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.57 1.5 5.56 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.707 2.271 . . . . 0.0 111.668 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.35 -24.05 67.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.776 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.59 154.73 18.85 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.306 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.414 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -92.47 141.6 28.34 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.026 -176.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.2 p90 -111.22 115.13 28.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.99 -172.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 3' ' ' THR . 97.3 m-85 -140.59 152.0 45.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.8 pttt -149.92 159.44 44.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.571 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.0 tt -158.73 150.76 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.631 0.253 . . . . 0.0 110.41 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 19.8 t0 -93.81 115.78 28.21 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.743 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -61.95 -25.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.829 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -37.31 86.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.421 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -84.94 -42.19 15.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.6 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.7 mm? -121.95 73.39 1.08 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.387 0.613 . . . . 0.0 112.12 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.86 -24.59 73.79 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.196 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 16.2 t70 -66.1 -27.63 68.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.594 0.712 . . . . 0.0 110.523 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 18.4 t -75.24 -52.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.202 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.05 -20.78 10.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.8 pt20 -85.82 -31.92 22.04 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.573 0.702 . . . . 0.0 110.086 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -27.87 65.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.573 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.0 p30 -108.76 -8.16 15.42 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 24.6 tt0 81.04 16.82 0.53 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.057 0.848 . . . . 0.0 112.095 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.615 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -93.84 109.23 21.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.374 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -108.17 -30.4 8.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.15 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.84 162.95 17.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.266 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -151.37 145.0 17.51 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.73 0.3 . . . . 0.0 110.826 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -79.69 148.58 80.12 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.579 -1.842 . . . . 0.0 112.853 -1.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.2 m -133.68 142.98 48.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 40' ' ' ILE . 3.9 mp -112.34 125.14 53.86 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.766 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.609 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -116.91 113.56 22.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 175.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.3 mp -96.55 134.35 39.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.609 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.2 m-85 -129.43 153.16 48.21 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.597 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -134.01 119.94 19.63 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 46.63 56.7 6.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 77.7 4.43 85.13 Favored Glycine 0 CA--C 1.51 -0.232 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.495 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.4 160.73 28.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.53 179.69 2.9 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.39 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.572 164.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -165.26 155.56 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.587 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -155.5 130.6 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.38 133.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.226 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.63 47.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 0.0 111.373 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.7 130.1 1.31 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.992 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 36' ' ' ILE . . . -65.19 112.03 3.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 89.87 26.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.731 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 56.0 Cg_exo -22.49 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.357 4.038 . . . . 0.0 115.667 -171.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 -28.82 29.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.99 74.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.799 0.333 . . . . 0.0 111.222 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.477 HG22 HD23 ' A' ' 75' ' ' LEU . 45.9 mm -83.38 -32.76 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.428 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.731 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.5 mttt -57.65 -47.44 82.26 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -60.19 -32.29 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.64 61.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.2 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.475 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 4.4 mm -54.0 -41.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.047 0.451 . . . . 0.0 110.647 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -25.72 63.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.204 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.96 19.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.472 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -79.91 -16.93 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.069 -172.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.223 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.472 ' HB ' ' HD2' ' A' ' 54' ' ' LYS . 85.5 t . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.806 0.336 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.5 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.7 m -83.47 143.9 29.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.208 0.527 . . . . 0.0 112.335 -172.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.2 tp-100 -94.82 132.47 39.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.645 -175.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.647 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 13.0 m-85 -93.11 160.41 14.87 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.669 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.6 ptpp? -135.9 -4.45 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.817 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 18.8 p -141.89 157.29 45.16 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 111.368 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . . . -71.41 -29.03 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.013 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -62.92 -38.15 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.669 ' OE1' ' HG2' ' A' ' 6' ' ' LYS . 24.5 mt-10 -55.44 -44.0 75.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.441 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.671 ' CE2' HG13 ' A' ' 23' ' ' VAL . 24.1 t80 -56.21 -56.3 22.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.39 -44.16 79.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -57.38 -38.48 74.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.82 64.3 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 11' ' ' PHE . 14.3 mm -65.01 -40.53 89.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.63 13.51 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.048 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -85.49 140.21 30.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -79.38 47.39 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.432 0.634 . . . . 0.0 109.984 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HB2' ' HZ3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -154.2 178.97 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.469 177.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD1' HG21 ' A' ' 99' ' ' ILE . 1.6 tm? -75.74 123.89 26.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.076 0.465 . . . . 0.0 110.782 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -105.36 116.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.208 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.89 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.671 HG13 ' CE2' ' A' ' 11' ' ' PHE . 40.5 t -102.82 126.06 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.741 0.781 . . . . 0.0 111.351 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.621 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -105.03 97.31 7.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.762 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.4 m-85 -104.35 116.82 32.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.613 0.721 . . . . 0.0 111.953 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.603 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 p90 -135.67 173.88 11.23 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.136 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.787 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -125.41 130.74 52.47 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -63.3 -19.48 64.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -92.97 -13.07 29.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.396 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.787 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 59.8 m -75.55 159.81 30.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.312 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.32 -83.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.227 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 89.0 Cg_endo -79.37 36.02 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.094 2.529 . . . . 0.0 113.858 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 p -65.3 -36.97 85.7 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 122.04 0.924 . . . . 0.0 109.814 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.82 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 7.7 ttpm? -68.05 -11.33 58.79 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.536 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.31 70.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.552 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -74.52 -24.66 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.932 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -52.3 -67.52 0.53 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.824 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.82 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 3.9 Cg_endo -85.32 -23.86 2.19 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 121.457 1.556 . . . . 0.0 113.621 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.535 ' HG3' ' HA ' ' A' ' 92' ' ' PRO . 2.7 ttp -71.74 -44.54 63.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.35 0.595 . . . . 0.0 109.733 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -73.36 -36.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.241 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 tp10 -63.01 -29.81 71.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.525 174.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -74.4 -33.87 63.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.474 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 19.9 m-85 -57.24 -57.72 11.39 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 p -76.91 -14.22 59.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.932 0.396 . . . . 0.0 110.805 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.3 -35.14 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -84.51 -44.56 13.48 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.595 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' HH ' ' HB ' ' A' ' 99' ' ' ILE . 3.4 p90 -129.7 89.54 46.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.641 0.734 . . . . 0.0 112.042 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.2 -0.69 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.219 1.946 . . . . 0.0 112.152 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.99 -3.71 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.3 163.08 12.69 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.436 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.38 139.72 30.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.237 -177.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.4 p90 -122.96 114.58 20.62 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.551 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.5 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 96.9 m-85 -141.06 148.4 40.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 17.4 ptmt -148.48 152.58 37.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 -172.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.625 HD23 ' CE2' ' A' ' 25' ' ' PHE . 6.4 tt -160.88 149.02 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.603 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 8.1 p-10 -100.04 129.89 46.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.474 0.654 . . . . 0.0 110.831 174.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG23 ' HE1' ' A' ' 72' ' ' MET . 2.4 m -72.6 -11.79 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.081 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.6 -44.16 74.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -79.61 -41.53 26.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.969 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.9 mm? -122.42 79.1 1.58 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.696 0.76 . . . . 0.0 112.838 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.03 -38.83 34.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.001 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -68.46 -24.69 64.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.173 0.486 . . . . 0.0 110.619 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.48 -50.0 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -52.99 -39.29 62.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.867 175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -70.4 -28.59 65.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.84 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.558 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 9.6 tptt -67.38 -27.87 67.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.487 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.558 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 14.1 m-20 -104.54 -7.91 19.4 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 -170.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 32.9 tt0 80.88 17.4 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.469 1.105 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -93.29 106.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.627 0.727 . . . . 0.0 109.918 175.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 p -114.47 -18.38 11.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.832 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 147.06 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.548 ' HE1' HG23 ' A' ' 57' ' ' VAL . 1.9 mpt? -135.89 143.85 46.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.17 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 67.4 Cg_endo -80.78 153.19 82.77 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.287 -1.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -135.01 143.36 46.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.887 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -115.39 128.36 56.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.333 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.84 114.13 21.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 85' ' ' ALA . 6.5 mp -94.07 126.26 39.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.086 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.462 ' CG ' HD13 ' A' ' 15' ' ' ILE . 52.8 m-85 -125.32 151.95 45.37 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.579 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -136.96 112.99 9.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.048 0.451 . . . . 0.0 110.475 172.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.68 55.33 4.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.115 175.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 70.53 10.38 66.68 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.248 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -127.38 159.82 33.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -73.85 179.74 4.11 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -153.65 -30.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 165.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -162.01 157.95 24.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 111.557 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -147.57 121.66 9.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.416 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG22 HD12 ' A' ' 95' ' ' ILE . 21.3 t -131.04 135.34 60.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 -172.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.31 49.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.925 0.393 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.25 122.63 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.686 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -58.35 105.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.453 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.69 88.64 35.53 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.524 175.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.535 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.7 Cg_exo -35.45 -59.08 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.414 3.409 . . . . 0.0 115.411 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -50.09 8.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -31.93 71.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 75' ' ' LEU . 22.2 mm -84.52 -36.05 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.569 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 8.9 tmtt? -58.44 -38.98 78.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.73 -23.64 62.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.539 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -77.53 -58.06 3.48 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.7 -40.7 27.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.295 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -34.15 77.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -37.02 69.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 57.5 m-80 -84.73 -19.35 32.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.316 -175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.47 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 52' ' ' PHE . 87.8 t . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.939 0.4 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -76.14 138.97 41.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.98 126.45 32.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.076 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.712 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.5 m-30 -80.02 169.78 17.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.296 0.569 . . . . 0.0 110.605 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 70.6 mmtt -128.7 -38.3 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.41 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 30.7 p -134.98 178.9 6.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.443 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.44 64.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.07 -44.6 83.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.166 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.712 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 4.5 mm-40 -54.34 -50.53 67.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.307 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.632 ' O ' HG12 ' A' ' 15' ' ' ILE . 12.7 t80 -58.73 -59.33 5.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.14 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 24.5 t70 -63.19 -34.4 77.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.841 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -62.88 -42.87 99.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.62 0.248 . . . . 0.0 110.441 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.74 92.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.6 mm -58.12 -38.41 67.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.022 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.68 5.32 3.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -79.34 150.54 31.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.67 0.272 . . . . 0.0 110.465 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.39 45.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 111.068 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 30.6 pttt -156.91 -179.99 8.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.4 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.0 tm? -79.22 118.81 21.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 0.0 111.265 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -112.82 109.12 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.936 176.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -107.76 116.94 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.697 0.761 . . . . 0.0 110.039 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 11' ' ' PHE . 48.1 t -103.19 128.43 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.934 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.547 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . . . -88.22 97.73 11.18 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.895 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.739 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.71 114.43 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -178.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 17.4 p90 -140.64 -179.56 6.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.852 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.07 130.72 46.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.088 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -66.01 -19.41 65.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.118 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -86.06 -13.35 47.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.632 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 52.0 t -90.35 148.45 22.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.587 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -80.67 -62.33 2.05 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.742 -176.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.571 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.7 Cg_exo -60.24 -7.49 6.74 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.909 2.406 . . . . 0.0 113.894 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 71.5 m -63.89 -26.87 68.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.424 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 55.3 pttt -62.77 -15.96 55.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.777 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.653 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 23.9 ttt -77.46 -27.15 51.98 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.147 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.645 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -75.73 -23.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.735 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.546 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -54.46 -66.57 0.88 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.24 172.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 69.0 Cg_endo -82.52 -34.14 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 CA-C-N 121.055 1.412 . . . . 0.0 114.315 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.587 ' CE ' HG13 ' A' ' 40' ' ' ILE . 2.5 tmm? -66.54 -36.72 83.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.492 0.663 . . . . 0.0 110.085 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.9 mt -81.11 -34.05 13.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -66.31 -25.33 66.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.912 171.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -78.38 -33.59 48.75 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.689 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.634 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -59.57 -47.9 83.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.827 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 97.6 p -85.25 -15.69 42.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.973 -0.454 . . . . 0.0 110.981 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.4 -29.68 70.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -89.02 -50.17 6.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.286 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' A' ' 43' ' ' PHE . 10.1 p90 -124.71 91.27 49.71 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 0.94 5.07 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.066 1.844 . . . . 0.0 111.224 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.0 tt0 -63.02 -23.37 67.42 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.918 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 17.85 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.1 m-20 -91.07 126.7 36.23 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.803 0.811 . . . . 0.0 111.005 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.493 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -103.6 114.17 28.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.282 -172.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.3 m-85 -136.05 147.58 47.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.711 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 76.4 mttt -132.71 152.08 51.81 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.956 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.739 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.8 tt -159.24 149.73 19.43 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.827 0.346 . . . . 0.0 110.711 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.596 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 9.0 t0 -101.43 119.78 39.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.954 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 26' ' ' TYR . 7.7 p -69.74 -21.34 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.97 -37.16 83.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.214 0.53 . . . . 0.0 109.748 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.47 -42.99 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.342 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.622 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -115.02 80.49 1.42 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.13 -40.49 34.37 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.502 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.34 -24.77 65.75 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.116 0.484 . . . . 0.0 110.703 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.622 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 95.3 t -68.0 -51.44 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.361 174.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -46.67 -42.84 17.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.042 0.448 . . . . 0.0 111.579 174.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -73.73 -25.26 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.858 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 13.5 tptt -69.37 -25.04 63.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.686 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.537 ' HB2' HG13 ' A' ' 69' ' ' VAL . 12.1 m-20 -108.24 -13.72 14.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.664 -171.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.3 tp10 79.79 30.99 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.26 0.975 . . . . 0.0 110.999 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -107.47 120.2 58.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.873 -0.517 . . . . 0.0 110.491 171.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -115.72 -39.49 3.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.42 164.79 13.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.322 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.428 ' CE ' HG13 ' A' ' 57' ' ' VAL . 1.1 pmm? -146.01 151.57 45.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.915 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' CG ' HD12 ' A' ' 36' ' ' ILE . 58.7 Cg_endo -78.23 149.84 87.42 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.81 -3.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.4 m -132.27 133.64 44.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.793 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.07 124.07 47.85 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.692 HD21 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -117.57 112.36 20.46 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.427 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 2.8 mp -96.41 133.09 41.25 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.692 ' CE1' HD21 ' A' ' 76' ' ' LEU . 62.0 m-85 -128.65 157.11 42.22 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.522 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -139.42 116.26 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.3 t30 65.37 50.39 1.74 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.675 0.75 . . . . 0.0 111.239 171.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.9 5.15 64.13 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.011 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -126.91 160.37 31.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 28.3 tt0 -69.53 178.89 2.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -148.67 -32.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.892 163.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.31 138.22 1.56 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.929 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 23.0 pttm -133.31 134.95 44.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.92 173.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -131.98 122.69 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.322 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 t -91.58 62.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 110.267 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.62 125.66 0.81 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.25 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.653 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -58.27 111.57 1.25 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.211 0.529 . . . . 0.0 111.491 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.52 88.97 25.91 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -31.76 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.723 3.615 . . . . 0.0 115.427 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.13 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.63 61.87 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.507 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.0 mm -76.58 -49.24 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 19.5 mtpp -62.58 -26.08 68.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.444 0.64 . . . . 0.0 110.21 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -80.03 -33.13 39.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.564 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.12 -52.8 57.43 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.583 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.8 mm -53.23 -39.59 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.394 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 -20.42 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.249 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.26 -43.45 17.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.981 0.42 . . . . 0.0 111.047 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -80.01 -22.63 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.822 -0.608 . . . . 0.0 111.324 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 52' ' ' PHE . 54.9 t . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 120.733 0.302 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.9 m -80.82 144.78 31.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.22 0.533 . . . . 0.0 112.377 -170.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.571 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.6 tp-100 -94.16 136.21 34.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.932 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.3 m-85 -98.57 158.6 15.5 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 14.8 ptmm? -135.01 -1.54 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.832 169.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 33.8 p -138.57 159.75 41.31 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 111.15 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.219 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.155 173.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.683 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 27.3 mt-10 -54.06 -47.26 71.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.05 173.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.672 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.1 t80 -58.74 -59.03 6.06 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.958 0.409 . . . . 0.0 109.959 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.58 -35.22 72.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.549 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -63.51 -48.43 77.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.621 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.91 73.2 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.0 110.381 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.1 mm -63.39 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.065 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.33 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.81 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.54 142.9 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.06 74.54 9.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.26 0.552 . . . . 0.0 110.801 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -174.62 179.22 1.77 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.52 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.9 tm? -81.2 120.75 25.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.1 t -100.59 109.8 26.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.154 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 t -92.55 103.38 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG11 ' CE2' ' A' ' 11' ' ' PHE . 22.1 t -105.65 131.08 55.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.311 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -108.21 100.45 9.76 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.939 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.1 m-85 -103.58 115.52 30.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.514 0.673 . . . . 0.0 111.813 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 25.8 p90 -137.76 175.96 9.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.29 133.5 51.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -15.11 63.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.359 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.44 ' HD1' ' OD2' ' A' ' 58' ' ' ASP . 51.8 p-90 -89.11 -13.47 38.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 110.794 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.8 t -84.39 143.83 29.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.056 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.03 2.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.96 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 19.5 Cg_exo -68.98 15.81 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.447 2.765 . . . . 0.0 114.531 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.01 -29.28 69.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 122.02 0.914 . . . . 0.0 108.98 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -65.62 -8.83 22.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.21 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -37.26 39.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.61 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.2 mp -75.11 -25.2 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.751 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.78 -66.46 1.07 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.481 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 85.6 Cg_endo -83.23 -26.85 2.08 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 120.617 1.256 . . . . 0.0 114.226 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 2.1 ttp -69.75 -41.95 74.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.55 0.69 . . . . 0.0 109.587 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.72 -39.26 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.767 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 38.6 mt-10 -66.59 -26.69 67.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.045 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.34 -37.74 74.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.275 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.6 m-85 -52.45 -62.32 1.72 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.257 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 m -76.77 -13.76 59.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.567 0.223 . . . . 0.0 111.301 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 35.3 tt0 -60.0 -31.93 70.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.422 HE22 ' CD ' ' A' ' 96' ' ' LYS . 20.6 mt-30 -89.3 -46.69 8.57 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.07 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.2 p90 -127.35 90.13 49.63 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.26 0.552 . . . . 0.0 111.941 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.34 -0.72 9.6 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.444 2.096 . . . . 0.0 112.381 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.4 -13.5 58.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.433 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.12 151.66 21.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.99 141.44 28.62 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.668 -177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.516 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -116.25 115.38 25.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.164 -170.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 93.8 m-85 -140.69 149.1 41.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.783 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.7 pttt -149.32 157.71 43.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.665 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 7.1 tt -160.61 151.88 19.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.636 0.255 . . . . 0.0 111.344 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.7 m-20 -91.72 111.74 23.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.699 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' TYR . 3.4 p -66.4 -19.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' HD1' ' A' ' 29' ' ' TRP . 6.4 t70 -53.21 -43.81 67.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.596 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -94.28 -42.42 8.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.994 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.1 mm? -111.67 73.25 0.81 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.5 64.75 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.129 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 22.1 m-20 -65.82 -26.5 67.71 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.428 0.632 . . . . 0.0 110.555 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 84.7 t -71.52 -52.48 25.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.634 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.78 -34.71 65.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.75 0.31 . . . . 0.0 111.369 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.07 -37.85 81.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 109.441 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 8' ' ' ALA . 17.0 tptt -60.78 -22.89 64.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.964 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.558 ' HB2' HG11 ' A' ' 69' ' ' VAL . 33.9 m-20 -106.71 -13.63 15.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 34.0 tt0 79.63 27.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 124.269 0.981 . . . . 0.0 110.854 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.47 126.92 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 170.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -126.59 -40.1 1.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.307 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.25 160.67 16.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -143.02 151.46 56.01 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.878 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HB2' HG12 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -78.65 148.4 83.4 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 -1.907 . . . . 0.0 113.049 -3.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -131.21 135.89 47.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.731 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.433 HD22 ' CD1' ' A' ' 40' ' ' ILE . 4.1 mp -106.02 130.79 53.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.661 177.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.648 HD23 ' CE1' ' A' ' 78' ' ' PHE . 1.6 mt -124.58 113.69 18.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.095 0.474 . . . . 0.0 110.824 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -96.97 131.06 44.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.648 ' CE1' HD23 ' A' ' 76' ' ' LEU . 59.9 m-85 -128.26 157.1 41.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 34.5 ttpt -141.73 125.14 16.59 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.9 p30 47.08 55.5 7.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.557 1.143 . . . . 0.0 113.698 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 75.34 3.55 71.09 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.704 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.41 160.81 26.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' HG12 ' A' ' 84' ' ' VAL . 28.9 tt0 -71.0 -179.05 2.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -152.44 -29.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.707 164.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -169.32 150.79 4.37 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.635 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -145.31 126.63 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.255 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.67 133.46 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.949 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.28 59.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 122.287 1.042 . . . . 0.0 110.189 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 129.43 1.12 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.527 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 39' ' ' MET . . . -65.07 106.08 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.676 0.391 . . . . 0.0 111.957 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.68 89.54 37.74 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.788 175.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.1 Cg_exo -35.5 -61.02 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.397 3.398 . . . . 0.0 115.161 -174.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.3 14.42 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -172.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.08 71.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.648 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 99' ' ' ILE . 46.1 mm -87.24 -32.43 6.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.229 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 10.1 ttpp -60.13 -39.57 86.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 170.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.32 -28.91 67.58 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.653 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.02 -61.65 1.93 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.55 -34.96 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.712 0.632 . . . . 0.0 110.576 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.75 -21.62 54.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.949 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.82 -35.56 15.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.062 0.458 . . . . 0.0 110.56 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.619 ' ND2' HD22 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -88.07 -18.26 29.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 -176.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.662 177.082 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 52' ' ' PHE . 59.7 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.3 m -75.65 145.12 41.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.251 -170.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -94.39 138.97 31.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.2 m-85 -88.73 164.0 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.199 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.13 -14.71 2.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.758 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -147.16 174.38 11.64 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.94 -23.57 62.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 t -60.02 -47.93 83.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.555 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.538 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -53.14 -42.66 66.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.94 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.676 ' O ' HG12 ' A' ' 15' ' ' ILE . 28.2 t80 -57.35 -58.3 8.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 8.7 m-20 -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.816 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -60.24 -44.27 95.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.578 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.29 76.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.464 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 11' ' ' PHE . 9.2 mm -66.99 -39.99 84.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.56 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.17 7.52 3.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -80.73 146.35 31.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.99 40.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -142.28 176.33 9.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.897 -176.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.7 tm? -81.13 121.9 26.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 0.0 109.828 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.9 t -100.74 122.41 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.218 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.21 102.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.631 HG11 ' CE2' ' A' ' 11' ' ' PHE . 59.2 t -104.11 119.34 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.813 0.816 . . . . 0.0 111.077 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -97.49 96.75 8.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.67 -177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CE2' HD22 ' A' ' 55' ' ' LEU . 1.9 m-85 -100.35 124.79 46.28 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.408 0.623 . . . . 0.0 111.953 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 47.9 p90 -151.5 -178.46 6.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.992 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -128.81 137.53 51.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 111.047 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 p -68.9 -21.61 64.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -84.62 -6.61 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.089 0.471 . . . . 0.0 110.633 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 41.9 t -88.28 159.9 17.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.24 -61.72 1.02 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.081 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 28.1 Cg_exo -65.49 -1.38 4.67 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.647 . . . . 0.0 114.026 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 16.9 p -62.04 -28.34 69.52 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.103 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -8.31 24.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.557 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.63 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.4 ttt -84.04 -28.87 27.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.302 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -76.93 -24.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.249 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.457 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -56.54 -64.36 2.51 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.189 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 78.1 Cg_endo -82.64 -31.13 0.86 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.592 1.528 . . . . 0.0 114.427 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 1.7 ttp -68.24 -41.68 80.84 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.496 0.589 . . . . 0.0 109.679 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.72 -39.39 60.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.39 -36.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 22.5 ttmm -68.77 -29.47 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.707 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 23.0 m-85 -56.84 -59.22 5.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.2 m -77.25 -14.01 59.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.627 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 42' ' ' LYS . 40.1 tt0 -62.26 -29.51 70.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 21.4 mt-30 -89.95 -50.68 5.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.451 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.2 p90 -125.9 90.91 49.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.254 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.02 0.89 5.17 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.831 2.354 . . . . 0.0 112.361 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 5.1 tt0 -63.46 -23.67 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.936 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.68 154.65 18.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.436 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -91.53 126.07 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.64 -173.63 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 2' ' ' VAL . 2.7 p90 -96.57 115.76 27.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.252 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.532 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.7 m-85 -141.53 149.46 40.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.723 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB2' ' A' ' 24' ' ' ALA . 20.8 pttp -148.79 158.82 44.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.64 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.65 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.4 tt -159.16 150.06 19.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 110.294 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.8 t0 -98.74 120.08 38.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.758 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG23 ' HE2' ' A' ' 72' ' ' MET . 3.1 m -66.54 -20.6 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.453 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.75 -37.79 82.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.392 0.615 . . . . 0.0 109.521 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -42.89 24.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.674 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 93.7 mt -131.07 75.26 1.65 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.586 0.708 . . . . 0.0 112.17 -175.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -70.25 -29.05 70.61 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.792 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.3 -29.33 70.07 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.535 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 22.0 t -69.57 -51.06 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.612 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.09 -20.11 9.04 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.569 0.543 . . . . 0.0 112.307 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 77.6 mm-40 -85.35 -33.75 21.97 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 0.0 110.822 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 11.1 tptt -68.31 -36.2 78.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 110.644 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.3 p30 -96.48 -13.23 23.22 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.7 mt-10 78.69 17.86 0.99 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.927 174.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.38 108.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 109.462 172.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -109.59 -19.65 13.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.002 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.97 149.52 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.514 ' HE2' HG23 ' A' ' 57' ' ' VAL . 1.9 mpt? -133.61 133.88 23.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.116 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HB2' HG12 ' A' ' 36' ' ' ILE . 73.3 Cg_endo -82.33 153.97 76.63 Favored 'Cis proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.301 -1.541 . . . . 0.0 113.802 -0.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -137.45 142.44 41.59 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.183 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mp -109.8 126.05 53.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.693 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -117.01 113.72 22.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.052 0.453 . . . . 0.0 111.039 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -96.84 134.96 39.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.282 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CE1' HD21 ' A' ' 76' ' ' LEU . 49.8 m-85 -132.04 151.08 51.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.677 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 15.9 mtpp -128.18 108.0 10.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.986 0.179 . . . . 0.0 110.743 170.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 58.2 53.8 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.682 0.753 . . . . 0.0 111.852 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 84.77 -6.0 79.9 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.832 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 64.7 pttt -121.45 160.74 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.7 tt0 -67.98 179.45 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -152.15 -29.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.635 163.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -160.23 155.26 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.085 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HB3' ' HZ3' ' A' ' 86' ' ' LYS . 7.7 ttpm? -155.17 113.69 3.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.669 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.65 135.25 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.629 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.2 m -102.12 43.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.29 123.91 0.88 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.323 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.63 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -57.77 104.45 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.48 89.2 26.46 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.713 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.5 Cg_exo -31.23 -76.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.474 3.449 . . . . 0.0 115.079 -172.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.92 -41.08 68.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.12 -29.91 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.455 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.7 mm -87.55 -31.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.808 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 64.6 mttm -54.6 -44.37 72.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -65.42 -32.87 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.883 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.17 -57.82 6.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.4 mm -54.03 -35.12 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.679 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.81 -29.74 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.273 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.64 -40.89 61.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 111.011 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.677 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 46.0 m-80 -82.98 -16.28 47.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.029 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.548 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 52' ' ' PHE . 88.3 t . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.2 m -72.36 144.8 48.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.186 -170.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -97.3 125.07 41.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.809 -174.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.4 m-85 -75.15 170.44 16.04 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HG2' ' HG2' ' A' ' 10' ' ' GLU . 59.9 pttt -133.93 -21.62 1.89 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.288 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 178.8 9.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.365 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' N ' HG21 ' A' ' 63' ' ' VAL . . . -70.23 -29.08 65.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.792 0.329 . . . . 0.0 110.781 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -54.56 -48.12 72.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.839 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 6.0 mp0 -55.38 -46.85 76.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.55 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.68 ' O ' HG12 ' A' ' 15' ' ' ILE . 30.9 t80 -56.45 -59.51 4.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.811 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.0 -36.78 77.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.663 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.6 m -61.79 -45.7 92.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.655 0.264 . . . . 0.0 110.991 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -34.12 77.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.877 0.37 . . . . 0.0 110.322 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.5 mm -65.94 -40.51 87.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.312 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.41 2.16 14.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.481 -173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.446 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 9.9 tt0 -76.51 144.49 39.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.882 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 57.2 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 8.8 ptmm? -168.73 176.53 5.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.005 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.15 115.18 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.213 0.53 . . . . 0.0 110.895 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.4 t -101.22 135.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.982 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.59 115.97 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.524 HG13 ' CE2' ' A' ' 11' ' ' PHE . 33.6 t -107.52 131.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.577 0.703 . . . . 0.0 110.9 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HG2' ' A' ' 54' ' ' LYS . . . -102.88 96.6 6.94 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.469 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' HE2' ' A' ' 11' ' ' PHE . 26.7 m-85 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.667 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.643 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.9 p90 -163.24 179.17 7.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.727 169.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.61 128.74 46.05 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 p -65.05 -18.67 65.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -88.96 -10.59 47.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.417 . . . . 0.0 110.713 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 49.7 t -97.64 148.88 22.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.831 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.22 2.86 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.411 -0.66 . . . . 0.0 114.655 -173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.3 Cg_exo -59.49 -2.56 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.17 2.58 . . . . 0.0 114.044 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -63.19 -24.44 67.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.27 0.557 . . . . 0.0 110.929 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 57.0 mtpt -65.63 -9.36 26.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.765 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.415 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.03 -35.49 49.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 109.354 176.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.656 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 0.8 OUTLIER -75.29 -25.82 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.408 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.13 -66.2 0.88 Allowed Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.923 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 76.4 Cg_endo -83.44 -32.72 0.45 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.319 1.346 . . . . 0.0 114.479 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.529 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.5 tmm? -69.86 -38.08 76.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.412 0.625 . . . . 0.0 109.85 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.6 mt -79.84 -33.64 14.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.804 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 41.1 tt0 -67.87 -23.23 65.11 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.156 172.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 49.4 tptt -78.64 -37.27 42.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.584 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.1 p90 -59.05 -49.63 77.14 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.572 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 94.1 p -85.13 -14.5 46.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.673 -175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 5.5 tp10 -59.59 -33.69 71.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.02 -47.62 8.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.419 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.5 ' HH ' ' HB ' ' A' ' 99' ' ' ILE . 9.4 p90 -126.69 90.89 48.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.469 0.652 . . . . 0.0 112.489 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.05 -0.34 8.94 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.357 2.038 . . . . 0.0 112.182 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 1.1 pp0? -66.02 -9.37 29.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.225 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.47 155.58 17.98 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.526 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 5.8 m-20 -91.08 120.55 32.13 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.719 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.2 p90 -100.66 115.27 29.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.979 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.492 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 95.9 m-85 -139.92 141.46 36.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.088 0.471 . . . . 0.0 111.324 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' HB1' ' A' ' 24' ' ' ALA . 76.2 mttt -122.21 155.05 36.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.006 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 55' ' ' LEU . 8.4 tt -159.5 142.04 13.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.23 130.79 52.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.308 0.575 . . . . 0.0 111.196 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.9 m -69.42 -16.11 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.256 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.35 -41.56 84.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.216 0.532 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.46 -42.72 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.899 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -121.4 77.71 1.36 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.165 0.507 . . . . 0.0 112.282 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.28 -38.06 35.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.327 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.05 -32.58 74.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 110.295 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.566 HG12 HD22 ' A' ' 67' ' ' ASN . 86.5 t -64.53 -52.16 58.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.119 176.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' HG12 ' A' ' 69' ' ' VAL . . . -50.48 -38.84 46.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.024 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.68 -33.5 71.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.656 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.4 tptt -62.04 -28.45 69.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 175.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.566 HD22 HG12 ' A' ' 63' ' ' VAL . 17.7 m-20 -100.55 -12.53 19.19 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.004 -169.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.4 tp10 79.82 26.42 0.36 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.298 0.999 . . . . 0.0 110.225 -177.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 25' ' ' PHE . 1.2 p -106.61 118.23 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.425 0.631 . . . . 0.0 111.412 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.5 m -131.25 11.92 5.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.426 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.94 30.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.514 ' CE ' HG21 ' A' ' 57' ' ' VAL . 14.8 mmt -127.19 117.98 21.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.583 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 17.7 Cg_endo -89.52 175.21 22.44 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.561 -1.016 . . . . 0.0 111.702 -4.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.559 HG21 ' N ' ' A' ' 75' ' ' LEU . 48.0 m -147.55 146.48 29.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.559 ' N ' HG21 ' A' ' 74' ' ' THR . 4.5 mp -120.88 139.64 52.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 2.3 mt -125.77 120.33 30.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 3.5 mp -97.96 129.26 44.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CG ' HG21 ' A' ' 15' ' ' ILE . 35.1 m-85 -128.13 146.66 50.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -121.52 110.9 16.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.329 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p30 46.1 56.35 6.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.1 6.28 89.24 Favored Glycine 0 CA--C 1.511 -0.211 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.646 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.93 153.61 42.42 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 178.35 2.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.23 -32.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.437 164.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -161.98 150.97 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -145.11 129.2 17.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.55 126.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.638 0.256 . . . . 0.0 110.525 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -96.21 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.32 0.581 . . . . 0.0 111.177 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.64 140.15 2.8 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.571 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -70.08 108.88 4.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.057 0.456 . . . . 0.0 110.896 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.23 89.04 29.71 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.261 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -28.92 -72.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.829 3.686 . . . . 0.0 115.321 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -43.34 56.86 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.667 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.21 72.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.434 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.9 mm -74.78 -49.64 28.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.999 0.428 . . . . 0.0 110.211 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 18.1 mtpp -67.18 -24.2 65.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.387 0.613 . . . . 0.0 110.63 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.92 -31.97 51.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.099 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.49 -54.3 30.28 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.212 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.5 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.0 mm -53.56 -36.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.14 60.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.227 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.61 -40.46 20.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.453 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' ND2' HD22 ' A' ' 77' ' ' LEU . 45.9 m-80 -83.51 -11.63 57.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.278 -175.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.699 177.26 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 40' ' ' ILE . 69.8 t . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -79.08 144.1 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.295 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.647 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.87 131.24 37.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.974 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -80.11 167.38 20.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.053 0.454 . . . . 0.0 110.847 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.45 -39.74 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -144.47 -179.94 6.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.011 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.8 67.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.902 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 t -57.81 -49.91 75.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.64 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.0 mp0 -51.17 -46.53 62.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.579 173.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.629 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.3 t80 -58.19 -58.31 9.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 -178.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.94 -36.48 84.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.732 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.5 m -65.49 -30.94 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 111.104 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.45 -35.45 58.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.091 0.472 . . . . 0.0 109.874 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.4 mm -62.72 -39.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.478 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.46 3.39 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.424 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -77.01 141.62 40.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.083 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.2 31.96 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.533 0.682 . . . . 0.0 111.254 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.18 179.36 6.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.549 175.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 84' ' ' VAL . 1.7 tm? -76.01 117.13 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.631 -174.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.5 t -103.02 119.14 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.748 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 13.9 t -106.91 112.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.537 HG13 ' CE2' ' A' ' 11' ' ' PHE . 23.8 t -106.57 122.17 60.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.807 0.813 . . . . 0.0 110.83 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB3' ' CB ' ' A' ' 54' ' ' LYS . . . -91.22 97.39 11.1 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.935 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.696 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 1.5 m-85 -96.66 124.33 40.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.697 0.761 . . . . 0.0 112.631 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -154.79 165.47 36.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.141 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -118.01 140.5 49.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.181 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 p -65.39 -19.64 66.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.663 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -80.87 -18.54 46.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.364 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 46.3 t -83.37 141.92 31.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.056 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -75.54 -55.32 5.09 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.611 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.433 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 33.4 Cg_endo -65.75 4.73 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 114.196 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.7 p -64.01 -29.85 70.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.691 0.757 . . . . 0.0 109.646 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -68.84 -9.21 50.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.403 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -35.12 39.36 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.706 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.0 -25.72 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.26 -65.74 1.16 Allowed Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.859 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 64.9 Cg_endo -83.03 -29.58 1.19 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.696 1.284 . . . . 0.0 114.092 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.483 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.7 tmm? -71.41 -33.4 69.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.596 0.712 . . . . 0.0 109.851 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -84.26 -34.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.973 -179.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 39.6 mt-10 -68.64 -20.09 64.45 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.534 171.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -76.58 -39.07 53.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.738 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.5 p90 -57.5 -47.0 83.1 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.321 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.463 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 89.7 p -84.59 -15.41 45.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.977 -0.452 . . . . 0.0 110.655 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.59 -29.15 69.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.527 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.99 -42.32 13.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.0 175.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.646 ' HH ' ' HA ' ' A' ' 96' ' ' LYS . 8.4 p90 -138.53 91.61 12.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 112.21 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.57 1.09 4.61 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.469 2.113 . . . . 0.0 111.744 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.89 -22.77 67.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.332 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.16 159.99 14.67 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.1 m-20 -91.02 125.89 35.95 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.477 0.656 . . . . 0.0 111.232 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -104.4 114.68 29.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.049 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.4 m-85 -142.49 151.14 41.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.647 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.6 pttt -149.59 159.07 44.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.36 -175.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.696 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 6.8 tt -155.71 151.96 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.907 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 29.0 t0 -95.56 113.33 24.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.809 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.44 -27.12 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.183 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -66.27 -32.5 73.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 110.166 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.44 -41.97 11.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.4 mm? -118.44 65.88 0.76 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.364 0.602 . . . . 0.0 111.555 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -67.75 -31.72 76.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.625 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.12 -22.07 63.99 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 25.2 t -72.96 -50.98 28.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.7 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.82 -21.44 4.2 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 21.5 mt-30 -86.17 -28.97 23.6 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.858 -0.527 . . . . 0.0 110.801 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -70.17 -29.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.905 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 2.3 p30 -108.58 -12.55 14.97 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.023 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.2 tp10 79.23 30.1 0.32 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.052 0.845 . . . . 0.0 111.216 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.7 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -106.48 107.69 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.366 0.603 . . . . 0.0 110.611 169.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -111.35 -35.92 5.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.32 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.2 152.49 29.13 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.7 ptp -144.49 147.32 35.99 Favored Pre-proline 0 C--N 1.321 -0.667 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.547 -174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 59.9 Cg_endo -80.65 149.6 78.23 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.599 -1.834 . . . . 0.0 112.518 -3.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.429 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 3.3 m -133.06 133.18 42.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.295 0.569 . . . . 0.0 111.109 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.461 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.2 mp -98.79 125.77 44.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.53 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' CE1' ' A' ' 78' ' ' PHE . 1.2 mt -114.27 113.74 25.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.118 0.485 . . . . 0.0 110.473 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 85' ' ' ALA . 3.1 mp -95.54 127.88 41.94 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CE1' HD23 ' A' ' 76' ' ' LEU . 61.4 m-85 -127.17 154.61 44.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.804 -0.18 . . . . 0.0 110.653 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.415 ' HG2' HD21 ' A' ' 80' ' ' ASN . 81.8 tttt -139.23 127.06 22.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 168.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.415 HD21 ' HG2' ' A' ' 79' ' ' LYS . 9.3 p30 50.22 49.24 20.88 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.494 1.117 . . . . 0.0 113.453 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 78.46 1.09 81.2 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.238 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 82' ' ' LYS . 6.5 mtpm? -118.27 160.14 22.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.19 179.69 2.74 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -151.73 -29.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 164.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -171.59 160.32 5.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.229 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 21.5 ptmt -153.18 134.22 14.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.029 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.04 120.87 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.646 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 62.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 122.209 1.004 . . . . 0.0 110.199 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.27 130.75 1.28 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.306 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -72.72 98.28 2.35 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.667 0.27 . . . . 0.0 110.87 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -116.4 88.48 23.73 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.285 -179.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.26 -58.93 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.344 3.363 . . . . 0.0 114.903 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.56 -46.51 38.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.87 -27.57 65.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.481 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' O ' HG12 ' A' ' 99' ' ' ILE . 34.3 mm -76.6 -45.2 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.646 ' HA ' ' HH ' ' A' ' 47' ' ' TYR . 72.8 tttt -60.98 -28.49 69.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.404 0.621 . . . . 0.0 110.642 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -84.35 -27.3 27.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.553 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.64 -56.65 5.97 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -51.82 -41.22 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.416 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.3 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.127 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.21 60.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -80.79 -21.22 41.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.386 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.073 179.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 52' ' ' PHE . 91.2 t . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.591 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 14.9 m -71.03 144.35 50.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.68 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -91.51 119.57 31.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.136 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 2.2 m-30 -76.09 167.48 21.79 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.496 173.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -129.61 -40.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -142.77 179.55 6.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.558 0.218 . . . . 0.0 111.405 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . . . -65.99 -29.81 70.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.623 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -58.13 -46.02 86.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -54.45 -43.63 71.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 172.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 15' ' ' ILE . 26.9 t80 -58.28 -58.72 7.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 110.495 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.597 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 47.9 m-20 -60.0 -33.91 72.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.027 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.1 m -63.48 -41.72 98.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.689 0.281 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.08 -36.73 82.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.014 0.435 . . . . 0.0 110.154 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.3 mm -63.6 -39.71 86.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.662 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.21 12.84 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.44 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -87.72 146.41 25.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.051 0.453 . . . . 0.0 111.082 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.6 32.27 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.723 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 7.0 ptmm? -150.63 168.94 22.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 102' ' ' ASN . 1.5 tm? -72.44 118.56 15.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.185 0.517 . . . . 0.0 110.959 -171.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.1 t -100.74 120.56 50.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.892 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 18.8 t -109.61 106.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 11' ' ' PHE . 15.4 t -103.0 123.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.801 0.81 . . . . 0.0 110.986 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -91.39 96.86 10.75 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.049 -175.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.52 106.87 17.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.58 0.705 . . . . 0.0 112.004 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 40.2 p90 -128.77 -173.61 3.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.634 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.66 130.69 40.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 p -66.47 -21.82 66.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -84.45 -9.76 58.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.718 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.646 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.8 t -93.42 147.31 23.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.155 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.97 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.648 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.646 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.2 Cg_exo -67.23 4.62 1.14 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.096 2.531 . . . . 0.0 114.356 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 29.7 p -62.94 -32.19 73.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.028 0.918 . . . . 0.0 109.361 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -70.76 -8.98 56.28 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.968 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.627 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 25.6 ttt -82.76 -28.69 30.22 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.685 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -75.31 -25.03 17.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.594 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.478 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -53.92 -65.89 1.07 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.399 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 91.7 Cg_endo -83.16 -30.71 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.264 1.31 . . . . 0.0 114.521 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.408 ' HE1' ' HA ' ' A' ' 36' ' ' ILE . 3.2 tmm? -68.4 -39.48 81.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 -176.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -77.42 -36.37 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.565 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.68 -20.73 65.33 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.116 -0.633 . . . . 0.0 109.563 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 22.8 ttmm -83.32 -32.67 26.17 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.277 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.2 p90 -57.51 -46.37 83.87 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.265 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 93.5 p -84.8 -15.64 44.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.506 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 38.9 tt0 -56.48 -32.72 65.27 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.475 ' NE2' ' HD2' ' A' ' 96' ' ' LYS . 39.8 mt-30 -87.24 -50.43 6.6 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.837 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.8 p90 -127.78 90.67 47.34 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.166 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.61 -0.68 7.99 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.483 2.122 . . . . 0.0 112.29 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.47 -18.05 65.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.492 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.45 157.62 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.541 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 7.6 m-20 -91.75 128.12 37.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.584 0.707 . . . . 0.0 111.473 -173.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.513 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.3 p90 -106.96 114.7 28.94 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.87 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.591 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.41 146.53 40.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.196 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 42.2 mtpt -131.2 148.81 52.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.886 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD21 ' CE2' ' A' ' 25' ' ' PHE . 8.7 tt -160.7 148.12 15.78 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.1 p-10 -105.6 131.59 52.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.383 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.29 -12.69 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.54 -46.05 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.184 0.516 . . . . 0.0 109.794 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.51 -41.72 17.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.43 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB2' HD22 ' A' ' 55' ' ' LEU . 2.8 mm? -122.68 75.11 1.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.433 0.635 . . . . 0.0 112.129 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.62 -34.18 54.32 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.358 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.65 -28.41 69.6 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.332 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.578 HG12 HD22 ' A' ' 67' ' ' ASN . 57.8 t -70.86 -50.19 45.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.67 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.61 -40.41 52.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.059 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 mt-30 -69.17 -35.58 76.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.313 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.597 ' HE3' ' OD2' ' A' ' 12' ' ' ASP . 14.4 tptp -62.57 -25.54 68.12 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.305 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.578 HD22 HG12 ' A' ' 63' ' ' VAL . 7.3 m-20 -105.9 -9.98 16.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.233 -171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 37.4 mt-10 80.51 27.31 0.26 Allowed 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.455 1.097 . . . . 0.0 111.217 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.572 HG11 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -105.2 115.35 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 110.256 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.6 p -115.95 -23.38 8.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.166 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.84 166.24 12.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.179 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -149.63 140.88 14.5 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.015 0.436 . . . . 0.0 111.359 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 36' ' ' ILE . 57.7 Cg_endo -80.27 151.56 82.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.475 -1.885 . . . . 0.0 113.194 -4.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -129.58 139.14 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD22 ' HE3' ' A' ' 39' ' ' MET . 4.3 mp -110.63 126.54 54.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.358 173.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.59 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -115.62 115.35 26.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.04 0.447 . . . . 0.0 110.69 176.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.588 HD21 ' ND2' ' A' ' 102' ' ' ASN . 2.1 mp -96.96 131.2 43.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.099 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.59 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.3 m-85 -130.45 148.69 52.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.619 0.247 . . . . 0.0 111.229 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -127.0 108.59 11.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.619 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.9 t30 60.41 55.51 3.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 111.633 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 72.04 6.45 64.31 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.497 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -121.8 157.86 30.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.27 179.09 4.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -151.83 -32.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 165.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -170.78 152.54 3.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 111.722 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 134.18 30.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.909 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.1 t -131.75 123.78 52.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.12 53.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.2 0.524 . . . . 0.0 111.497 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.93 136.01 1.94 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.625 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -66.88 107.54 2.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.12 0.486 . . . . 0.0 110.964 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -111.51 88.38 9.15 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.3 Cg_exo -31.43 -74.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 124.477 3.451 . . . . 0.0 115.319 -169.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -38.09 68.53 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.235 -0.291 . . . . 0.0 111.626 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.18 -31.3 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.383 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.551 ' O ' HG12 ' A' ' 99' ' ' ILE . 33.3 mm -76.41 -49.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 110.265 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 47.0 mtmt -64.37 -22.94 67.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.486 0.66 . . . . 0.0 110.152 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -80.89 -37.05 30.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.66 171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.93 -61.34 2.71 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.578 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.5 mm -47.93 -38.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.068 0.855 . . . . 0.0 110.671 -176.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.95 -22.24 59.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.615 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.5 -28.97 18.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.156 0.503 . . . . 0.0 110.443 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.588 ' ND2' HD21 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -95.73 -10.34 29.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.027 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.736 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.104 0.478 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.5 t -103.74 125.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.759 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 14.4 m -72.71 145.0 47.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.653 0.739 . . . . 0.0 112.68 -168.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.48 139.47 30.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.237 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 11' ' ' PHE . 5.9 m-85 -85.11 170.54 12.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.772 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 54.1 mttm -121.62 -39.24 2.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -148.56 -179.07 6.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.55 -27.92 69.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 m -60.01 -45.37 93.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.2 mp0 -57.99 -42.69 85.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.52 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.682 ' O ' HG12 ' A' ' 15' ' ' ILE . 13.5 t80 -60.4 -54.63 43.26 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.51 -39.12 79.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.684 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -61.65 -47.07 87.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.706 0.288 . . . . 0.0 110.565 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.71 72.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.471 . . . . 0.0 110.379 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.682 HG12 ' O ' ' A' ' 11' ' ' PHE . 10.4 mm -65.21 -40.37 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.38 2.21 9.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.297 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -73.95 139.62 45.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.711 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.33 40.46 0.56 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.315 0.578 . . . . 0.0 110.823 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 2.3 pttp -153.54 163.11 40.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.884 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' A' ' 84' ' ' VAL . 1.9 tm? -69.54 113.82 7.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.029 0.442 . . . . 0.0 110.995 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 4.4 p -110.01 118.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.957 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.559 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -110.23 119.66 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 109.85 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 11' ' ' PHE . 58.0 t -102.59 127.41 56.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.243 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -87.86 97.01 10.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.443 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -107.15 110.36 22.43 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.092 0.472 . . . . 0.0 110.818 -176.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 26.3 p90 -145.31 -171.54 3.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.092 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 57' ' ' VAL . . . -136.25 136.69 40.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.415 HG23 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -61.02 -24.12 65.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -88.69 -10.44 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.275 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' HG3' ' A' ' 72' ' ' MET . 44.2 t -77.44 158.39 30.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.034 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.1 -76.57 0.6 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.217 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 6.3 Cg_exo -74.39 14.77 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.187 2.591 . . . . 0.0 113.757 -173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.4 p -59.92 -34.95 73.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.882 0.848 . . . . 0.0 109.916 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -70.29 -8.0 46.87 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.423 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 24.1 ttt -84.44 -28.99 26.47 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.098 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.607 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 1.4 mp -77.5 -25.73 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -54.32 -64.98 1.46 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 94.8 Cg_endo -82.46 -30.55 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 121.192 1.261 . . . . 0.0 114.133 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.57 ' SD ' ' HB1' ' A' ' 90' ' ' ALA . 1.5 ttp -67.44 -42.8 82.53 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 118.508 0.595 . . . . 0.0 109.905 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.626 ' CD1' HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -73.31 -37.35 51.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.432 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.9 -38.52 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.658 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 56.8 mttp -65.36 -31.37 72.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.107 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.9 m-30 -55.65 -62.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.703 0.287 . . . . 0.0 110.268 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -73.84 -14.05 61.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.678 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 tt0 -60.32 -33.4 72.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.4 -47.96 8.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 175.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.2 p90 -128.68 86.4 57.68 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.158 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 -0.68 8.95 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.475 2.116 . . . . 0.0 112.252 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -67.47 -13.35 61.96 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.17 17.27 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.2 m-20 -91.8 126.42 36.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.254 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -102.27 114.16 28.07 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.493 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 3' ' ' THR . 98.6 m-85 -139.89 152.65 46.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.06 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.7 pttp -148.98 153.46 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.849 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.777 HD23 ' CZ ' ' A' ' 25' ' ' PHE . 8.0 tt -159.14 146.44 17.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.1 m-20 -99.68 125.23 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' CE1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -65.21 -22.72 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.07 -35.65 73.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.454 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.67 -43.53 11.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.964 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 46.0 mt -131.77 89.98 2.77 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.559 0.695 . . . . 0.0 112.445 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.06 -33.78 39.78 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.246 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.53 -30.13 68.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.151 0.501 . . . . 0.0 110.03 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.545 HG12 HD22 ' A' ' 67' ' ' ASN . 89.2 t -62.89 -50.23 80.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -46.76 -42.42 16.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.191 0.519 . . . . 0.0 111.406 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.04 -34.72 69.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.631 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 16.0 tptt -61.1 -26.44 67.66 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.545 HD22 HG12 ' A' ' 63' ' ' VAL . 9.1 m-20 -105.09 -10.89 16.87 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.187 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 43.1 mt-10 80.17 26.68 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.391 1.057 . . . . 0.0 111.271 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -104.72 110.71 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.687 0.756 . . . . 0.0 111.241 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -114.0 -34.66 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.54 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.65 159.65 26.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.872 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.451 ' HG3' ' SG ' ' A' ' 30' ' ' CYS . 20.3 ptp -151.17 140.84 14.06 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.906 0.384 . . . . 0.0 110.958 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.524 ' CG ' HD12 ' A' ' 36' ' ' ILE . 72.2 Cg_endo -80.83 150.47 79.1 Favored 'Cis proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.726 -1.781 . . . . 0.0 113.154 -2.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -120.79 145.93 47.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.229 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' A' ' 40' ' ' ILE . 3.6 mp -120.76 123.47 42.75 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 174.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 mt -122.5 112.72 18.37 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.841 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.559 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 4.0 mp -94.46 134.8 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.54 ' CG ' HD12 ' A' ' 15' ' ' ILE . 52.0 m-85 -133.45 156.73 47.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.406 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.42 122.75 19.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.47 167.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 t30 60.78 41.49 14.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.661 0.743 . . . . 0.0 111.352 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 86.16 -4.32 86.12 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.272 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -121.86 161.61 22.45 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 25.1 tt0 -66.92 178.75 1.28 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -150.59 -28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.047 162.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -154.81 146.39 23.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 112.073 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -135.14 115.33 13.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.665 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.06 141.54 45.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -121.62 48.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.152 0.501 . . . . 0.0 110.743 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.35 129.2 1.18 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.309 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -62.63 108.21 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.122 0.487 . . . . 0.0 112.114 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.54 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.98 90.32 32.55 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -33.07 -63.15 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.659 3.573 . . . . 0.0 115.074 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 -46.02 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.969 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 91' ' ' ASN . 29.5 mm -87.36 -34.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.271 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 31.9 tttt -59.83 -37.87 80.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.595 0.712 . . . . 0.0 109.121 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.75 -30.27 69.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.466 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -56.59 8.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.441 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.0 mm -51.07 -41.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.223 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.74 70.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.36 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -78.98 -21.04 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.979 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.787 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.584 0.23 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 52' ' ' PHE . 96.1 t -87.65 131.93 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.193 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.482 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.6 m -83.04 139.18 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 112.447 -170.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.602 ' OE1' ' HA ' ' A' ' 55' ' ' LEU . 8.4 tp-100 -90.56 138.91 31.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.097 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.677 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 16.0 m-85 -95.69 161.4 14.05 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.613 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.8 ptpp? -134.37 -3.72 2.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.315 170.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -141.94 158.86 43.27 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.939 0.399 . . . . 0.0 111.322 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 63' ' ' VAL . . . -71.21 -27.94 63.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.097 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -57.61 -46.4 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.344 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.677 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.1 mt-10 -55.41 -43.27 75.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.984 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.665 ' CE2' HG13 ' A' ' 23' ' ' VAL . 28.8 t80 -60.55 -58.41 8.6 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.36 -37.39 80.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.259 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -59.41 -43.22 93.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.892 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.02 -33.73 74.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.475 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 11' ' ' PHE . 15.2 mm -63.01 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.279 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.93 -1.3 16.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.693 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 8.3 tt0 -72.31 141.32 48.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.791 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.32 48.16 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.501 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 5.3 ptpp? -157.9 -179.88 8.55 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.461 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.7 tm? -73.8 123.11 23.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 109.885 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.9 t -102.2 117.9 48.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.231 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -97.06 103.0 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 11' ' ' PHE . 38.4 t -105.34 124.17 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.973 0.892 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -102.17 96.76 7.2 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.733 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.7 m-85 -101.0 128.62 46.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.778 0.799 . . . . 0.0 111.908 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 25.7 p90 -152.95 178.47 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.113 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.5 138.92 51.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.738 0.304 . . . . 0.0 110.277 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 p -66.19 -18.87 65.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.473 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -86.44 -10.75 53.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.59 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.16 152.75 24.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.597 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.59 -61.87 1.67 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.953 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.35 3.28 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.094 2.529 . . . . 0.0 113.872 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 29.0 p -60.43 -32.42 71.35 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.603 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.6 tptm -68.2 -11.88 60.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.801 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.677 ' SD ' ' HB1' ' A' ' 90' ' ' ALA . 24.0 ttt -79.43 -28.11 41.71 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.556 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -76.21 -22.73 15.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.616 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 34' ' ' LYS . . . -53.57 -68.25 0.49 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.474 172.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 78.9 Cg_endo -84.11 -32.04 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 CA-C-N 120.941 1.372 . . . . 0.0 114.43 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.546 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -64.97 -48.55 73.61 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.374 0.534 . . . . 0.0 109.71 -176.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.599 HD12 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -68.19 -37.9 78.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.045 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.14 -26.52 67.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 109.499 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 50.2 tptt -77.13 -30.85 55.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.948 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.659 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 18.1 m-30 -52.65 -64.55 0.78 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.012 0.434 . . . . 0.0 109.872 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.4 m -80.03 -13.2 59.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.216 -173.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.0 -35.99 80.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.15 -39.39 14.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.212 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 10.4 p90 -131.77 90.87 35.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 111.937 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 1.87 6.12 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.792 2.328 . . . . 0.0 112.652 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.31 -23.25 67.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.542 . . . . 0.0 111.257 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.4 157.95 16.42 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.04 138.42 31.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.358 0.599 . . . . 0.0 111.23 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -110.78 115.91 30.37 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.234 -171.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.482 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 92.1 m-85 -138.89 154.25 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 111.843 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 53.1 mttm -140.93 155.86 46.19 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.99 0.916 . . . . 0.0 109.972 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.664 HD23 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.03 147.49 16.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.937 0.398 . . . . 0.0 111.024 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.3 t0 -96.7 118.85 34.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.015 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 26' ' ' TYR . 21.7 t -66.12 -28.57 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.172 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.46 -25.47 65.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.93 -42.06 9.27 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.309 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.7 mm? -122.45 76.18 1.31 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.272 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.41 -40.72 91.47 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.027 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.78 -31.56 71.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.907 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 85.3 t -61.73 -52.55 59.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.132 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 69' ' ' VAL . . . -51.33 -39.33 56.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 111.075 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.71 -33.14 72.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.417 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -22.12 66.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.969 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.585 ' HB2' HG11 ' A' ' 69' ' ' VAL . 8.9 m-20 -109.79 -11.54 14.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 -173.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 80.28 27.28 0.29 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.439 1.087 . . . . 0.0 111.381 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.585 HG11 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -106.36 126.11 62.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.957 0.408 . . . . 0.0 110.375 173.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -139.85 5.52 2.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.08 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.46 ' HG2' ' CB ' ' A' ' 27' ' ' ALA . 2.4 mpt? -124.31 121.39 26.05 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.032 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HB2' HG12 ' A' ' 36' ' ' ILE . 40.3 Cg_endo -90.5 162.53 32.46 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.983 -1.257 . . . . 0.0 113.162 -1.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 m -136.89 131.93 33.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.325 0.583 . . . . 0.0 111.176 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 95' ' ' ILE . 4.1 mp -101.93 125.25 48.57 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.47 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.633 HD23 ' CE1' ' A' ' 78' ' ' PHE . 2.1 mt -118.61 113.2 20.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.149 0.5 . . . . 0.0 110.437 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.8 mp -97.19 133.32 41.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.633 ' CE1' HD23 ' A' ' 76' ' ' LEU . 55.1 m-85 -130.67 158.2 40.7 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.578 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -140.93 125.26 17.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 48.09 51.85 14.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.131 0.972 . . . . 0.0 113.508 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' HG21 ' A' ' 15' ' ' ILE . . . 76.67 3.19 78.46 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.653 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -119.03 160.93 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.23 -179.31 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -151.51 -34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 164.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -167.85 149.96 5.57 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.569 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 17.8 pttm -144.54 131.36 20.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.439 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.87 123.76 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.09 55.85 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.244 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.11 128.28 0.94 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 35' ' ' MET . . . -61.11 115.98 4.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.92 90.33 32.3 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.8 Cg_exo -25.13 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 125.256 3.971 . . . . 0.0 115.68 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.96 -28.42 35.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.15 -0.344 . . . . 0.0 111.833 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.1 83.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 HG22 HD21 ' A' ' 75' ' ' LEU . 41.0 mm -82.54 -31.0 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.818 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 33.4 mtmt -61.2 -40.07 92.55 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -64.7 -30.29 71.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.16 173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -52.54 45.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.469 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 4.2 mm -51.96 -41.09 30.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.56 -31.46 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.286 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.72 66.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.605 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -86.25 -20.79 27.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.59 177.283 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttm . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.77 0.319 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 41' ' ' GLU . 74.5 t -87.99 136.69 22.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.629 -175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.547 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.0 m -81.77 145.54 30.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.086 -172.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -92.37 124.62 36.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 9.0 m-85 -84.58 157.31 21.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 21.6 pttm -135.16 -3.27 2.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.239 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -140.83 164.9 28.98 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.153 0.501 . . . . 0.0 111.792 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . . . -76.47 -31.85 58.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.284 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 m -59.28 -42.94 92.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.656 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.601 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 24.2 mt-10 -53.66 -45.61 70.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.741 ' CE2' HG13 ' A' ' 23' ' ' VAL . 12.3 t80 -56.84 -59.49 4.96 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.244 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -60.72 -27.83 68.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.766 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -64.42 -44.59 90.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.051 0.453 . . . . 0.0 110.055 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.15 -20.2 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.887 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 11' ' ' PHE . 17.9 mm -77.9 -38.35 24.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.109 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.59 14.59 2.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -99.18 163.37 12.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.955 0.407 . . . . 0.0 111.05 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.62 36.47 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.075 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.5 173.67 12.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.921 0.391 . . . . 0.0 110.916 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.5 tm? -79.37 126.12 30.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.331 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.68 128.23 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.35 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.38 102.96 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.741 HG13 ' CE2' ' A' ' 11' ' ' PHE . 41.6 t -96.98 129.61 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.595 0.712 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -111.62 97.46 6.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.131 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.494 ' CD2' HG11 ' A' ' 69' ' ' VAL . 3.4 m-85 -103.23 137.24 41.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.571 0.7 . . . . 0.0 112.058 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 22.6 p90 -156.48 -171.37 3.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.688 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.63 135.1 32.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 p -69.3 -19.47 63.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.981 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -84.14 -14.77 49.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.01 0.434 . . . . 0.0 110.319 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 49.7 t -88.7 141.73 28.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.855 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.03 -60.85 5.31 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.83 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 41.1 Cg_endo -67.55 8.86 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.117 2.545 . . . . 0.0 114.766 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -60.52 -30.49 69.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.81 0.814 . . . . 0.0 109.958 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.661 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 19.7 ptmt -67.25 -9.6 42.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.646 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.422 ' HE2' ' HG3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -81.24 -34.57 32.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.68 -24.66 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.674 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -57.04 -65.89 1.5 Allowed Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.978 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.5 Cg_endo -84.32 -30.58 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.692 1.594 . . . . 0.0 113.545 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -67.26 -39.74 86.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 109.804 -176.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -75.07 -39.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.137 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 33.0 mt-10 -63.13 -32.02 73.31 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 173.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 39' ' ' MET . 27.3 ttpp -64.41 -41.06 96.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.284 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.1 m-85 -53.65 -63.23 1.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.949 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -76.4 -13.54 60.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.278 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.42 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.03 -41.07 13.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.29 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.533 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.6 p90 -133.8 90.81 26.56 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.28 0.562 . . . . 0.0 112.179 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.81 1.4 5.81 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.691 2.261 . . . . 0.0 112.584 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -63.15 -19.9 64.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.123 0.487 . . . . 0.0 110.694 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.13 153.26 19.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.73 143.39 26.59 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.914 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.2 p90 -111.84 116.05 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.309 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.547 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 90.6 m-85 -141.76 137.85 31.9 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 120.987 0.423 . . . . 0.0 112.12 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 31.1 mtmt -123.19 153.36 40.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.465 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 60' ' ' LEU . 8.8 tt -161.17 144.42 12.82 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.6 p-10 -100.52 129.63 46.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.082 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 26' ' ' TYR . 3.8 p -72.67 -16.63 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.488 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -57.93 -43.54 86.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.991 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -88.89 -42.32 11.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.0 mm? -111.9 76.45 0.98 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.276 0.56 . . . . 0.0 112.01 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 57' ' ' VAL . . . -67.34 -47.23 64.65 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.413 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.36 -30.95 70.84 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 111.177 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 89.5 t -65.53 -54.14 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.9 70.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 111.187 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.48 -30.22 69.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -66.96 -23.53 65.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.536 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.557 ' HB2' HG13 ' A' ' 69' ' ' VAL . 58.1 m-20 -106.63 -12.58 15.53 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.868 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 26.5 tt0 80.46 22.27 0.43 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.308 1.005 . . . . 0.0 110.938 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.25 124.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 121.818 -0.551 . . . . 0.0 109.834 173.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 m -131.63 -25.48 2.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.477 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.1 159.68 14.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -128.26 142.69 45.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 121.069 0.461 . . . . 0.0 111.434 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -82.23 166.39 70.63 Favored 'Cis proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.289 -1.546 . . . . 0.0 112.009 -9.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 m -140.8 136.64 32.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.539 . . . . 0.0 111.023 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 95' ' ' ILE . 4.8 mp -112.18 136.45 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.445 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 78' ' ' PHE . 4.7 mt -128.8 115.94 18.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.121 0.486 . . . . 0.0 110.856 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.67 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -99.3 129.31 45.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.055 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.468 ' CG ' HD12 ' A' ' 15' ' ' ILE . 54.0 m-85 -130.15 151.32 50.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.593 0.235 . . . . 0.0 110.788 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 56.0 tttp -132.96 124.57 28.02 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.1 p30 44.8 50.37 8.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 84.03 -4.98 81.58 Favored Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.589 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -119.97 160.85 21.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.18 179.94 0.87 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -152.68 -24.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.601 164.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -170.99 157.63 5.35 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 111.436 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.21 133.91 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.428 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.23 144.05 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 88' ' ' VAL . 9.0 p -117.1 49.04 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 122.218 1.008 . . . . 0.0 109.897 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.02 130.5 1.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.275 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' HB1' ' CD1' ' A' ' 36' ' ' ILE . . . -60.59 111.88 1.78 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -118.57 91.12 41.12 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.334 175.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 46.7 Cg_exo -31.69 -65.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.922 3.748 . . . . 0.0 115.359 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.65 -45.45 11.69 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.05 -30.59 71.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.3 mt -85.95 -31.61 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.308 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 15.4 ttpp -59.83 -38.77 82.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -64.4 -34.61 78.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.857 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -64.67 -60.78 2.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -50.73 -30.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.582 0.551 . . . . 0.0 110.802 -176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.5 -20.86 39.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.771 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.71 -32.11 17.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.67 ' ND2' HD22 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -92.19 -12.07 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.907 -178.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.942 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 15.9 ptm . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.688 0.28 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t -103.12 128.33 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.9 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 4.8 m -65.03 145.03 56.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.775 -168.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -96.71 123.88 40.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.807 -175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 12.5 m-85 -84.63 158.95 20.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.235 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -128.65 -27.25 2.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.007 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 29.6 p -127.54 162.8 25.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.409 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.09 -26.72 62.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.13 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.508 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.0 mt-10 -58.1 -41.43 83.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.522 172.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.638 ' CE2' HG13 ' A' ' 23' ' ' VAL . 31.8 t80 -57.36 -59.72 4.72 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -56.36 -40.75 75.05 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.722 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -42.5 82.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.665 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 -36.27 71.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.364 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.7 mm -61.89 -40.73 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.8 2.24 8.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.257 -172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.85 143.15 44.02 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.56 34.43 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.563 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 172.31 13.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.153 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.545 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -68.49 123.08 19.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.488 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.6 t -103.2 114.28 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -93.64 103.61 14.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.638 HG13 ' CE2' ' A' ' 11' ' ' PHE . 56.1 t -105.61 124.65 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.787 0.803 . . . . 0.0 111.256 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -103.43 98.37 8.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.933 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CE2' HD21 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.5 121.59 44.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.482 0.658 . . . . 0.0 111.698 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 28.3 p90 -147.98 169.6 19.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.213 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.7 49.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -23.28 55.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -87.29 -10.17 53.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.518 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.13 158.83 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.758 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.62 -74.22 0.44 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.611 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 5.9 Cg_exo -77.91 25.66 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.315 2.677 . . . . 0.0 114.078 -171.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 p -65.65 -35.67 81.46 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.011 0.91 . . . . 0.0 109.566 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -68.31 -8.01 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.993 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -36.2 30.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.613 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.31 -25.58 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.864 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -55.36 -66.2 1.12 Allowed Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.738 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 90.0 Cg_endo -82.47 -30.05 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.263 1.309 . . . . 0.0 114.251 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.523 ' HE3' ' HA ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -66.13 -44.97 82.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.606 0.639 . . . . 0.0 109.463 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.614 HD11 ' CB ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -71.64 -37.57 63.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.219 -178.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.52 -33.19 75.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.809 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 5.0 tppp? -67.46 -34.97 78.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.331 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 20.5 m-30 -49.59 -62.99 1.24 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.267 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -76.55 -14.34 60.02 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.016 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.39 -33.09 70.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.568 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.74 -45.52 10.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.567 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.3 p90 -130.49 86.67 52.54 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.143 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.4 -1.79 10.25 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.446 2.097 . . . . 0.0 112.168 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -9.98 45.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.481 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.8 16.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -92.75 135.83 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.125 0.488 . . . . 0.0 111.234 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -113.66 116.55 29.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.235 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -140.47 151.25 44.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.928 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -148.77 158.24 44.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.609 HD21 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.04 146.75 16.04 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 177.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.3 m-20 -95.83 118.33 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.183 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.574 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -67.74 -16.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.43 . . . . 0.0 110.895 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.58 -40.17 96.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.03 -42.76 14.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.195 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.441 ' HB2' HD22 ' A' ' 55' ' ' LEU . 2.8 mm? -127.15 73.02 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 111.555 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.84 -36.89 87.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.17 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.11 -38.83 73.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 110.866 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.469 HG12 HD22 ' A' ' 67' ' ' ASN . 95.4 t -63.66 -51.21 72.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.035 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.82 -39.06 62.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.884 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 30.1 mm-40 -69.27 -33.33 73.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.366 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 12.3 tptt -62.37 -30.05 70.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.815 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -102.71 -7.5 21.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.674 -170.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 45.1 mt-10 79.08 24.95 0.49 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.047 0.842 . . . . 0.0 111.043 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -100.68 112.09 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.231 0.538 . . . . 0.0 110.103 175.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.5 t -124.78 -20.83 4.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.28 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.574 ' CE ' HG21 ' A' ' 57' ' ' VAL . 19.9 mmt -129.36 121.55 20.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.056 -174.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 73.4 Cg_endo -88.01 167.71 40.26 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.005 -1.248 . . . . 0.0 113.018 -3.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 10.7 m -136.58 138.16 40.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.686 0.755 . . . . 0.0 111.555 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -109.02 127.79 54.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.569 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.561 HD22 ' CE1' ' A' ' 78' ' ' PHE . 3.1 mt -121.5 113.6 20.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.112 0.482 . . . . 0.0 110.632 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.638 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -98.83 131.59 44.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.139 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.561 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.1 m-85 -129.69 158.34 39.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.465 0.174 . . . . 0.0 110.586 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -141.25 123.76 15.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p30 48.07 54.02 10.76 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 15' ' ' ILE . . . 79.62 -1.6 76.89 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.48 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -127.62 161.33 29.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.3 tt0 -65.55 179.43 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.06 0.457 . . . . 0.0 110.907 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -151.03 -28.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 163.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -168.63 152.68 5.73 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.539 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.81 129.58 17.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.866 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.17 129.89 60.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.545 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.94 50.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.018 0.437 . . . . 0.0 111.503 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.49 128.47 0.99 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.251 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -60.33 114.42 2.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.507 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.12 90.21 32.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.68 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 74.1 Cg_exo -21.93 -83.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 1 C-N-CA 125.512 4.141 . . . . 0.0 115.595 -171.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 96' ' ' LYS . . . -83.87 -30.51 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -173.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.66 77.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.36 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.507 HG12 ' HB3' ' A' ' 91' ' ' ASN . 34.7 mm -83.39 -29.85 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.798 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 37.3 mtpt -59.31 -39.25 82.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -66.63 -33.03 74.76 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.516 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -61.71 -60.78 3.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.52 -36.56 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 123.831 0.707 . . . . 0.0 110.683 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.55 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.831 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -37.12 14.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.296 0.57 . . . . 0.0 109.991 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.638 ' ND2' HD22 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -85.42 -11.65 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.522 174.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptm . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 52' ' ' PHE . 52.8 t -122.01 129.39 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.86 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.557 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 11.2 m -71.82 144.64 49.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 0.0 112.525 -169.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -90.86 121.51 32.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.232 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 11' ' ' PHE . 3.7 m-85 -69.75 168.5 14.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 0.0 110.418 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 16.7 mtpp -127.86 -36.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.019 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -144.6 179.28 7.39 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.51 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.74 68.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -57.48 -48.5 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.787 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -55.02 -43.04 73.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.729 174.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.704 ' CE2' HG12 ' A' ' 23' ' ' VAL . 15.5 t80 -58.03 -60.08 4.29 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.7 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.01 -38.87 76.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.803 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -60.36 -47.83 84.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.695 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.24 75.0 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.844 0.354 . . . . 0.0 110.402 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 11' ' ' PHE . 14.3 mm -59.67 -36.81 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.308 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 14.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -83.14 153.73 24.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.65 0.262 . . . . 0.0 110.537 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -87.99 39.34 0.89 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.478 0.656 . . . . 0.0 110.36 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 17.7 ptpt -152.61 -179.8 7.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.051 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 99' ' ' ILE . 2.0 tm? -76.35 121.63 23.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.629 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 15' ' ' ILE . 1.1 t -96.21 116.19 37.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.051 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.41 103.16 14.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.704 HG12 ' CE2' ' A' ' 11' ' ' PHE . 43.4 t -104.93 126.53 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.592 0.71 . . . . 0.0 111.285 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -105.66 101.16 10.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.847 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.6 m-85 -104.69 121.64 44.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 42.1 p90 -151.4 162.64 40.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.525 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -111.7 132.31 54.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -62.0 -24.55 67.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.687 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -84.27 -17.13 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.823 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.39 152.45 39.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.342 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.89 -75.56 0.48 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.348 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 20.85 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.156 2.571 . . . . 0.0 114.226 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.4 p -65.74 -28.57 69.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.903 0.858 . . . . 0.0 109.345 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 22.5 pttp -68.33 -8.45 39.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.501 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.597 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 25.0 ttt -84.92 -25.56 27.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.148 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.644 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -79.99 -24.7 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.306 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.557 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.39 -63.57 2.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.633 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.6 Cg_endo -83.91 -34.47 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.084 1.856 . . . . 0.0 114.045 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.532 ' SD ' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -66.25 -42.99 87.81 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.426 0.631 . . . . 0.0 109.681 -176.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -73.51 -36.82 48.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.883 -178.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.43 -30.49 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.035 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 51.1 tttp -75.78 -28.91 58.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.524 -176.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.2 m-85 -56.59 -57.87 10.5 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.4 p -76.5 -13.75 60.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.496 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 34.1 tt0 -60.79 -31.9 71.27 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.34 -47.04 8.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.095 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.6 p90 -129.6 90.06 44.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.099 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -1.09 9.61 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.266 1.977 . . . . 0.0 112.174 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -10.62 51.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.964 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 154.63 18.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.1 m-20 -91.61 126.34 36.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' HB2' HG23 ' A' ' 2' ' ' VAL . 1.2 p90 -101.86 116.21 32.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.177 -174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.58 152.48 46.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.988 0.423 . . . . 0.0 111.029 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . 63.5 pttt -148.91 160.92 42.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.611 HD23 ' CE2' ' A' ' 25' ' ' PHE . 8.4 tt -157.58 151.19 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 18.6 t0 -97.86 119.1 35.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.62 -26.99 42.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.809 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.19 -35.59 80.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.373 0.606 . . . . 0.0 109.98 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.53 -42.46 20.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.498 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -135.09 84.01 2.07 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.91 -33.76 54.42 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.553 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.28 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 67' ' ' ASN . 79.6 t -63.74 -51.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.911 173.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -51.41 -39.69 57.76 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 110.76 176.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 75.9 mt-30 -69.97 -32.56 70.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.588 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -20.73 66.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.877 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.586 ' HB2' HG12 ' A' ' 69' ' ' VAL . 15.4 m-20 -110.71 -8.75 14.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.482 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 25.7 tt0 80.69 25.85 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.102 0.876 . . . . 0.0 110.883 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -105.92 107.81 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.333 0.587 . . . . 0.0 110.668 174.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -116.76 -24.52 7.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.138 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.12 157.76 26.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.3 ptp -151.3 137.4 11.19 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.269 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.516 ' CG ' HD11 ' A' ' 36' ' ' ILE . 58.0 Cg_endo -77.88 155.82 94.87 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.768 -1.763 . . . . 0.0 113.021 -3.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.5 m -134.73 142.87 46.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.442 0.639 . . . . 0.0 111.339 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 HD22 HG22 ' A' ' 95' ' ' ILE . 4.0 mp -114.24 129.36 56.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.768 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.576 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 mt -122.21 117.17 25.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 0.0 110.999 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.474 HD22 ' HB1' ' A' ' 85' ' ' ALA . 1.8 mp -101.06 129.45 46.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.102 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.576 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.6 m-85 -127.79 161.39 29.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 4.6 ttpm? -143.55 115.45 8.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.008 168.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 64.26 55.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.762 0.791 . . . . 0.0 111.205 172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.39 2.66 60.04 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.488 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 8.5 ptpp? -133.44 160.97 35.84 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 31.6 tt0 -64.99 177.63 0.96 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 110.856 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -148.84 -35.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 160.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 77' ' ' LEU . . . -162.99 152.96 15.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.51 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 42.3 pttt -147.61 127.16 13.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.168 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.66 134.22 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.278 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.9 52.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.234 0.54 . . . . 0.0 110.782 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.28 129.46 1.25 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.073 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.597 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -64.69 103.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.734 0.302 . . . . 0.0 111.601 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -117.49 88.89 30.42 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.032 175.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -35.37 -67.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.496 3.464 . . . . 0.0 115.272 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 -32.16 48.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.24 63.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.163 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.565 ' O ' HG12 ' A' ' 99' ' ' ILE . 40.3 mm -87.56 -34.4 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.23 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.681 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 55.0 tttt -59.48 -35.06 73.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -72.89 -31.22 64.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -68.75 -52.76 27.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.5 mm -54.43 -37.51 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.337 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.112 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -44.51 34.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.832 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.6 m-80 -79.03 -16.95 56.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.654 -172.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.628 177.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptp . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.541 0.21 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' CG1' ' HG3' ' A' ' 54' ' ' LYS . 95.2 t -122.6 130.88 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.992 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 21.3 m -81.53 144.53 31.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.513 -170.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -90.13 135.83 33.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.122 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.707 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 8.9 m-30 -88.37 167.88 13.13 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 170.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 55.7 pttt -134.67 -20.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.206 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -145.49 174.69 10.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' CA ' HG22 ' A' ' 63' ' ' VAL . . . -70.8 -27.48 63.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -59.27 -43.8 92.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.304 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 42.9 mm-40 -55.35 -46.62 76.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.382 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.666 ' CE2' HG13 ' A' ' 23' ' ' VAL . 16.6 t80 -59.24 -57.73 11.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.695 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.59 -40.98 93.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.828 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -62.02 -40.09 94.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.192 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.628 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.78 -42.58 90.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.648 175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 11' ' ' PHE . 4.9 mm -60.2 -40.33 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.97 7.65 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.433 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 24.3 mt-30 -83.95 148.66 26.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.53 44.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HZ1' ' HB3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -144.26 167.87 21.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.089 177.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.3 tm? -78.88 117.58 20.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 14' ' ' ALA . 41.1 t -108.36 122.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.227 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 28.9 t -106.59 112.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.666 HG13 ' CE2' ' A' ' 11' ' ' PHE . 54.6 t -100.14 121.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.641 0.734 . . . . 0.0 110.87 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . . . -85.26 96.61 9.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -96.84 126.03 41.7 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.966 0.413 . . . . 0.0 110.077 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.402 ' O ' HG13 ' A' ' 57' ' ' VAL . 8.6 p90 -149.8 -175.28 4.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.573 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -132.76 130.04 39.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.637 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -65.55 -19.47 65.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.959 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -84.98 -13.5 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.174 0.511 . . . . 0.0 110.552 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.647 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.2 t -90.48 136.56 32.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.37 7.67 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 113.532 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.647 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.3 Cg_exo -61.33 3.59 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.103 2.535 . . . . 0.0 114.145 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.1 t -59.03 -29.88 67.6 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.737 0.779 . . . . 0.0 110.429 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -67.97 -8.99 41.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.306 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -38.13 44.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.639 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.05 -25.46 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.861 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -55.65 -65.69 1.38 Allowed Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.891 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 73.2 Cg_endo -83.55 -26.87 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.72 1.613 . . . . 0.0 114.378 -175.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.506 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.3 tmm? -72.72 -37.45 67.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.291 0.567 . . . . 0.0 109.753 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.6 mt -79.85 -33.34 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.659 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.53 -29.05 70.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -72.79 -38.77 67.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.823 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.57 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -57.12 -49.63 75.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.5 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 95.8 p -85.39 -13.97 47.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.56 -27.98 69.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -89.68 -40.7 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.12 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 11.5 p90 -138.85 93.11 10.8 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 112.431 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.44 2.37 2.9 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.451 2.1 . . . . 0.0 112.107 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.06 -23.74 67.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.48 157.58 16.7 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.3 135.75 33.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.904 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.5 p90 -111.52 115.46 29.24 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.249 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 3' ' ' THR . 95.8 m-85 -140.66 156.74 46.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.716 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 43.4 mtmt -137.52 149.21 46.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.155 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.589 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 8.8 tt -157.87 148.81 21.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.034 0.445 . . . . 0.0 110.745 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 5.3 t0 -104.38 123.35 47.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.479 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.8 p -70.29 -24.39 25.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.061 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.62 -23.96 65.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.532 0.682 . . . . 0.0 109.694 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -99.12 -42.49 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.507 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.609 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -120.22 76.16 1.15 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.276 0.56 . . . . 0.0 112.163 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.81 62.67 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.85 -25.58 65.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.914 0.388 . . . . 0.0 110.797 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 51.5 t -68.68 -50.33 56.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.62 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -52.82 -22.84 5.85 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -86.26 -27.3 24.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -75.39 -26.5 58.48 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.107 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.62 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.5 p30 -110.13 -12.6 14.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 29.3 tt0 79.84 17.35 0.75 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.85 0.718 . . . . 0.0 112.635 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -89.55 130.89 38.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 121.567 -0.708 . . . . 0.0 110.639 173.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -123.94 -27.34 3.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.98 166.36 11.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.535 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.479 ' CE ' HG11 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -148.09 141.71 15.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.84 0.353 . . . . 0.0 110.951 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.89 150.29 78.55 Favored 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.836 -1.735 . . . . 0.0 112.635 -2.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -132.46 136.93 47.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.552 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD22 ' HE2' ' A' ' 39' ' ' MET . 4.3 mp -107.83 123.26 48.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -116.06 116.43 27.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.573 0.701 . . . . 0.0 109.876 175.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 HD23 ' HB1' ' A' ' 85' ' ' ALA . 2.2 mp -95.75 128.46 42.65 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.504 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.672 ' CE1' HD22 ' A' ' 76' ' ' LEU . 58.9 m-85 -125.96 153.26 44.55 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.493 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -135.87 125.39 25.13 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 46.8 53.82 9.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.223 1.009 . . . . 0.0 113.49 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' HG21 ' A' ' 15' ' ' ILE . . . 73.8 5.4 69.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.528 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -120.08 161.12 21.51 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 84' ' ' VAL . 27.0 tt0 -71.58 179.89 2.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.451 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -153.86 -33.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 164.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -167.58 149.76 5.78 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.423 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -146.82 127.86 14.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.032 0.444 . . . . 0.0 110.54 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 95' ' ' ILE . 4.2 m -132.44 139.42 50.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -101.69 48.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.255 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.33 131.58 1.71 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.317 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -69.72 108.13 3.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.474 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -117.28 89.75 32.06 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 12.2 Cg_exo -28.53 -67.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.79 3.66 . . . . 0.0 115.588 -171.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.9 21.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.74 71.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.739 0.304 . . . . 0.0 111.32 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.3 mm -72.62 -49.24 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.673 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mtmp? -63.46 -28.59 70.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -38.38 68.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.038 173.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.72 68.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.498 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.61 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 4.2 mm -52.73 -39.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.711 -178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.7 -19.85 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.175 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.9 -38.08 23.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.254 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' ND2' HD22 ' A' ' 77' ' ' LEU . 58.1 m-80 -83.95 -21.16 31.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.448 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.894 178.17 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 7.1 ptp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.017 0.437 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 52' ' ' PHE . 43.7 t -112.76 124.79 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.384 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.628 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 1.4 m -60.48 144.42 51.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.414 -168.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -101.52 117.43 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.224 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.4 m-85 -71.07 167.58 18.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.138 0.494 . . . . 0.0 111.755 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -125.38 -41.31 2.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.924 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -138.5 -179.96 6.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 111.443 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.435 ' N ' HG21 ' A' ' 63' ' ' VAL . . . -67.86 -25.5 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.978 0.418 . . . . 0.0 110.186 175.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -61.2 -46.83 88.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -54.96 -42.74 72.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.448 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.738 ' CE2' HG12 ' A' ' 23' ' ' VAL . 17.6 t80 -57.37 -58.88 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.01 -36.35 74.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -63.54 -41.46 98.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.845 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.21 -35.54 78.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.037 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.1 mm -62.26 -39.16 83.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.052 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.06 0.97 9.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -75.5 143.58 42.45 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.73 40.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 0.0 110.986 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.19 167.44 22.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.381 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.7 tm? -70.1 126.42 29.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 15' ' ' ILE . 2.0 t -106.07 120.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.2 104.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' CE2' ' A' ' 11' ' ' PHE . 39.4 t -102.72 127.18 56.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.663 0.744 . . . . 0.0 111.083 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.574 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -105.33 98.17 7.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.125 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 55' ' ' LEU . 3.3 m-85 -103.21 123.97 47.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.417 ' O ' HG11 ' A' ' 57' ' ' VAL . 48.9 p90 -152.92 179.02 9.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.398 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.455 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -129.92 135.97 48.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.652 0.263 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.625 HG21 ' OD2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -63.96 -22.04 66.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.38 -13.26 52.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.562 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 52.9 t -81.99 148.79 28.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.706 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.39 -65.98 1.98 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.525 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 13.1 Cg_exo -71.8 18.52 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.24 2.627 . . . . 0.0 114.23 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -67.44 -29.24 68.66 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.048 0.927 . . . . 0.0 109.44 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 99.2 mttt -68.08 -7.36 28.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.133 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -38.33 58.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.22 -25.47 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.044 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -55.45 -65.8 1.3 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.976 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 96.2 Cg_endo -82.46 -29.75 1.36 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.456 1.437 . . . . 0.0 114.299 -173.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.534 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -66.3 -44.9 82.14 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.36 0.6 . . . . 0.0 109.456 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -69.55 -37.5 74.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.22 -179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 40.8 mt-10 -62.83 -31.99 73.1 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.065 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.53 -32.74 70.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.69 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 16.8 m-30 -52.44 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -76.07 -13.4 60.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.263 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -60.55 -39.57 88.41 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -79.05 -47.61 15.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.611 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.5 p90 -133.06 89.9 32.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.214 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.28 2.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.503 2.135 . . . . 0.0 112.661 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -24.74 67.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.304 0.573 . . . . 0.0 110.716 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.48 153.29 20.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.352 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.92 150.17 21.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.162 -175.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.532 ' HB2' HG21 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -118.33 115.96 25.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.969 -172.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.628 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.9 m-85 -141.8 149.51 40.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 111.635 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 36.9 mtmt -131.03 160.78 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.932 0.893 . . . . 0.0 110.1 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD23 ' CE2' ' A' ' 25' ' ' PHE . 9.0 tt -159.8 147.8 17.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.625 ' OD2' HG21 ' A' ' 28' ' ' THR . 0.4 OUTLIER -98.89 117.99 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.131 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -71.83 -17.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 0.0 110.376 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.02 -31.99 69.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 60' ' ' LEU . 37.2 tt0 -87.69 -42.77 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.024 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.4 mm? -124.22 80.63 1.85 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.0 -39.77 93.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.701 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.83 -33.98 76.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 67' ' ' ASN . 86.6 t -65.56 -49.53 77.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.095 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -50.7 -39.26 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.713 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.6 mm100 -69.24 -38.11 78.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.12 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -59.46 -24.96 63.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.475 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.54 ' HB2' HG12 ' A' ' 69' ' ' VAL . 8.7 m-20 -109.47 -8.02 15.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 122.278 -0.264 . . . . 0.0 111.366 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.2 mt-10 79.21 27.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.997 0.811 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -106.22 109.84 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.4 0.619 . . . . 0.0 110.481 175.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.0 m -117.41 -34.51 4.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.182 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.07 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.624 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 19.6 ptp -151.79 149.27 23.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.959 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.3 Cg_endo -79.63 150.82 84.38 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.525 -1.864 . . . . 0.0 112.422 -4.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.1 m -126.05 140.21 52.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.595 0.712 . . . . 0.0 111.784 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.99 124.65 52.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.436 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.626 HD23 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -116.32 118.74 33.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.462 . . . . 0.0 110.57 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 85' ' ' ALA . 2.4 mp -99.72 131.84 45.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.279 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 76' ' ' LEU . 60.3 m-85 -131.23 160.31 35.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.558 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -144.69 131.19 19.83 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.85 52.88 11.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 78.45 1.6 82.39 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.46 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -125.46 160.31 29.78 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 28.1 tt0 -66.57 -178.36 0.69 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.12 -31.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.647 162.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -164.0 154.43 15.23 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.918 0.39 . . . . 0.0 111.736 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -145.69 126.53 14.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.3 m -133.65 142.74 40.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.669 0.271 . . . . 0.0 110.521 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.23 43.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.963 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.48 121.9 0.82 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.119 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.554 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -59.63 109.59 0.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.952 0.406 . . . . 0.0 111.566 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.14 90.66 34.24 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.2 Cg_exo -26.26 -79.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.826 3.684 . . . . 0.0 115.288 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.91 -35.31 43.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.81 76.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.417 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.7 mm -86.15 -31.61 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.633 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 22.4 mtmm -63.05 -32.93 74.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.704 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -69.96 -32.86 71.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.035 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.55 48.56 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.089 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.531 ' CG1' ' HH ' ' A' ' 47' ' ' TYR . 4.1 mm -54.26 -38.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.453 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.77 60.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.097 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.98 -38.14 32.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.437 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' ND2' HD23 ' A' ' 77' ' ' LEU . 52.5 m-80 -86.67 -14.58 42.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.269 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.73 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t -121.46 124.32 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.651 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 2.7 m -72.47 146.14 47.08 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -167.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -93.54 139.06 31.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.954 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 11' ' ' PHE . 11.5 m-85 -103.67 154.87 19.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.029 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 25.3 pttm -133.85 -3.35 2.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.205 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -143.22 164.11 31.08 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -56.93 -47.66 80.11 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -53.5 -44.95 69.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.603 ' O ' HG12 ' A' ' 15' ' ' ILE . 17.0 t80 -58.89 -57.25 13.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.7 -34.86 78.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.757 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -62.35 -40.35 96.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.678 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.61 -20.78 63.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.466 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 11' ' ' PHE . 12.5 mm -82.58 -36.49 13.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.335 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 12.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -101.09 148.2 25.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 120.817 0.342 . . . . 0.0 110.313 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.73 66.22 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.619 0.723 . . . . 0.0 110.747 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -154.03 174.59 14.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.44 117.16 24.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.158 0.504 . . . . 0.0 109.846 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.3 t -102.23 128.43 54.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.2 t -115.78 108.79 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 11' ' ' PHE . 14.5 t -106.31 129.58 59.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.706 0.765 . . . . 0.0 110.885 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -98.68 100.17 11.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.081 -175.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' A' ' 55' ' ' LEU . 2.1 m-85 -105.89 108.88 20.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.492 0.663 . . . . 0.0 111.945 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.4 p90 -131.76 -174.51 3.44 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.532 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.97 139.91 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.892 0.377 . . . . 0.0 110.404 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -20.28 62.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.709 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -88.7 -15.75 34.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.36 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 33' ' ' CYS . 16.3 p -90.92 150.25 21.57 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.2 -46.99 9.55 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.912 -0.585 . . . . 0.0 114.321 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 42.0 Cg_endo -67.11 5.08 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.578 2.186 . . . . 0.0 114.307 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 24.4 p -61.98 -34.1 75.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.457 0.646 . . . . 0.0 110.383 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.4 -8.66 42.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.402 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.531 ' CG ' ' HB1' ' A' ' 90' ' ' ALA . 16.9 tpt -79.7 -33.34 41.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -79.95 -26.75 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.049 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -52.05 -62.04 3.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.269 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 42' ' ' LYS . 83.9 Cg_endo -80.39 -41.2 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 120.152 1.09 . . . . 0.0 113.706 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.473 ' HE2' ' CB ' ' A' ' 90' ' ' ALA . 2.8 tmm? -62.04 -36.21 80.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.246 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -82.17 -35.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.288 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -64.57 -23.43 67.26 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.189 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 27.0 mtpp -85.56 -26.05 26.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -60.69 -42.07 96.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.965 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -15.43 49.35 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 122.054 -0.404 . . . . 0.0 111.008 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 24.0 tt0 -56.53 -39.18 72.94 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.22 -50.23 8.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.908 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.584 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 14.3 p90 -134.13 91.02 24.46 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.252 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.99 0.78 8.48 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.885 1.723 . . . . 0.0 111.195 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -9.66 29.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.779 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.84 161.15 13.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.18 130.76 37.81 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HB2' HG21 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -114.96 116.32 28.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.053 -172.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.651 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 88.2 m-85 -140.57 151.34 44.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.526 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 19.5 pttm -148.64 152.44 36.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.15 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 60' ' ' LEU . 6.7 tt -160.33 152.44 20.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.757 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.7 p-10 -99.77 128.54 45.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 111.263 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -72.42 -12.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.082 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.49 -48.6 72.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.025 0.441 . . . . 0.0 109.926 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -80.12 -41.56 25.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.832 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.7 mm? -116.04 71.81 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.142 0.496 . . . . 0.0 112.249 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -75.15 -36.09 46.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.966 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.98 -30.58 71.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.403 0.621 . . . . 0.0 110.79 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 60.7 t -68.99 -52.55 32.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.6 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.91 -40.9 58.08 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.23 0.331 . . . . 0.0 111.238 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 71.6 mt-30 -69.66 -32.04 70.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.8 tptt -62.98 -27.95 69.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.729 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.602 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -103.94 -10.11 18.39 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.3 tt0 80.99 19.49 0.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.201 0.938 . . . . 0.0 111.029 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -96.44 118.66 43.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 121.804 -0.56 . . . . 0.0 110.145 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 m -117.32 -31.33 5.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.618 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.11 163.87 13.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.269 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -144.51 138.51 14.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.609 ' CG ' HD13 ' A' ' 36' ' ' ILE . 59.3 Cg_endo -83.39 152.18 69.03 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.741 -1.775 . . . . 0.0 113.024 -0.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.7 m -131.56 135.03 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.681 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.432 HD22 HD12 ' A' ' 40' ' ' ILE . 4.1 mp -104.9 129.93 53.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.533 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.586 HD21 ' CE2' ' A' ' 78' ' ' PHE . 1.3 mt -120.64 115.67 23.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.011 0.434 . . . . 0.0 110.92 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 2.1 mp -98.81 133.15 43.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CE2' HD21 ' A' ' 76' ' ' LEU . 47.9 m-85 -130.85 153.91 48.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.571 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 4.1 tppp? -132.68 118.15 18.75 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.571 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 8.8 p30 43.78 55.74 4.96 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.255 1.022 . . . . 0.0 113.735 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 80.34 -5.63 63.08 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.601 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.97 160.08 16.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.19 178.52 4.39 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -149.23 -34.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 163.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -167.01 157.17 11.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.465 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 pttt -152.03 134.71 15.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 t -132.1 124.5 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.343 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.09 52.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.203 0.525 . . . . 0.0 111.27 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.34 126.83 0.85 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.824 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -63.4 121.44 13.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.435 0.636 . . . . 0.0 111.558 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -117.24 90.69 34.76 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.999 176.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 51.1 Cg_exo -21.37 -75.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.377 4.051 . . . . 0.0 115.926 -171.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.0 -34.44 24.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.72 -29.58 70.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.433 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 99' ' ' ILE . 37.9 mm -73.35 -43.69 56.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.067 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 87.4 mttt -64.26 -24.83 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.634 0.73 . . . . 0.0 109.806 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -84.09 -29.04 27.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.676 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.13 -54.35 31.27 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.98 0.419 . . . . 0.0 110.207 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.572 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.8 mm -50.89 -39.79 19.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.646 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.94 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.383 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.18 41.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' ND2' HD22 ' A' ' 77' ' ' LEU . 47.5 m-80 -96.55 -15.34 21.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.968 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.791 177.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.597 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.957 0.408 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 52' ' ' PHE . 62.4 t -119.79 138.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 23.4 m -90.24 131.62 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.649 0.738 . . . . 0.0 112.555 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.457 ' OE1' ' HG3' ' A' ' 54' ' ' LYS . 8.5 mm100 -69.01 137.54 53.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.939 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -83.26 170.5 14.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.798 169.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.538 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 3.7 mtpm? -122.7 -41.38 2.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -140.67 179.28 6.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.873 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -66.09 -27.84 68.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.513 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -59.45 -46.99 87.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -53.13 -44.2 67.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.369 172.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.734 ' O ' HG12 ' A' ' 15' ' ' ILE . 14.8 t80 -59.84 -60.91 3.07 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.85 -39.78 65.91 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.939 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -64.29 -44.8 90.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.4 75.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.144 0.497 . . . . 0.0 110.312 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 11' ' ' PHE . 13.6 mm -63.49 -38.13 81.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.55 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.55 6.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.449 ' HB3' ' CD ' ' A' ' 19' ' ' LYS . 25.4 mt-30 -83.69 141.95 31.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.539 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 32.23 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 111.966 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.75 178.98 6.7 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -74.58 122.32 22.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.5 t -101.15 111.2 30.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -93.54 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 176.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.637 HG12 ' CE2' ' A' ' 11' ' ' PHE . 57.1 t -103.54 123.78 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.86 0.838 . . . . 0.0 111.188 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.649 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -95.98 96.63 9.02 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.215 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -99.29 130.63 45.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.8 p90 -157.49 -171.77 3.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.908 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -142.1 139.29 32.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -15.25 62.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -87.58 -12.74 44.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.014 0.435 . . . . 0.0 110.619 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.0 t -83.24 149.91 26.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.025 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.71 -67.89 1.58 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.791 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 41.7 Cg_endo -69.21 12.8 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.099 2.533 . . . . 0.0 114.356 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 26.5 p -63.94 -32.71 74.34 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.087 0.946 . . . . 0.0 109.879 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.652 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 44.2 mtmt -69.16 -8.86 49.43 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.009 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.45 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.31 -33.11 49.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -76.22 -24.55 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.814 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.584 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -55.77 -65.37 1.54 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.587 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.2 Cg_endo -82.91 -35.62 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.606 1.537 . . . . 0.0 113.238 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.51 ' HE3' ' HA ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.41 -40.16 95.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.623 0.725 . . . . 0.0 109.936 -175.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.12 -38.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.754 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.597 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 44.5 mt-10 -65.28 -29.57 70.35 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.525 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 13.1 mmmm -66.92 -40.2 87.57 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.444 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.0 m-30 -52.51 -62.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.781 0.324 . . . . 0.0 111.207 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.8 p -77.16 -13.29 59.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.731 0.301 . . . . 0.0 111.368 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.7 -39.68 85.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -81.84 -42.67 19.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.044 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.5 p90 -130.0 89.82 44.42 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 111.927 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.39 0.74 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.189 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -64.96 -12.11 46.14 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.207 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.32 147.13 26.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.903 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.509 ' HB2' HG23 ' A' ' 2' ' ' VAL . 2.3 p90 -91.51 116.09 28.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.142 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 3' ' ' THR . 94.9 m-85 -141.19 155.17 46.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HG3' ' OE1' ' A' ' 4' ' ' GLN . 19.3 ptmt -149.29 151.86 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.871 -172.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD23 ' HB2' ' A' ' 60' ' ' LEU . 10.1 tt -159.55 148.34 17.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.746 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.6 p-10 -101.65 120.75 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.221 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG11 ' CE ' ' A' ' 72' ' ' MET . 3.6 p -67.13 -16.75 21.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.611 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.85 -49.14 63.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.291 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -90.77 -42.98 10.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.819 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -105.33 73.65 1.05 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.548 0.689 . . . . 0.0 111.866 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -69.61 -43.64 67.29 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.135 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 3.7 p30 -67.63 -20.9 65.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 0.0 110.797 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 HD22 ' A' ' 67' ' ' ASN . 96.1 t -69.75 -51.98 35.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 69' ' ' VAL . . . -51.31 -40.44 59.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.343 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.2 pt20 -68.31 -36.12 78.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.088 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.26 -28.67 68.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.777 176.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.587 ' HB2' HG13 ' A' ' 69' ' ' VAL . 39.7 m-20 -102.77 -13.12 17.16 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.281 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 5.4 tp10 80.08 19.88 0.59 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.467 1.104 . . . . 0.0 111.067 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -95.09 119.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.187 0.518 . . . . 0.0 109.757 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -134.45 8.21 3.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.402 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.53 153.69 38.88 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.462 ' CE ' HG11 ' A' ' 57' ' ' VAL . 2.2 mpt? -129.8 130.68 23.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.915 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HB2' HG12 ' A' ' 36' ' ' ILE . 60.2 Cg_endo -86.14 165.76 51.87 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.247 -1.564 . . . . 0.0 112.377 -5.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.1 m -141.56 128.91 21.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.508 0.671 . . . . 0.0 111.09 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.457 HD23 HG23 ' A' ' 95' ' ' ILE . 4.1 mp -97.68 123.51 41.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.044 173.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.9 mt -115.9 113.79 23.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.317 0.58 . . . . 0.0 110.742 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD22 ' HB2' ' A' ' 85' ' ' ALA . 2.1 mp -99.24 127.53 45.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.04 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE1' HD22 ' A' ' 76' ' ' LEU . 48.8 m-85 -128.08 159.14 36.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.546 0.212 . . . . 0.0 111.219 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -143.81 135.8 26.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p30 49.54 41.57 21.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.183 0.993 . . . . 0.0 113.319 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.457 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 83.39 1.49 90.29 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.576 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -122.67 161.09 24.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.5 tt0 -68.88 179.61 1.76 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 118.404 0.547 . . . . 0.0 109.77 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -149.11 -28.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.497 162.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.495 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -163.95 152.64 13.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.098 0.475 . . . . 0.0 111.61 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -142.92 120.11 11.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.311 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.6 128.6 63.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.831 0.348 . . . . 0.0 110.978 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -99.8 52.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.126 0.488 . . . . 0.0 110.957 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.57 124.86 0.89 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.291 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -65.62 102.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.925 0.49 . . . . 0.0 112.131 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.43 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.0 89.52 34.64 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.176 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 29.5 Cg_exo -32.82 -66.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.326 3.351 . . . . 0.0 115.378 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.47 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.29 68.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.67 0.271 . . . . 0.0 111.69 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.531 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.3 mm -87.66 -33.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.083 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -61.55 -32.27 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.457 0.646 . . . . 0.0 109.512 170.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -71.59 -32.84 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.17 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.3 -52.27 48.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.123 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -53.36 -36.9 27.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -30.98 60.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.098 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.86 -37.41 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.499 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -86.83 -20.15 27.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.267 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.086 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HE1' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 52' ' ' PHE . 83.4 t -121.57 131.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.464 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.5 m -74.14 144.8 44.73 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -170.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 55' ' ' LEU . 20.9 tp60 -101.16 122.71 44.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.657 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.643 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.2 m-85 -84.46 160.13 20.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.652 173.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -135.44 -1.76 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 166.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.0 p -140.46 159.82 41.35 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -72.97 -28.72 62.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.37 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.62 -42.87 93.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -54.67 -44.2 73.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.716 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.643 ' O ' HG12 ' A' ' 15' ' ' ILE . 18.5 t80 -57.53 -60.68 3.3 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -55.12 -40.62 70.72 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.708 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.8 t -58.77 -45.49 89.66 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.944 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.72 76.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.5 mm -65.97 -36.09 76.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.553 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 12.73 0.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -88.11 150.84 23.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.681 0.277 . . . . 0.0 110.585 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.52 36.9 0.49 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 110.766 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 79' ' ' LYS . 19.6 ptpt -137.3 177.49 7.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' A' ' 102' ' ' ASN . 2.2 tm? -82.38 118.49 23.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.0 t -102.78 119.99 51.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.832 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 31.2 t -107.13 106.79 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.595 HG13 ' CE2' ' A' ' 11' ' ' PHE . 11.9 t -101.76 123.79 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.94 0.876 . . . . 0.0 110.643 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -95.39 97.61 9.95 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.106 -174.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.63 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.2 m-85 -102.57 126.67 49.71 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.552 0.692 . . . . 0.0 111.866 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.63 174.85 12.97 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . . . -125.64 124.5 41.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.57 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -19.48 65.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.106 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -90.76 -6.98 53.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 54.1 t -93.29 152.42 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.559 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.21 -72.01 0.74 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.668 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 59.8 Cg_endo -76.39 31.58 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.904 2.402 . . . . 0.0 114.512 -172.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.19 -34.74 75.4 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.914 0.864 . . . . 0.0 110.114 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -68.1 -7.28 28.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.984 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.521 ' CG ' ' HB1' ' A' ' 90' ' ' ALA . 17.0 tpt -75.89 -35.2 59.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 109.067 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.645 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -80.19 -25.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.017 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -52.79 -63.04 2.58 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.764 176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 95.7 Cg_endo -82.23 -34.98 0.38 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.035 1.156 . . . . 0.0 113.652 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.459 ' HE3' ' CB ' ' A' ' 90' ' ' ALA . 3.2 tmm? -65.03 -37.89 89.07 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.187 0.518 . . . . 0.0 110.017 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -78.98 -36.26 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.798 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -63.94 -26.16 68.46 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.936 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 94.2 mttt -80.03 -34.92 37.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.5 p90 -55.51 -48.56 74.44 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.229 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 79.0 p -85.37 -14.4 46.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.51 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.42 -38.69 69.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.579 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -90.61 -37.93 13.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.399 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.582 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 12.3 p90 -132.72 90.7 31.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.683 . . . . 0.0 112.835 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.23 0.08 6.53 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.728 2.286 . . . . 0.0 112.645 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -14.88 62.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.977 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.7 154.83 18.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.54 127.79 37.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.874 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.506 ' HB2' HG23 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -100.78 116.11 31.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.233 -173.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.1 m-85 -138.23 150.94 47.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.655 0.264 . . . . 0.0 111.353 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 33.6 mtmt -134.38 158.5 43.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.755 0.822 . . . . 0.0 110.233 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.63 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.3 tt -160.43 141.61 12.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 110.79 170.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.85 117.24 29.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG23 ' HE1' ' A' ' 72' ' ' MET . 1.9 m -65.87 -19.08 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.491 0.663 . . . . 0.0 109.672 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.83 -38.31 78.4 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.059 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -96.38 -38.79 9.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.806 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.7 mm? -121.1 76.11 1.2 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.095 0.474 . . . . 0.0 111.682 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.5 78.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.259 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.25 -35.54 80.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.156 0.503 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 62.1 t -64.59 -48.71 83.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.23 -39.49 60.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.195 0.522 . . . . 0.0 110.773 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -74.86 -29.3 60.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.522 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.585 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -62.37 -27.49 69.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.052 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.585 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 30.1 m-20 -104.38 -13.1 16.22 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.315 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 39.7 mt-10 80.63 31.23 0.18 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.532 1.145 . . . . 0.0 111.045 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -107.94 107.71 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.552 . . . . 0.0 110.113 170.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 m -115.31 -10.59 12.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.758 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.46 142.33 36.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.487 ' HE1' HG23 ' A' ' 57' ' ' VAL . 2.0 mpt? -130.87 140.99 40.35 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.74 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 36' ' ' ILE . 58.9 Cg_endo -81.1 163.75 78.96 Favored 'Cis proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.858 -1.726 . . . . 0.0 113.305 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.6 m -148.78 138.22 21.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.043 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD23 ' HE1' ' A' ' 39' ' ' MET . 4.2 mp -106.56 130.28 54.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.305 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.654 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -120.41 114.07 21.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.016 0.436 . . . . 0.0 110.39 175.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.634 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -97.0 133.35 41.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.654 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.0 m-85 -130.31 152.85 49.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.8 tppp? -127.08 110.11 12.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.404 168.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.9 t30 57.44 56.46 5.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 111.788 167.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 72.86 12.27 78.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.731 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -131.42 159.23 38.63 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 178.22 4.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.48 -32.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 164.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.418 ' HB2' HD23 ' A' ' 77' ' ' LEU . . . -167.98 154.54 7.71 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.508 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.99 134.15 19.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.174 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.79 122.12 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.173 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.39 55.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.134 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.78 135.42 2.0 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.645 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -67.76 122.6 18.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.091 0.472 . . . . 0.0 111.523 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -117.73 90.29 35.59 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 29.2 Cg_exo -21.03 -78.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.639 4.226 . . . . 0.0 116.102 -169.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.78 -31.64 25.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . . . -63.53 -32.01 73.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.69 0.281 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.549 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.6 mm -71.35 -43.73 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.175 175.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 27.1 mmtp -61.8 -35.16 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -69.25 -37.51 77.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.459 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.6 -61.18 2.8 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -48.3 -35.3 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.956 0.785 . . . . 0.0 110.756 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.25 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.977 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -31.96 17.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 110.287 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.634 ' ND2' HD22 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -91.67 -13.75 31.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.728 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.86 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.703 0.287 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.8 t -99.65 128.26 51.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 -176.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.601 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 6.8 m -70.52 145.4 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.6 mm-40 -87.39 139.08 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.534 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.649 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.0 m-85 -102.52 148.08 25.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -129.54 1.41 5.01 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.663 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 24.0 p -142.13 156.59 45.37 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.991 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.971 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -58.32 -41.95 85.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.663 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.649 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mt-10 -56.15 -48.29 76.56 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.279 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.727 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.1 t80 -55.07 -57.98 9.52 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.12 -33.26 68.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.488 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -65.13 -49.73 68.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.54 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.72 75.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 11' ' ' PHE . 15.6 mm -62.94 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.827 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 13.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.532 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -89.52 147.08 24.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.848 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.58 52.44 1.88 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.251 0.548 . . . . 0.0 112.145 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 51' ' ' ASP . 18.8 ptpt -154.86 178.49 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CD2' HG23 ' A' ' 84' ' ' VAL . 2.0 tm? -76.59 118.86 19.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -102.78 124.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.806 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 17.2 t -113.74 111.13 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 11' ' ' PHE . 11.6 t -108.29 129.08 63.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.827 0.822 . . . . 0.0 110.95 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.668 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -97.04 101.11 12.62 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.905 -175.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE2' HD21 ' A' ' 55' ' ' LEU . 2.7 m-85 -108.48 115.65 30.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.332 0.587 . . . . 0.0 111.673 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 37.5 p90 -139.98 175.33 9.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.801 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.8 131.39 53.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.705 0.288 . . . . 0.0 110.572 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -26.99 69.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.419 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -81.34 -8.83 59.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.416 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.7 t -87.71 159.02 18.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.859 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.66 -67.2 1.46 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.344 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 39.8 Cg_endo -68.11 10.92 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.247 2.632 . . . . 0.0 114.219 -175.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.2 p -61.88 -34.52 76.16 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 21.8 ptmt -67.71 -8.62 36.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.666 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 21.2 ttt -82.55 -27.3 31.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.702 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -77.23 -25.16 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.064 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.83 -64.6 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.848 173.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.8 Cg_endo -82.95 -30.47 0.94 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 120.765 1.309 . . . . 0.0 114.411 -175.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.401 ' HE2' HD21 ' A' ' 75' ' ' LEU . 3.6 tmm? -70.45 -33.94 71.87 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.455 0.645 . . . . 0.0 109.767 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -83.63 -34.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.932 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 37.7 mt-10 -65.64 -21.6 66.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.274 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 55.1 tttm -79.87 -36.0 37.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.886 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.4 p90 -58.87 -46.36 87.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.183 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.3 p -85.26 -14.67 45.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.476 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 6.8 tp10 -60.67 -31.67 70.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.35 -50.1 9.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.723 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.583 ' O ' ' HD1' ' A' ' 47' ' ' TYR . 3.9 p90 -134.79 92.8 18.68 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.732 0.777 . . . . 0.0 112.923 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.9 -0.26 5.97 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.198 1.932 . . . . 0.0 112.338 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -67.11 -16.87 64.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.774 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.92 152.01 20.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -91.53 140.1 30.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.337 -175.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -113.21 115.18 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.947 -172.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.601 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -139.03 147.85 42.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.626 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.514 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 21.4 pttm -145.52 153.58 41.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.833 -174.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.637 HD21 ' CE2' ' A' ' 25' ' ' PHE . 8.0 tt -159.78 146.84 16.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.78 0.324 . . . . 0.0 110.687 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.2 m-20 -92.84 121.91 34.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG22 ' CE ' ' A' ' 72' ' ' MET . 1.3 m -68.31 -16.6 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.248 0.547 . . . . 0.0 110.04 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.79 -39.55 91.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -79.21 -41.96 27.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 60.7 mt -136.96 83.58 2.01 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.449 0.642 . . . . 0.0 111.865 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -72.55 -38.04 57.84 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.499 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.13 -27.21 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.395 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 91.1 t -67.47 -55.8 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.573 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -49.86 -41.15 44.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 111.14 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -69.2 -31.48 70.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.264 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 8.0 tptt -63.94 -25.78 68.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.31 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.59 ' HB2' HG13 ' A' ' 69' ' ' VAL . 14.8 m-20 -102.97 -12.91 17.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 17.9 tp10 80.78 28.36 0.21 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.505 1.128 . . . . 0.0 110.645 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -106.58 116.41 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.248 0.546 . . . . 0.0 110.011 170.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -117.47 -30.94 5.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.22 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.46 13.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.173 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.46 ' CE ' HG22 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -150.0 143.5 16.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 111.016 -179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.581 ' CG ' HD12 ' A' ' 36' ' ' ILE . 58.5 Cg_endo -80.04 149.74 80.84 Favored 'Cis proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.445 -1.898 . . . . 0.0 113.036 -3.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -130.48 138.35 50.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.218 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 39' ' ' MET . 4.1 mp -108.98 130.5 55.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.515 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.546 HD21 ' CE2' ' A' ' 78' ' ' PHE . 3.1 mt -119.6 116.13 25.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.188 0.518 . . . . 0.0 110.825 176.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -99.08 128.33 45.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.915 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.546 ' CE2' HD21 ' A' ' 76' ' ' LEU . 62.3 m-85 -131.13 155.9 46.19 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.941 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.545 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 40.3 ttmt -134.97 125.47 26.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.545 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.4 p-10 43.67 56.47 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 78.27 -1.66 69.5 Favored Glycine 0 CA--C 1.51 -0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.653 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -118.94 160.09 22.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HA ' ' CD1' ' A' ' 78' ' ' PHE . 28.6 tt0 -72.94 179.12 3.87 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -153.25 -32.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.657 163.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.42 157.37 7.31 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.893 0.377 . . . . 0.0 111.954 177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 132.07 15.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.339 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 95' ' ' ILE . 55.2 t -133.27 132.32 58.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.308 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.67 50.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.075 0.464 . . . . 0.0 111.574 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.49 134.88 1.82 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.666 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -65.18 112.85 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.275 0.56 . . . . 0.0 111.421 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.97 90.2 32.11 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.426 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 32.8 Cg_exo -28.79 -68.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.933 3.755 . . . . 0.0 115.147 -170.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.21 -40.07 18.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -64.78 -30.44 71.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.406 HD13 HG11 ' A' ' 87' ' ' VAL . 25.9 mm -74.59 -51.49 22.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.999 0.428 . . . . 0.0 110.226 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 9.9 mtmp? -64.36 -23.3 67.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -82.98 -25.83 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.47 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.73 12.53 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.531 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 11.6 mt -50.36 -43.61 22.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.551 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.8 74.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.004 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.384 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -82.77 -17.66 43.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.373 176.165 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 tpp . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.139 0.495 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 52' ' ' PHE . 53.5 t -88.78 131.39 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.225 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -72.23 144.16 48.56 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -90.65 135.85 33.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.656 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 7.6 m-85 -82.64 170.02 15.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.359 0.6 . . . . 0.0 110.773 172.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 36.8 mttp -129.71 -27.16 2.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.21 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 26.2 p -147.48 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -69.95 -26.42 64.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.93 -43.11 99.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.673 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.8 mm-40 -52.74 -45.56 67.06 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.673 ' O ' HG12 ' A' ' 15' ' ' ILE . 20.5 t80 -60.08 -62.48 1.84 Allowed 'General case' 0 N--CA 1.458 -0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.055 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.32 -37.35 74.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.112 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -61.34 -45.95 92.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.691 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.09 82.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 110.21 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 11' ' ' PHE . 10.5 mm -64.16 -37.08 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.627 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 1.79 4.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.382 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 26.2 mt-30 -78.31 136.9 37.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.983 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 26.3 t0 -81.61 46.55 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.995 0.902 . . . . 0.0 110.285 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 19.8 ptpt -131.38 179.43 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.312 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 99' ' ' ILE . 1.9 tm? -83.43 113.95 21.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 3.5 t -104.51 121.33 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.88 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.7 t -108.8 114.95 48.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 11' ' ' PHE . 21.9 t -107.68 129.25 62.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -98.23 100.96 12.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.663 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CE2' HD21 ' A' ' 55' ' ' LEU . 2.2 m-85 -103.66 120.86 41.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.499 0.666 . . . . 0.0 111.585 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 39.6 p90 -152.23 161.24 42.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.769 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -113.5 133.55 55.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.664 0.268 . . . . 0.0 110.34 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.5 p -65.96 -21.54 66.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.418 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -77.83 -18.28 56.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.053 0.454 . . . . 0.0 110.387 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 48.1 t -82.38 147.06 29.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 -177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.58 -64.08 2.34 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.331 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 43.8 Cg_endo -68.06 10.5 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.284 2.656 . . . . 0.0 114.743 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 27.6 p -66.28 -24.79 66.62 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.833 0.825 . . . . 0.0 110.033 177.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.9 mttp -61.96 -20.64 64.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.94 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.451 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -68.16 -37.89 81.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 109.488 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 0.8 OUTLIER -74.36 -25.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.06 -65.87 0.98 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.145 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.6 Cg_endo -83.26 -31.73 0.61 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 CA-C-N 121.066 1.416 . . . . 0.0 114.298 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.46 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.4 tmm? -67.96 -34.75 77.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.499 0.666 . . . . 0.0 109.68 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -82.18 -37.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.28 -179.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 2' ' ' VAL . 36.3 mt-10 -64.56 -23.25 67.2 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.666 171.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -77.93 -36.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.995 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -58.61 -41.85 86.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.995 -179.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.18 -16.92 41.69 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.961 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.52 -27.24 68.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.02 -47.45 8.11 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.306 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.594 ' OH ' ' HB ' ' A' ' 99' ' ' ILE . 8.0 p90 -137.48 93.15 12.87 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 121.645 0.736 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.66 2.52 3.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.235 1.956 . . . . 0.0 111.662 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.04 -23.27 67.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.171 179.042 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.13 154.52 18.36 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.9 123.68 34.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.225 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.7 p90 -96.05 116.35 28.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 99.2 m-85 -139.75 151.7 46.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.321 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . 63.9 pttt -149.13 161.88 41.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 -175.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD21 ' CE2' ' A' ' 25' ' ' PHE . 7.9 tt -159.23 145.3 16.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.227 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t0 -90.98 116.47 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.077 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.48 -23.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -68.03 -34.37 76.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.342 0.591 . . . . 0.0 109.739 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -78.89 -42.01 28.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.056 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 91.1 mt -136.3 78.48 1.71 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.537 0.684 . . . . 0.0 111.971 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -69.03 -32.69 73.34 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.455 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.44 -36.9 81.68 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.085 0.469 . . . . 0.0 110.984 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 HD22 ' A' ' 67' ' ' ASN . 93.0 t -64.19 -49.01 83.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.892 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' VAL . . . -52.06 -38.27 56.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 25.3 mt-30 -70.5 -34.21 72.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.415 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 2.7 tptp -61.76 -25.86 67.72 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.188 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.587 ' HB2' HG13 ' A' ' 69' ' ' VAL . 17.1 m-20 -106.94 -13.05 15.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.272 -0.267 . . . . 0.0 111.627 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 13.3 tp10 79.82 31.26 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.378 1.049 . . . . 0.0 110.906 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.16 114.98 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.135 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.6 t -120.3 -19.12 7.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.891 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.64 156.58 16.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.731 0.301 . . . . 0.0 110.756 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -126.66 127.95 24.39 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.418 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HB2' HG12 ' A' ' 36' ' ' ILE . 17.8 Cg_endo -89.26 164.4 37.8 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.605 -0.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.3 m -141.47 131.8 25.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.604 . . . . 0.0 111.302 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.8 mp -102.34 135.78 43.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.474 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.7 HD22 ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -125.17 113.43 17.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.271 0.558 . . . . 0.0 110.58 172.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 85' ' ' ALA . 3.8 mp -93.95 130.05 40.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.7 ' CE2' HD22 ' A' ' 76' ' ' LEU . 43.4 m-85 -128.64 154.86 45.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.745 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 58.2 tttm -134.05 125.58 28.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.21 166.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 3.7 p-10 46.58 49.05 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.343 1.057 . . . . 0.0 113.553 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 81.53 -1.78 84.62 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.837 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HE2' HD22 ' A' ' 80' ' ' ASN . 37.8 mtmt -115.11 160.12 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -71.82 179.76 3.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.86 -32.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.478 163.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -171.67 140.58 1.35 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.05 136.17 41.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.81 123.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 m -88.34 58.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.12 137.42 2.2 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.969 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -68.46 118.76 11.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.04 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.03 89.93 31.52 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 89.8 Cg_exo -22.67 -80.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 1 C-N-CA 125.449 4.1 . . . . 0.0 115.537 -169.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 92' ' ' PRO . . . -84.09 -27.94 27.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.77 78.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.085 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.35 -46.32 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.1 mttt -64.0 -23.15 67.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.855 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.53 -33.64 36.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.521 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -67.46 -52.98 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.594 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.19 -42.22 25.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.571 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.13 63.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -36.45 57.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.492 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.3 m-80 -83.76 -21.91 32.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.842 178.417 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.763 0.315 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 40' ' ' ILE . 94.0 t -85.51 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.141 0.496 . . . . 0.0 111.028 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.1 m -80.02 144.29 33.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.967 -171.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.9 tp-100 -93.3 136.79 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.168 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 8.6 m-85 -83.59 170.01 14.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.715 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 42.6 mtpt -123.55 -40.6 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.527 176.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -142.48 179.95 6.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' HG11 ' A' ' 63' ' ' VAL . . . -66.46 -25.76 66.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.652 0.263 . . . . 0.0 110.393 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -58.02 -49.99 74.96 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 6' ' ' LYS . 1.6 mp0 -55.16 -41.69 72.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.692 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.655 ' CE2' HG12 ' A' ' 23' ' ' VAL . 27.0 t80 -61.17 -59.76 4.81 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.61 -35.81 75.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.547 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -61.5 -45.03 95.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -32.7 74.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 110.342 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 11' ' ' PHE . 10.1 mm -63.54 -39.26 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 5.76 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.442 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.77 140.83 39.5 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.63 38.57 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.382 0.611 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -145.22 176.29 9.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.95 122.45 22.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.2 t -100.54 111.24 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.047 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.42 103.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.655 HG12 ' CE2' ' A' ' 11' ' ' PHE . 60.1 t -104.88 119.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.867 0.842 . . . . 0.0 111.166 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -97.05 96.79 8.72 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.74 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.8 m-85 -99.99 113.69 26.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.471 0.653 . . . . 0.0 111.791 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -140.27 163.8 31.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.616 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -115.84 134.54 54.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.5 p -60.67 -26.13 66.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.671 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -78.58 -15.47 58.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.418 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 44.7 t -80.7 144.38 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.071 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.47 -67.63 1.9 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.274 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 66.0 Cg_endo -74.22 20.73 0.4 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.942 2.428 . . . . 0.0 114.321 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.0 p -68.02 -27.92 66.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.839 0.828 . . . . 0.0 109.556 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.6 pttt -68.25 -7.65 32.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.041 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.449 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -79.67 -35.91 38.48 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.647 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.2 mp -75.49 -25.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.039 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -57.31 -61.55 6.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.809 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 88.0 Cg_endo -83.41 -30.67 0.78 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.417 1.412 . . . . 0.0 114.219 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.552 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 ttp -66.15 -50.41 64.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.67 0.668 . . . . 0.0 109.199 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -65.56 -37.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.228 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 26.6 tt0 -69.02 -27.81 66.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.2 0.524 . . . . 0.0 110.057 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -74.84 -29.05 60.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.052 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.552 ' CE1' ' HG2' ' A' ' 39' ' ' MET . 18.7 m-30 -51.49 -64.0 0.95 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 110.245 175.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 60.5 p -79.27 -14.11 59.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.1 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -58.38 -35.77 72.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -83.15 -47.97 11.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.2 p90 -129.3 91.34 42.0 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.204 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.57 1.5 5.56 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.707 2.271 . . . . 0.0 111.668 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.35 -24.05 67.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.776 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.59 154.73 18.85 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.306 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.414 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -92.47 141.6 28.34 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.026 -176.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.2 p90 -111.22 115.13 28.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.99 -172.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 3' ' ' THR . 97.3 m-85 -140.59 152.0 45.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.8 pttt -149.92 159.44 44.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.571 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.0 tt -158.73 150.76 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.631 0.253 . . . . 0.0 110.41 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 19.8 t0 -93.81 115.78 28.21 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.743 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -61.95 -25.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.829 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -37.31 86.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.421 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -84.94 -42.19 15.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.6 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.7 mm? -121.95 73.39 1.08 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.387 0.613 . . . . 0.0 112.12 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.86 -24.59 73.79 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.196 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 16.2 t70 -66.1 -27.63 68.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.594 0.712 . . . . 0.0 110.523 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 18.4 t -75.24 -52.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.202 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.05 -20.78 10.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.8 pt20 -85.82 -31.92 22.04 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.573 0.702 . . . . 0.0 110.086 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -27.87 65.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.573 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.0 p30 -108.76 -8.16 15.42 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 24.6 tt0 81.04 16.82 0.53 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.057 0.848 . . . . 0.0 112.095 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.615 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -93.84 109.23 21.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.374 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -108.17 -30.4 8.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.15 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.84 162.95 17.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.266 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -151.37 145.0 17.51 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.73 0.3 . . . . 0.0 110.826 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -79.69 148.58 80.12 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.579 -1.842 . . . . 0.0 112.853 -1.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.2 m -133.68 142.98 48.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 40' ' ' ILE . 3.9 mp -112.34 125.14 53.86 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.766 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.609 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -116.91 113.56 22.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 175.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.3 mp -96.55 134.35 39.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.609 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.2 m-85 -129.43 153.16 48.21 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.597 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -134.01 119.94 19.63 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 46.63 56.7 6.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 77.7 4.43 85.13 Favored Glycine 0 CA--C 1.51 -0.232 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.495 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.4 160.73 28.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.53 179.69 2.9 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.39 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.572 164.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -165.26 155.56 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.587 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -155.5 130.6 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.38 133.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.226 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.63 47.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 0.0 111.373 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.7 130.1 1.31 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.992 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 36' ' ' ILE . . . -65.19 112.03 3.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 89.87 26.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.731 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 56.0 Cg_exo -22.49 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.357 4.038 . . . . 0.0 115.667 -171.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 -28.82 29.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.99 74.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.799 0.333 . . . . 0.0 111.222 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.477 HG22 HD23 ' A' ' 75' ' ' LEU . 45.9 mm -83.38 -32.76 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.428 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.731 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.5 mttt -57.65 -47.44 82.26 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -60.19 -32.29 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.64 61.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.2 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.475 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 4.4 mm -54.0 -41.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.047 0.451 . . . . 0.0 110.647 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -25.72 63.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.204 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.96 19.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.472 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -79.91 -16.93 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.069 -172.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.223 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 46.2 ttm . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.04 0.447 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.472 ' HB ' ' HD2' ' A' ' 54' ' ' LYS . 85.5 t -81.22 136.6 22.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.747 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.5 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.7 m -83.47 143.9 29.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.208 0.527 . . . . 0.0 112.335 -172.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.2 tp-100 -94.82 132.47 39.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.645 -175.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.647 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 13.0 m-85 -93.11 160.41 14.87 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.669 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.6 ptpp? -135.9 -4.45 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.817 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 18.8 p -141.89 157.29 45.16 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 111.368 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . . . -71.41 -29.03 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.013 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -62.92 -38.15 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.669 ' OE1' ' HG2' ' A' ' 6' ' ' LYS . 24.5 mt-10 -55.44 -44.0 75.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.441 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.671 ' CE2' HG13 ' A' ' 23' ' ' VAL . 24.1 t80 -56.21 -56.3 22.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.39 -44.16 79.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -57.38 -38.48 74.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.82 64.3 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 11' ' ' PHE . 14.3 mm -65.01 -40.53 89.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.63 13.51 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.048 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -85.49 140.21 30.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -79.38 47.39 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.432 0.634 . . . . 0.0 109.984 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HB2' ' HZ3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -154.2 178.97 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.469 177.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD1' HG21 ' A' ' 99' ' ' ILE . 1.6 tm? -75.74 123.89 26.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.076 0.465 . . . . 0.0 110.782 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -105.36 116.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.208 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.89 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.671 HG13 ' CE2' ' A' ' 11' ' ' PHE . 40.5 t -102.82 126.06 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.741 0.781 . . . . 0.0 111.351 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -105.03 97.31 7.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.762 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.4 m-85 -104.35 116.82 32.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.613 0.721 . . . . 0.0 111.953 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 p90 -135.67 173.88 11.23 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.136 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.787 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -125.41 130.74 52.47 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -63.3 -19.48 64.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -92.97 -13.07 29.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.396 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.787 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 59.8 m -75.55 159.81 30.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.312 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.32 -83.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.227 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 89.0 Cg_endo -79.37 36.02 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.094 2.529 . . . . 0.0 113.858 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 p -65.3 -36.97 85.7 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 122.04 0.924 . . . . 0.0 109.814 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.82 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 7.7 ttpm? -68.05 -11.33 58.79 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.536 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.31 70.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.552 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -74.52 -24.66 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.932 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -52.3 -67.52 0.53 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.824 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.82 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 3.9 Cg_endo -85.32 -23.86 2.19 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 121.457 1.556 . . . . 0.0 113.621 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.535 ' HG3' ' HA ' ' A' ' 92' ' ' PRO . 2.7 ttp -71.74 -44.54 63.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.35 0.595 . . . . 0.0 109.733 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -73.36 -36.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.241 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 tp10 -63.01 -29.81 71.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.525 174.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -74.4 -33.87 63.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.474 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 19.9 m-85 -57.24 -57.72 11.39 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 p -76.91 -14.22 59.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.932 0.396 . . . . 0.0 110.805 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.3 -35.14 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -84.51 -44.56 13.48 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.595 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' HH ' ' HB ' ' A' ' 99' ' ' ILE . 3.4 p90 -129.7 89.54 46.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.641 0.734 . . . . 0.0 112.042 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.2 -0.69 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.219 1.946 . . . . 0.0 112.152 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.99 -3.71 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.3 163.08 12.69 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.436 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.38 139.72 30.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.237 -177.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.4 p90 -122.96 114.58 20.62 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.551 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.5 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 96.9 m-85 -141.06 148.4 40.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 17.4 ptmt -148.48 152.58 37.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 -172.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.625 HD23 ' CE2' ' A' ' 25' ' ' PHE . 6.4 tt -160.88 149.02 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.603 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 8.1 p-10 -100.04 129.89 46.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.474 0.654 . . . . 0.0 110.831 174.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG23 ' HE1' ' A' ' 72' ' ' MET . 2.4 m -72.6 -11.79 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.081 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.6 -44.16 74.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -79.61 -41.53 26.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.969 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.9 mm? -122.42 79.1 1.58 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.696 0.76 . . . . 0.0 112.838 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.03 -38.83 34.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.001 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -68.46 -24.69 64.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.173 0.486 . . . . 0.0 110.619 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.48 -50.0 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -52.99 -39.29 62.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.867 175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -70.4 -28.59 65.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.84 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.558 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 9.6 tptt -67.38 -27.87 67.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.487 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.558 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 14.1 m-20 -104.54 -7.91 19.4 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 -170.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 32.9 tt0 80.88 17.4 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.469 1.105 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -93.29 106.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.627 0.727 . . . . 0.0 109.918 175.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 p -114.47 -18.38 11.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.832 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 147.06 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.548 ' HE1' HG23 ' A' ' 57' ' ' VAL . 1.9 mpt? -135.89 143.85 46.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.17 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 67.4 Cg_endo -80.78 153.19 82.77 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.287 -1.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -135.01 143.36 46.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.887 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -115.39 128.36 56.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.333 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.84 114.13 21.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 85' ' ' ALA . 6.5 mp -94.07 126.26 39.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.086 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.462 ' CG ' HD13 ' A' ' 15' ' ' ILE . 52.8 m-85 -125.32 151.95 45.37 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.579 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -136.96 112.99 9.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.048 0.451 . . . . 0.0 110.475 172.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.68 55.33 4.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.115 175.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 70.53 10.38 66.68 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.248 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -127.38 159.82 33.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -73.85 179.74 4.11 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -153.65 -30.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 165.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -162.01 157.95 24.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 111.557 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -147.57 121.66 9.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.416 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG22 HD12 ' A' ' 95' ' ' ILE . 21.3 t -131.04 135.34 60.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 -172.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.31 49.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.925 0.393 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.25 122.63 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.686 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -58.35 105.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.453 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.69 88.64 35.53 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.524 175.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.535 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.7 Cg_exo -35.45 -59.08 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.414 3.409 . . . . 0.0 115.411 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -50.09 8.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -31.93 71.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 75' ' ' LEU . 22.2 mm -84.52 -36.05 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.569 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 8.9 tmtt? -58.44 -38.98 78.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.73 -23.64 62.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.539 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -77.53 -58.06 3.48 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.7 -40.7 27.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.295 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -34.15 77.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -37.02 69.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 57.5 m-80 -84.73 -19.35 32.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.316 -175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.47 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HB2' ' HE3' ' A' ' 1' ' ' MET . 13.1 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 52' ' ' PHE . 87.8 t -116.86 127.67 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 120.939 0.4 . . . . 0.0 109.942 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -76.14 138.97 41.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.98 126.45 32.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.076 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.712 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.5 m-30 -80.02 169.78 17.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.296 0.569 . . . . 0.0 110.605 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 70.6 mmtt -128.7 -38.3 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.41 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 30.7 p -134.98 178.9 6.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.443 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.44 64.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.07 -44.6 83.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.166 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.712 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 4.5 mm-40 -54.34 -50.53 67.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.307 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.632 ' O ' HG12 ' A' ' 15' ' ' ILE . 12.7 t80 -58.73 -59.33 5.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.14 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 24.5 t70 -63.19 -34.4 77.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.841 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -62.88 -42.87 99.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.62 0.248 . . . . 0.0 110.441 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.74 92.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.6 mm -58.12 -38.41 67.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.022 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.68 5.32 3.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -79.34 150.54 31.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.67 0.272 . . . . 0.0 110.465 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.39 45.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 111.068 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 30.6 pttt -156.91 -179.99 8.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.4 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.0 tm? -79.22 118.81 21.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 0.0 111.265 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -112.82 109.12 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.936 176.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -107.76 116.94 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.697 0.761 . . . . 0.0 110.039 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 11' ' ' PHE . 48.1 t -103.19 128.43 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.934 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.547 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . . . -88.22 97.73 11.18 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.895 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.739 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.71 114.43 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -178.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 17.4 p90 -140.64 -179.56 6.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.852 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.07 130.72 46.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.088 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -66.01 -19.41 65.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.118 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -86.06 -13.35 47.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.632 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 52.0 t -90.35 148.45 22.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.587 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -80.67 -62.33 2.05 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.742 -176.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.571 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.7 Cg_exo -60.24 -7.49 6.74 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.909 2.406 . . . . 0.0 113.894 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 71.5 m -63.89 -26.87 68.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.424 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 55.3 pttt -62.77 -15.96 55.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.777 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.653 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 23.9 ttt -77.46 -27.15 51.98 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.147 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.645 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -75.73 -23.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.735 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.546 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -54.46 -66.57 0.88 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.24 172.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 69.0 Cg_endo -82.52 -34.14 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 CA-C-N 121.055 1.412 . . . . 0.0 114.315 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.587 ' CE ' HG13 ' A' ' 40' ' ' ILE . 2.5 tmm? -66.54 -36.72 83.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.492 0.663 . . . . 0.0 110.085 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.9 mt -81.11 -34.05 13.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -66.31 -25.33 66.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.912 171.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -78.38 -33.59 48.75 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.689 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.634 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -59.57 -47.9 83.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.827 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 97.6 p -85.25 -15.69 42.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.973 -0.454 . . . . 0.0 110.981 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.4 -29.68 70.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -89.02 -50.17 6.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.286 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' A' ' 43' ' ' PHE . 10.1 p90 -124.71 91.27 49.71 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 0.94 5.07 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.066 1.844 . . . . 0.0 111.224 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.0 tt0 -63.02 -23.37 67.42 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.918 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 17.85 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.1 m-20 -91.07 126.7 36.23 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.803 0.811 . . . . 0.0 111.005 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.493 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -103.6 114.17 28.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.282 -172.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.3 m-85 -136.05 147.58 47.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.711 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 76.4 mttt -132.71 152.08 51.81 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.956 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.739 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.8 tt -159.24 149.73 19.43 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.827 0.346 . . . . 0.0 110.711 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.596 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 9.0 t0 -101.43 119.78 39.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.954 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 26' ' ' TYR . 7.7 p -69.74 -21.34 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.97 -37.16 83.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.214 0.53 . . . . 0.0 109.748 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.47 -42.99 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.342 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.622 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -115.02 80.49 1.42 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.13 -40.49 34.37 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.502 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.34 -24.77 65.75 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.116 0.484 . . . . 0.0 110.703 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.622 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 95.3 t -68.0 -51.44 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.361 174.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 69' ' ' VAL . . . -46.67 -42.84 17.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.042 0.448 . . . . 0.0 111.579 174.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -73.73 -25.26 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.858 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 13.5 tptt -69.37 -25.04 63.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.686 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.537 ' HB2' HG13 ' A' ' 69' ' ' VAL . 12.1 m-20 -108.24 -13.72 14.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.664 -171.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.3 tp10 79.79 30.99 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.26 0.975 . . . . 0.0 110.999 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -107.47 120.2 58.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.873 -0.517 . . . . 0.0 110.491 171.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -115.72 -39.49 3.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.42 164.79 13.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.322 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.428 ' CE ' HG13 ' A' ' 57' ' ' VAL . 1.1 pmm? -146.01 151.57 45.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.915 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' CG ' HD12 ' A' ' 36' ' ' ILE . 58.7 Cg_endo -78.23 149.84 87.42 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.81 -3.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.4 m -132.27 133.64 44.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.793 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.07 124.07 47.85 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.692 HD21 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -117.57 112.36 20.46 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.427 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 2.8 mp -96.41 133.09 41.25 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.692 ' CE1' HD21 ' A' ' 76' ' ' LEU . 62.0 m-85 -128.65 157.11 42.22 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.522 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -139.42 116.26 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.3 t30 65.37 50.39 1.74 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.675 0.75 . . . . 0.0 111.239 171.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.9 5.15 64.13 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.011 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -126.91 160.37 31.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 28.3 tt0 -69.53 178.89 2.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -148.67 -32.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.892 163.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.31 138.22 1.56 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.929 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 23.0 pttm -133.31 134.95 44.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.92 173.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -131.98 122.69 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.322 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 t -91.58 62.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 110.267 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.62 125.66 0.81 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.25 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.653 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -58.27 111.57 1.25 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.211 0.529 . . . . 0.0 111.491 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.52 88.97 25.91 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -31.76 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.723 3.615 . . . . 0.0 115.427 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.13 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.63 61.87 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.507 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.0 mm -76.58 -49.24 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 19.5 mtpp -62.58 -26.08 68.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.444 0.64 . . . . 0.0 110.21 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -80.03 -33.13 39.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.564 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.12 -52.8 57.43 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.583 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.8 mm -53.23 -39.59 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.394 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 -20.42 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.249 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.26 -43.45 17.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.981 0.42 . . . . 0.0 111.047 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -80.01 -22.63 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.822 -0.608 . . . . 0.0 111.324 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 47.0 ttm . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.008 0.432 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 52' ' ' PHE . 54.9 t -100.96 136.41 32.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.596 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.9 m -80.82 144.78 31.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.22 0.533 . . . . 0.0 112.377 -170.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.571 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.6 tp-100 -94.16 136.21 34.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.932 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.3 m-85 -98.57 158.6 15.5 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 14.8 ptmm? -135.01 -1.54 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.832 169.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 33.8 p -138.57 159.75 41.31 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 111.15 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . . . -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.219 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.155 173.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.683 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 27.3 mt-10 -54.06 -47.26 71.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.05 173.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.672 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.1 t80 -58.74 -59.03 6.06 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.958 0.409 . . . . 0.0 109.959 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.58 -35.22 72.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.549 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -63.51 -48.43 77.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.621 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.91 73.2 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.0 110.381 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.1 mm -63.39 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.065 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.33 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.81 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.54 142.9 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.06 74.54 9.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.26 0.552 . . . . 0.0 110.801 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -174.62 179.22 1.77 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.52 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.9 tm? -81.2 120.75 25.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.1 t -100.59 109.8 26.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.154 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 t -92.55 103.38 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG11 ' CE2' ' A' ' 11' ' ' PHE . 22.1 t -105.65 131.08 55.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.311 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -108.21 100.45 9.76 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.939 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 55' ' ' LEU . 2.1 m-85 -103.58 115.52 30.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.514 0.673 . . . . 0.0 111.813 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 25.8 p90 -137.76 175.96 9.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.29 133.5 51.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -15.11 63.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.359 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.44 ' HD1' ' OD2' ' A' ' 58' ' ' ASP . 51.8 p-90 -89.11 -13.47 38.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 110.794 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.8 t -84.39 143.83 29.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.056 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.03 2.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.96 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 19.5 Cg_exo -68.98 15.81 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.447 2.765 . . . . 0.0 114.531 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.01 -29.28 69.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 122.02 0.914 . . . . 0.0 108.98 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -65.62 -8.83 22.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.21 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -37.26 39.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.61 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.2 mp -75.11 -25.2 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.751 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.78 -66.46 1.07 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.481 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 85.6 Cg_endo -83.23 -26.85 2.08 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 120.617 1.256 . . . . 0.0 114.226 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 2.1 ttp -69.75 -41.95 74.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.55 0.69 . . . . 0.0 109.587 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.72 -39.26 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.767 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 38.6 mt-10 -66.59 -26.69 67.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.045 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.34 -37.74 74.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.275 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.6 m-85 -52.45 -62.32 1.72 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.257 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 m -76.77 -13.76 59.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.567 0.223 . . . . 0.0 111.301 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 35.3 tt0 -60.0 -31.93 70.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.422 HE22 ' CD ' ' A' ' 96' ' ' LYS . 20.6 mt-30 -89.3 -46.69 8.57 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.07 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.2 p90 -127.35 90.13 49.63 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.26 0.552 . . . . 0.0 111.941 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.34 -0.72 9.6 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.444 2.096 . . . . 0.0 112.381 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.4 -13.5 58.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.433 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.12 151.66 21.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.99 141.44 28.62 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.668 -177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.516 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -116.25 115.38 25.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.164 -170.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 93.8 m-85 -140.69 149.1 41.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.783 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.7 pttt -149.32 157.71 43.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.665 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 7.1 tt -160.61 151.88 19.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.636 0.255 . . . . 0.0 111.344 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.7 m-20 -91.72 111.74 23.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.699 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' TYR . 3.4 p -66.4 -19.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' HD1' ' A' ' 29' ' ' TRP . 6.4 t70 -53.21 -43.81 67.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.596 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -94.28 -42.42 8.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.994 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.1 mm? -111.67 73.25 0.81 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.5 64.75 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.129 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 22.1 m-20 -65.82 -26.5 67.71 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.428 0.632 . . . . 0.0 110.555 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 84.7 t -71.52 -52.48 25.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.634 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.78 -34.71 65.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.75 0.31 . . . . 0.0 111.369 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.07 -37.85 81.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 109.441 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 8' ' ' ALA . 17.0 tptt -60.78 -22.89 64.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.964 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.558 ' HB2' HG11 ' A' ' 69' ' ' VAL . 33.9 m-20 -106.71 -13.63 15.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 34.0 tt0 79.63 27.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 124.269 0.981 . . . . 0.0 110.854 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.47 126.92 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 170.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -126.59 -40.1 1.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.307 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.25 160.67 16.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -143.02 151.46 56.01 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.878 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HB2' HG12 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -78.65 148.4 83.4 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 -1.907 . . . . 0.0 113.049 -3.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -131.21 135.89 47.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.731 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD22 ' CD1' ' A' ' 40' ' ' ILE . 4.1 mp -106.02 130.79 53.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.661 177.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.648 HD23 ' CE1' ' A' ' 78' ' ' PHE . 1.6 mt -124.58 113.69 18.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.095 0.474 . . . . 0.0 110.824 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD22 ' ND2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -96.97 131.06 44.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.648 ' CE1' HD23 ' A' ' 76' ' ' LEU . 59.9 m-85 -128.26 157.1 41.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 34.5 ttpt -141.73 125.14 16.59 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.9 p30 47.08 55.5 7.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.557 1.143 . . . . 0.0 113.698 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 75.34 3.55 71.09 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.704 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.41 160.81 26.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' HG12 ' A' ' 84' ' ' VAL . 28.9 tt0 -71.0 -179.05 2.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -152.44 -29.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.707 164.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -169.32 150.79 4.37 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.635 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -145.31 126.63 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.255 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.67 133.46 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.949 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.28 59.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 122.287 1.042 . . . . 0.0 110.189 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 129.43 1.12 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.527 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 39' ' ' MET . . . -65.07 106.08 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.676 0.391 . . . . 0.0 111.957 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.68 89.54 37.74 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.788 175.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.1 Cg_exo -35.5 -61.02 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.397 3.398 . . . . 0.0 115.161 -174.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.3 14.42 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -172.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.08 71.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.648 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 99' ' ' ILE . 46.1 mm -87.24 -32.43 6.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.229 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 10.1 ttpp -60.13 -39.57 86.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 170.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.32 -28.91 67.58 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.653 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.02 -61.65 1.93 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.55 -34.96 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.712 0.632 . . . . 0.0 110.576 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.75 -21.62 54.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.949 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.82 -35.56 15.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.062 0.458 . . . . 0.0 110.56 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.619 ' ND2' HD22 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -88.07 -18.26 29.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 -176.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.662 177.082 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 1.5 pmm? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 52' ' ' PHE . 59.7 t -121.7 130.24 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.3 m -75.65 145.12 41.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.251 -170.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -94.39 138.97 31.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.2 m-85 -88.73 164.0 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.199 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.13 -14.71 2.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.758 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -147.16 174.38 11.64 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.94 -23.57 62.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 t -60.02 -47.93 83.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.555 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.538 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -53.14 -42.66 66.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.94 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.676 ' O ' HG12 ' A' ' 15' ' ' ILE . 28.2 t80 -57.35 -58.3 8.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 8.7 m-20 -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.816 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -60.24 -44.27 95.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.578 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.29 76.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.464 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 11' ' ' PHE . 9.2 mm -66.99 -39.99 84.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.56 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.17 7.52 3.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -80.73 146.35 31.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.99 40.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -142.28 176.33 9.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.897 -176.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.7 tm? -81.13 121.9 26.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 0.0 109.828 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.9 t -100.74 122.41 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.218 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.21 102.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.631 HG11 ' CE2' ' A' ' 11' ' ' PHE . 59.2 t -104.11 119.34 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.813 0.816 . . . . 0.0 111.077 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -97.49 96.75 8.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.67 -177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CE2' HD22 ' A' ' 55' ' ' LEU . 1.9 m-85 -100.35 124.79 46.28 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.408 0.623 . . . . 0.0 111.953 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 47.9 p90 -151.5 -178.46 6.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.992 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -128.81 137.53 51.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 111.047 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 p -68.9 -21.61 64.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -84.62 -6.61 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.089 0.471 . . . . 0.0 110.633 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 41.9 t -88.28 159.9 17.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.24 -61.72 1.02 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.081 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 28.1 Cg_exo -65.49 -1.38 4.67 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.647 . . . . 0.0 114.026 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 16.9 p -62.04 -28.34 69.52 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.103 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -8.31 24.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.557 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.63 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.4 ttt -84.04 -28.87 27.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.302 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -76.93 -24.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.249 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.457 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -56.54 -64.36 2.51 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.189 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 78.1 Cg_endo -82.64 -31.13 0.86 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.592 1.528 . . . . 0.0 114.427 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 1.7 ttp -68.24 -41.68 80.84 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.496 0.589 . . . . 0.0 109.679 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.72 -39.39 60.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 45.4 tt0 -62.39 -36.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 22.5 ttmm -68.77 -29.47 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.707 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 23.0 m-85 -56.84 -59.22 5.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.2 m -77.25 -14.01 59.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.627 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 42' ' ' LYS . 40.1 tt0 -62.26 -29.51 70.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 21.4 mt-30 -89.95 -50.68 5.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.451 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.2 p90 -125.9 90.91 49.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.254 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.02 0.89 5.17 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.831 2.354 . . . . 0.0 112.361 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 5.1 tt0 -63.46 -23.67 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.936 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.68 154.65 18.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.436 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -91.53 126.07 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.64 -173.63 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 2' ' ' VAL . 2.7 p90 -96.57 115.76 27.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.252 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.532 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.7 m-85 -141.53 149.46 40.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.723 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB2' ' A' ' 24' ' ' ALA . 20.8 pttp -148.79 158.82 44.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.64 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.65 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.4 tt -159.16 150.06 19.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 110.294 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.8 t0 -98.74 120.08 38.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.758 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG23 ' HE2' ' A' ' 72' ' ' MET . 3.1 m -66.54 -20.6 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.453 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.75 -37.79 82.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.392 0.615 . . . . 0.0 109.521 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -42.89 24.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.674 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 93.7 mt -131.07 75.26 1.65 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.586 0.708 . . . . 0.0 112.17 -175.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -70.25 -29.05 70.61 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.792 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.3 -29.33 70.07 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.535 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 22.0 t -69.57 -51.06 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.612 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.09 -20.11 9.04 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.569 0.543 . . . . 0.0 112.307 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 77.6 mm-40 -85.35 -33.75 21.97 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 0.0 110.822 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 11.1 tptt -68.31 -36.2 78.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 110.644 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.3 p30 -96.48 -13.23 23.22 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.7 mt-10 78.69 17.86 0.99 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.927 174.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.38 108.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 109.462 172.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -109.59 -19.65 13.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.002 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.97 149.52 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.514 ' HE2' HG23 ' A' ' 57' ' ' VAL . 1.9 mpt? -133.61 133.88 23.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.116 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HB2' HG12 ' A' ' 36' ' ' ILE . 73.3 Cg_endo -82.33 153.97 76.63 Favored 'Cis proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.301 -1.541 . . . . 0.0 113.802 -0.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -137.45 142.44 41.59 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.183 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mp -109.8 126.05 53.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.693 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -117.01 113.72 22.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.052 0.453 . . . . 0.0 111.039 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -96.84 134.96 39.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.282 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CE1' HD21 ' A' ' 76' ' ' LEU . 49.8 m-85 -132.04 151.08 51.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.677 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 15.9 mtpp -128.18 108.0 10.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.986 0.179 . . . . 0.0 110.743 170.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 58.2 53.8 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.682 0.753 . . . . 0.0 111.852 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 84.77 -6.0 79.9 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.832 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 64.7 pttt -121.45 160.74 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.7 tt0 -67.98 179.45 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -152.15 -29.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.635 163.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB3' HD23 ' A' ' 77' ' ' LEU . . . -160.23 155.26 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.085 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HB3' ' HZ3' ' A' ' 86' ' ' LYS . 7.7 ttpm? -155.17 113.69 3.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.669 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.65 135.25 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.629 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.2 m -102.12 43.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.29 123.91 0.88 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.323 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.63 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -57.77 104.45 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.48 89.2 26.46 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.713 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.5 Cg_exo -31.23 -76.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.474 3.449 . . . . 0.0 115.079 -172.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.92 -41.08 68.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.12 -29.91 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.455 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.7 mm -87.55 -31.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.808 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 64.6 mttm -54.6 -44.37 72.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -65.42 -32.87 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.883 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.17 -57.82 6.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.4 mm -54.03 -35.12 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.679 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.81 -29.74 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.273 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.64 -40.89 61.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 111.011 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.677 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 46.0 m-80 -82.98 -16.28 47.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.029 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.548 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.852 0.358 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 52' ' ' PHE . 88.3 t -81.24 125.56 39.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.425 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.2 m -72.36 144.8 48.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.186 -170.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -97.3 125.07 41.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.809 -174.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.4 m-85 -75.15 170.44 16.04 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HG2' ' HG2' ' A' ' 10' ' ' GLU . 59.9 pttt -133.93 -21.62 1.89 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.288 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 178.8 9.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.365 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' N ' HG21 ' A' ' 63' ' ' VAL . . . -70.23 -29.08 65.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.792 0.329 . . . . 0.0 110.781 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -54.56 -48.12 72.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.839 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 6.0 mp0 -55.38 -46.85 76.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.55 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.68 ' O ' HG12 ' A' ' 15' ' ' ILE . 30.9 t80 -56.45 -59.51 4.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.811 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.0 -36.78 77.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.663 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.6 m -61.79 -45.7 92.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.655 0.264 . . . . 0.0 110.991 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -34.12 77.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.877 0.37 . . . . 0.0 110.322 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.5 mm -65.94 -40.51 87.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.312 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.41 2.16 14.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.481 -173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.446 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 9.9 tt0 -76.51 144.49 39.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.882 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 57.2 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 8.8 ptmm? -168.73 176.53 5.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.005 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.15 115.18 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.213 0.53 . . . . 0.0 110.895 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.4 t -101.22 135.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.982 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.59 115.97 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.524 HG13 ' CE2' ' A' ' 11' ' ' PHE . 33.6 t -107.52 131.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.577 0.703 . . . . 0.0 110.9 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HG2' ' A' ' 54' ' ' LYS . . . -102.88 96.6 6.94 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.469 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' HE2' ' A' ' 11' ' ' PHE . 26.7 m-85 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.667 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.643 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.9 p90 -163.24 179.17 7.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.727 169.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.61 128.74 46.05 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 p -65.05 -18.67 65.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -88.96 -10.59 47.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.417 . . . . 0.0 110.713 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 49.7 t -97.64 148.88 22.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.831 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.22 2.86 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.411 -0.66 . . . . 0.0 114.655 -173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.3 Cg_exo -59.49 -2.56 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.17 2.58 . . . . 0.0 114.044 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -63.19 -24.44 67.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.27 0.557 . . . . 0.0 110.929 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 57.0 mtpt -65.63 -9.36 26.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.765 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.415 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.03 -35.49 49.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 109.354 176.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.656 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 0.8 OUTLIER -75.29 -25.82 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.408 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.13 -66.2 0.88 Allowed Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.923 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 76.4 Cg_endo -83.44 -32.72 0.45 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.319 1.346 . . . . 0.0 114.479 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.529 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.5 tmm? -69.86 -38.08 76.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.412 0.625 . . . . 0.0 109.85 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.6 mt -79.84 -33.64 14.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.804 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 41.1 tt0 -67.87 -23.23 65.11 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.156 172.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 49.4 tptt -78.64 -37.27 42.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.584 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.1 p90 -59.05 -49.63 77.14 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.572 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 94.1 p -85.13 -14.5 46.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.673 -175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 5.5 tp10 -59.59 -33.69 71.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.02 -47.62 8.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.419 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.5 ' HH ' ' HB ' ' A' ' 99' ' ' ILE . 9.4 p90 -126.69 90.89 48.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.469 0.652 . . . . 0.0 112.489 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.05 -0.34 8.94 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.357 2.038 . . . . 0.0 112.182 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 1.1 pp0? -66.02 -9.37 29.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.225 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.47 155.58 17.98 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 5.8 m-20 -91.08 120.55 32.13 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.719 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.2 p90 -100.66 115.27 29.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.979 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.492 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 95.9 m-85 -139.92 141.46 36.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.088 0.471 . . . . 0.0 111.324 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' HB1' ' A' ' 24' ' ' ALA . 76.2 mttt -122.21 155.05 36.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.006 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 55' ' ' LEU . 8.4 tt -159.5 142.04 13.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.23 130.79 52.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.308 0.575 . . . . 0.0 111.196 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.9 m -69.42 -16.11 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.256 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.35 -41.56 84.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.216 0.532 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.46 -42.72 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.899 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -121.4 77.71 1.36 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.165 0.507 . . . . 0.0 112.282 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.28 -38.06 35.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.327 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.05 -32.58 74.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 110.295 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.566 HG12 HD22 ' A' ' 67' ' ' ASN . 86.5 t -64.53 -52.16 58.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.119 176.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' HG12 ' A' ' 69' ' ' VAL . . . -50.48 -38.84 46.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.024 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.68 -33.5 71.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.656 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.4 tptt -62.04 -28.45 69.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 175.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.566 HD22 HG12 ' A' ' 63' ' ' VAL . 17.7 m-20 -100.55 -12.53 19.19 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.004 -169.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.4 tp10 79.82 26.42 0.36 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.298 0.999 . . . . 0.0 110.225 -177.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 25' ' ' PHE . 1.2 p -106.61 118.23 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.425 0.631 . . . . 0.0 111.412 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.5 m -131.25 11.92 5.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.426 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.94 30.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.514 ' CE ' HG21 ' A' ' 57' ' ' VAL . 14.8 mmt -127.19 117.98 21.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.583 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 17.7 Cg_endo -89.52 175.21 22.44 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.561 -1.016 . . . . 0.0 111.702 -4.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.559 HG21 ' N ' ' A' ' 75' ' ' LEU . 48.0 m -147.55 146.48 29.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.559 ' N ' HG21 ' A' ' 74' ' ' THR . 4.5 mp -120.88 139.64 52.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 2.3 mt -125.77 120.33 30.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 3.5 mp -97.96 129.26 44.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CG ' HG21 ' A' ' 15' ' ' ILE . 35.1 m-85 -128.13 146.66 50.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -121.52 110.9 16.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.329 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p30 46.1 56.35 6.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.1 6.28 89.24 Favored Glycine 0 CA--C 1.511 -0.211 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.646 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.93 153.61 42.42 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 178.35 2.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.23 -32.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.437 164.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -161.98 150.97 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -145.11 129.2 17.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.55 126.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.638 0.256 . . . . 0.0 110.525 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -96.21 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.32 0.581 . . . . 0.0 111.177 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.64 140.15 2.8 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.571 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -70.08 108.88 4.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.057 0.456 . . . . 0.0 110.896 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.23 89.04 29.71 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.261 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -28.92 -72.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.829 3.686 . . . . 0.0 115.321 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -43.34 56.86 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.667 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.21 72.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.434 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.9 mm -74.78 -49.64 28.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.999 0.428 . . . . 0.0 110.211 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 18.1 mtpp -67.18 -24.2 65.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.387 0.613 . . . . 0.0 110.63 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.92 -31.97 51.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.099 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.49 -54.3 30.28 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.212 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.5 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.0 mm -53.56 -36.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.14 60.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.227 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.61 -40.46 20.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.453 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' ND2' HD22 ' A' ' 77' ' ' LEU . 45.9 m-80 -83.51 -11.63 57.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.278 -175.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.699 177.26 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 ttm . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 40' ' ' ILE . 69.8 t -90.88 131.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.947 0.403 . . . . 0.0 111.251 -175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -79.08 144.1 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.295 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.647 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.87 131.24 37.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.974 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -80.11 167.38 20.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.053 0.454 . . . . 0.0 110.847 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.45 -39.74 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -144.47 -179.94 6.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.011 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.8 67.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.902 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 t -57.81 -49.91 75.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.64 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.0 mp0 -51.17 -46.53 62.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.579 173.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.629 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.3 t80 -58.19 -58.31 9.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 -178.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.94 -36.48 84.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.732 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.5 m -65.49 -30.94 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 111.104 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.45 -35.45 58.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.091 0.472 . . . . 0.0 109.874 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.4 mm -62.72 -39.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.478 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.46 3.39 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.424 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -77.01 141.62 40.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.083 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.2 31.96 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.533 0.682 . . . . 0.0 111.254 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.18 179.36 6.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.549 175.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 84' ' ' VAL . 1.7 tm? -76.01 117.13 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.631 -174.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.5 t -103.02 119.14 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.748 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 13.9 t -106.91 112.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG13 ' CE2' ' A' ' 11' ' ' PHE . 23.8 t -106.57 122.17 60.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.807 0.813 . . . . 0.0 110.83 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB3' ' CB ' ' A' ' 54' ' ' LYS . . . -91.22 97.39 11.1 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.935 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.696 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 1.5 m-85 -96.66 124.33 40.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.697 0.761 . . . . 0.0 112.631 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -154.79 165.47 36.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.141 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -118.01 140.5 49.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.181 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 p -65.39 -19.64 66.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.663 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -80.87 -18.54 46.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.364 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 46.3 t -83.37 141.92 31.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.056 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -75.54 -55.32 5.09 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.611 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.433 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 33.4 Cg_endo -65.75 4.73 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 114.196 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.7 p -64.01 -29.85 70.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.691 0.757 . . . . 0.0 109.646 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -68.84 -9.21 50.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.403 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -35.12 39.36 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.706 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.0 -25.72 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.26 -65.74 1.16 Allowed Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.859 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 64.9 Cg_endo -83.03 -29.58 1.19 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.696 1.284 . . . . 0.0 114.092 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.483 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.7 tmm? -71.41 -33.4 69.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.596 0.712 . . . . 0.0 109.851 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -84.26 -34.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.973 -179.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 39.6 mt-10 -68.64 -20.09 64.45 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.534 171.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -76.58 -39.07 53.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.738 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.5 p90 -57.5 -47.0 83.1 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.321 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 89.7 p -84.59 -15.41 45.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.977 -0.452 . . . . 0.0 110.655 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.59 -29.15 69.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.527 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.99 -42.32 13.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.0 175.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.646 ' HH ' ' HA ' ' A' ' 96' ' ' LYS . 8.4 p90 -138.53 91.61 12.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 112.21 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.57 1.09 4.61 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.469 2.113 . . . . 0.0 111.744 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.89 -22.77 67.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.332 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.16 159.99 14.67 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.1 m-20 -91.02 125.89 35.95 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.477 0.656 . . . . 0.0 111.232 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -104.4 114.68 29.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.049 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.4 m-85 -142.49 151.14 41.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.647 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.6 pttt -149.59 159.07 44.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.36 -175.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.696 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 6.8 tt -155.71 151.96 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.907 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 29.0 t0 -95.56 113.33 24.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.809 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.44 -27.12 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.183 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -66.27 -32.5 73.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 110.166 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.44 -41.97 11.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.4 mm? -118.44 65.88 0.76 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.364 0.602 . . . . 0.0 111.555 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -67.75 -31.72 76.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.625 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.12 -22.07 63.99 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 25.2 t -72.96 -50.98 28.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.7 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.82 -21.44 4.2 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 21.5 mt-30 -86.17 -28.97 23.6 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.858 -0.527 . . . . 0.0 110.801 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -70.17 -29.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.905 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 2.3 p30 -108.58 -12.55 14.97 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.023 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.2 tp10 79.23 30.1 0.32 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.052 0.845 . . . . 0.0 111.216 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.7 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -106.48 107.69 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.366 0.603 . . . . 0.0 110.611 169.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -111.35 -35.92 5.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.32 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.2 152.49 29.13 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.7 ptp -144.49 147.32 35.99 Favored Pre-proline 0 C--N 1.321 -0.667 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.547 -174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 59.9 Cg_endo -80.65 149.6 78.23 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.599 -1.834 . . . . 0.0 112.518 -3.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.429 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 3.3 m -133.06 133.18 42.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.295 0.569 . . . . 0.0 111.109 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.461 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.2 mp -98.79 125.77 44.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.53 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' CE1' ' A' ' 78' ' ' PHE . 1.2 mt -114.27 113.74 25.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.118 0.485 . . . . 0.0 110.473 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 85' ' ' ALA . 3.1 mp -95.54 127.88 41.94 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CE1' HD23 ' A' ' 76' ' ' LEU . 61.4 m-85 -127.17 154.61 44.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.804 -0.18 . . . . 0.0 110.653 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.415 ' HG2' HD21 ' A' ' 80' ' ' ASN . 81.8 tttt -139.23 127.06 22.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 168.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.415 HD21 ' HG2' ' A' ' 79' ' ' LYS . 9.3 p30 50.22 49.24 20.88 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.494 1.117 . . . . 0.0 113.453 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 78.46 1.09 81.2 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.238 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 82' ' ' LYS . 6.5 mtpm? -118.27 160.14 22.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.19 179.69 2.74 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -151.73 -29.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 164.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -171.59 160.32 5.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.229 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 21.5 ptmt -153.18 134.22 14.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.029 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.04 120.87 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.646 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 62.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 122.209 1.004 . . . . 0.0 110.199 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.27 130.75 1.28 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.306 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -72.72 98.28 2.35 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.667 0.27 . . . . 0.0 110.87 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -116.4 88.48 23.73 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.285 -179.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.26 -58.93 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.344 3.363 . . . . 0.0 114.903 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.56 -46.51 38.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.87 -27.57 65.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.481 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' O ' HG12 ' A' ' 99' ' ' ILE . 34.3 mm -76.6 -45.2 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.646 ' HA ' ' HH ' ' A' ' 47' ' ' TYR . 72.8 tttt -60.98 -28.49 69.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.404 0.621 . . . . 0.0 110.642 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -84.35 -27.3 27.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.553 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.64 -56.65 5.97 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -51.82 -41.22 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.416 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.3 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.127 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.21 60.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -80.79 -21.22 41.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.386 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.073 179.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 52' ' ' PHE . 91.2 t -79.55 127.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.348 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.591 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 14.9 m -71.03 144.35 50.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.68 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -91.51 119.57 31.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.136 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 2.2 m-30 -76.09 167.48 21.79 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.496 173.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -129.61 -40.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -142.77 179.55 6.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.558 0.218 . . . . 0.0 111.405 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . . . -65.99 -29.81 70.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.623 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -58.13 -46.02 86.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -54.45 -43.63 71.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 172.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 15' ' ' ILE . 26.9 t80 -58.28 -58.72 7.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 110.495 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.597 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 47.9 m-20 -60.0 -33.91 72.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.027 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.1 m -63.48 -41.72 98.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.689 0.281 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.08 -36.73 82.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.014 0.435 . . . . 0.0 110.154 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 11' ' ' PHE . 11.3 mm -63.6 -39.71 86.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.662 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.21 12.84 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.44 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -87.72 146.41 25.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.051 0.453 . . . . 0.0 111.082 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.6 32.27 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.723 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 7.0 ptmm? -150.63 168.94 22.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 102' ' ' ASN . 1.5 tm? -72.44 118.56 15.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.185 0.517 . . . . 0.0 110.959 -171.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.1 t -100.74 120.56 50.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.892 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 18.8 t -109.61 106.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 11' ' ' PHE . 15.4 t -103.0 123.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.801 0.81 . . . . 0.0 110.986 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -91.39 96.86 10.75 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.049 -175.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.52 106.87 17.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.58 0.705 . . . . 0.0 112.004 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 40.2 p90 -128.77 -173.61 3.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.634 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.66 130.69 40.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 p -66.47 -21.82 66.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -84.45 -9.76 58.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.718 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.646 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.8 t -93.42 147.31 23.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.155 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.97 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.648 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.646 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.2 Cg_exo -67.23 4.62 1.14 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.096 2.531 . . . . 0.0 114.356 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 29.7 p -62.94 -32.19 73.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.028 0.918 . . . . 0.0 109.361 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -70.76 -8.98 56.28 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.968 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.627 ' SD ' ' HB2' ' A' ' 90' ' ' ALA . 25.6 ttt -82.76 -28.69 30.22 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.685 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.3 mp -75.31 -25.03 17.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.594 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -53.92 -65.89 1.07 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.399 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 91.7 Cg_endo -83.16 -30.71 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.264 1.31 . . . . 0.0 114.521 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.408 ' HE1' ' HA ' ' A' ' 36' ' ' ILE . 3.2 tmm? -68.4 -39.48 81.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 -176.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -77.42 -36.37 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.565 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.68 -20.73 65.33 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.116 -0.633 . . . . 0.0 109.563 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 22.8 ttmm -83.32 -32.67 26.17 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.277 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.2 p90 -57.51 -46.37 83.87 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.265 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 93.5 p -84.8 -15.64 44.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.506 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 38.9 tt0 -56.48 -32.72 65.27 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.475 ' NE2' ' HD2' ' A' ' 96' ' ' LYS . 39.8 mt-30 -87.24 -50.43 6.6 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.837 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.8 p90 -127.78 90.67 47.34 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.166 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.61 -0.68 7.99 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.483 2.122 . . . . 0.0 112.29 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.47 -18.05 65.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.492 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.45 157.62 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.541 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 7.6 m-20 -91.75 128.12 37.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.584 0.707 . . . . 0.0 111.473 -173.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.513 ' HB2' HG21 ' A' ' 2' ' ' VAL . 1.3 p90 -106.96 114.7 28.94 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.87 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.591 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.41 146.53 40.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.196 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 42.2 mtpt -131.2 148.81 52.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.886 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD21 ' CE2' ' A' ' 25' ' ' PHE . 8.7 tt -160.7 148.12 15.78 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.1 p-10 -105.6 131.59 52.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.383 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.29 -12.69 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.54 -46.05 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.184 0.516 . . . . 0.0 109.794 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.51 -41.72 17.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.43 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB2' HD22 ' A' ' 55' ' ' LEU . 2.8 mm? -122.68 75.11 1.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.433 0.635 . . . . 0.0 112.129 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.62 -34.18 54.32 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.358 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.65 -28.41 69.6 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.332 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.578 HG12 HD22 ' A' ' 67' ' ' ASN . 57.8 t -70.86 -50.19 45.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.67 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.61 -40.41 52.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.059 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 mt-30 -69.17 -35.58 76.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.313 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.597 ' HE3' ' OD2' ' A' ' 12' ' ' ASP . 14.4 tptp -62.57 -25.54 68.12 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.305 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.578 HD22 HG12 ' A' ' 63' ' ' VAL . 7.3 m-20 -105.9 -9.98 16.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.233 -171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 37.4 mt-10 80.51 27.31 0.26 Allowed 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.455 1.097 . . . . 0.0 111.217 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.572 HG11 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -105.2 115.35 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 110.256 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.6 p -115.95 -23.38 8.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.166 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.84 166.24 12.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.179 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -149.63 140.88 14.5 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.015 0.436 . . . . 0.0 111.359 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 36' ' ' ILE . 57.7 Cg_endo -80.27 151.56 82.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.475 -1.885 . . . . 0.0 113.194 -4.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -129.58 139.14 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD22 ' HE3' ' A' ' 39' ' ' MET . 4.3 mp -110.63 126.54 54.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.358 173.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.59 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -115.62 115.35 26.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.04 0.447 . . . . 0.0 110.69 176.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.588 HD21 ' ND2' ' A' ' 102' ' ' ASN . 2.1 mp -96.96 131.2 43.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.099 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.59 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.3 m-85 -130.45 148.69 52.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.619 0.247 . . . . 0.0 111.229 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -127.0 108.59 11.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.619 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.9 t30 60.41 55.51 3.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 111.633 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 15' ' ' ILE . . . 72.04 6.45 64.31 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.497 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -121.8 157.86 30.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.27 179.09 4.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -151.83 -32.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 165.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' HD22 ' A' ' 77' ' ' LEU . . . -170.78 152.54 3.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 111.722 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 134.18 30.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.909 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.1 t -131.75 123.78 52.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.12 53.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.2 0.524 . . . . 0.0 111.497 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.93 136.01 1.94 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.625 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -66.88 107.54 2.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.12 0.486 . . . . 0.0 110.964 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -111.51 88.38 9.15 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.3 Cg_exo -31.43 -74.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 124.477 3.451 . . . . 0.0 115.319 -169.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -38.09 68.53 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.235 -0.291 . . . . 0.0 111.626 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.18 -31.3 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.383 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.551 ' O ' HG12 ' A' ' 99' ' ' ILE . 33.3 mm -76.41 -49.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 110.265 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 47.0 mtmt -64.37 -22.94 67.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.486 0.66 . . . . 0.0 110.152 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -80.89 -37.05 30.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.66 171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.93 -61.34 2.71 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.578 ' HB ' ' HH ' ' A' ' 47' ' ' TYR . 3.5 mm -47.93 -38.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.068 0.855 . . . . 0.0 110.671 -176.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.95 -22.24 59.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.615 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.5 -28.97 18.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.156 0.503 . . . . 0.0 110.443 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.588 ' ND2' HD21 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -95.73 -10.34 29.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.027 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.736 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 52' ' ' PHE . 71.5 t . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 14.4 m -72.71 145.0 47.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.653 0.739 . . . . 0.0 112.68 -168.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.48 139.47 30.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.237 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.546 ' HB2' HD12 ' A' ' 55' ' ' LEU . 5.9 m-85 -85.11 170.54 12.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.772 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 54.1 mttm -121.62 -39.24 2.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -148.56 -179.07 6.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.55 -27.92 69.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 m -60.01 -45.37 93.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.2 mp0 -57.99 -42.69 85.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.52 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' O ' HG12 ' A' ' 15' ' ' ILE . 13.5 t80 -60.4 -54.63 43.26 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.51 -39.12 79.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.684 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -61.65 -47.07 87.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.706 0.288 . . . . 0.0 110.565 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -63.76 -31.71 72.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.471 . . . . 0.0 110.379 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.696 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.4 mm -65.21 -40.37 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.38 2.21 9.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.297 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 98.0 mt-30 -73.95 139.62 45.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.711 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.33 40.46 0.56 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.315 0.578 . . . . 0.0 110.823 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 2.3 pttp -153.54 163.11 40.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.884 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.9 tm? -69.54 113.82 7.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.029 0.442 . . . . 0.0 110.995 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 4.4 p -110.01 118.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.957 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.605 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -110.23 119.66 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 109.85 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.498 HG11 ' CE2' ' A' ' 11' ' ' PHE . 58.0 t -102.59 127.41 56.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.243 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -87.86 97.01 10.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.443 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -107.15 110.36 22.43 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.092 0.472 . . . . 0.0 110.818 -176.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 26.3 p90 -145.31 -171.54 3.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.092 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -136.25 136.69 40.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -61.02 -24.12 65.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -88.69 -10.44 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.275 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 72' ' ' MET . 44.2 t -77.44 158.39 30.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.034 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.1 -76.57 0.6 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.217 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 6.3 Cg_exo -74.39 14.77 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.187 2.591 . . . . 0.0 113.757 -173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 27.4 p -59.92 -34.95 73.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.882 0.848 . . . . 0.0 109.916 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -70.29 -8.0 46.87 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.423 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.586 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.1 ttt -84.44 -28.99 26.47 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.098 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -77.5 -25.73 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.32 -64.98 1.46 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 94.8 Cg_endo -82.46 -30.55 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 121.192 1.261 . . . . 0.0 114.133 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.545 ' CE ' HD21 ' A' ' 75' ' ' LEU . 1.5 ttp -67.44 -42.8 82.53 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 118.508 0.595 . . . . 0.0 109.905 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.31 -37.35 51.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.432 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.9 -38.52 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.658 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 56.8 mttp -65.36 -31.37 72.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.107 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.9 m-30 -55.65 -62.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.703 0.287 . . . . 0.0 110.268 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -73.84 -14.05 61.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.678 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 tt0 -60.32 -33.4 72.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.494 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.4 -47.96 8.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 175.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.518 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.2 p90 -128.68 86.4 57.68 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.158 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 -0.68 8.95 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.475 2.116 . . . . 0.0 112.252 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -67.47 -13.35 61.96 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.17 17.27 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.453 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.2 m-20 -91.8 126.42 36.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.254 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -102.27 114.16 28.07 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.493 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 98.6 m-85 -139.89 152.65 46.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.06 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.7 pttp -148.98 153.46 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.849 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.824 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 8.0 tt -159.14 146.44 17.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.1 m-20 -99.68 125.23 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -65.21 -22.72 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.07 -35.65 73.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.454 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.67 -43.53 11.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.964 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 55' ' ' LEU . 46.0 mt -131.77 89.98 2.77 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.559 0.695 . . . . 0.0 112.445 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.06 -33.78 39.78 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.246 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.53 -30.13 68.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.151 0.501 . . . . 0.0 110.03 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 89.2 t -62.89 -50.23 80.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 69' ' ' VAL . . . -46.76 -42.42 16.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.191 0.519 . . . . 0.0 111.406 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -72.04 -34.72 69.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.631 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 16.0 tptt -61.1 -26.44 67.66 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.711 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.3 m120 -105.09 -10.89 16.87 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.187 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 43.1 mt-10 80.17 26.68 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.391 1.057 . . . . 0.0 111.271 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -104.72 110.71 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.687 0.756 . . . . 0.0 111.241 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -114.0 -34.66 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.54 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.65 159.65 26.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.872 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.446 ' HG3' ' SG ' ' A' ' 30' ' ' CYS . 20.3 ptp -151.17 140.84 14.06 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.906 0.384 . . . . 0.0 110.958 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.2 Cg_endo -80.83 150.47 79.1 Favored 'Cis proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.726 -1.781 . . . . 0.0 113.154 -2.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -120.79 145.93 47.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.229 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 95' ' ' ILE . 3.6 mp -120.76 123.47 42.75 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 78' ' ' PHE . 7.1 mt -122.5 112.72 18.37 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.841 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.605 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 4.0 mp -94.46 134.8 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HB3' HG23 ' A' ' 15' ' ' ILE . 52.0 m-85 -133.45 156.73 47.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.406 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.42 122.75 19.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.47 167.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 t30 60.78 41.49 14.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.661 0.743 . . . . 0.0 111.352 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 86.16 -4.32 86.12 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.272 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -121.86 161.61 22.45 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 25.1 tt0 -66.92 178.75 1.28 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.59 -28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.047 162.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -154.81 146.39 23.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 112.073 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -135.14 115.33 13.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.665 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 95' ' ' ILE . 12.3 t -131.06 141.54 45.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -121.62 48.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.152 0.501 . . . . 0.0 110.743 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.35 129.2 1.18 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.309 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -62.63 108.21 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.122 0.487 . . . . 0.0 112.114 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.98 90.32 32.55 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -33.07 -63.15 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.659 3.573 . . . . 0.0 115.074 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 -46.02 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.969 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 75' ' ' LEU . 29.5 mm -87.36 -34.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.271 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.518 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 31.9 tttt -59.83 -37.87 80.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.595 0.712 . . . . 0.0 109.121 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.75 -30.27 69.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.466 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -56.59 8.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.441 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -51.07 -41.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.223 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.74 70.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.36 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -78.98 -21.04 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.979 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.787 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 52' ' ' PHE . 96.1 t . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.6 m -83.04 139.18 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 112.447 -170.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 55' ' ' LEU . 8.4 tp-100 -90.56 138.91 31.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.097 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.694 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 16.0 m-85 -95.69 161.4 14.05 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.622 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.8 ptpp? -134.37 -3.72 2.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.315 170.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.9 p -141.94 158.86 43.27 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.939 0.399 . . . . 0.0 111.322 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.21 -27.94 63.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.097 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -57.61 -46.4 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.344 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.694 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.1 mt-10 -55.41 -43.27 75.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.984 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.8 t80 -60.55 -58.41 8.6 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.36 -37.39 80.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.259 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -59.41 -43.22 93.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.892 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.02 -33.73 74.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.475 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.808 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.2 mm -63.01 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.279 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.93 -1.3 16.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.693 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.454 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 47.3 tt0 -72.31 141.32 48.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.791 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.32 48.16 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.501 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 5.3 ptpp? -157.9 -179.88 8.55 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -73.8 123.11 23.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 109.885 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -102.2 117.9 48.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.231 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -97.06 103.0 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 11' ' ' PHE . 38.4 t -105.34 124.17 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.973 0.892 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.806 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.17 96.76 7.2 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.733 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -101.0 128.62 46.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.778 0.799 . . . . 0.0 111.908 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 25.7 p90 -152.95 178.47 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.113 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.5 138.92 51.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.738 0.304 . . . . 0.0 110.277 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 p -66.19 -18.87 65.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.473 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -86.44 -10.75 53.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.59 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 39.4 t -84.16 152.75 24.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.597 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.59 -61.87 1.67 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.953 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.35 3.28 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.094 2.529 . . . . 0.0 113.872 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 29.0 p -60.43 -32.42 71.35 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.6 tptm -68.2 -11.88 60.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.801 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.0 ttt -79.43 -28.11 41.71 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -76.21 -22.73 15.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.616 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.57 -68.25 0.49 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.474 172.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.9 Cg_endo -84.11 -32.04 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 CA-C-N 120.941 1.372 . . . . 0.0 114.43 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.554 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.97 -48.55 73.61 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.374 0.534 . . . . 0.0 109.71 -176.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.806 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -68.19 -37.9 78.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.045 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.14 -26.52 67.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 109.499 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 50.2 tptt -77.13 -30.85 55.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.948 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.671 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 18.1 m-30 -52.65 -64.55 0.78 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.012 0.434 . . . . 0.0 109.872 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.4 m -80.03 -13.2 59.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.216 -173.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.0 -35.99 80.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.15 -39.39 14.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.212 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 10.4 p90 -131.77 90.87 35.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 111.937 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 1.87 6.12 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.792 2.328 . . . . 0.0 112.652 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.31 -23.25 67.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.542 . . . . 0.0 111.257 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.4 157.95 16.42 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.04 138.42 31.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.358 0.599 . . . . 0.0 111.23 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -110.78 115.91 30.37 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.234 -171.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.492 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 92.1 m-85 -138.89 154.25 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 111.843 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HG3' HG11 ' A' ' 2' ' ' VAL . 53.1 mttm -140.93 155.86 46.19 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.99 0.916 . . . . 0.0 109.972 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.03 147.49 16.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.937 0.398 . . . . 0.0 111.024 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.3 t0 -96.7 118.85 34.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.015 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 26' ' ' TYR . 21.7 t -66.12 -28.57 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.172 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.46 -25.47 65.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.93 -42.06 9.27 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.309 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -122.45 76.18 1.31 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.272 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.41 -40.72 91.47 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.027 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.78 -31.56 71.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.907 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 85.3 t -61.73 -52.55 59.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.132 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.33 -39.33 56.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 111.075 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.71 -33.14 72.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.417 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -22.12 66.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.969 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.624 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.3 m120 -109.79 -11.54 14.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 -173.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 80.28 27.28 0.29 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.439 1.087 . . . . 0.0 111.381 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.624 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -106.36 126.11 62.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.957 0.408 . . . . 0.0 110.375 173.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -139.85 5.52 2.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.08 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.48 ' HG2' ' CB ' ' A' ' 27' ' ' ALA . 2.4 mpt? -124.31 121.39 26.05 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.032 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 36' ' ' ILE . 40.3 Cg_endo -90.5 162.53 32.46 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.983 -1.257 . . . . 0.0 113.162 -1.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 m -136.89 131.93 33.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.325 0.583 . . . . 0.0 111.176 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -101.93 125.25 48.57 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.47 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.664 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.1 mt -118.61 113.2 20.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.149 0.5 . . . . 0.0 110.437 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -97.19 133.32 41.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.664 ' CE1' HD22 ' A' ' 76' ' ' LEU . 55.1 m-85 -130.67 158.2 40.7 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.578 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -140.93 125.26 17.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 48.09 51.85 14.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.131 0.972 . . . . 0.0 113.508 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.808 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 76.67 3.19 78.46 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.653 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -119.03 160.93 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.4 tt0 -71.23 -179.31 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.51 -34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 164.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.85 149.96 5.57 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.569 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.61 ' HB3' HD23 ' A' ' 76' ' ' LEU . 17.8 pttm -144.54 131.36 20.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.439 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.87 123.76 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.09 55.85 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.244 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.11 128.28 0.94 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -61.11 115.98 4.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.402 ' CB ' HG12 ' A' ' 95' ' ' ILE . 3.6 t30 -116.92 90.33 32.3 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.8 Cg_exo -25.13 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 125.256 3.971 . . . . 0.0 115.68 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.96 -28.42 35.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.15 -0.344 . . . . 0.0 111.833 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.1 83.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 75' ' ' LEU . 41.0 mm -82.54 -31.0 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.818 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 33.4 mtmt -61.2 -40.07 92.55 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -64.7 -30.29 71.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.16 173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -52.54 45.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 99' ' ' ILE . 4.2 mm -51.96 -41.09 30.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.56 -31.46 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.286 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.72 66.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.605 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -86.25 -20.79 27.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.59 177.283 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' HG2' ' A' ' 41' ' ' GLU . 74.5 t . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.554 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.0 m -81.77 145.54 30.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.086 -172.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -92.37 124.62 36.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 9.0 m-85 -84.58 157.31 21.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 21.6 pttm -135.16 -3.27 2.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.239 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -140.83 164.9 28.98 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.153 0.501 . . . . 0.0 111.792 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -76.47 -31.85 58.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.284 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 m -59.28 -42.94 92.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.656 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.614 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 24.2 mt-10 -53.66 -45.61 70.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 23' ' ' VAL . 12.3 t80 -56.84 -59.49 4.96 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.244 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 62.1 m-20 -60.72 -27.83 68.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.766 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -64.42 -44.59 90.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.051 0.453 . . . . 0.0 110.055 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -69.15 -20.2 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.887 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.799 HG22 ' HA2' ' A' ' 81' ' ' GLY . 17.9 mm -77.9 -38.35 24.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.109 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.59 14.59 2.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -99.18 163.37 12.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.955 0.407 . . . . 0.0 111.05 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.62 36.47 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.075 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.5 173.67 12.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.921 0.391 . . . . 0.0 110.916 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.5 tm? -79.37 126.12 30.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.331 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG21 ' HB1' ' A' ' 14' ' ' ALA . 7.7 p -111.68 128.23 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.35 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.38 102.96 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 11' ' ' PHE . 41.6 t -96.98 129.61 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.595 0.712 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.663 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -111.62 97.46 6.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.131 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.719 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.4 m-85 -103.23 137.24 41.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.571 0.7 . . . . 0.0 112.058 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 22.6 p90 -156.48 -171.37 3.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.688 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.63 135.1 32.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 p -69.3 -19.47 63.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.981 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -84.14 -14.77 49.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.01 0.434 . . . . 0.0 110.319 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 49.7 t -88.7 141.73 28.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.855 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.03 -60.85 5.31 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.83 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 41.1 Cg_endo -67.55 8.86 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.117 2.545 . . . . 0.0 114.766 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -60.52 -30.49 69.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.81 0.814 . . . . 0.0 109.958 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.68 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 19.7 ptmt -67.25 -9.6 42.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.646 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -81.24 -34.57 32.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -75.68 -24.66 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.674 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.04 -65.89 1.5 Allowed Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.978 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.5 Cg_endo -84.32 -30.58 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.692 1.594 . . . . 0.0 113.545 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -67.26 -39.74 86.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 109.804 -176.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -75.07 -39.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.137 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 2' ' ' VAL . 33.0 mt-10 -63.13 -32.02 73.31 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 173.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 39' ' ' MET . 27.3 ttpp -64.41 -41.06 96.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.284 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.1 m-85 -53.65 -63.23 1.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.949 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -76.4 -13.54 60.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.278 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.42 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.03 -41.07 13.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.29 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.6 p90 -133.8 90.81 26.56 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.28 0.562 . . . . 0.0 112.179 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.81 1.4 5.81 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.691 2.261 . . . . 0.0 112.584 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -63.15 -19.9 64.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.123 0.487 . . . . 0.0 110.694 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.13 153.26 19.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.73 143.39 26.59 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.914 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.856 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.84 116.05 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.309 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 90.6 m-85 -141.76 137.85 31.9 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 120.987 0.423 . . . . 0.0 112.12 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HG3' HG11 ' A' ' 2' ' ' VAL . 31.1 mtmt -123.19 153.36 40.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.465 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.719 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.8 tt -161.17 144.42 12.82 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.6 p-10 -100.52 129.63 46.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.082 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.511 HG23 ' HA2' ' A' ' 61' ' ' GLY . 3.8 p -72.67 -16.63 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.488 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -57.93 -43.54 86.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.991 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -88.89 -42.32 11.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.0 mm? -111.9 76.45 0.98 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.276 0.56 . . . . 0.0 112.01 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -67.34 -47.23 64.65 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.413 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.36 -30.95 70.84 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 111.177 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 89.5 t -65.53 -54.14 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.9 70.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 111.187 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.48 -30.22 69.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -66.96 -23.53 65.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.536 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB2' HG12 ' A' ' 69' ' ' VAL . 14.0 m120 -106.63 -12.58 15.53 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.868 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 26.5 tt0 80.46 22.27 0.43 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.308 1.005 . . . . 0.0 110.938 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.25 124.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 121.818 -0.551 . . . . 0.0 109.834 173.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 m -131.63 -25.48 2.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.477 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.1 159.68 14.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.3 mpt? -128.26 142.69 45.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 121.069 0.461 . . . . 0.0 111.434 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . 7.0 Cg_exo -82.23 166.39 70.63 Favored 'Cis proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.289 -1.546 . . . . 0.0 112.009 -9.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 69' ' ' VAL . 15.6 m -140.8 136.64 32.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.539 . . . . 0.0 111.023 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.8 mp -112.18 136.45 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.445 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 78' ' ' PHE . 4.7 mt -128.8 115.94 18.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.121 0.486 . . . . 0.0 110.856 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.704 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -99.3 129.31 45.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.055 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.625 ' HB3' HG23 ' A' ' 15' ' ' ILE . 54.0 m-85 -130.15 151.32 50.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.593 0.235 . . . . 0.0 110.788 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -132.96 124.57 28.02 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 44.8 50.37 8.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.799 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.03 -4.98 81.58 Favored Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.589 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -119.97 160.85 21.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 84' ' ' VAL . 23.4 tt0 -66.18 179.94 0.87 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -152.68 -24.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.601 164.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.631 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.99 157.63 5.35 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 111.436 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.21 133.91 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.428 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 95' ' ' ILE . 5.6 t -132.23 144.05 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 88' ' ' VAL . 9.0 p -117.1 49.04 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 122.218 1.008 . . . . 0.0 109.897 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.02 130.5 1.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.275 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.59 111.88 1.78 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.57 91.12 41.12 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.334 175.084 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 46.7 Cg_exo -31.69 -65.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.922 3.748 . . . . 0.0 115.359 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.65 -45.45 11.69 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.05 -30.59 71.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.3 mt -85.95 -31.61 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.308 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.557 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 15.4 ttpp -59.83 -38.77 82.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -64.4 -34.61 78.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.857 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -64.67 -60.78 2.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -50.73 -30.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.582 0.551 . . . . 0.0 110.802 -176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.5 -20.86 39.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.771 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.71 -32.11 17.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.704 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -92.19 -12.07 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.907 -178.1 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.942 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.556 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 4.8 m -65.03 145.03 56.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.775 -168.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -96.71 123.88 40.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.807 -175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 12.5 m-85 -84.63 158.95 20.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.235 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -128.65 -27.25 2.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.007 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 29.6 p -127.54 162.8 25.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.409 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.09 -26.72 62.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.13 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.508 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.0 mt-10 -58.1 -41.43 83.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.522 172.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 23' ' ' VAL . 31.8 t80 -57.36 -59.72 4.72 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -56.36 -40.75 75.05 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.722 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -42.5 82.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.665 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 -36.27 71.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.364 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.7 mm -61.89 -40.73 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.8 2.24 8.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.257 -172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -74.85 143.15 44.02 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.56 34.43 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.563 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 172.31 13.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.153 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.56 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -68.49 123.08 19.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.488 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.6 t -103.2 114.28 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -93.64 103.61 14.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 11' ' ' PHE . 56.1 t -105.61 124.65 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.787 0.803 . . . . 0.0 111.256 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -103.43 98.37 8.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.933 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.5 121.59 44.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.482 0.658 . . . . 0.0 111.698 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 28.3 p90 -147.98 169.6 19.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.213 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -117.31 124.7 49.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -23.28 55.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -87.29 -10.17 53.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.518 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.13 158.83 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.758 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.62 -74.22 0.44 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.611 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.51 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 5.9 Cg_exo -77.91 25.66 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.315 2.677 . . . . 0.0 114.078 -171.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 p -65.65 -35.67 81.46 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.011 0.91 . . . . 0.0 109.566 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -68.31 -8.01 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.993 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -36.2 30.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -75.31 -25.58 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.864 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.36 -66.2 1.12 Allowed Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.738 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 90.0 Cg_endo -82.47 -30.05 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.263 1.309 . . . . 0.0 114.251 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -66.13 -44.97 82.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.606 0.639 . . . . 0.0 109.463 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.904 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -71.64 -37.57 63.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.219 -178.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.52 -33.19 75.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.809 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 5.0 tppp? -67.46 -34.97 78.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.331 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 20.5 m-30 -49.59 -62.99 1.24 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.267 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -76.55 -14.34 60.02 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.016 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 10.3 tp10 -59.39 -33.09 70.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 170.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.638 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.74 -45.52 10.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.567 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.3 p90 -130.49 86.67 52.54 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.143 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.4 -1.79 10.25 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.446 2.097 . . . . 0.0 112.168 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -9.98 45.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.481 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.8 16.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -92.75 135.83 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.125 0.488 . . . . 0.0 111.234 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -113.66 116.55 29.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.235 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -140.47 151.25 44.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.928 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -148.77 158.24 44.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.693 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.04 146.75 16.04 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 177.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.3 m-20 -95.83 118.33 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.183 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.653 HG21 ' HE1' ' A' ' 72' ' ' MET . 1.5 m -67.74 -16.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.43 . . . . 0.0 110.895 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.58 -40.17 96.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.03 -42.76 14.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.195 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -127.15 73.02 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 111.555 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.84 -36.89 87.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.17 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.11 -38.83 73.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 110.866 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 8' ' ' ALA . 95.4 t -63.66 -51.21 72.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.035 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.82 -39.06 62.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.884 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 30.1 mm-40 -69.27 -33.33 73.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.366 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.688 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 12.3 tptt -62.37 -30.05 70.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.815 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.696 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.7 m120 -102.71 -7.5 21.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.674 -170.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 45.1 mt-10 79.08 24.95 0.49 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.047 0.842 . . . . 0.0 111.043 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -100.68 112.09 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.231 0.538 . . . . 0.0 110.103 175.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.5 t -124.78 -20.83 4.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.28 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.653 ' HE1' HG21 ' A' ' 57' ' ' VAL . 19.9 mmt -129.36 121.55 20.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.056 -174.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 73.4 Cg_endo -88.01 167.71 40.26 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.005 -1.248 . . . . 0.0 113.018 -3.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 10.7 m -136.58 138.16 40.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.686 0.755 . . . . 0.0 111.555 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -109.02 127.79 54.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.569 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 78' ' ' PHE . 3.1 mt -121.5 113.6 20.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.112 0.482 . . . . 0.0 110.632 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -98.83 131.59 44.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.139 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.1 m-85 -129.69 158.34 39.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.465 0.174 . . . . 0.0 110.586 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -141.25 123.76 15.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p30 48.07 54.02 10.76 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 79.62 -1.6 76.89 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.48 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -127.62 161.33 29.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.3 tt0 -65.55 179.43 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.06 0.457 . . . . 0.0 110.907 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -151.03 -28.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 163.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -168.63 152.68 5.73 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.539 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HB3' HD23 ' A' ' 76' ' ' LEU . 21.7 pttp -145.81 129.58 17.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.866 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.17 129.89 60.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.545 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.94 50.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.018 0.437 . . . . 0.0 111.503 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.49 128.47 0.99 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.251 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.33 114.42 2.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 95' ' ' ILE . 7.3 t-20 -117.12 90.21 32.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.688 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 74.1 Cg_exo -21.93 -83.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 1 C-N-CA 125.512 4.141 . . . . 0.0 115.595 -171.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 96' ' ' LYS . . . -83.87 -30.51 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -173.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.66 77.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.36 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 75' ' ' LEU . 34.7 mm -83.39 -29.85 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.798 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 37.3 mtpt -59.31 -39.25 82.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -66.63 -33.03 74.76 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.516 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -61.71 -60.78 3.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.52 -36.56 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 123.831 0.707 . . . . 0.0 110.683 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.55 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.831 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -37.12 14.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.296 0.57 . . . . 0.0 109.991 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.668 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -85.42 -11.65 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.522 174.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 52' ' ' PHE . 52.8 t . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.566 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 11.2 m -71.82 144.64 49.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 0.0 112.525 -169.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -90.86 121.51 32.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.232 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 3.7 m-85 -69.75 168.5 14.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 0.0 110.418 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 16.7 mtpp -127.86 -36.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.019 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -144.6 179.28 7.39 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.51 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -65.95 -27.74 68.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -57.48 -48.5 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.787 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.503 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -55.02 -43.04 73.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.729 174.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.5 t80 -58.03 -60.08 4.29 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.7 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.01 -38.87 76.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.803 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -60.36 -47.83 84.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.695 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.24 75.0 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.844 0.354 . . . . 0.0 110.402 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.706 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -59.67 -36.81 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.308 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 14.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.469 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -83.14 153.73 24.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.65 0.262 . . . . 0.0 110.537 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -87.99 39.34 0.89 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.478 0.656 . . . . 0.0 110.36 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 17.7 ptpt -152.61 -179.8 7.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.051 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.35 121.63 23.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.629 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.1 t -96.21 116.19 37.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.051 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.41 103.16 14.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 11' ' ' PHE . 43.4 t -104.93 126.53 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.592 0.71 . . . . 0.0 111.285 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.66 101.16 10.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.847 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.699 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.6 m-85 -104.69 121.64 44.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 42.1 p90 -151.4 162.64 40.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.525 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -111.7 132.31 54.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -62.0 -24.55 67.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.687 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -84.27 -17.13 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.823 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.39 152.45 39.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.342 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.89 -75.56 0.48 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.348 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 20.85 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.156 2.571 . . . . 0.0 114.226 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.4 p -65.74 -28.57 69.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.903 0.858 . . . . 0.0 109.345 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 22.5 pttp -68.33 -8.45 39.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.501 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.542 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.0 ttt -84.92 -25.56 27.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.148 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -79.99 -24.7 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.306 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.39 -63.57 2.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.6 Cg_endo -83.91 -34.47 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.084 1.856 . . . . 0.0 114.045 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.528 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 0.5 OUTLIER -66.25 -42.99 87.81 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.426 0.631 . . . . 0.0 109.681 -176.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.51 -36.82 48.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.883 -178.128 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.3 mt-10 -63.43 -30.49 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.035 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 51.1 tttp -75.78 -28.91 58.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.524 -176.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.2 m-85 -56.59 -57.87 10.5 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.4 p -76.5 -13.75 60.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.496 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 34.1 tt0 -60.79 -31.9 71.27 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -88.34 -47.04 8.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.095 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.6 p90 -129.6 90.06 44.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.099 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -1.09 9.61 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.266 1.977 . . . . 0.0 112.174 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -10.62 51.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.964 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 154.63 18.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.1 m-20 -91.61 126.34 36.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -101.86 116.21 32.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.177 -174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.566 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.58 152.48 46.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.988 0.423 . . . . 0.0 111.029 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.5 pttt -148.91 160.92 42.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.4 tt -157.58 151.19 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 18.6 t0 -97.86 119.1 35.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.62 -26.99 42.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.809 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.19 -35.59 80.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.373 0.606 . . . . 0.0 109.98 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.53 -42.46 20.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.498 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB2' HD21 ' A' ' 55' ' ' LEU . 74.2 mt -135.09 84.01 2.07 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.91 -33.76 54.42 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.553 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.28 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 8' ' ' ALA . 79.6 t -63.74 -51.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.911 173.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.41 -39.69 57.76 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 110.76 176.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 75.9 mt-30 -69.97 -32.56 70.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.588 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -20.73 66.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.877 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.65 ' HB2' HG12 ' A' ' 69' ' ' VAL . 5.7 m120 -110.71 -8.75 14.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.482 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 25.7 tt0 80.69 25.85 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.102 0.876 . . . . 0.0 110.883 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -105.92 107.81 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.333 0.587 . . . . 0.0 110.668 174.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -116.76 -24.52 7.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.138 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.12 157.76 26.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.3 ptp -151.3 137.4 11.19 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.269 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.0 Cg_endo -77.88 155.82 94.87 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.768 -1.763 . . . . 0.0 113.021 -3.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.5 m -134.73 142.87 46.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.442 0.639 . . . . 0.0 111.339 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 95' ' ' ILE . 4.0 mp -114.24 129.36 56.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.768 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.592 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 mt -122.21 117.17 25.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 0.0 110.999 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -101.06 129.45 46.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.102 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.6 m-85 -127.79 161.39 29.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 4.6 ttpm? -143.55 115.45 8.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.008 168.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 64.26 55.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.762 0.791 . . . . 0.0 111.205 172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.706 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.39 2.66 60.04 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.488 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 8.5 ptpp? -133.44 160.97 35.84 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 31.6 tt0 -64.99 177.63 0.96 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 110.856 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -148.84 -35.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 160.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.99 152.96 15.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.51 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HB3' HD23 ' A' ' 76' ' ' LEU . 42.3 pttt -147.61 127.16 13.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.168 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.66 134.22 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.278 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.9 52.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.234 0.54 . . . . 0.0 110.782 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.28 129.46 1.25 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.073 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -64.69 103.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.734 0.302 . . . . 0.0 111.601 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.3 OUTLIER -117.49 88.89 30.42 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.032 175.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -35.37 -67.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.496 3.464 . . . . 0.0 115.272 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 -32.16 48.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.24 63.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.163 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 99' ' ' ILE . 40.3 mm -87.56 -34.4 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.23 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.704 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 55.0 tttt -59.48 -35.06 73.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -72.89 -31.22 64.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.76 27.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.5 mm -54.43 -37.51 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.337 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.112 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -44.51 34.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.832 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.03 -16.95 56.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.654 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.628 177.664 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.64 HG21 HG22 ' A' ' 40' ' ' ILE . 95.2 t . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 21.3 m -81.53 144.53 31.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.513 -170.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -90.13 135.83 33.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.122 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 8.9 m-30 -88.37 167.88 13.13 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 170.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 55.7 pttt -134.67 -20.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.206 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 22.6 p -145.49 174.69 10.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -70.8 -27.48 63.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -59.27 -43.8 92.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.304 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.718 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 42.9 mm-40 -55.35 -46.62 76.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.382 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 23' ' ' VAL . 16.6 t80 -59.24 -57.73 11.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.695 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.59 -40.98 93.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.828 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -62.02 -40.09 94.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.192 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.78 -42.58 90.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.648 175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.857 HG22 ' HA2' ' A' ' 81' ' ' GLY . 4.9 mm -60.2 -40.33 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.97 7.65 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 24.3 mt-30 -83.95 148.66 26.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.53 44.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -144.26 167.87 21.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.089 177.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -78.88 117.58 20.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 14' ' ' ALA . 41.1 t -108.36 122.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.227 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 28.9 t -106.59 112.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.723 HG11 ' CE2' ' A' ' 11' ' ' PHE . 54.6 t -100.14 121.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.641 0.734 . . . . 0.0 110.87 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.765 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -85.26 96.61 9.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.659 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -96.84 126.03 41.7 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.966 0.413 . . . . 0.0 110.077 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 36' ' ' ILE . 8.6 p90 -149.8 -175.28 4.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.573 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -132.76 130.04 39.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.637 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -65.55 -19.47 65.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.959 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -84.98 -13.5 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.174 0.511 . . . . 0.0 110.552 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.648 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.2 t -90.48 136.56 32.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.37 7.67 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 113.532 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.648 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.3 Cg_exo -61.33 3.59 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.103 2.535 . . . . 0.0 114.145 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.1 t -59.03 -29.88 67.6 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.737 0.779 . . . . 0.0 110.429 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -67.97 -8.99 41.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.306 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -38.13 44.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.05 -25.46 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.861 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.65 -65.69 1.38 Allowed Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.891 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 73.2 Cg_endo -83.55 -26.87 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.72 1.613 . . . . 0.0 114.378 -175.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.539 ' HE3' HG13 ' A' ' 40' ' ' ILE . 3.3 tmm? -72.72 -37.45 67.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.291 0.567 . . . . 0.0 109.753 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.765 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.85 -33.34 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.659 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.53 -29.05 70.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -72.79 -38.77 67.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.823 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.576 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -57.12 -49.63 75.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.5 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 95.8 p -85.39 -13.97 47.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.56 -27.98 69.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 13.3 mm-40 -89.68 -40.7 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.12 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 11.5 p90 -138.85 93.11 10.8 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 112.431 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.44 2.37 2.9 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.451 2.1 . . . . 0.0 112.107 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.06 -23.74 67.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.48 157.58 16.7 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.3 135.75 33.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.904 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.5 p90 -111.52 115.46 29.24 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.249 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 3' ' ' THR . 95.8 m-85 -140.66 156.74 46.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.716 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 43.4 mtmt -137.52 149.21 46.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.155 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD22 ' CE1' ' A' ' 25' ' ' PHE . 8.8 tt -157.87 148.81 21.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.034 0.445 . . . . 0.0 110.745 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 5.3 t0 -104.38 123.35 47.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.8 p -70.29 -24.39 25.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.061 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.62 -23.96 65.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.532 0.682 . . . . 0.0 109.694 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -99.12 -42.49 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.507 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -120.22 76.16 1.15 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.276 0.56 . . . . 0.0 112.163 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.81 62.67 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.85 -25.58 65.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.914 0.388 . . . . 0.0 110.797 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.623 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 51.5 t -68.68 -50.33 56.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -52.82 -22.84 5.85 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -86.26 -27.3 24.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -75.39 -26.5 58.48 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.107 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.642 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.5 p30 -110.13 -12.6 14.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 29.3 tt0 79.84 17.35 0.75 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.85 0.718 . . . . 0.0 112.635 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -89.55 130.89 38.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 121.567 -0.708 . . . . 0.0 110.639 173.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -123.94 -27.34 3.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.98 166.36 11.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.535 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -148.09 141.71 15.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.84 0.353 . . . . 0.0 110.951 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.89 150.29 78.55 Favored 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.836 -1.735 . . . . 0.0 112.635 -2.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -132.46 136.93 47.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.552 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -107.83 123.26 48.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.689 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -116.06 116.43 27.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.573 0.701 . . . . 0.0 109.876 175.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.2 mp -95.75 128.46 42.65 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.504 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 76' ' ' LEU . 58.9 m-85 -125.96 153.26 44.55 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.493 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -135.87 125.39 25.13 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 46.8 53.82 9.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.223 1.009 . . . . 0.0 113.49 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.857 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.8 5.4 69.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.528 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -120.08 161.12 21.51 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 84' ' ' VAL . 27.0 tt0 -71.58 179.89 2.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -153.86 -33.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 164.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.58 149.76 5.78 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.423 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -146.82 127.86 14.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.032 0.444 . . . . 0.0 110.54 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 95' ' ' ILE . 4.2 m -132.44 139.42 50.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -101.69 48.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.255 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.33 131.58 1.71 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.317 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.647 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -69.72 108.13 3.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -117.28 89.75 32.06 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 12.2 Cg_exo -28.53 -67.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.79 3.66 . . . . 0.0 115.588 -171.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.9 21.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.74 71.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.739 0.304 . . . . 0.0 111.32 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 91' ' ' ASN . 35.3 mm -72.62 -49.24 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.695 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mtmp? -63.46 -28.59 70.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -38.38 68.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.038 173.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.72 68.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.498 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -52.73 -39.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.711 -178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.7 -19.85 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.175 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.9 -38.08 23.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.254 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' ND2' HD23 ' A' ' 77' ' ' LEU . 58.1 m-80 -83.95 -21.16 31.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.448 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.894 178.17 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.646 HG23 ' HG2' ' A' ' 41' ' ' GLU . 43.7 t . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.636 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 1.4 m -60.48 144.42 51.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.414 -168.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.52 117.43 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.224 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.4 m-85 -71.07 167.58 18.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.138 0.494 . . . . 0.0 111.755 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -125.38 -41.31 2.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.924 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -138.5 -179.96 6.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 111.443 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -67.86 -25.5 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.978 0.418 . . . . 0.0 110.186 175.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -61.2 -46.83 88.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -54.96 -42.74 72.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.448 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.801 ' CE2' HG11 ' A' ' 23' ' ' VAL . 17.6 t80 -57.37 -58.88 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.01 -36.35 74.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -63.54 -41.46 98.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.845 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.21 -35.54 78.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.037 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.763 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -62.26 -39.16 83.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.052 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.06 0.97 9.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 98.5 mt-30 -75.5 143.58 42.45 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.73 40.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 0.0 110.986 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 20.7 ptmt -142.19 167.44 22.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.381 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -70.1 126.42 29.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.0 t -106.07 120.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.2 104.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.801 HG11 ' CE2' ' A' ' 11' ' ' PHE . 39.4 t -102.72 127.18 56.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.663 0.744 . . . . 0.0 111.083 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.849 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.33 98.17 7.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.125 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.3 m-85 -103.21 123.97 47.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.439 ' O ' HG13 ' A' ' 57' ' ' VAL . 48.9 p90 -152.92 179.02 9.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.398 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -129.92 135.97 48.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.652 0.263 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.61 HG23 ' OD2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -63.96 -22.04 66.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.38 -13.26 52.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.562 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 52.9 t -81.99 148.79 28.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.706 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.39 -65.98 1.98 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 13.1 Cg_exo -71.8 18.52 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.24 2.627 . . . . 0.0 114.23 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -67.44 -29.24 68.66 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.048 0.927 . . . . 0.0 109.44 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 99.2 mttt -68.08 -7.36 28.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.133 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -38.33 58.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.659 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.22 -25.47 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.044 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.671 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.45 -65.8 1.3 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.976 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 96.2 Cg_endo -82.46 -29.75 1.36 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.456 1.437 . . . . 0.0 114.299 -173.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -66.3 -44.9 82.14 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.36 0.6 . . . . 0.0 109.456 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.849 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -69.55 -37.5 74.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.22 -179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 2' ' ' VAL . 40.8 mt-10 -62.83 -31.99 73.1 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.065 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.53 -32.74 70.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.696 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 16.8 m-30 -52.44 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -76.07 -13.4 60.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.263 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -60.55 -39.57 88.41 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.62 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -79.05 -47.61 15.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.5 p90 -133.06 89.9 32.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.214 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.28 2.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.503 2.135 . . . . 0.0 112.661 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -63.76 -24.74 67.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.304 0.573 . . . . 0.0 110.716 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.48 153.29 20.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.352 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.92 150.17 21.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.162 -175.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -118.33 115.96 25.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.969 -172.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.636 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.9 m-85 -141.8 149.51 40.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 111.635 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 36.9 mtmt -131.03 160.78 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.932 0.893 . . . . 0.0 110.1 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 25' ' ' PHE . 9.0 tt -159.8 147.8 17.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -98.89 117.99 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.131 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -71.83 -17.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 0.0 110.376 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.02 -31.99 69.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' O ' HD13 ' A' ' 60' ' ' LEU . 37.2 tt0 -87.69 -42.77 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.024 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.4 mm? -124.22 80.63 1.85 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.0 -39.77 93.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.701 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.83 -33.98 76.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.481 HG11 HD13 ' A' ' 55' ' ' LEU . 86.6 t -65.56 -49.53 77.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.095 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.7 -39.26 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.713 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 81.6 mm-40 -69.24 -38.11 78.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.12 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.559 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 5.9 tptp -59.46 -24.96 63.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.475 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.0 m120 -109.47 -8.02 15.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 122.278 -0.264 . . . . 0.0 111.366 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.2 mt-10 79.21 27.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.997 0.811 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -106.22 109.84 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.4 0.619 . . . . 0.0 110.481 175.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.0 m -117.41 -34.51 4.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.182 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.07 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.624 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 19.6 ptp -151.79 149.27 23.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.959 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.3 Cg_endo -79.63 150.82 84.38 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.525 -1.864 . . . . 0.0 112.422 -4.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.1 m -126.05 140.21 52.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.595 0.712 . . . . 0.0 111.784 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 mp -114.99 124.65 52.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.436 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.646 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -116.32 118.74 33.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.462 . . . . 0.0 110.57 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.4 mp -99.72 131.84 45.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.279 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.646 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.3 m-85 -131.23 160.31 35.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.558 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 7.0 ttpm? -144.69 131.19 19.83 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.85 52.88 11.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.763 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.45 1.6 82.39 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.46 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -125.46 160.31 29.78 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.1 tt0 -66.57 -178.36 0.69 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.12 -31.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.647 162.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.681 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -164.0 154.43 15.23 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.918 0.39 . . . . 0.0 111.736 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -145.69 126.53 14.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 75' ' ' LEU . 12.3 m -133.65 142.74 40.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.669 0.271 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.23 43.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.963 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.48 121.9 0.82 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.119 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -59.63 109.59 0.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.952 0.406 . . . . 0.0 111.566 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.466 ' HB3' HG12 ' A' ' 95' ' ' ILE . 4.2 t30 -117.14 90.66 34.24 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.2 Cg_exo -26.26 -79.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.826 3.684 . . . . 0.0 115.288 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.91 -35.31 43.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.81 76.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.417 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.7 mm -86.15 -31.61 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.633 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 22.4 mtmm -63.05 -32.93 74.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.704 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -69.96 -32.86 71.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.035 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.55 48.56 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.089 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.1 mm -54.26 -38.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.453 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.77 60.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.097 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.98 -38.14 32.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.437 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 77' ' ' LEU . 52.5 m-80 -86.67 -14.58 42.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.269 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.73 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 40' ' ' ILE . 53.6 t . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.001 0.429 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.655 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 2.7 m -72.47 146.14 47.08 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -167.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -93.54 139.06 31.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.954 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 11' ' ' PHE . 11.5 m-85 -103.67 154.87 19.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.029 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 25.3 pttm -133.85 -3.35 2.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.205 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -143.22 164.11 31.08 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.477 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -56.93 -47.66 80.11 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -53.5 -44.95 69.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.609 ' O ' HG12 ' A' ' 15' ' ' ILE . 17.0 t80 -58.89 -57.25 13.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.7 -34.86 78.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.757 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -62.35 -40.35 96.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.678 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.61 -20.78 63.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.466 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.76 HG22 ' HA2' ' A' ' 81' ' ' GLY . 12.5 mm -82.58 -36.49 13.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.335 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 12.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -101.09 148.2 25.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 120.817 0.342 . . . . 0.0 110.313 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.73 66.22 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.619 0.723 . . . . 0.0 110.747 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -154.03 174.59 14.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.44 117.16 24.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.158 0.504 . . . . 0.0 109.846 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.3 t -102.23 128.43 54.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.2 t -115.78 108.79 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 11' ' ' PHE . 14.5 t -106.31 129.58 59.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.706 0.765 . . . . 0.0 110.885 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.893 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.68 100.17 11.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.081 -175.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -105.89 108.88 20.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.492 0.663 . . . . 0.0 111.945 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.4 p90 -131.76 -174.51 3.44 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.532 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.97 139.91 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.892 0.377 . . . . 0.0 110.404 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -20.28 62.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.709 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -88.7 -15.75 34.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.36 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 33' ' ' CYS . 16.3 p -90.92 150.25 21.57 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.2 -46.99 9.55 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.912 -0.585 . . . . 0.0 114.321 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 42.0 Cg_endo -67.11 5.08 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.578 2.186 . . . . 0.0 114.307 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 24.4 p -61.98 -34.1 75.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.457 0.646 . . . . 0.0 110.383 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.4 -8.66 42.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.402 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 90' ' ' ALA . 16.9 tpt -79.7 -33.34 41.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -79.95 -26.75 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.049 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.05 -62.04 3.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.269 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 83.9 Cg_endo -80.39 -41.2 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 120.152 1.09 . . . . 0.0 113.706 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.461 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 2.8 tmm? -62.04 -36.21 80.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.246 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -82.17 -35.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.288 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -64.57 -23.43 67.26 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.189 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 27.0 mtpp -85.56 -26.05 26.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -60.69 -42.07 96.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.965 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -15.43 49.35 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 122.054 -0.404 . . . . 0.0 111.008 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 24.0 tt0 -56.53 -39.18 72.94 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -84.22 -50.23 8.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.908 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 14.3 p90 -134.13 91.02 24.46 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.252 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.99 0.78 8.48 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.885 1.723 . . . . 0.0 111.195 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -65.63 -9.66 29.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.779 176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.84 161.15 13.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.18 130.76 37.81 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -114.96 116.32 28.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.053 -172.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 88.2 m-85 -140.57 151.34 44.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.526 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 19.5 pttm -148.64 152.44 36.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.15 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 60' ' ' LEU . 6.7 tt -160.33 152.44 20.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.757 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.7 p-10 -99.77 128.54 45.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 111.263 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -72.42 -12.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.082 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.49 -48.6 72.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.025 0.441 . . . . 0.0 109.926 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -80.12 -41.56 25.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.832 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.748 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -116.04 71.81 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.142 0.496 . . . . 0.0 112.249 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -75.15 -36.09 46.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.966 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.98 -30.58 71.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.403 0.621 . . . . 0.0 110.79 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 60.7 t -68.99 -52.55 32.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.6 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.91 -40.9 58.08 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.23 0.331 . . . . 0.0 111.238 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 71.6 mt-30 -69.66 -32.04 70.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.726 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 10.8 tptt -62.98 -27.95 69.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.729 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.726 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 4.7 m120 -103.94 -10.11 18.39 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.3 tt0 80.99 19.49 0.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.201 0.938 . . . . 0.0 111.029 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.677 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -96.44 118.66 43.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 121.804 -0.56 . . . . 0.0 110.145 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 m -117.32 -31.33 5.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.618 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.11 163.87 13.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.269 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.425 ' CE ' HG21 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -144.51 138.51 14.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' CG ' HD13 ' A' ' 36' ' ' ILE . 59.3 Cg_endo -83.39 152.18 69.03 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.741 -1.775 . . . . 0.0 113.024 -0.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.7 m -131.56 135.03 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.681 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -104.9 129.93 53.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.533 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE2' ' A' ' 78' ' ' PHE . 1.3 mt -120.64 115.67 23.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.011 0.434 . . . . 0.0 110.92 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -98.81 133.15 43.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE2' HD22 ' A' ' 76' ' ' LEU . 47.9 m-85 -130.85 153.91 48.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 4.1 tppp? -132.68 118.15 18.75 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 1.8 p-10 43.78 55.74 4.96 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.255 1.022 . . . . 0.0 113.735 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.76 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.34 -5.63 63.08 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.601 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.97 160.08 16.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.19 178.52 4.39 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -149.23 -34.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 163.206 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.655 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.01 157.17 11.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.465 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HB3' HD23 ' A' ' 76' ' ' LEU . 29.2 pttt -152.03 134.71 15.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 t -132.1 124.5 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.343 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.09 52.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.203 0.525 . . . . 0.0 111.27 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.34 126.83 0.85 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.824 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -63.4 121.44 13.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.435 0.636 . . . . 0.0 111.558 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 3.6 t-20 -117.24 90.69 34.76 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.999 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 51.1 Cg_exo -21.37 -75.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.377 4.051 . . . . 0.0 115.926 -171.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.0 -34.44 24.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.72 -29.58 70.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.433 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.458 ' O ' HG12 ' A' ' 99' ' ' ILE . 37.9 mm -73.35 -43.69 56.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.067 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.591 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 87.4 mttt -64.26 -24.83 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.634 0.73 . . . . 0.0 109.806 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -84.09 -29.04 27.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.676 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.13 -54.35 31.27 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.98 0.419 . . . . 0.0 110.207 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -50.89 -39.79 19.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.646 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.94 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.383 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.18 41.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' HD23 ' A' ' 77' ' ' LEU . 47.5 m-80 -96.55 -15.34 21.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.968 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.791 177.022 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 41' ' ' GLU . 62.4 t . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 23.4 m -90.24 131.62 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.649 0.738 . . . . 0.0 112.555 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 57.9 mm-40 -69.01 137.54 53.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.939 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -83.26 170.5 14.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.798 169.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -122.7 -41.38 2.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -140.67 179.28 6.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.873 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -66.09 -27.84 68.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.513 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -59.45 -46.99 87.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.547 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -53.13 -44.2 67.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.369 172.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.743 ' O ' HG12 ' A' ' 15' ' ' ILE . 14.8 t80 -59.84 -60.91 3.07 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.85 -39.78 65.91 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.939 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -64.29 -44.8 90.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.4 75.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.144 0.497 . . . . 0.0 110.312 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.813 HG22 ' HA2' ' A' ' 81' ' ' GLY . 13.6 mm -63.49 -38.13 81.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.55 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.55 6.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HB3' ' CD ' ' A' ' 19' ' ' LYS . 96.8 mt-30 -83.69 141.95 31.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.539 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 32.23 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 111.966 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.75 178.98 6.7 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -74.58 122.32 22.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.5 t -101.15 111.2 30.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -93.54 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 176.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 11' ' ' PHE . 57.1 t -103.54 123.78 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.86 0.838 . . . . 0.0 111.188 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -95.98 96.63 9.02 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.215 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.809 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -99.29 130.63 45.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.8 p90 -157.49 -171.77 3.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.908 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -142.1 139.29 32.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -15.25 62.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -87.58 -12.74 44.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.014 0.435 . . . . 0.0 110.619 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.0 t -83.24 149.91 26.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.025 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.71 -67.89 1.58 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.791 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 41.7 Cg_endo -69.21 12.8 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.099 2.533 . . . . 0.0 114.356 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 26.5 p -63.94 -32.71 74.34 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.087 0.946 . . . . 0.0 109.879 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.673 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 44.2 mtmt -69.16 -8.86 49.43 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.009 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.31 -33.11 49.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -76.22 -24.55 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.814 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.77 -65.37 1.54 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.587 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.2 Cg_endo -82.91 -35.62 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.606 1.537 . . . . 0.0 113.238 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.41 -40.16 95.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.623 0.725 . . . . 0.0 109.936 -175.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.784 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.12 -38.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.754 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HG2' HG23 ' A' ' 2' ' ' VAL . 44.5 mt-10 -65.28 -29.57 70.35 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.525 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 13.1 mmmm -66.92 -40.2 87.57 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.444 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.0 m-30 -52.51 -62.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.781 0.324 . . . . 0.0 111.207 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.8 p -77.16 -13.29 59.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.731 0.301 . . . . 0.0 111.368 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.7 -39.68 85.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -81.84 -42.67 19.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.044 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.5 p90 -130.0 89.82 44.42 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 111.927 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.39 0.74 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.189 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -64.96 -12.11 46.14 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.207 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.32 147.13 26.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.903 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.641 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.3 p90 -91.51 116.09 28.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.142 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 3' ' ' THR . 94.9 m-85 -141.19 155.17 46.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.604 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 19.3 ptmt -149.29 151.86 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.871 -172.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.908 HD21 ' HB2' ' A' ' 60' ' ' LEU . 10.1 tt -159.55 148.34 17.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.746 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.6 p-10 -101.65 120.75 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.221 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 72' ' ' MET . 3.6 p -67.13 -16.75 21.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.611 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.85 -49.14 63.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.291 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -90.77 -42.98 10.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.819 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.908 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -105.33 73.65 1.05 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.548 0.689 . . . . 0.0 111.866 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -69.61 -43.64 67.29 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.135 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 3.7 p30 -67.63 -20.9 65.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 0.0 110.797 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 96.1 t -69.75 -51.98 35.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.31 -40.44 59.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.343 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 4.4 pt20 -68.31 -36.12 78.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.088 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.744 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.26 -28.67 68.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.777 176.097 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.744 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 10.3 m120 -102.77 -13.12 17.16 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.281 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 5.4 tp10 80.08 19.88 0.59 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.467 1.104 . . . . 0.0 111.067 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -95.09 119.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.187 0.518 . . . . 0.0 109.757 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -134.45 8.21 3.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.402 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.53 153.69 38.88 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 57' ' ' VAL . 2.2 mpt? -129.8 130.68 23.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.915 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.527 ' HB2' HG12 ' A' ' 36' ' ' ILE . 60.2 Cg_endo -86.14 165.76 51.87 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.247 -1.564 . . . . 0.0 112.377 -5.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.1 m -141.56 128.91 21.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.508 0.671 . . . . 0.0 111.09 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -97.68 123.51 41.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.044 173.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.9 mt -115.9 113.79 23.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.317 0.58 . . . . 0.0 110.742 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -99.24 127.53 45.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.04 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HB3' HG23 ' A' ' 15' ' ' ILE . 48.8 m-85 -128.08 159.14 36.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.546 0.212 . . . . 0.0 111.219 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -143.81 135.8 26.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p30 49.54 41.57 21.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.183 0.993 . . . . 0.0 113.319 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 83.39 1.49 90.29 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.576 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -122.67 161.09 24.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.5 tt0 -68.88 179.61 1.76 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 118.404 0.547 . . . . 0.0 109.77 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -149.11 -28.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.497 162.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.95 152.64 13.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.098 0.475 . . . . 0.0 111.61 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -142.92 120.11 11.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.311 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 95' ' ' ILE . 59.1 t -130.6 128.6 63.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.831 0.348 . . . . 0.0 110.978 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -99.8 52.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.126 0.488 . . . . 0.0 110.957 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.57 124.86 0.89 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.291 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.62 102.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.925 0.49 . . . . 0.0 112.131 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' CB ' HG12 ' A' ' 95' ' ' ILE . 1.5 t-20 -118.0 89.52 34.64 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.176 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 29.5 Cg_exo -32.82 -66.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.326 3.351 . . . . 0.0 115.378 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.47 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.29 68.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.67 0.271 . . . . 0.0 111.69 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 HD22 ' A' ' 75' ' ' LEU . 42.3 mm -87.66 -33.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.083 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -61.55 -32.27 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.457 0.646 . . . . 0.0 109.512 170.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -71.59 -32.84 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.17 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.3 -52.27 48.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.123 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -53.36 -36.9 27.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -30.98 60.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.098 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.86 -37.41 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.499 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -86.83 -20.15 27.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.267 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.086 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 54' ' ' LYS . 83.4 t . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.471 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.5 m -74.14 144.8 44.73 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -170.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -101.16 122.71 44.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.657 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.2 m-85 -84.46 160.13 20.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.652 173.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -1.76 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 166.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.0 p -140.46 159.82 41.35 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.97 -28.72 62.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.37 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.62 -42.87 93.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -54.67 -44.2 73.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.716 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 15' ' ' ILE . 18.5 t80 -57.53 -60.68 3.3 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -55.12 -40.62 70.72 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.708 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.8 t -58.77 -45.49 89.66 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.944 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.72 76.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.668 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.97 -36.09 76.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.553 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 12.73 0.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -88.11 150.84 23.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.681 0.277 . . . . 0.0 110.585 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.52 36.9 0.49 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 110.766 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 79' ' ' LYS . 19.6 ptpt -137.3 177.49 7.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.2 tm? -82.38 118.49 23.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.0 t -102.78 119.99 51.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.832 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 31.2 t -107.13 106.79 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.9 t -101.76 123.79 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.94 0.876 . . . . 0.0 110.643 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -95.39 97.61 9.95 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.106 -174.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.2 m-85 -102.57 126.67 49.71 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.552 0.692 . . . . 0.0 111.866 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.63 174.85 12.97 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -125.64 124.5 41.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.57 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -19.48 65.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.106 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -90.76 -6.98 53.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 54.1 t -93.29 152.42 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.559 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.21 -72.01 0.74 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.668 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 59.8 Cg_endo -76.39 31.58 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.904 2.402 . . . . 0.0 114.512 -172.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.19 -34.74 75.4 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.914 0.864 . . . . 0.0 110.114 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -68.1 -7.28 28.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.984 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.549 ' HG3' ' HB3' ' A' ' 90' ' ' ALA . 17.0 tpt -75.89 -35.2 59.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 109.067 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -80.19 -25.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.017 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.79 -63.04 2.58 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.764 176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 95.7 Cg_endo -82.23 -34.98 0.38 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.035 1.156 . . . . 0.0 113.652 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 3.2 tmm? -65.03 -37.89 89.07 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.187 0.518 . . . . 0.0 110.017 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD13 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -78.98 -36.26 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.798 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -63.94 -26.16 68.46 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.936 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 94.2 mttt -80.03 -34.92 37.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.5 p90 -55.51 -48.56 74.44 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.229 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 79.0 p -85.37 -14.4 46.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.51 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 9.1 tp10 -55.42 -38.69 69.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.579 172.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -90.61 -37.93 13.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.399 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 12.3 p90 -132.72 90.7 31.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.683 . . . . 0.0 112.835 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.23 0.08 6.53 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.728 2.286 . . . . 0.0 112.645 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -14.88 62.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.977 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.7 154.83 18.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.54 127.79 37.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.874 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -100.78 116.11 31.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.233 -173.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.471 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.1 m-85 -138.23 150.94 47.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.655 0.264 . . . . 0.0 111.353 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HG3' HG11 ' A' ' 2' ' ' VAL . 33.6 mtmt -134.38 158.5 43.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.755 0.822 . . . . 0.0 110.233 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.3 tt -160.43 141.61 12.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 110.79 170.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.85 117.24 29.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.9 m -65.87 -19.08 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.491 0.663 . . . . 0.0 109.672 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.83 -38.31 78.4 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.059 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -96.38 -38.79 9.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.806 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.651 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -121.1 76.11 1.2 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.095 0.474 . . . . 0.0 111.682 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.5 78.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.259 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.25 -35.54 80.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.156 0.503 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 62.1 t -64.59 -48.71 83.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.23 -39.49 60.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.195 0.522 . . . . 0.0 110.773 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -74.86 -29.3 60.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.522 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.753 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -62.37 -27.49 69.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.052 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.753 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 8.5 m120 -104.38 -13.1 16.22 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.315 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 39.7 mt-10 80.63 31.23 0.18 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.532 1.145 . . . . 0.0 111.045 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -107.94 107.71 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.552 . . . . 0.0 110.113 170.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 m -115.31 -10.59 12.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.758 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.46 142.33 36.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HE2' HG21 ' A' ' 57' ' ' VAL . 2.0 mpt? -130.87 140.99 40.35 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.74 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD3' ' HG2' ' A' ' 32' ' ' PRO . 58.9 Cg_endo -81.1 163.75 78.96 Favored 'Cis proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.858 -1.726 . . . . 0.0 113.305 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.6 m -148.78 138.22 21.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.043 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.56 130.28 54.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.305 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -120.41 114.07 21.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.016 0.436 . . . . 0.0 110.39 175.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.665 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -97.0 133.35 41.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.0 m-85 -130.31 152.85 49.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.8 tppp? -127.08 110.11 12.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.404 168.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.9 t30 57.44 56.46 5.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 111.788 167.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.668 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.86 12.27 78.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.731 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -131.42 159.23 38.63 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 178.22 4.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.48 -32.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 164.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.98 154.54 7.71 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.508 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.99 134.15 19.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.174 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.79 122.12 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.173 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.39 55.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.134 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.78 135.42 2.0 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.78 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -67.76 122.6 18.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.091 0.472 . . . . 0.0 111.523 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.45 ' H ' ' CG1' ' A' ' 95' ' ' ILE . 16.1 t30 -117.73 90.29 35.59 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.662 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 29.2 Cg_exo -21.03 -78.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.639 4.226 . . . . 0.0 116.102 -169.059 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.78 -31.64 25.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -63.53 -32.01 73.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.69 0.281 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.6 mm -71.35 -43.73 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.175 175.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 27.1 mmtp -61.8 -35.16 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -69.25 -37.51 77.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.459 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.6 -61.18 2.8 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -48.3 -35.3 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.956 0.785 . . . . 0.0 110.756 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.25 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.977 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -31.96 17.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 110.287 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.665 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -91.67 -13.75 31.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.728 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.86 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.8 t . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.609 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 6.8 m -70.52 145.4 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -87.39 139.08 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.534 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.0 m-85 -102.52 148.08 25.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -129.54 1.41 5.01 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.663 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 24.0 p -142.13 156.59 45.37 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.991 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.971 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -58.32 -41.95 85.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.663 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mt-10 -56.15 -48.29 76.56 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.279 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.1 t80 -55.07 -57.98 9.52 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.12 -33.26 68.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.488 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -65.13 -49.73 68.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.54 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.72 75.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.6 mm -62.94 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.827 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 13.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.532 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -89.52 147.08 24.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.848 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.58 52.44 1.88 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.251 0.548 . . . . 0.0 112.145 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 51' ' ' ASP . 18.8 ptpt -154.86 178.49 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.59 118.86 19.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -102.78 124.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.806 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 17.2 t -113.74 111.13 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.6 t -108.29 129.08 63.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.827 0.822 . . . . 0.0 110.95 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.814 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.04 101.11 12.62 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.905 -175.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -108.48 115.65 30.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.332 0.587 . . . . 0.0 111.673 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 37.5 p90 -139.98 175.33 9.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.801 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -123.8 131.39 53.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.705 0.288 . . . . 0.0 110.572 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -26.99 69.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.419 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -81.34 -8.83 59.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.7 t -87.71 159.02 18.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.859 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.66 -67.2 1.46 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.344 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 39.8 Cg_endo -68.11 10.92 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.247 2.632 . . . . 0.0 114.219 -175.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.2 p -61.88 -34.52 76.16 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 21.8 ptmt -67.71 -8.62 36.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.61 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 21.2 ttt -82.55 -27.3 31.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -77.23 -25.16 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.064 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.83 -64.6 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.848 173.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.8 Cg_endo -82.95 -30.47 0.94 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 120.765 1.309 . . . . 0.0 114.411 -175.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.45 -33.94 71.87 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.455 0.645 . . . . 0.0 109.767 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -83.63 -34.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.932 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 37.7 mt-10 -65.64 -21.6 66.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.274 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 55.1 tttm -79.87 -36.0 37.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.886 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.4 p90 -58.87 -46.36 87.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.183 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.3 p -85.26 -14.67 45.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.476 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 6.8 tp10 -60.67 -31.67 70.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.35 -50.1 9.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.723 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.569 ' HD1' ' O ' ' A' ' 47' ' ' TYR . 3.9 p90 -134.79 92.8 18.68 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.732 0.777 . . . . 0.0 112.923 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.9 -0.26 5.97 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.198 1.932 . . . . 0.0 112.338 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 3.9 pp0? -67.11 -16.87 64.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.774 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.92 152.01 20.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -91.53 140.1 30.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.337 -175.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -113.21 115.18 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.947 -172.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -139.03 147.85 42.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.626 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 21.4 pttm -145.52 153.58 41.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.833 -174.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.0 tt -159.78 146.84 16.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.78 0.324 . . . . 0.0 110.687 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.2 m-20 -92.84 121.91 34.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.3 m -68.31 -16.6 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.248 0.547 . . . . 0.0 110.04 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.79 -39.55 91.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -79.21 -41.96 27.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 60.7 mt -136.96 83.58 2.01 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.449 0.642 . . . . 0.0 111.865 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -72.55 -38.04 57.84 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.499 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.13 -27.21 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.395 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 8' ' ' ALA . 91.1 t -67.47 -55.8 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.573 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -49.86 -41.15 44.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 111.14 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -69.2 -31.48 70.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.264 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 8.0 tptt -63.94 -25.78 68.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.31 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.687 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 5.5 m120 -102.97 -12.91 17.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 17.9 tp10 80.78 28.36 0.21 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.505 1.128 . . . . 0.0 110.645 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -106.58 116.41 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.248 0.546 . . . . 0.0 110.011 170.422 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -117.47 -30.94 5.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.22 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.46 13.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.173 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -150.0 143.5 16.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 111.016 -179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.495 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.5 Cg_endo -80.04 149.74 80.84 Favored 'Cis proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.445 -1.898 . . . . 0.0 113.036 -3.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -130.48 138.35 50.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.218 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -108.98 130.5 55.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.515 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 78' ' ' PHE . 3.1 mt -119.6 116.13 25.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.188 0.518 . . . . 0.0 110.825 176.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 85' ' ' ALA . 4.9 mp -99.08 128.33 45.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.915 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 76' ' ' LEU . 62.3 m-85 -131.13 155.9 46.19 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.941 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 40.3 ttmt -134.97 125.47 26.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.4 p-10 43.67 56.47 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.27 -1.66 69.5 Favored Glycine 0 CA--C 1.51 -0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.653 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -118.94 160.09 22.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.6 tt0 -72.94 179.12 3.87 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -153.25 -32.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.657 163.214 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.698 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.42 157.37 7.31 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.893 0.377 . . . . 0.0 111.954 177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -150.24 132.07 15.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.339 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 95' ' ' ILE . 55.2 t -133.27 132.32 58.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.308 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.67 50.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.075 0.464 . . . . 0.0 111.574 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.49 134.88 1.82 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.784 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.18 112.85 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.275 0.56 . . . . 0.0 111.421 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.97 90.2 32.11 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.424 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 32.8 Cg_exo -28.79 -68.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.933 3.755 . . . . 0.0 115.147 -170.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.21 -40.07 18.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -64.78 -30.44 71.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 87' ' ' VAL . 25.9 mm -74.59 -51.49 22.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.999 0.428 . . . . 0.0 110.226 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 99' ' ' ILE . 9.9 mtmp? -64.36 -23.3 67.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -82.98 -25.83 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.47 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.73 12.53 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.547 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 11.6 mt -50.36 -43.61 22.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.551 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.8 74.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.004 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.384 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -82.77 -17.66 43.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.373 176.165 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.5 t . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -72.23 144.16 48.56 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.5 tp-100 -90.65 135.85 33.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 7.6 m-85 -82.64 170.02 15.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.359 0.6 . . . . 0.0 110.773 172.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.648 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 36.8 mttp -129.71 -27.16 2.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.21 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 26.2 p -147.48 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -69.95 -26.42 64.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.93 -43.11 99.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.673 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.8 mm-40 -52.74 -45.56 67.06 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.682 ' O ' HG12 ' A' ' 15' ' ' ILE . 20.5 t80 -60.08 -62.48 1.84 Allowed 'General case' 0 N--CA 1.458 -0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.055 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.32 -37.35 74.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.112 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -61.34 -45.95 92.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.691 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.09 82.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 110.21 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.5 mm -64.16 -37.08 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.627 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 1.79 4.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.382 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 26.2 mt-30 -78.31 136.9 37.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.983 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 26.3 t0 -81.61 46.55 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.995 0.902 . . . . 0.0 110.285 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 19.8 ptpt -131.38 179.43 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.312 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 99' ' ' ILE . 1.9 tm? -83.43 113.95 21.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 3.5 t -104.51 121.33 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.88 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.7 t -108.8 114.95 48.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.55 HG11 ' CE2' ' A' ' 11' ' ' PHE . 21.9 t -107.68 129.25 62.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.853 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.23 100.96 12.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.663 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.2 m-85 -103.66 120.86 41.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.499 0.666 . . . . 0.0 111.585 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 39.6 p90 -152.23 161.24 42.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.769 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -113.5 133.55 55.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.664 0.268 . . . . 0.0 110.34 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.5 p -65.96 -21.54 66.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.418 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -77.83 -18.28 56.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.053 0.454 . . . . 0.0 110.387 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 48.1 t -82.38 147.06 29.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 -177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.58 -64.08 2.34 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.331 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 43.8 Cg_endo -68.06 10.5 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.284 2.656 . . . . 0.0 114.743 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 27.6 p -66.28 -24.79 66.62 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.833 0.825 . . . . 0.0 110.033 177.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.9 mttp -61.96 -20.64 64.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.94 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.452 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -68.16 -37.89 81.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 109.488 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.73 HD12 ' HB2' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.36 -25.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.06 -65.87 0.98 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.145 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.6 Cg_endo -83.26 -31.73 0.61 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 CA-C-N 121.066 1.416 . . . . 0.0 114.298 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.46 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.4 tmm? -67.96 -34.75 77.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.499 0.666 . . . . 0.0 109.68 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -82.18 -37.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.28 -179.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 2' ' ' VAL . 36.3 mt-10 -64.56 -23.25 67.2 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.666 171.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' NZ ' ' A' ' 96' ' ' LYS . 53.8 tptt -77.93 -36.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.995 -177.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -58.61 -41.85 86.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.995 -179.46 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.18 -16.92 41.69 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.961 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.52 -27.24 68.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.02 -47.45 8.11 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.306 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.606 ' OH ' ' HB ' ' A' ' 99' ' ' ILE . 8.0 p90 -137.48 93.15 12.87 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 121.645 0.736 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.66 2.52 3.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.235 1.956 . . . . 0.0 111.662 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.6 tt0 -63.04 -23.27 67.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.171 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.13 154.52 18.36 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -90.9 123.68 34.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.225 -173.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.7 p90 -96.05 116.35 28.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 99.2 m-85 -139.75 151.7 46.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.321 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.9 pttt -149.13 161.88 41.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 -175.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.9 tt -159.23 145.3 16.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.227 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t0 -90.98 116.47 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.077 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.48 -23.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -68.03 -34.37 76.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.342 0.591 . . . . 0.0 109.739 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -78.89 -42.01 28.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.056 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 63' ' ' VAL . 91.1 mt -136.3 78.48 1.71 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.537 0.684 . . . . 0.0 111.971 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -69.03 -32.69 73.34 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.455 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.44 -36.9 81.68 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.085 0.469 . . . . 0.0 110.984 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 60' ' ' LEU . 93.0 t -64.19 -49.01 83.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.892 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.06 -38.27 56.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 95.2 mt-30 -70.5 -34.21 72.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.415 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.641 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 2.7 tptp -61.76 -25.86 67.72 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.188 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.648 ' HB2' HG12 ' A' ' 69' ' ' VAL . 5.9 m120 -106.94 -13.05 15.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.272 -0.267 . . . . 0.0 111.627 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 13.3 tp10 79.82 31.26 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.378 1.049 . . . . 0.0 110.906 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.16 114.98 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.135 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.6 t -120.3 -19.12 7.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.891 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.64 156.58 16.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.731 0.301 . . . . 0.0 110.756 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mpt? -126.66 127.95 24.39 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.418 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.8 Cg_endo -89.26 164.4 37.8 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.605 -0.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.3 m -141.47 131.8 25.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.604 . . . . 0.0 111.302 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.514 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.8 mp -102.34 135.78 43.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.474 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -125.17 113.43 17.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.271 0.558 . . . . 0.0 110.58 172.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.8 mp -93.95 130.05 40.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 76' ' ' LEU . 43.4 m-85 -128.64 154.86 45.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.745 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 58.2 tttm -134.05 125.58 28.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.21 166.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.49 HD21 ' HE2' ' A' ' 82' ' ' LYS . 3.7 p-10 46.58 49.05 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.343 1.057 . . . . 0.0 113.553 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 81.53 -1.78 84.62 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.837 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HE2' HD21 ' A' ' 80' ' ' ASN . 37.8 mtmt -115.11 160.12 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -71.82 179.76 3.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.86 -32.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.478 163.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.67 140.58 1.35 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.05 136.17 41.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 95' ' ' ILE . 41.1 t -132.81 123.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 m -88.34 58.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.12 137.42 2.2 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.969 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -68.46 118.76 11.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.04 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' H ' ' CG1' ' A' ' 95' ' ' ILE . 6.6 t-20 -117.03 89.93 31.52 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 89.8 Cg_exo -22.67 -80.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 1 C-N-CA 125.449 4.1 . . . . 0.0 115.537 -169.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.09 -27.94 27.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.77 78.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.085 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' CG1' ' H ' ' A' ' 91' ' ' ASN . 32.1 mm -72.35 -46.32 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.1 mttt -64.0 -23.15 67.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.855 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -80.53 -33.64 36.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.521 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -67.46 -52.98 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.606 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.19 -42.22 25.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.571 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.13 63.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -36.45 57.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.492 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.3 m-80 -83.76 -21.91 32.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.842 178.417 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 40' ' ' ILE . 94.0 t . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.1 m -80.02 144.29 33.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.967 -171.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.521 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.9 tp-100 -93.3 136.79 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.168 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 8.6 m-85 -83.59 170.01 14.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.715 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 42.6 mtpt -123.55 -40.6 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.527 176.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -142.48 179.95 6.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -66.46 -25.76 66.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.652 0.263 . . . . 0.0 110.393 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -58.02 -49.99 74.96 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -55.16 -41.69 72.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.692 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 23' ' ' VAL . 27.0 t80 -61.17 -59.76 4.81 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.61 -35.81 75.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.547 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -61.5 -45.03 95.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -32.7 74.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 110.342 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.84 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.1 mm -63.54 -39.26 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 5.76 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.442 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -77.77 140.83 39.5 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.63 38.57 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.382 0.611 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -145.22 176.29 9.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.95 122.45 22.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.2 t -100.54 111.24 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.047 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.42 103.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 11' ' ' PHE . 60.1 t -104.88 119.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.867 0.842 . . . . 0.0 111.166 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.05 96.79 8.72 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.74 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.8 m-85 -99.99 113.69 26.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.471 0.653 . . . . 0.0 111.791 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -140.27 163.8 31.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.616 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -115.84 134.54 54.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.5 p -60.67 -26.13 66.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.671 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -78.58 -15.47 58.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 44.7 t -80.7 144.38 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.071 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.47 -67.63 1.9 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.274 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 66.0 Cg_endo -74.22 20.73 0.4 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.942 2.428 . . . . 0.0 114.321 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.0 p -68.02 -27.92 66.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.839 0.828 . . . . 0.0 109.556 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.6 pttt -68.25 -7.65 32.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.041 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.447 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -79.67 -35.91 38.48 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.49 -25.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.039 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.31 -61.55 6.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.809 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 88.0 Cg_endo -83.41 -30.67 0.78 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.417 1.412 . . . . 0.0 114.219 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.567 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 ttp -66.15 -50.41 64.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.67 0.668 . . . . 0.0 109.199 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -65.56 -37.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.228 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 26.6 tt0 -69.02 -27.81 66.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.2 0.524 . . . . 0.0 110.057 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -74.84 -29.05 60.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.052 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 39' ' ' MET . 18.7 m-30 -51.49 -64.0 0.95 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 110.245 175.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 60.5 p -79.27 -14.11 59.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.1 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -58.38 -35.77 72.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -83.15 -47.97 11.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.2 p90 -129.3 91.34 42.0 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.204 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.57 1.5 5.56 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.707 2.271 . . . . 0.0 111.668 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.9 tt0 -63.35 -24.05 67.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.776 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.59 154.73 18.85 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.306 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -92.47 141.6 28.34 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.026 -176.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.22 115.13 28.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.99 -172.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' THR . 97.3 m-85 -140.59 152.0 45.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.8 pttt -149.92 159.44 44.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.571 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.0 tt -158.73 150.76 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.631 0.253 . . . . 0.0 110.41 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 19.8 t0 -93.81 115.78 28.21 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.743 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -61.95 -25.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.829 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -37.31 86.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.421 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -84.94 -42.19 15.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.6 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.512 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.7 mm? -121.95 73.39 1.08 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.387 0.613 . . . . 0.0 112.12 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.86 -24.59 73.79 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.196 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 16.2 t70 -66.1 -27.63 68.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.594 0.712 . . . . 0.0 110.523 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 60' ' ' LEU . 18.4 t -75.24 -52.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.202 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.629 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.05 -20.78 10.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.8 pt20 -85.82 -31.92 22.04 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.573 0.702 . . . . 0.0 110.086 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -69.12 -27.87 65.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.573 179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.629 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.0 p30 -108.76 -8.16 15.42 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 24.6 tt0 81.04 16.82 0.53 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.057 0.848 . . . . 0.0 112.095 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.628 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -93.84 109.23 21.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.374 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -108.17 -30.4 8.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.15 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.84 162.95 17.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.266 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.439 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -151.37 145.0 17.51 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.73 0.3 . . . . 0.0 110.826 177.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -79.69 148.58 80.12 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.579 -1.842 . . . . 0.0 112.853 -1.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.2 m -133.68 142.98 48.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.68 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -112.34 125.14 53.86 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.766 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.626 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -116.91 113.56 22.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 175.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.3 mp -96.55 134.35 39.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.2 m-85 -129.43 153.16 48.21 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.597 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 21.6 tptm -134.01 119.94 19.63 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 2.2 p-10 46.63 56.7 6.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.84 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 77.7 4.43 85.13 Favored Glycine 0 CA--C 1.51 -0.232 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.495 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.4 160.73 28.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 29.0 tt0 -71.53 179.69 2.9 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -150.39 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.572 164.054 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -165.26 155.56 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.587 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.5 130.6 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.38 133.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.226 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.63 47.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 0.0 111.373 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.7 130.1 1.31 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.992 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.736 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.19 112.03 3.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.406 ' CB ' HG12 ' A' ' 95' ' ' ILE . 1.5 t-20 -116.09 89.87 26.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 56.0 Cg_exo -22.49 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.357 4.038 . . . . 0.0 115.667 -171.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 -28.82 29.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.99 74.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.799 0.333 . . . . 0.0 111.222 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.68 HG21 HD22 ' A' ' 75' ' ' LEU . 45.9 mm -83.38 -32.76 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.428 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.748 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.5 mttt -57.65 -47.44 82.26 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -60.19 -32.29 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.64 61.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.2 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.4 mm -54.0 -41.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.047 0.451 . . . . 0.0 110.647 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -25.72 63.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.204 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.96 19.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.472 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -79.91 -16.93 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.069 -172.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.223 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.516 ' HB ' ' HD2' ' A' ' 54' ' ' LYS . 85.5 t . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.806 0.336 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.7 m -83.47 143.9 29.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.208 0.527 . . . . 0.0 112.335 -172.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.2 tp-100 -94.82 132.47 39.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.645 -175.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 13.0 m-85 -93.11 160.41 14.87 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.688 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.6 ptpp? -135.9 -4.45 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.817 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 18.8 p -141.89 157.29 45.16 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 111.368 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -71.41 -29.03 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.013 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -62.92 -38.15 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.688 ' OE1' ' HG2' ' A' ' 6' ' ' LYS . 24.5 mt-10 -55.44 -44.0 75.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.441 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 23' ' ' VAL . 24.1 t80 -56.21 -56.3 22.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.39 -44.16 79.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -57.38 -38.48 74.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.82 64.3 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.87 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -65.01 -40.53 89.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.63 13.51 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.048 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -85.49 140.21 30.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -79.38 47.39 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.432 0.634 . . . . 0.0 109.984 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -154.2 178.97 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.469 177.026 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 99' ' ' ILE . 1.6 tm? -75.74 123.89 26.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.076 0.465 . . . . 0.0 110.782 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -105.36 116.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.208 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.89 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 11' ' ' PHE . 40.5 t -102.82 126.06 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.741 0.781 . . . . 0.0 111.351 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.03 97.31 7.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.762 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.4 m-85 -104.35 116.82 32.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.613 0.721 . . . . 0.0 111.953 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 p90 -135.67 173.88 11.23 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.136 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -125.41 130.74 52.47 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -63.3 -19.48 64.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -92.97 -13.07 29.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.396 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 59.8 m -75.55 159.81 30.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.312 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.32 -83.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.227 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 89.0 Cg_endo -79.37 36.02 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.094 2.529 . . . . 0.0 113.858 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 p -65.3 -36.97 85.7 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 122.04 0.924 . . . . 0.0 109.814 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.855 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 7.7 ttpm? -68.05 -11.33 58.79 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.536 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.31 70.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -74.52 -24.66 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.932 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.715 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.3 -67.52 0.53 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.824 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.855 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 3.9 Cg_endo -85.32 -23.86 2.19 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 121.457 1.556 . . . . 0.0 113.621 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.677 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.7 ttp -71.74 -44.54 63.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.35 0.595 . . . . 0.0 109.733 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.825 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.36 -36.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.241 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 tp10 -63.01 -29.81 71.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.525 174.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -74.4 -33.87 63.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.474 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.647 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 19.9 m-85 -57.24 -57.72 11.39 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 p -76.91 -14.22 59.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.932 0.396 . . . . 0.0 110.805 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.3 -35.14 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -84.51 -44.56 13.48 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.595 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.4 p90 -129.7 89.54 46.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.641 0.734 . . . . 0.0 112.042 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.2 -0.69 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.219 1.946 . . . . 0.0 112.152 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.99 -3.71 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.3 163.08 12.69 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.38 139.72 30.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.237 -177.418 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.4 p90 -122.96 114.58 20.62 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.551 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.508 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 96.9 m-85 -141.06 148.4 40.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HD2' ' HB ' ' A' ' 2' ' ' VAL . 17.4 ptmt -148.48 152.58 37.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 -172.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.4 tt -160.88 149.02 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 8.1 p-10 -100.04 129.89 46.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.474 0.654 . . . . 0.0 110.831 174.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 72' ' ' MET . 2.4 m -72.6 -11.79 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.081 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.6 -44.16 74.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -79.61 -41.53 26.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.969 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.9 mm? -122.42 79.1 1.58 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.696 0.76 . . . . 0.0 112.838 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.03 -38.83 34.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.001 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -68.46 -24.69 64.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.173 0.486 . . . . 0.0 110.619 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 8' ' ' ALA . 87.3 t -68.48 -50.0 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 174.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.99 -39.29 62.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.867 175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -70.4 -28.59 65.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.84 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.733 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 9.6 tptt -67.38 -27.87 67.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.487 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.733 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 5.3 m120 -104.54 -7.91 19.4 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 -170.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 32.9 tt0 80.88 17.4 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.469 1.105 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -93.29 106.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.627 0.727 . . . . 0.0 109.918 175.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 p -114.47 -18.38 11.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.832 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 147.06 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -135.89 143.85 46.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.17 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 67.4 Cg_endo -80.78 153.19 82.77 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.287 -1.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -135.01 143.36 46.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.887 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -115.39 128.36 56.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.333 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.84 114.13 21.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 85' ' ' ALA . 6.5 mp -94.07 126.26 39.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.086 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CG ' HD12 ' A' ' 15' ' ' ILE . 52.8 m-85 -125.32 151.95 45.37 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.579 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -136.96 112.99 9.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.048 0.451 . . . . 0.0 110.475 172.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.68 55.33 4.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.115 175.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.87 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 70.53 10.38 66.68 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.248 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -127.38 159.82 33.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 84' ' ' VAL . 26.8 tt0 -73.85 179.74 4.11 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -153.65 -30.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 165.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.01 157.95 24.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 111.557 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -147.57 121.66 9.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.416 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 95' ' ' ILE . 21.3 t -131.04 135.34 60.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 -172.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.31 49.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.925 0.393 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.25 122.63 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.686 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.35 105.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.465 ' HB3' HG12 ' A' ' 95' ' ' ILE . 1.7 t-20 -118.69 88.64 35.53 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.524 175.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.7 Cg_exo -35.45 -59.08 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.414 3.409 . . . . 0.0 115.411 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -50.09 8.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -31.93 71.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.598 HG21 HD22 ' A' ' 75' ' ' LEU . 22.2 mm -84.52 -36.05 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.569 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 8.9 tmtt? -58.44 -38.98 78.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.73 -23.64 62.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.539 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -77.53 -58.06 3.48 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG23 ' CD1' ' A' ' 20' ' ' LEU . 9.4 mt -51.7 -40.7 27.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.295 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -34.15 77.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -37.02 69.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 57.5 m-80 -84.73 -19.35 32.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.316 -175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.47 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG11 ' HG3' ' A' ' 54' ' ' LYS . 87.8 t . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.939 0.4 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -76.14 138.97 41.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -82.98 126.45 32.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.076 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.725 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.5 m-30 -80.02 169.78 17.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.296 0.569 . . . . 0.0 110.605 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 70.6 mmtt -128.7 -38.3 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.41 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 30.7 p -134.98 178.9 6.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.443 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.17 -28.44 64.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.07 -44.6 83.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.166 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 4.5 mm-40 -54.34 -50.53 67.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.307 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.639 ' O ' HG12 ' A' ' 15' ' ' ILE . 12.7 t80 -58.73 -59.33 5.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.14 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 24.5 t70 -63.19 -34.4 77.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.841 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -62.88 -42.87 99.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.62 0.248 . . . . 0.0 110.441 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.74 92.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.6 mm -58.12 -38.41 67.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.022 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.68 5.32 3.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.429 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -79.34 150.54 31.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.67 0.272 . . . . 0.0 110.465 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.39 45.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 111.068 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 30.6 pttt -156.91 -179.99 8.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.4 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.0 tm? -79.22 118.81 21.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 0.0 111.265 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -112.82 109.12 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.936 176.05 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -107.76 116.94 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.697 0.761 . . . . 0.0 110.039 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.527 HG11 ' CE2' ' A' ' 11' ' ' PHE . 48.1 t -103.19 128.43 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.934 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -88.22 97.73 11.18 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.895 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.71 114.43 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -178.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 17.4 p90 -140.64 -179.56 6.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.852 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.07 130.72 46.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.088 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -66.01 -19.41 65.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.118 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -86.06 -13.35 47.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.632 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 52.0 t -90.35 148.45 22.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.587 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -80.67 -62.33 2.05 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.742 -176.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.7 Cg_exo -60.24 -7.49 6.74 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.909 2.406 . . . . 0.0 113.894 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 71.5 m -63.89 -26.87 68.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.424 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 55.3 pttt -62.77 -15.96 55.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.777 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 23.9 ttt -77.46 -27.15 51.98 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.147 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.698 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -75.73 -23.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.735 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.46 -66.57 0.88 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.24 172.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 69.0 Cg_endo -82.52 -34.14 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 CA-C-N 121.055 1.412 . . . . 0.0 114.315 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.591 ' CE ' HG13 ' A' ' 40' ' ' ILE . 2.5 tmm? -66.54 -36.72 83.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.492 0.663 . . . . 0.0 110.085 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.778 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.9 mt -81.11 -34.05 13.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -66.31 -25.33 66.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.912 171.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -78.38 -33.59 48.75 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.689 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -59.57 -47.9 83.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.827 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 97.6 p -85.25 -15.69 42.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.973 -0.454 . . . . 0.0 110.981 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.4 -29.68 70.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 13.6 tp60 -89.02 -50.17 6.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.286 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 43' ' ' PHE . 10.1 p90 -124.71 91.27 49.71 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 0.94 5.07 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.066 1.844 . . . . 0.0 111.224 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.0 tt0 -63.02 -23.37 67.42 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.918 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 17.85 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.1 m-20 -91.07 126.7 36.23 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.803 0.811 . . . . 0.0 111.005 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.541 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -103.6 114.17 28.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.282 -172.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.3 m-85 -136.05 147.58 47.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.711 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 76.4 mttt -132.71 152.08 51.81 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.956 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.751 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.8 tt -159.24 149.73 19.43 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.827 0.346 . . . . 0.0 110.711 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 9.0 t0 -101.43 119.78 39.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.954 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.7 p -69.74 -21.34 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.97 -37.16 83.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.214 0.53 . . . . 0.0 109.748 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.47 -42.99 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.342 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -115.02 80.49 1.42 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.13 -40.49 34.37 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.502 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.34 -24.77 65.75 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.116 0.484 . . . . 0.0 110.703 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.634 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 95.3 t -68.0 -51.44 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.361 174.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -46.67 -42.84 17.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.042 0.448 . . . . 0.0 111.579 174.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -73.73 -25.26 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.858 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.696 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 13.5 tptt -69.37 -25.04 63.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.686 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.696 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 5.0 m120 -108.24 -13.72 14.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.664 -171.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.3 tp10 79.79 30.99 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.26 0.975 . . . . 0.0 110.999 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.649 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -107.47 120.2 58.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.873 -0.517 . . . . 0.0 110.491 171.065 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -115.72 -39.49 3.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.42 164.79 13.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.322 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.45 ' CE ' HG11 ' A' ' 57' ' ' VAL . 1.1 pmm? -146.01 151.57 45.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.915 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.7 Cg_endo -78.23 149.84 87.42 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.81 -3.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.4 m -132.27 133.64 44.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.793 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -103.07 124.07 47.85 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.699 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -117.57 112.36 20.46 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.427 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.8 mp -96.41 133.09 41.25 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.699 ' CE1' HD22 ' A' ' 76' ' ' LEU . 62.0 m-85 -128.65 157.11 42.22 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.522 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -139.42 116.26 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.3 t30 65.37 50.39 1.74 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.675 0.75 . . . . 0.0 111.239 171.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.747 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.9 5.15 64.13 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.011 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -126.91 160.37 31.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 28.3 tt0 -69.53 178.89 2.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -148.67 -32.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.892 163.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.31 138.22 1.56 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.929 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.54 ' HB3' HD23 ' A' ' 76' ' ' LEU . 23.0 pttm -133.31 134.95 44.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.92 173.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -131.98 122.69 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.322 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 t -91.58 62.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 110.267 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.62 125.66 0.81 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.25 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.27 111.57 1.25 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.211 0.529 . . . . 0.0 111.491 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.7 OUTLIER -116.52 88.97 25.91 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -31.76 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.723 3.615 . . . . 0.0 115.427 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.13 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.63 61.87 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.5 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.0 mm -76.58 -49.24 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.623 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 19.5 mtpp -62.58 -26.08 68.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.444 0.64 . . . . 0.0 110.21 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -80.03 -33.13 39.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.564 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.12 -52.8 57.43 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -53.23 -39.59 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.394 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 -20.42 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.249 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.26 -43.45 17.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.981 0.42 . . . . 0.0 111.047 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -80.01 -22.63 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.822 -0.608 . . . . 0.0 111.324 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' HG2' ' A' ' 41' ' ' GLU . 54.9 t . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 120.733 0.302 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.9 m -80.82 144.78 31.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.22 0.533 . . . . 0.0 112.377 -170.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.6 tp-100 -94.16 136.21 34.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.932 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.696 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.3 m-85 -98.57 158.6 15.5 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 14.8 ptmm? -135.01 -1.54 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.832 169.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 33.8 p -138.57 159.75 41.31 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 111.15 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.219 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.155 173.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.696 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 27.3 mt-10 -54.06 -47.26 71.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.05 173.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.1 t80 -58.74 -59.03 6.06 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.958 0.409 . . . . 0.0 109.959 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.58 -35.22 72.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.549 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -63.51 -48.43 77.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.621 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.91 73.2 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.0 110.381 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.824 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -63.39 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.065 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.33 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.81 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -84.54 142.9 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.06 74.54 9.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.26 0.552 . . . . 0.0 110.801 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -174.62 179.22 1.77 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.9 tm? -81.2 120.75 25.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.1 t -100.59 109.8 26.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.154 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 t -92.55 103.38 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 11' ' ' PHE . 22.1 t -105.65 131.08 55.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.311 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -108.21 100.45 9.76 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.939 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -103.58 115.52 30.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.514 0.673 . . . . 0.0 111.813 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 25.8 p90 -137.76 175.96 9.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB3' ' HG3' ' A' ' 72' ' ' MET . . . -126.29 133.5 51.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -15.11 63.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.359 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.436 ' HD1' ' OD2' ' A' ' 58' ' ' ASP . 51.8 p-90 -89.11 -13.47 38.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 110.794 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.8 t -84.39 143.83 29.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.056 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.03 2.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.96 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 19.5 Cg_exo -68.98 15.81 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.447 2.765 . . . . 0.0 114.531 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.01 -29.28 69.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 122.02 0.914 . . . . 0.0 108.98 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -65.62 -8.83 22.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.21 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -37.26 39.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.11 -25.2 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.751 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.78 -66.46 1.07 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.481 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 85.6 Cg_endo -83.23 -26.85 2.08 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 120.617 1.256 . . . . 0.0 114.226 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.608 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.1 ttp -69.75 -41.95 74.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.55 0.69 . . . . 0.0 109.587 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -74.72 -39.26 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.767 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.803 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.6 mt-10 -66.59 -26.69 67.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.045 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.34 -37.74 74.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.275 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.6 m-85 -52.45 -62.32 1.72 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.257 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 m -76.77 -13.76 59.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.567 0.223 . . . . 0.0 111.301 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 35.3 tt0 -60.0 -31.93 70.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.3 -46.69 8.57 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.07 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.2 p90 -127.35 90.13 49.63 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.26 0.552 . . . . 0.0 111.941 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.34 -0.72 9.6 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.444 2.096 . . . . 0.0 112.381 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -13.5 58.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.433 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.12 151.66 21.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.99 141.44 28.62 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.668 -177.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.728 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -116.25 115.38 25.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.164 -170.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 93.8 m-85 -140.69 149.1 41.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.783 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.7 pttt -149.32 157.71 43.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.665 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 60' ' ' LEU . 7.1 tt -160.61 151.88 19.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.636 0.255 . . . . 0.0 111.344 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.7 m-20 -91.72 111.74 23.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.699 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 26' ' ' TYR . 3.4 p -66.4 -19.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD2' ' HD1' ' A' ' 29' ' ' TRP . 6.4 t70 -53.21 -43.81 67.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.596 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -94.28 -42.42 8.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.994 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.1 mm? -111.67 73.25 0.81 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.5 64.75 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.129 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 22.1 m-20 -65.82 -26.5 67.71 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.428 0.632 . . . . 0.0 110.555 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 84.7 t -71.52 -52.48 25.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.634 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.78 -34.71 65.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.75 0.31 . . . . 0.0 111.369 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -68.07 -37.85 81.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 109.441 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 17.0 tptt -60.78 -22.89 64.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.964 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 69' ' ' VAL . 9.3 m120 -106.71 -13.63 15.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 34.0 tt0 79.63 27.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 124.269 0.981 . . . . 0.0 110.854 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.47 126.92 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 170.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -126.59 -40.1 1.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.307 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.25 160.67 16.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 1.3 pmm? -143.02 151.46 56.01 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.878 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' HG12 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -78.65 148.4 83.4 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 -1.907 . . . . 0.0 113.049 -3.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -131.21 135.89 47.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.731 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 40' ' ' ILE . 4.1 mp -106.02 130.79 53.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.661 177.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.656 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.6 mt -124.58 113.69 18.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.095 0.474 . . . . 0.0 110.824 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -96.97 131.06 44.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.656 ' CE1' HD22 ' A' ' 76' ' ' LEU . 59.9 m-85 -128.26 157.1 41.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 34.5 ttpt -141.73 125.14 16.59 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.9 p30 47.08 55.5 7.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.557 1.143 . . . . 0.0 113.698 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.824 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 75.34 3.55 71.09 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.704 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.41 160.81 26.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -71.0 -179.05 2.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -152.44 -29.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.707 164.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.633 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.32 150.79 4.37 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.635 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HB3' HD23 ' A' ' 76' ' ' LEU . 14.1 ptmm? -145.31 126.63 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.255 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.67 133.46 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.949 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.28 59.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 122.287 1.042 . . . . 0.0 110.189 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 129.43 1.12 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.527 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.07 106.08 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.676 0.391 . . . . 0.0 111.957 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 89.54 37.74 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.788 175.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -35.5 -61.02 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.397 3.398 . . . . 0.0 115.161 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.3 14.42 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -172.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.08 71.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.648 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 99' ' ' ILE . 46.1 mm -87.24 -32.43 6.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.229 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 10.1 ttpp -60.13 -39.57 86.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 170.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.32 -28.91 67.58 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.653 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.02 -61.65 1.93 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.55 -34.96 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.712 0.632 . . . . 0.0 110.576 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.75 -21.62 54.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.949 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.82 -35.56 15.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.062 0.458 . . . . 0.0 110.56 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.655 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -88.07 -18.26 29.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 -176.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.662 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 52' ' ' PHE . 59.7 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.544 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.3 m -75.65 145.12 41.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.251 -170.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -94.39 138.97 31.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.2 m-85 -88.73 164.0 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.199 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.13 -14.71 2.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.758 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -147.16 174.38 11.64 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.94 -23.57 62.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 t -60.02 -47.93 83.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.555 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -53.14 -42.66 66.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.94 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.728 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.2 t80 -57.35 -58.3 8.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 8.7 m-20 -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.816 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -60.24 -44.27 95.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.578 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.29 76.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.464 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.684 HG22 ' HA2' ' A' ' 81' ' ' GLY . 9.2 mm -66.99 -39.99 84.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.56 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.17 7.52 3.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -80.73 146.35 31.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.99 40.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.28 176.33 9.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.897 -176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.7 tm? -81.13 121.9 26.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 0.0 109.828 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -100.74 122.41 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.218 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.21 102.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.728 HG11 ' CE2' ' A' ' 11' ' ' PHE . 59.2 t -104.11 119.34 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.813 0.816 . . . . 0.0 111.077 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.49 96.75 8.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.67 -177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE2' HD22 ' A' ' 55' ' ' LEU . 1.9 m-85 -100.35 124.79 46.28 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.408 0.623 . . . . 0.0 111.953 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 47.9 p90 -151.5 -178.46 6.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.992 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -128.81 137.53 51.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 111.047 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 p -68.9 -21.61 64.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -84.62 -6.61 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.089 0.471 . . . . 0.0 110.633 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 41.9 t -88.28 159.9 17.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.24 -61.72 1.02 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.081 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 28.1 Cg_exo -65.49 -1.38 4.67 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.647 . . . . 0.0 114.026 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 16.9 p -62.04 -28.34 69.52 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.103 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -8.31 24.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.557 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.4 ttt -84.04 -28.87 27.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.302 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -76.93 -24.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.249 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -56.54 -64.36 2.51 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.189 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.1 Cg_endo -82.64 -31.13 0.86 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.592 1.528 . . . . 0.0 114.427 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 1.7 ttp -68.24 -41.68 80.84 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.496 0.589 . . . . 0.0 109.679 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.827 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.72 -39.39 60.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.39 -36.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 22.5 ttmm -68.77 -29.47 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.707 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 23.0 m-85 -56.84 -59.22 5.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.2 m -77.25 -14.01 59.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.627 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' LYS . 40.1 tt0 -62.26 -29.51 70.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 21.4 mt-30 -89.95 -50.68 5.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.2 p90 -125.9 90.91 49.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.254 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.02 0.89 5.17 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.831 2.354 . . . . 0.0 112.361 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 5.1 tt0 -63.46 -23.67 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.936 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.68 154.65 18.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -91.53 126.07 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.64 -173.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.7 p90 -96.57 115.76 27.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.252 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.7 m-85 -141.53 149.46 40.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.723 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.8 pttp -148.79 158.82 44.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.64 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.7 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.4 tt -159.16 150.06 19.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 110.294 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.8 t0 -98.74 120.08 38.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.758 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 27' ' ' ALA . 3.1 m -66.54 -20.6 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.453 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.75 -37.79 82.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.392 0.615 . . . . 0.0 109.521 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -42.89 24.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.674 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HB3' HG23 ' A' ' 63' ' ' VAL . 93.7 mt -131.07 75.26 1.65 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.586 0.708 . . . . 0.0 112.17 -175.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -70.25 -29.05 70.61 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.792 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.3 -29.33 70.07 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.535 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 60' ' ' LEU . 22.0 t -69.57 -51.06 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.63 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.09 -20.11 9.04 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.569 0.543 . . . . 0.0 112.307 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 77.6 mm-40 -85.35 -33.75 21.97 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 0.0 110.822 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 11.1 tptt -68.31 -36.2 78.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 110.644 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.63 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.3 p30 -96.48 -13.23 23.22 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.7 mt-10 78.69 17.86 0.99 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.927 174.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.38 108.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 109.462 172.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -109.59 -19.65 13.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.002 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.97 149.52 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.53 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -133.61 133.88 23.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.116 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HB2' HG12 ' A' ' 36' ' ' ILE . 73.3 Cg_endo -82.33 153.97 76.63 Favored 'Cis proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.301 -1.541 . . . . 0.0 113.802 -0.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -137.45 142.44 41.59 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.183 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 95' ' ' ILE . 4.4 mp -109.8 126.05 53.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.693 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -117.01 113.72 22.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.052 0.453 . . . . 0.0 111.039 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.6 mp -96.84 134.96 39.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.282 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 76' ' ' LEU . 49.8 m-85 -132.04 151.08 51.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 15.9 mtpp -128.18 108.0 10.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.986 0.179 . . . . 0.0 110.743 170.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 58.2 53.8 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.682 0.753 . . . . 0.0 111.852 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.77 -6.0 79.9 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.832 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 64.7 pttt -121.45 160.74 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.7 tt0 -67.98 179.45 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -152.15 -29.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.635 163.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -160.23 155.26 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.085 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -155.17 113.69 3.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.669 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 95' ' ' ILE . 22.0 t -127.65 135.25 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.629 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.2 m -102.12 43.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.29 123.91 0.88 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.323 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -57.77 104.45 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.467 ' O ' HG12 ' A' ' 95' ' ' ILE . 1.8 t-20 -116.48 89.2 26.46 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.72 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.5 Cg_exo -31.23 -76.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.474 3.449 . . . . 0.0 115.079 -172.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.92 -41.08 68.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.12 -29.91 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.455 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.7 mm -87.55 -31.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.808 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 64.6 mttm -54.6 -44.37 72.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -65.42 -32.87 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.883 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.17 -57.82 6.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.4 mm -54.03 -35.12 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.679 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.81 -29.74 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.273 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.64 -40.89 61.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 111.011 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 46.0 m-80 -82.98 -16.28 47.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.029 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.548 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 40' ' ' ILE . 88.3 t . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.505 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.2 m -72.36 144.8 48.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.186 -170.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -97.3 125.07 41.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.809 -174.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.4 m-85 -75.15 170.44 16.04 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 10' ' ' GLU . 59.9 pttt -133.93 -21.62 1.89 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.288 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 178.8 9.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.365 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -70.23 -29.08 65.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.792 0.329 . . . . 0.0 110.781 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -54.56 -48.12 72.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.839 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.571 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 6.0 mp0 -55.38 -46.85 76.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.55 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.685 ' O ' HG12 ' A' ' 15' ' ' ILE . 30.9 t80 -56.45 -59.51 4.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.811 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.0 -36.78 77.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.663 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.6 m -61.79 -45.7 92.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.655 0.264 . . . . 0.0 110.991 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -34.12 77.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.877 0.37 . . . . 0.0 110.322 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.773 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.94 -40.51 87.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.312 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.41 2.16 14.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.481 -173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 63.2 tt0 -76.51 144.49 39.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.882 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 57.2 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 8.8 ptmm? -168.73 176.53 5.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.005 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.15 115.18 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.213 0.53 . . . . 0.0 110.895 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.4 t -101.22 135.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.982 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.59 115.97 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 11' ' ' PHE . 33.6 t -107.52 131.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.577 0.703 . . . . 0.0 110.9 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.88 96.6 6.94 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.469 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CD1' HG11 ' A' ' 69' ' ' VAL . 26.7 m-85 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.667 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.659 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.9 p90 -163.24 179.17 7.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.727 169.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -127.61 128.74 46.05 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 p -65.05 -18.67 65.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -88.96 -10.59 47.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.417 . . . . 0.0 110.713 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 49.7 t -97.64 148.88 22.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.831 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.22 2.86 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.411 -0.66 . . . . 0.0 114.655 -173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.3 Cg_exo -59.49 -2.56 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.17 2.58 . . . . 0.0 114.044 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 26' ' ' TYR . 69.5 m -63.19 -24.44 67.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.27 0.557 . . . . 0.0 110.929 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 57.0 mtpt -65.63 -9.36 26.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.765 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.414 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.03 -35.49 49.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 109.354 176.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -75.29 -25.82 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.408 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.13 -66.2 0.88 Allowed Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.923 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 76.4 Cg_endo -83.44 -32.72 0.45 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.319 1.346 . . . . 0.0 114.479 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.5 tmm? -69.86 -38.08 76.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.412 0.625 . . . . 0.0 109.85 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.84 -33.64 14.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.804 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 41.1 tt0 -67.87 -23.23 65.11 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.156 172.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 49.4 tptt -78.64 -37.27 42.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.584 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.1 p90 -59.05 -49.63 77.14 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.572 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 94.1 p -85.13 -14.5 46.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.673 -175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 5.5 tp10 -59.59 -33.69 71.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.02 -47.62 8.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.419 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 9.4 p90 -126.69 90.89 48.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.469 0.652 . . . . 0.0 112.489 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.05 -0.34 8.94 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.357 2.038 . . . . 0.0 112.182 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.37 29.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.225 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.47 155.58 17.98 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 5.8 m-20 -91.08 120.55 32.13 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.719 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -100.66 115.27 29.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.979 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.505 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 95.9 m-85 -139.92 141.46 36.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.088 0.471 . . . . 0.0 111.324 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 76.2 mttt -122.21 155.05 36.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.006 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 63' ' ' VAL . 8.4 tt -159.5 142.04 13.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.23 130.79 52.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.308 0.575 . . . . 0.0 111.196 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.9 m -69.42 -16.11 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.256 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.35 -41.56 84.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.216 0.532 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.46 -42.72 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.899 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -121.4 77.71 1.36 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.165 0.507 . . . . 0.0 112.282 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.06 35.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.327 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.05 -32.58 74.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 110.295 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.492 HG11 HD13 ' A' ' 55' ' ' LEU . 86.5 t -64.53 -52.16 58.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.119 176.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.48 -38.84 46.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.024 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 89.8 mm-40 -70.68 -33.5 71.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 10.4 tptt -62.04 -28.45 69.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 175.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.834 ' HB2' HG12 ' A' ' 69' ' ' VAL . 6.0 m120 -100.55 -12.53 19.19 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.004 -169.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.4 tp10 79.82 26.42 0.36 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.298 0.999 . . . . 0.0 110.225 -177.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -106.61 118.23 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.425 0.631 . . . . 0.0 111.412 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.5 m -131.25 11.92 5.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.426 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.94 30.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' HG21 ' A' ' 57' ' ' VAL . 14.8 mmt -127.19 117.98 21.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.583 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.7 Cg_endo -89.52 175.21 22.44 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.561 -1.016 . . . . 0.0 111.702 -4.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 48.0 m -147.55 146.48 29.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 mp -120.88 139.64 52.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 2.3 mt -125.77 120.33 30.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.5 mp -97.96 129.26 44.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.511 ' CD2' HD12 ' A' ' 15' ' ' ILE . 35.1 m-85 -128.13 146.66 50.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -121.52 110.9 16.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.329 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p30 46.1 56.35 6.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.773 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.1 6.28 89.24 Favored Glycine 0 CA--C 1.511 -0.211 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.646 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.93 153.61 42.42 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 178.35 2.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -150.23 -32.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.437 164.313 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -161.98 150.97 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -145.11 129.2 17.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.55 126.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.638 0.256 . . . . 0.0 110.525 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -96.21 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.32 0.581 . . . . 0.0 111.177 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.64 140.15 2.8 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.571 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -70.08 108.88 4.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.057 0.456 . . . . 0.0 110.896 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 6.1 t-20 -117.23 89.04 29.71 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.261 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -28.92 -72.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.829 3.686 . . . . 0.0 115.321 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -43.34 56.86 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.667 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -61.09 -33.21 72.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.434 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.9 mm -74.78 -49.64 28.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.999 0.428 . . . . 0.0 110.211 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 18.1 mtpp -67.18 -24.2 65.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.387 0.613 . . . . 0.0 110.63 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.92 -31.97 51.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.099 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.49 -54.3 30.28 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.212 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -53.56 -36.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.14 60.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.227 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.61 -40.46 20.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.453 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' HD23 ' A' ' 77' ' ' LEU . 45.9 m-80 -83.51 -11.63 57.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.278 -175.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.699 177.26 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.665 HG23 ' HG2' ' A' ' 41' ' ' GLU . 69.8 t . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -79.08 144.1 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.295 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.515 ' OE1' ' HG3' ' A' ' 54' ' ' LYS . 8.7 tp60 -91.87 131.24 37.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.974 -178.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -80.11 167.38 20.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.053 0.454 . . . . 0.0 110.847 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.45 -39.74 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -144.47 -179.94 6.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.011 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.8 67.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.902 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 t -57.81 -49.91 75.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.0 mp0 -51.17 -46.53 62.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.579 173.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.3 t80 -58.19 -58.31 9.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 -178.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.94 -36.48 84.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.732 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.5 m -65.49 -30.94 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 111.104 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.45 -35.45 58.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.091 0.472 . . . . 0.0 109.874 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.848 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.4 mm -62.72 -39.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.478 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.46 3.39 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.424 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.402 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 99.0 mt-30 -77.01 141.62 40.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.083 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.2 31.96 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.533 0.682 . . . . 0.0 111.254 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.18 179.36 6.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.549 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.7 tm? -76.01 117.13 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.631 -174.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.5 t -103.02 119.14 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.748 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 13.9 t -106.91 112.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 11' ' ' PHE . 23.8 t -106.57 122.17 60.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.807 0.813 . . . . 0.0 110.83 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.22 97.39 11.1 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.935 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.712 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.5 m-85 -96.66 124.33 40.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.697 0.761 . . . . 0.0 112.631 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -154.79 165.47 36.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.141 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -118.01 140.5 49.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.181 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 p -65.39 -19.64 66.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.663 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -80.87 -18.54 46.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.364 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 46.3 t -83.37 141.92 31.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.056 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -75.54 -55.32 5.09 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.611 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 33.4 Cg_endo -65.75 4.73 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 114.196 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 21.7 p -64.01 -29.85 70.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.691 0.757 . . . . 0.0 109.646 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -68.84 -9.21 50.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.403 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -35.12 39.36 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.0 -25.72 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.26 -65.74 1.16 Allowed Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.859 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 64.9 Cg_endo -83.03 -29.58 1.19 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.696 1.284 . . . . 0.0 114.092 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.482 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.7 tmm? -71.41 -33.4 69.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.596 0.712 . . . . 0.0 109.851 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -84.26 -34.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.973 -179.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.665 ' HG2' HG23 ' A' ' 2' ' ' VAL . 39.6 mt-10 -68.64 -20.09 64.45 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.534 171.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -76.58 -39.07 53.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.738 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.5 p90 -57.5 -47.0 83.1 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.321 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.463 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 89.7 p -84.59 -15.41 45.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.977 -0.452 . . . . 0.0 110.655 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.59 -29.15 69.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.569 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.99 -42.32 13.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.0 175.355 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 8.4 p90 -138.53 91.61 12.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 112.21 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.57 1.09 4.61 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.469 2.113 . . . . 0.0 111.744 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.2 tt0 -63.89 -22.77 67.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.332 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.16 159.99 14.67 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.1 m-20 -91.02 125.89 35.95 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.477 0.656 . . . . 0.0 111.232 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.66 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -104.4 114.68 29.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.049 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.4 m-85 -142.49 151.14 41.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 64.6 pttt -149.59 159.07 44.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.36 -175.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.8 tt -155.71 151.96 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.907 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 29.0 t0 -95.56 113.33 24.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.809 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 41.0 t -62.44 -27.12 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.183 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -66.27 -32.5 73.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 110.166 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.44 -41.97 11.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.4 mm? -118.44 65.88 0.76 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.364 0.602 . . . . 0.0 111.555 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -67.75 -31.72 76.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.625 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.12 -22.07 63.99 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 25.2 t -72.96 -50.98 28.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.701 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.82 -21.44 4.2 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 86.6 mt-30 -86.17 -28.97 23.6 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.858 -0.527 . . . . 0.0 110.801 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -70.17 -29.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.905 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 2.3 p30 -108.58 -12.55 14.97 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.023 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.2 tp10 79.23 30.1 0.32 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.052 0.845 . . . . 0.0 111.216 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.701 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -106.48 107.69 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.366 0.603 . . . . 0.0 110.611 169.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -111.35 -35.92 5.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.32 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.2 152.49 29.13 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 27' ' ' ALA . 19.7 ptp -144.49 147.32 35.99 Favored Pre-proline 0 C--N 1.321 -0.667 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.547 -174.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG12 ' A' ' 36' ' ' ILE . 59.9 Cg_endo -80.65 149.6 78.23 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.599 -1.834 . . . . 0.0 112.518 -3.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 3.3 m -133.06 133.18 42.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.295 0.569 . . . . 0.0 111.109 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.2 mp -98.79 125.77 44.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.53 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.2 mt -114.27 113.74 25.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.118 0.485 . . . . 0.0 110.473 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.1 mp -95.54 127.88 41.94 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 76' ' ' LEU . 61.4 m-85 -127.17 154.61 44.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.804 -0.18 . . . . 0.0 110.653 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -139.23 127.06 22.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 50.22 49.24 20.88 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.494 1.117 . . . . 0.0 113.453 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.848 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.46 1.09 81.2 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.238 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -118.27 160.14 22.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.19 179.69 2.74 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -151.73 -29.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 164.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.59 160.32 5.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.229 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 21.5 ptmt -153.18 134.22 14.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.029 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.04 120.87 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.646 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 62.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 122.209 1.004 . . . . 0.0 110.199 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.27 130.75 1.28 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.306 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -72.72 98.28 2.35 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.667 0.27 . . . . 0.0 110.87 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.4 OUTLIER -116.4 88.48 23.73 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.285 -179.03 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.26 -58.93 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.344 3.363 . . . . 0.0 114.903 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.56 -46.51 38.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.87 -27.57 65.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.481 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 99' ' ' ILE . 34.3 mm -76.6 -45.2 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.572 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 72.8 tttt -60.98 -28.49 69.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.404 0.621 . . . . 0.0 110.642 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -84.35 -27.3 27.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.553 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.64 -56.65 5.97 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -51.82 -41.22 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.416 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.3 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.127 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.21 60.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -80.79 -21.22 41.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.386 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.073 179.518 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' PHE . 91.2 t . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.599 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 14.9 m -71.03 144.35 50.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.68 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -91.51 119.57 31.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.136 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 2.2 m-30 -76.09 167.48 21.79 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.496 173.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -129.61 -40.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -142.77 179.55 6.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.558 0.218 . . . . 0.0 111.405 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -65.99 -29.81 70.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.623 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -58.13 -46.02 86.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -54.45 -43.63 71.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 172.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.614 ' O ' HG12 ' A' ' 15' ' ' ILE . 26.9 t80 -58.28 -58.72 7.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 110.495 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.606 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 47.9 m-20 -60.0 -33.91 72.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.027 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.1 m -63.48 -41.72 98.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.689 0.281 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.08 -36.73 82.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.014 0.435 . . . . 0.0 110.154 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.768 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.3 mm -63.6 -39.71 86.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.662 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.21 12.84 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.44 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.72 146.41 25.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.051 0.453 . . . . 0.0 111.082 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.6 32.27 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.723 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 7.0 ptmm? -150.63 168.94 22.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.5 tm? -72.44 118.56 15.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.185 0.517 . . . . 0.0 110.959 -171.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.1 t -100.74 120.56 50.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.892 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 18.8 t -109.61 106.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.567 HG11 ' CE2' ' A' ' 11' ' ' PHE . 15.4 t -103.0 123.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.801 0.81 . . . . 0.0 110.986 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.39 96.86 10.75 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.049 -175.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.721 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.52 106.87 17.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.58 0.705 . . . . 0.0 112.004 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 40.2 p90 -128.77 -173.61 3.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.634 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -132.66 130.69 40.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 p -66.47 -21.82 66.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -84.45 -9.76 58.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.718 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.665 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.8 t -93.42 147.31 23.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.155 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.97 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.648 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.665 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.2 Cg_exo -67.23 4.62 1.14 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.096 2.531 . . . . 0.0 114.356 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 29.7 p -62.94 -32.19 73.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.028 0.918 . . . . 0.0 109.361 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -70.76 -8.98 56.28 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.968 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.6 ttt -82.76 -28.69 30.22 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 40' ' ' ILE . 1.3 mp -75.31 -25.03 17.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.594 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.92 -65.89 1.07 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.399 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 91.7 Cg_endo -83.16 -30.71 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.264 1.31 . . . . 0.0 114.521 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -68.4 -39.48 81.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -77.42 -36.37 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.565 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.68 -20.73 65.33 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.116 -0.633 . . . . 0.0 109.563 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 22.8 ttmm -83.32 -32.67 26.17 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.277 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.2 p90 -57.51 -46.37 83.87 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.265 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 93.5 p -84.8 -15.64 44.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.506 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 38.9 tt0 -56.48 -32.72 65.27 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.24 -50.43 6.6 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.837 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.597 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.8 p90 -127.78 90.67 47.34 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.166 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.61 -0.68 7.99 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.483 2.122 . . . . 0.0 112.29 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.47 -18.05 65.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.492 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.45 157.62 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 7.6 m-20 -91.75 128.12 37.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.584 0.707 . . . . 0.0 111.473 -173.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.559 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.3 p90 -106.96 114.7 28.94 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.87 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.599 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.41 146.53 40.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.196 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 42.2 mtpt -131.2 148.81 52.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.886 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.7 tt -160.7 148.12 15.78 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.1 p-10 -105.6 131.59 52.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.383 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.5 m -69.29 -12.69 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.146 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.54 -46.05 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.184 0.516 . . . . 0.0 109.794 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.51 -41.72 17.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.43 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -122.68 75.11 1.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.433 0.635 . . . . 0.0 112.129 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.62 -34.18 54.32 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.358 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.65 -28.41 69.6 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.332 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 8' ' ' ALA . 57.8 t -70.86 -50.19 45.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.67 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.61 -40.41 52.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.059 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 91.1 mt-30 -69.17 -35.58 76.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.313 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HE3' ' OD2' ' A' ' 12' ' ' ASP . 14.4 tptp -62.57 -25.54 68.12 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.305 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.651 ' HB2' HG12 ' A' ' 69' ' ' VAL . 3.6 m120 -105.9 -9.98 16.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.233 -171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 37.4 mt-10 80.51 27.31 0.26 Allowed 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.455 1.097 . . . . 0.0 111.217 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -105.2 115.35 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 110.256 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.6 p -115.95 -23.38 8.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.166 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.84 166.24 12.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.179 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -149.63 140.88 14.5 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.015 0.436 . . . . 0.0 111.359 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 57.7 Cg_endo -80.27 151.56 82.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.475 -1.885 . . . . 0.0 113.194 -4.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -129.58 139.14 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.63 126.54 54.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.358 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -115.62 115.35 26.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.04 0.447 . . . . 0.0 110.69 176.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -96.96 131.2 43.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.099 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.3 m-85 -130.45 148.69 52.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.619 0.247 . . . . 0.0 111.229 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -127.0 108.59 11.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.619 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.9 t30 60.41 55.51 3.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 111.633 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.768 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.04 6.45 64.31 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.497 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -121.8 157.86 30.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' VAL . 33.9 tt0 -73.27 179.09 4.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -151.83 -32.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 165.001 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.78 152.54 3.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 111.722 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 134.18 30.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.909 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.1 t -131.75 123.78 52.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.12 53.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.2 0.524 . . . . 0.0 111.497 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.93 136.01 1.94 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.625 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -66.88 107.54 2.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.12 0.486 . . . . 0.0 110.964 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 7.3 t-20 -111.51 88.38 9.15 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.3 Cg_exo -31.43 -74.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 124.477 3.451 . . . . 0.0 115.319 -169.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -38.09 68.53 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.235 -0.291 . . . . 0.0 111.626 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.18 -31.3 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.383 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 99' ' ' ILE . 33.3 mm -76.41 -49.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 110.265 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 47.0 mtmt -64.37 -22.94 67.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.486 0.66 . . . . 0.0 110.152 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -80.89 -37.05 30.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.66 171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.93 -61.34 2.71 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.5 mm -47.93 -38.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.068 0.855 . . . . 0.0 110.671 -176.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.95 -22.24 59.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.615 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.5 -28.97 18.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.156 0.503 . . . . 0.0 110.443 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.628 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -95.73 -10.34 29.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.027 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.736 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.104 0.478 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 52' ' ' PHE . 71.5 t -103.74 125.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.759 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 14.4 m -72.71 145.0 47.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.653 0.739 . . . . 0.0 112.68 -168.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.48 139.47 30.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.237 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.546 ' HB2' HD12 ' A' ' 55' ' ' LEU . 5.9 m-85 -85.11 170.54 12.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.772 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 54.1 mttm -121.62 -39.24 2.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -148.56 -179.07 6.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.55 -27.92 69.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 m -60.01 -45.37 93.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.2 mp0 -57.99 -42.69 85.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.52 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' O ' HG12 ' A' ' 15' ' ' ILE . 13.5 t80 -60.4 -54.63 43.26 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.51 -39.12 79.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.684 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -61.65 -47.07 87.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.706 0.288 . . . . 0.0 110.565 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -63.76 -31.71 72.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.471 . . . . 0.0 110.379 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.696 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.4 mm -65.21 -40.37 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.38 2.21 9.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.297 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 98.0 mt-30 -73.95 139.62 45.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.711 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.33 40.46 0.56 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.315 0.578 . . . . 0.0 110.823 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 2.3 pttp -153.54 163.11 40.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.884 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.9 tm? -69.54 113.82 7.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.029 0.442 . . . . 0.0 110.995 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 4.4 p -110.01 118.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.957 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.605 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -110.23 119.66 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 109.85 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.498 HG11 ' CE2' ' A' ' 11' ' ' PHE . 58.0 t -102.59 127.41 56.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.243 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -87.86 97.01 10.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.443 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -107.15 110.36 22.43 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.092 0.472 . . . . 0.0 110.818 -176.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 26.3 p90 -145.31 -171.54 3.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.092 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -136.25 136.69 40.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -61.02 -24.12 65.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -88.69 -10.44 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.275 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 72' ' ' MET . 44.2 t -77.44 158.39 30.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.034 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.1 -76.57 0.6 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.217 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 6.3 Cg_exo -74.39 14.77 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.187 2.591 . . . . 0.0 113.757 -173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 27.4 p -59.92 -34.95 73.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.882 0.848 . . . . 0.0 109.916 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -70.29 -8.0 46.87 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.423 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.586 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.1 ttt -84.44 -28.99 26.47 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.098 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -77.5 -25.73 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.32 -64.98 1.46 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 94.8 Cg_endo -82.46 -30.55 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 121.192 1.261 . . . . 0.0 114.133 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.545 ' CE ' HD21 ' A' ' 75' ' ' LEU . 1.5 ttp -67.44 -42.8 82.53 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 118.508 0.595 . . . . 0.0 109.905 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.31 -37.35 51.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.432 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.9 -38.52 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.658 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 56.8 mttp -65.36 -31.37 72.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.107 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.9 m-30 -55.65 -62.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.703 0.287 . . . . 0.0 110.268 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -73.84 -14.05 61.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.678 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 tt0 -60.32 -33.4 72.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.494 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.4 -47.96 8.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 175.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.518 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.2 p90 -128.68 86.4 57.68 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.158 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 -0.68 8.95 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.475 2.116 . . . . 0.0 112.252 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -67.47 -13.35 61.96 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.17 17.27 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.453 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.2 m-20 -91.8 126.42 36.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.254 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -102.27 114.16 28.07 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.493 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 98.6 m-85 -139.89 152.65 46.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.06 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.7 pttp -148.98 153.46 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.849 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.824 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 8.0 tt -159.14 146.44 17.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.1 m-20 -99.68 125.23 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -65.21 -22.72 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.07 -35.65 73.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.454 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.67 -43.53 11.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.964 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 55' ' ' LEU . 46.0 mt -131.77 89.98 2.77 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.559 0.695 . . . . 0.0 112.445 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.06 -33.78 39.78 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.246 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.53 -30.13 68.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.151 0.501 . . . . 0.0 110.03 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 89.2 t -62.89 -50.23 80.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 69' ' ' VAL . . . -46.76 -42.42 16.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.191 0.519 . . . . 0.0 111.406 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -72.04 -34.72 69.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.631 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 16.0 tptt -61.1 -26.44 67.66 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.711 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.3 m120 -105.09 -10.89 16.87 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.187 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 43.1 mt-10 80.17 26.68 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.391 1.057 . . . . 0.0 111.271 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -104.72 110.71 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.687 0.756 . . . . 0.0 111.241 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -114.0 -34.66 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.54 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.65 159.65 26.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.872 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.446 ' HG3' ' SG ' ' A' ' 30' ' ' CYS . 20.3 ptp -151.17 140.84 14.06 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.906 0.384 . . . . 0.0 110.958 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.2 Cg_endo -80.83 150.47 79.1 Favored 'Cis proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.726 -1.781 . . . . 0.0 113.154 -2.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -120.79 145.93 47.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.229 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 95' ' ' ILE . 3.6 mp -120.76 123.47 42.75 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 78' ' ' PHE . 7.1 mt -122.5 112.72 18.37 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.841 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.605 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 4.0 mp -94.46 134.8 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HB3' HG23 ' A' ' 15' ' ' ILE . 52.0 m-85 -133.45 156.73 47.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.406 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.42 122.75 19.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.47 167.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 t30 60.78 41.49 14.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.661 0.743 . . . . 0.0 111.352 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 86.16 -4.32 86.12 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.272 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -121.86 161.61 22.45 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 25.1 tt0 -66.92 178.75 1.28 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.59 -28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.047 162.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -154.81 146.39 23.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 112.073 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -135.14 115.33 13.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.665 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 95' ' ' ILE . 12.3 t -131.06 141.54 45.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -121.62 48.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.152 0.501 . . . . 0.0 110.743 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.35 129.2 1.18 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.309 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -62.63 108.21 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.122 0.487 . . . . 0.0 112.114 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.98 90.32 32.55 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -33.07 -63.15 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.659 3.573 . . . . 0.0 115.074 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 -46.02 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.969 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 75' ' ' LEU . 29.5 mm -87.36 -34.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.271 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.518 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 31.9 tttt -59.83 -37.87 80.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.595 0.712 . . . . 0.0 109.121 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.75 -30.27 69.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.466 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -56.59 8.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.441 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -51.07 -41.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.223 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.74 70.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.36 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -78.98 -21.04 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.979 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.787 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.584 0.23 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 52' ' ' PHE . 96.1 t -87.65 131.93 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.193 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.6 m -83.04 139.18 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 112.447 -170.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 55' ' ' LEU . 8.4 tp-100 -90.56 138.91 31.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.097 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 16.0 m-85 -95.69 161.4 14.05 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.622 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.8 ptpp? -134.37 -3.72 2.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.315 170.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.9 p -141.94 158.86 43.27 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.939 0.399 . . . . 0.0 111.322 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.21 -27.94 63.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.097 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -57.61 -46.4 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.344 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.694 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.1 mt-10 -55.41 -43.27 75.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.984 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.8 t80 -60.55 -58.41 8.6 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.36 -37.39 80.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.259 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -59.41 -43.22 93.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.892 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.02 -33.73 74.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.475 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.808 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.2 mm -63.01 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.279 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.93 -1.3 16.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.693 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.454 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 47.3 tt0 -72.31 141.32 48.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.791 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.32 48.16 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.501 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 5.3 ptpp? -157.9 -179.88 8.55 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -73.8 123.11 23.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 109.885 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -102.2 117.9 48.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.231 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -97.06 103.0 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 11' ' ' PHE . 38.4 t -105.34 124.17 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.973 0.892 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.806 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.17 96.76 7.2 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.733 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -101.0 128.62 46.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.778 0.799 . . . . 0.0 111.908 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 25.7 p90 -152.95 178.47 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.113 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.5 138.92 51.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.738 0.304 . . . . 0.0 110.277 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 p -66.19 -18.87 65.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.473 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -86.44 -10.75 53.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.59 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 39.4 t -84.16 152.75 24.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.597 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.59 -61.87 1.67 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.953 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.35 3.28 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.094 2.529 . . . . 0.0 113.872 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 29.0 p -60.43 -32.42 71.35 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.6 tptm -68.2 -11.88 60.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.801 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.0 ttt -79.43 -28.11 41.71 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -76.21 -22.73 15.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.616 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.57 -68.25 0.49 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.474 172.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.9 Cg_endo -84.11 -32.04 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 CA-C-N 120.941 1.372 . . . . 0.0 114.43 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.554 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.97 -48.55 73.61 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.374 0.534 . . . . 0.0 109.71 -176.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.806 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -68.19 -37.9 78.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.045 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.14 -26.52 67.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 109.499 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 50.2 tptt -77.13 -30.85 55.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.948 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.671 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 18.1 m-30 -52.65 -64.55 0.78 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.012 0.434 . . . . 0.0 109.872 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.4 m -80.03 -13.2 59.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.216 -173.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.0 -35.99 80.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.15 -39.39 14.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.212 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 10.4 p90 -131.77 90.87 35.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 111.937 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 1.87 6.12 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.792 2.328 . . . . 0.0 112.652 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.31 -23.25 67.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.542 . . . . 0.0 111.257 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.4 157.95 16.42 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.04 138.42 31.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.358 0.599 . . . . 0.0 111.23 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -110.78 115.91 30.37 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.234 -171.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.492 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 92.1 m-85 -138.89 154.25 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 111.843 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HG3' HG11 ' A' ' 2' ' ' VAL . 53.1 mttm -140.93 155.86 46.19 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.99 0.916 . . . . 0.0 109.972 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.03 147.49 16.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.937 0.398 . . . . 0.0 111.024 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.3 t0 -96.7 118.85 34.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.015 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 26' ' ' TYR . 21.7 t -66.12 -28.57 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.172 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.46 -25.47 65.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.93 -42.06 9.27 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.309 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -122.45 76.18 1.31 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.272 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.41 -40.72 91.47 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.027 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.78 -31.56 71.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.907 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 85.3 t -61.73 -52.55 59.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.132 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.33 -39.33 56.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 111.075 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.71 -33.14 72.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.417 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -22.12 66.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.969 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.624 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.3 m120 -109.79 -11.54 14.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 -173.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 80.28 27.28 0.29 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.439 1.087 . . . . 0.0 111.381 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.624 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -106.36 126.11 62.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.957 0.408 . . . . 0.0 110.375 173.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -139.85 5.52 2.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.08 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.48 ' HG2' ' CB ' ' A' ' 27' ' ' ALA . 2.4 mpt? -124.31 121.39 26.05 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.032 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 36' ' ' ILE . 40.3 Cg_endo -90.5 162.53 32.46 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.983 -1.257 . . . . 0.0 113.162 -1.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 m -136.89 131.93 33.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.325 0.583 . . . . 0.0 111.176 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -101.93 125.25 48.57 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.47 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.664 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.1 mt -118.61 113.2 20.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.149 0.5 . . . . 0.0 110.437 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -97.19 133.32 41.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.664 ' CE1' HD22 ' A' ' 76' ' ' LEU . 55.1 m-85 -130.67 158.2 40.7 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.578 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -140.93 125.26 17.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 48.09 51.85 14.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.131 0.972 . . . . 0.0 113.508 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.808 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 76.67 3.19 78.46 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.653 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -119.03 160.93 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.4 tt0 -71.23 -179.31 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.51 -34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 164.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.85 149.96 5.57 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.569 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.61 ' HB3' HD23 ' A' ' 76' ' ' LEU . 17.8 pttm -144.54 131.36 20.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.439 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.87 123.76 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.09 55.85 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.244 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.11 128.28 0.94 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -61.11 115.98 4.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.402 ' CB ' HG12 ' A' ' 95' ' ' ILE . 3.6 t30 -116.92 90.33 32.3 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.8 Cg_exo -25.13 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 125.256 3.971 . . . . 0.0 115.68 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.96 -28.42 35.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.15 -0.344 . . . . 0.0 111.833 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.1 83.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 75' ' ' LEU . 41.0 mm -82.54 -31.0 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.818 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 33.4 mtmt -61.2 -40.07 92.55 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -64.7 -30.29 71.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.16 173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -52.54 45.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 99' ' ' ILE . 4.2 mm -51.96 -41.09 30.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.56 -31.46 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.286 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.72 66.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.605 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -86.25 -20.79 27.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.59 177.283 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttm . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.77 0.319 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' HG2' ' A' ' 41' ' ' GLU . 74.5 t -87.99 136.69 22.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.629 -175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.554 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.0 m -81.77 145.54 30.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.086 -172.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -92.37 124.62 36.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 9.0 m-85 -84.58 157.31 21.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 21.6 pttm -135.16 -3.27 2.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.239 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -140.83 164.9 28.98 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.153 0.501 . . . . 0.0 111.792 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -76.47 -31.85 58.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.284 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 m -59.28 -42.94 92.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.656 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.614 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 24.2 mt-10 -53.66 -45.61 70.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 23' ' ' VAL . 12.3 t80 -56.84 -59.49 4.96 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.244 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 62.1 m-20 -60.72 -27.83 68.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.766 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -64.42 -44.59 90.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.051 0.453 . . . . 0.0 110.055 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -69.15 -20.2 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.887 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.799 HG22 ' HA2' ' A' ' 81' ' ' GLY . 17.9 mm -77.9 -38.35 24.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.109 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.59 14.59 2.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -99.18 163.37 12.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.955 0.407 . . . . 0.0 111.05 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.62 36.47 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.075 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.5 173.67 12.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.921 0.391 . . . . 0.0 110.916 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.5 tm? -79.37 126.12 30.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.331 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG21 ' HB1' ' A' ' 14' ' ' ALA . 7.7 p -111.68 128.23 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.35 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.38 102.96 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 11' ' ' PHE . 41.6 t -96.98 129.61 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.595 0.712 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.663 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -111.62 97.46 6.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.131 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.719 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.4 m-85 -103.23 137.24 41.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.571 0.7 . . . . 0.0 112.058 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 22.6 p90 -156.48 -171.37 3.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.688 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.63 135.1 32.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 p -69.3 -19.47 63.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.981 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -84.14 -14.77 49.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.01 0.434 . . . . 0.0 110.319 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 49.7 t -88.7 141.73 28.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.855 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.03 -60.85 5.31 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.83 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 41.1 Cg_endo -67.55 8.86 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.117 2.545 . . . . 0.0 114.766 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -60.52 -30.49 69.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.81 0.814 . . . . 0.0 109.958 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.68 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 19.7 ptmt -67.25 -9.6 42.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.646 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -81.24 -34.57 32.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -75.68 -24.66 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.674 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.04 -65.89 1.5 Allowed Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.978 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.5 Cg_endo -84.32 -30.58 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.692 1.594 . . . . 0.0 113.545 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -67.26 -39.74 86.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 109.804 -176.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -75.07 -39.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.137 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 2' ' ' VAL . 33.0 mt-10 -63.13 -32.02 73.31 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 173.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 39' ' ' MET . 27.3 ttpp -64.41 -41.06 96.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.284 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.1 m-85 -53.65 -63.23 1.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.949 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -76.4 -13.54 60.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.278 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.42 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.03 -41.07 13.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.29 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.6 p90 -133.8 90.81 26.56 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.28 0.562 . . . . 0.0 112.179 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.81 1.4 5.81 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.691 2.261 . . . . 0.0 112.584 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -63.15 -19.9 64.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.123 0.487 . . . . 0.0 110.694 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.13 153.26 19.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.73 143.39 26.59 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.914 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.856 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.84 116.05 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.309 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 90.6 m-85 -141.76 137.85 31.9 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 120.987 0.423 . . . . 0.0 112.12 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HG3' HG11 ' A' ' 2' ' ' VAL . 31.1 mtmt -123.19 153.36 40.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.465 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.719 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.8 tt -161.17 144.42 12.82 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.6 p-10 -100.52 129.63 46.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.082 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.511 HG23 ' HA2' ' A' ' 61' ' ' GLY . 3.8 p -72.67 -16.63 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.488 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -57.93 -43.54 86.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.991 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -88.89 -42.32 11.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.0 mm? -111.9 76.45 0.98 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.276 0.56 . . . . 0.0 112.01 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -67.34 -47.23 64.65 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.413 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.36 -30.95 70.84 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 111.177 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 89.5 t -65.53 -54.14 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.9 70.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 111.187 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.48 -30.22 69.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -66.96 -23.53 65.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.536 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB2' HG12 ' A' ' 69' ' ' VAL . 14.0 m120 -106.63 -12.58 15.53 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.868 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 26.5 tt0 80.46 22.27 0.43 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.308 1.005 . . . . 0.0 110.938 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.25 124.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 121.818 -0.551 . . . . 0.0 109.834 173.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 m -131.63 -25.48 2.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.477 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.1 159.68 14.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.3 mpt? -128.26 142.69 45.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 121.069 0.461 . . . . 0.0 111.434 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . 7.0 Cg_exo -82.23 166.39 70.63 Favored 'Cis proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.289 -1.546 . . . . 0.0 112.009 -9.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 69' ' ' VAL . 15.6 m -140.8 136.64 32.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.539 . . . . 0.0 111.023 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.8 mp -112.18 136.45 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.445 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 78' ' ' PHE . 4.7 mt -128.8 115.94 18.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.121 0.486 . . . . 0.0 110.856 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.704 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -99.3 129.31 45.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.055 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.625 ' HB3' HG23 ' A' ' 15' ' ' ILE . 54.0 m-85 -130.15 151.32 50.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.593 0.235 . . . . 0.0 110.788 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -132.96 124.57 28.02 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 44.8 50.37 8.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.799 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.03 -4.98 81.58 Favored Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.589 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -119.97 160.85 21.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 84' ' ' VAL . 23.4 tt0 -66.18 179.94 0.87 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -152.68 -24.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.601 164.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.631 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.99 157.63 5.35 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 111.436 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.21 133.91 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.428 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 95' ' ' ILE . 5.6 t -132.23 144.05 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 88' ' ' VAL . 9.0 p -117.1 49.04 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 122.218 1.008 . . . . 0.0 109.897 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.02 130.5 1.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.275 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.59 111.88 1.78 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.57 91.12 41.12 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.334 175.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 46.7 Cg_exo -31.69 -65.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.922 3.748 . . . . 0.0 115.359 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.65 -45.45 11.69 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.05 -30.59 71.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.3 mt -85.95 -31.61 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.308 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.557 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 15.4 ttpp -59.83 -38.77 82.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -64.4 -34.61 78.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.857 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -64.67 -60.78 2.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -50.73 -30.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.582 0.551 . . . . 0.0 110.802 -176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.5 -20.86 39.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.771 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.71 -32.11 17.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.704 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -92.19 -12.07 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.907 -178.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.942 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptm . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.688 0.28 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t -103.12 128.33 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.9 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.556 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 4.8 m -65.03 145.03 56.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.775 -168.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -96.71 123.88 40.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.807 -175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 12.5 m-85 -84.63 158.95 20.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.235 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -128.65 -27.25 2.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.007 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 29.6 p -127.54 162.8 25.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.409 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.09 -26.72 62.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.13 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.508 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.0 mt-10 -58.1 -41.43 83.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.522 172.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 23' ' ' VAL . 31.8 t80 -57.36 -59.72 4.72 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -56.36 -40.75 75.05 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.722 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -42.5 82.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.665 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 -36.27 71.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.364 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.7 mm -61.89 -40.73 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.8 2.24 8.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.257 -172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -74.85 143.15 44.02 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.56 34.43 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.563 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 172.31 13.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.153 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.56 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -68.49 123.08 19.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.488 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.6 t -103.2 114.28 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -93.64 103.61 14.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 11' ' ' PHE . 56.1 t -105.61 124.65 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.787 0.803 . . . . 0.0 111.256 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -103.43 98.37 8.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.933 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.5 121.59 44.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.482 0.658 . . . . 0.0 111.698 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 28.3 p90 -147.98 169.6 19.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.213 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -117.31 124.7 49.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -23.28 55.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -87.29 -10.17 53.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.518 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.13 158.83 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.758 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.62 -74.22 0.44 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.611 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.51 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 5.9 Cg_exo -77.91 25.66 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.315 2.677 . . . . 0.0 114.078 -171.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 p -65.65 -35.67 81.46 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.011 0.91 . . . . 0.0 109.566 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -68.31 -8.01 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.993 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -36.2 30.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -75.31 -25.58 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.864 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.36 -66.2 1.12 Allowed Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.738 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 90.0 Cg_endo -82.47 -30.05 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.263 1.309 . . . . 0.0 114.251 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -66.13 -44.97 82.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.606 0.639 . . . . 0.0 109.463 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.904 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -71.64 -37.57 63.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.219 -178.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.52 -33.19 75.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.809 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 5.0 tppp? -67.46 -34.97 78.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.331 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 20.5 m-30 -49.59 -62.99 1.24 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.267 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -76.55 -14.34 60.02 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.016 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 10.3 tp10 -59.39 -33.09 70.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 170.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.638 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.74 -45.52 10.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.567 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.3 p90 -130.49 86.67 52.54 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.143 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.4 -1.79 10.25 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.446 2.097 . . . . 0.0 112.168 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -9.98 45.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.481 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.8 16.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -92.75 135.83 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.125 0.488 . . . . 0.0 111.234 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -113.66 116.55 29.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.235 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -140.47 151.25 44.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.928 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -148.77 158.24 44.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.693 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.04 146.75 16.04 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 177.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.3 m-20 -95.83 118.33 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.183 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.653 HG21 ' HE1' ' A' ' 72' ' ' MET . 1.5 m -67.74 -16.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.43 . . . . 0.0 110.895 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.58 -40.17 96.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.03 -42.76 14.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.195 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -127.15 73.02 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 111.555 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.84 -36.89 87.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.17 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.11 -38.83 73.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 110.866 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 8' ' ' ALA . 95.4 t -63.66 -51.21 72.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.035 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.82 -39.06 62.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.884 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 30.1 mm-40 -69.27 -33.33 73.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.366 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.688 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 12.3 tptt -62.37 -30.05 70.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.815 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.696 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.7 m120 -102.71 -7.5 21.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.674 -170.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 45.1 mt-10 79.08 24.95 0.49 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.047 0.842 . . . . 0.0 111.043 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -100.68 112.09 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.231 0.538 . . . . 0.0 110.103 175.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.5 t -124.78 -20.83 4.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.28 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.653 ' HE1' HG21 ' A' ' 57' ' ' VAL . 19.9 mmt -129.36 121.55 20.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.056 -174.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 73.4 Cg_endo -88.01 167.71 40.26 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.005 -1.248 . . . . 0.0 113.018 -3.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 10.7 m -136.58 138.16 40.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.686 0.755 . . . . 0.0 111.555 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -109.02 127.79 54.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.569 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 78' ' ' PHE . 3.1 mt -121.5 113.6 20.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.112 0.482 . . . . 0.0 110.632 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -98.83 131.59 44.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.139 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.1 m-85 -129.69 158.34 39.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.465 0.174 . . . . 0.0 110.586 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -141.25 123.76 15.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p30 48.07 54.02 10.76 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 79.62 -1.6 76.89 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.48 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -127.62 161.33 29.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.3 tt0 -65.55 179.43 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.06 0.457 . . . . 0.0 110.907 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -151.03 -28.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 163.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -168.63 152.68 5.73 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.539 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HB3' HD23 ' A' ' 76' ' ' LEU . 21.7 pttp -145.81 129.58 17.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.866 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.17 129.89 60.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.545 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.94 50.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.018 0.437 . . . . 0.0 111.503 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.49 128.47 0.99 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.251 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.33 114.42 2.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 95' ' ' ILE . 7.3 t-20 -117.12 90.21 32.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.688 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 74.1 Cg_exo -21.93 -83.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 1 C-N-CA 125.512 4.141 . . . . 0.0 115.595 -171.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 96' ' ' LYS . . . -83.87 -30.51 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -173.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.66 77.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.36 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 75' ' ' LEU . 34.7 mm -83.39 -29.85 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.798 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 37.3 mtpt -59.31 -39.25 82.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -66.63 -33.03 74.76 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.516 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -61.71 -60.78 3.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.52 -36.56 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 123.831 0.707 . . . . 0.0 110.683 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.55 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.831 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -37.12 14.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.296 0.57 . . . . 0.0 109.991 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.668 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -85.42 -11.65 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.522 174.95 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptm . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 52' ' ' PHE . 52.8 t -122.01 129.39 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.86 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.566 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 11.2 m -71.82 144.64 49.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 0.0 112.525 -169.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -90.86 121.51 32.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.232 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 3.7 m-85 -69.75 168.5 14.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 0.0 110.418 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 16.7 mtpp -127.86 -36.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.019 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -144.6 179.28 7.39 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.51 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -65.95 -27.74 68.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -57.48 -48.5 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.787 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.503 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -55.02 -43.04 73.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.729 174.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.5 t80 -58.03 -60.08 4.29 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.7 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.01 -38.87 76.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.803 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -60.36 -47.83 84.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.695 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.24 75.0 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.844 0.354 . . . . 0.0 110.402 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.706 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -59.67 -36.81 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.308 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 14.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.469 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -83.14 153.73 24.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.65 0.262 . . . . 0.0 110.537 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -87.99 39.34 0.89 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.478 0.656 . . . . 0.0 110.36 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 17.7 ptpt -152.61 -179.8 7.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.051 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.35 121.63 23.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.629 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.1 t -96.21 116.19 37.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.051 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.41 103.16 14.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 11' ' ' PHE . 43.4 t -104.93 126.53 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.592 0.71 . . . . 0.0 111.285 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.66 101.16 10.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.847 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.699 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.6 m-85 -104.69 121.64 44.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 42.1 p90 -151.4 162.64 40.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.525 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -111.7 132.31 54.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -62.0 -24.55 67.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.687 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -84.27 -17.13 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.823 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.39 152.45 39.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.342 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.89 -75.56 0.48 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.348 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 20.85 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.156 2.571 . . . . 0.0 114.226 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.4 p -65.74 -28.57 69.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.903 0.858 . . . . 0.0 109.345 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 22.5 pttp -68.33 -8.45 39.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.501 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.542 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.0 ttt -84.92 -25.56 27.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.148 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -79.99 -24.7 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.306 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.39 -63.57 2.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.6 Cg_endo -83.91 -34.47 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.084 1.856 . . . . 0.0 114.045 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.528 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 0.5 OUTLIER -66.25 -42.99 87.81 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.426 0.631 . . . . 0.0 109.681 -176.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.51 -36.82 48.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.883 -178.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.3 mt-10 -63.43 -30.49 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.035 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 51.1 tttp -75.78 -28.91 58.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.524 -176.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.2 m-85 -56.59 -57.87 10.5 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.4 p -76.5 -13.75 60.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.496 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 34.1 tt0 -60.79 -31.9 71.27 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -88.34 -47.04 8.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.095 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.6 p90 -129.6 90.06 44.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.099 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -1.09 9.61 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.266 1.977 . . . . 0.0 112.174 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -10.62 51.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.964 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 154.63 18.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.1 m-20 -91.61 126.34 36.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -101.86 116.21 32.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.177 -174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.566 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.58 152.48 46.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.988 0.423 . . . . 0.0 111.029 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.5 pttt -148.91 160.92 42.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.4 tt -157.58 151.19 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 18.6 t0 -97.86 119.1 35.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.62 -26.99 42.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.809 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.19 -35.59 80.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.373 0.606 . . . . 0.0 109.98 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.53 -42.46 20.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.498 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB2' HD21 ' A' ' 55' ' ' LEU . 74.2 mt -135.09 84.01 2.07 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.91 -33.76 54.42 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.553 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.28 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 8' ' ' ALA . 79.6 t -63.74 -51.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.911 173.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.41 -39.69 57.76 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 110.76 176.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 75.9 mt-30 -69.97 -32.56 70.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.588 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -20.73 66.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.877 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.65 ' HB2' HG12 ' A' ' 69' ' ' VAL . 5.7 m120 -110.71 -8.75 14.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.482 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 25.7 tt0 80.69 25.85 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.102 0.876 . . . . 0.0 110.883 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -105.92 107.81 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.333 0.587 . . . . 0.0 110.668 174.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -116.76 -24.52 7.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.138 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.12 157.76 26.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.3 ptp -151.3 137.4 11.19 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.269 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.0 Cg_endo -77.88 155.82 94.87 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.768 -1.763 . . . . 0.0 113.021 -3.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.5 m -134.73 142.87 46.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.442 0.639 . . . . 0.0 111.339 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 95' ' ' ILE . 4.0 mp -114.24 129.36 56.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.768 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.592 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 mt -122.21 117.17 25.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 0.0 110.999 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -101.06 129.45 46.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.102 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.6 m-85 -127.79 161.39 29.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 4.6 ttpm? -143.55 115.45 8.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.008 168.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 64.26 55.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.762 0.791 . . . . 0.0 111.205 172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.706 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.39 2.66 60.04 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.488 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 8.5 ptpp? -133.44 160.97 35.84 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 31.6 tt0 -64.99 177.63 0.96 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 110.856 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -148.84 -35.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 160.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.99 152.96 15.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.51 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HB3' HD23 ' A' ' 76' ' ' LEU . 42.3 pttt -147.61 127.16 13.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.168 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.66 134.22 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.278 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.9 52.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.234 0.54 . . . . 0.0 110.782 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.28 129.46 1.25 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.073 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -64.69 103.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.734 0.302 . . . . 0.0 111.601 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.3 OUTLIER -117.49 88.89 30.42 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.032 175.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -35.37 -67.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.496 3.464 . . . . 0.0 115.272 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 -32.16 48.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.24 63.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.163 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 99' ' ' ILE . 40.3 mm -87.56 -34.4 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.23 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.704 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 55.0 tttt -59.48 -35.06 73.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -72.89 -31.22 64.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.76 27.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.5 mm -54.43 -37.51 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.337 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.112 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -44.51 34.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.832 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.03 -16.95 56.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.654 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.628 177.664 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptp . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.541 0.21 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG21 HG22 ' A' ' 40' ' ' ILE . 95.2 t -122.6 130.88 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.992 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 21.3 m -81.53 144.53 31.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.513 -170.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -90.13 135.83 33.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.122 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 8.9 m-30 -88.37 167.88 13.13 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 170.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 55.7 pttt -134.67 -20.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.206 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 22.6 p -145.49 174.69 10.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -70.8 -27.48 63.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -59.27 -43.8 92.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.304 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.718 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 42.9 mm-40 -55.35 -46.62 76.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.382 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 23' ' ' VAL . 16.6 t80 -59.24 -57.73 11.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.695 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.59 -40.98 93.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.828 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -62.02 -40.09 94.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.192 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.78 -42.58 90.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.648 175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.857 HG22 ' HA2' ' A' ' 81' ' ' GLY . 4.9 mm -60.2 -40.33 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.97 7.65 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 24.3 mt-30 -83.95 148.66 26.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.53 44.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -144.26 167.87 21.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.089 177.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -78.88 117.58 20.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 14' ' ' ALA . 41.1 t -108.36 122.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.227 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 28.9 t -106.59 112.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.723 HG11 ' CE2' ' A' ' 11' ' ' PHE . 54.6 t -100.14 121.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.641 0.734 . . . . 0.0 110.87 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.765 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -85.26 96.61 9.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.659 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -96.84 126.03 41.7 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.966 0.413 . . . . 0.0 110.077 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 36' ' ' ILE . 8.6 p90 -149.8 -175.28 4.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.573 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -132.76 130.04 39.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.637 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -65.55 -19.47 65.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.959 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -84.98 -13.5 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.174 0.511 . . . . 0.0 110.552 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.648 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.2 t -90.48 136.56 32.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.37 7.67 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 113.532 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.648 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.3 Cg_exo -61.33 3.59 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.103 2.535 . . . . 0.0 114.145 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.1 t -59.03 -29.88 67.6 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.737 0.779 . . . . 0.0 110.429 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -67.97 -8.99 41.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.306 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -38.13 44.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.05 -25.46 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.861 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.65 -65.69 1.38 Allowed Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.891 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 73.2 Cg_endo -83.55 -26.87 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.72 1.613 . . . . 0.0 114.378 -175.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.539 ' HE3' HG13 ' A' ' 40' ' ' ILE . 3.3 tmm? -72.72 -37.45 67.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.291 0.567 . . . . 0.0 109.753 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.765 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.85 -33.34 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.659 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.53 -29.05 70.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -72.79 -38.77 67.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.823 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.576 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -57.12 -49.63 75.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.5 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 95.8 p -85.39 -13.97 47.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.56 -27.98 69.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 13.3 mm-40 -89.68 -40.7 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.12 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 11.5 p90 -138.85 93.11 10.8 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 112.431 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.44 2.37 2.9 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.451 2.1 . . . . 0.0 112.107 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.06 -23.74 67.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.48 157.58 16.7 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.3 135.75 33.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.904 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.5 p90 -111.52 115.46 29.24 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.249 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 3' ' ' THR . 95.8 m-85 -140.66 156.74 46.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.716 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 43.4 mtmt -137.52 149.21 46.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.155 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD22 ' CE1' ' A' ' 25' ' ' PHE . 8.8 tt -157.87 148.81 21.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.034 0.445 . . . . 0.0 110.745 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 5.3 t0 -104.38 123.35 47.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.8 p -70.29 -24.39 25.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.061 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.62 -23.96 65.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.532 0.682 . . . . 0.0 109.694 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -99.12 -42.49 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.507 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -120.22 76.16 1.15 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.276 0.56 . . . . 0.0 112.163 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.81 62.67 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.85 -25.58 65.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.914 0.388 . . . . 0.0 110.797 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.623 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 51.5 t -68.68 -50.33 56.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -52.82 -22.84 5.85 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -86.26 -27.3 24.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -75.39 -26.5 58.48 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.107 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.642 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.5 p30 -110.13 -12.6 14.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 29.3 tt0 79.84 17.35 0.75 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.85 0.718 . . . . 0.0 112.635 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -89.55 130.89 38.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 121.567 -0.708 . . . . 0.0 110.639 173.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -123.94 -27.34 3.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.98 166.36 11.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.535 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -148.09 141.71 15.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.84 0.353 . . . . 0.0 110.951 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.89 150.29 78.55 Favored 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.836 -1.735 . . . . 0.0 112.635 -2.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -132.46 136.93 47.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.552 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -107.83 123.26 48.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.689 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -116.06 116.43 27.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.573 0.701 . . . . 0.0 109.876 175.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.2 mp -95.75 128.46 42.65 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.504 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 76' ' ' LEU . 58.9 m-85 -125.96 153.26 44.55 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.493 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -135.87 125.39 25.13 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 46.8 53.82 9.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.223 1.009 . . . . 0.0 113.49 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.857 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.8 5.4 69.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.528 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -120.08 161.12 21.51 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 84' ' ' VAL . 27.0 tt0 -71.58 179.89 2.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -153.86 -33.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 164.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.58 149.76 5.78 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.423 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -146.82 127.86 14.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.032 0.444 . . . . 0.0 110.54 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 95' ' ' ILE . 4.2 m -132.44 139.42 50.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -101.69 48.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.255 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.33 131.58 1.71 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.317 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.647 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -69.72 108.13 3.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -117.28 89.75 32.06 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 12.2 Cg_exo -28.53 -67.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.79 3.66 . . . . 0.0 115.588 -171.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.9 21.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.74 71.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.739 0.304 . . . . 0.0 111.32 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 91' ' ' ASN . 35.3 mm -72.62 -49.24 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.695 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mtmp? -63.46 -28.59 70.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -38.38 68.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.038 173.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.72 68.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.498 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -52.73 -39.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.711 -178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.7 -19.85 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.175 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.9 -38.08 23.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.254 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' ND2' HD23 ' A' ' 77' ' ' LEU . 58.1 m-80 -83.95 -21.16 31.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.448 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.894 178.17 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 7.1 ptp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.017 0.437 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.646 HG23 ' HG2' ' A' ' 41' ' ' GLU . 43.7 t -112.76 124.79 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.384 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.636 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 1.4 m -60.48 144.42 51.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.414 -168.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.52 117.43 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.224 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.4 m-85 -71.07 167.58 18.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.138 0.494 . . . . 0.0 111.755 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -125.38 -41.31 2.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.924 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -138.5 -179.96 6.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 111.443 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -67.86 -25.5 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.978 0.418 . . . . 0.0 110.186 175.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -61.2 -46.83 88.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -54.96 -42.74 72.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.448 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.801 ' CE2' HG11 ' A' ' 23' ' ' VAL . 17.6 t80 -57.37 -58.88 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.01 -36.35 74.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -63.54 -41.46 98.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.845 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.21 -35.54 78.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.037 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.763 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -62.26 -39.16 83.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.052 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.06 0.97 9.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 98.5 mt-30 -75.5 143.58 42.45 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.73 40.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 0.0 110.986 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 20.7 ptmt -142.19 167.44 22.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.381 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -70.1 126.42 29.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.0 t -106.07 120.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.2 104.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.801 HG11 ' CE2' ' A' ' 11' ' ' PHE . 39.4 t -102.72 127.18 56.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.663 0.744 . . . . 0.0 111.083 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.849 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.33 98.17 7.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.125 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.3 m-85 -103.21 123.97 47.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.439 ' O ' HG13 ' A' ' 57' ' ' VAL . 48.9 p90 -152.92 179.02 9.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.398 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -129.92 135.97 48.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.652 0.263 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.61 HG23 ' OD2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -63.96 -22.04 66.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.38 -13.26 52.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.562 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 52.9 t -81.99 148.79 28.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.706 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.39 -65.98 1.98 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 13.1 Cg_exo -71.8 18.52 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.24 2.627 . . . . 0.0 114.23 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -67.44 -29.24 68.66 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.048 0.927 . . . . 0.0 109.44 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 99.2 mttt -68.08 -7.36 28.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.133 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -38.33 58.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.659 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.22 -25.47 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.044 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.671 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.45 -65.8 1.3 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.976 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 96.2 Cg_endo -82.46 -29.75 1.36 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.456 1.437 . . . . 0.0 114.299 -173.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -66.3 -44.9 82.14 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.36 0.6 . . . . 0.0 109.456 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.849 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -69.55 -37.5 74.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.22 -179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 2' ' ' VAL . 40.8 mt-10 -62.83 -31.99 73.1 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.065 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.53 -32.74 70.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.696 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 16.8 m-30 -52.44 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -76.07 -13.4 60.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.263 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -60.55 -39.57 88.41 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.62 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -79.05 -47.61 15.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.5 p90 -133.06 89.9 32.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.214 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.28 2.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.503 2.135 . . . . 0.0 112.661 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -63.76 -24.74 67.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.304 0.573 . . . . 0.0 110.716 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.48 153.29 20.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.352 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.92 150.17 21.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.162 -175.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -118.33 115.96 25.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.969 -172.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.636 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.9 m-85 -141.8 149.51 40.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 111.635 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 36.9 mtmt -131.03 160.78 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.932 0.893 . . . . 0.0 110.1 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 25' ' ' PHE . 9.0 tt -159.8 147.8 17.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -98.89 117.99 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.131 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -71.83 -17.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 0.0 110.376 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.02 -31.99 69.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' O ' HD13 ' A' ' 60' ' ' LEU . 37.2 tt0 -87.69 -42.77 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.024 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.4 mm? -124.22 80.63 1.85 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.0 -39.77 93.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.701 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.83 -33.98 76.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.481 HG11 HD13 ' A' ' 55' ' ' LEU . 86.6 t -65.56 -49.53 77.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.095 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.7 -39.26 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.713 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 81.6 mm-40 -69.24 -38.11 78.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.12 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.559 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 5.9 tptp -59.46 -24.96 63.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.475 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HB2' HG12 ' A' ' 69' ' ' VAL . 4.0 m120 -109.47 -8.02 15.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 122.278 -0.264 . . . . 0.0 111.366 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.2 mt-10 79.21 27.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.997 0.811 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -106.22 109.84 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.4 0.619 . . . . 0.0 110.481 175.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.0 m -117.41 -34.51 4.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.182 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.07 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.624 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 19.6 ptp -151.79 149.27 23.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.959 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.3 Cg_endo -79.63 150.82 84.38 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.525 -1.864 . . . . 0.0 112.422 -4.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.1 m -126.05 140.21 52.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.595 0.712 . . . . 0.0 111.784 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 mp -114.99 124.65 52.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.436 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.646 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -116.32 118.74 33.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.462 . . . . 0.0 110.57 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.4 mp -99.72 131.84 45.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.279 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.646 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.3 m-85 -131.23 160.31 35.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.558 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 7.0 ttpm? -144.69 131.19 19.83 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.85 52.88 11.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.763 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.45 1.6 82.39 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.46 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -125.46 160.31 29.78 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.1 tt0 -66.57 -178.36 0.69 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.12 -31.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.647 162.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.681 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -164.0 154.43 15.23 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.918 0.39 . . . . 0.0 111.736 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -145.69 126.53 14.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 75' ' ' LEU . 12.3 m -133.65 142.74 40.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.669 0.271 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.23 43.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.963 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.48 121.9 0.82 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.119 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -59.63 109.59 0.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.952 0.406 . . . . 0.0 111.566 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.466 ' HB3' HG12 ' A' ' 95' ' ' ILE . 4.2 t30 -117.14 90.66 34.24 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.2 Cg_exo -26.26 -79.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.826 3.684 . . . . 0.0 115.288 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.91 -35.31 43.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.81 76.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.417 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.7 mm -86.15 -31.61 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.633 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 22.4 mtmm -63.05 -32.93 74.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.704 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -69.96 -32.86 71.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.035 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.55 48.56 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.089 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.1 mm -54.26 -38.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.453 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.77 60.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.097 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.98 -38.14 32.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.437 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 77' ' ' LEU . 52.5 m-80 -86.67 -14.58 42.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.269 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.73 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 40' ' ' ILE . 53.6 t -121.46 124.32 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.655 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 2.7 m -72.47 146.14 47.08 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -167.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -93.54 139.06 31.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.954 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 11' ' ' PHE . 11.5 m-85 -103.67 154.87 19.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.029 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 25.3 pttm -133.85 -3.35 2.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.205 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -143.22 164.11 31.08 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.477 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -56.93 -47.66 80.11 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -53.5 -44.95 69.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.609 ' O ' HG12 ' A' ' 15' ' ' ILE . 17.0 t80 -58.89 -57.25 13.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.7 -34.86 78.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.757 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -62.35 -40.35 96.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.678 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.61 -20.78 63.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.466 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.76 HG22 ' HA2' ' A' ' 81' ' ' GLY . 12.5 mm -82.58 -36.49 13.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.335 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 12.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -101.09 148.2 25.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 120.817 0.342 . . . . 0.0 110.313 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.73 66.22 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.619 0.723 . . . . 0.0 110.747 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -154.03 174.59 14.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.44 117.16 24.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.158 0.504 . . . . 0.0 109.846 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.3 t -102.23 128.43 54.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.2 t -115.78 108.79 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 11' ' ' PHE . 14.5 t -106.31 129.58 59.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.706 0.765 . . . . 0.0 110.885 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.893 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.68 100.17 11.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.081 -175.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -105.89 108.88 20.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.492 0.663 . . . . 0.0 111.945 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.4 p90 -131.76 -174.51 3.44 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.532 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.97 139.91 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.892 0.377 . . . . 0.0 110.404 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -20.28 62.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.709 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -88.7 -15.75 34.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.36 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 33' ' ' CYS . 16.3 p -90.92 150.25 21.57 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.2 -46.99 9.55 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.912 -0.585 . . . . 0.0 114.321 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 42.0 Cg_endo -67.11 5.08 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.578 2.186 . . . . 0.0 114.307 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 24.4 p -61.98 -34.1 75.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.457 0.646 . . . . 0.0 110.383 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.4 -8.66 42.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.402 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 90' ' ' ALA . 16.9 tpt -79.7 -33.34 41.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -79.95 -26.75 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.049 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.05 -62.04 3.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.269 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 83.9 Cg_endo -80.39 -41.2 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 120.152 1.09 . . . . 0.0 113.706 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.461 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 2.8 tmm? -62.04 -36.21 80.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.246 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -82.17 -35.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.288 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -64.57 -23.43 67.26 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.189 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 27.0 mtpp -85.56 -26.05 26.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -60.69 -42.07 96.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.965 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -15.43 49.35 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 122.054 -0.404 . . . . 0.0 111.008 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 24.0 tt0 -56.53 -39.18 72.94 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -84.22 -50.23 8.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.908 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 14.3 p90 -134.13 91.02 24.46 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.252 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.99 0.78 8.48 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.885 1.723 . . . . 0.0 111.195 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -65.63 -9.66 29.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.779 176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.84 161.15 13.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.18 130.76 37.81 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -114.96 116.32 28.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.053 -172.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 88.2 m-85 -140.57 151.34 44.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.526 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 19.5 pttm -148.64 152.44 36.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.15 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 60' ' ' LEU . 6.7 tt -160.33 152.44 20.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.757 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.7 p-10 -99.77 128.54 45.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 111.263 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -72.42 -12.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.082 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.49 -48.6 72.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.025 0.441 . . . . 0.0 109.926 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -80.12 -41.56 25.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.832 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.748 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -116.04 71.81 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.142 0.496 . . . . 0.0 112.249 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -75.15 -36.09 46.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.966 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.98 -30.58 71.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.403 0.621 . . . . 0.0 110.79 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 60.7 t -68.99 -52.55 32.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.6 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.91 -40.9 58.08 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.23 0.331 . . . . 0.0 111.238 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 71.6 mt-30 -69.66 -32.04 70.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.726 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 10.8 tptt -62.98 -27.95 69.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.729 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.726 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 4.7 m120 -103.94 -10.11 18.39 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.3 tt0 80.99 19.49 0.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.201 0.938 . . . . 0.0 111.029 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.677 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -96.44 118.66 43.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 121.804 -0.56 . . . . 0.0 110.145 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 m -117.32 -31.33 5.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.618 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.11 163.87 13.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.269 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.425 ' CE ' HG21 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -144.51 138.51 14.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' CG ' HD13 ' A' ' 36' ' ' ILE . 59.3 Cg_endo -83.39 152.18 69.03 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.741 -1.775 . . . . 0.0 113.024 -0.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.7 m -131.56 135.03 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.681 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -104.9 129.93 53.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.533 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE2' ' A' ' 78' ' ' PHE . 1.3 mt -120.64 115.67 23.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.011 0.434 . . . . 0.0 110.92 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -98.81 133.15 43.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE2' HD22 ' A' ' 76' ' ' LEU . 47.9 m-85 -130.85 153.91 48.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 4.1 tppp? -132.68 118.15 18.75 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 1.8 p-10 43.78 55.74 4.96 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.255 1.022 . . . . 0.0 113.735 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.76 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.34 -5.63 63.08 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.601 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.97 160.08 16.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.19 178.52 4.39 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -149.23 -34.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 163.206 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.655 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.01 157.17 11.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.465 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HB3' HD23 ' A' ' 76' ' ' LEU . 29.2 pttt -152.03 134.71 15.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 t -132.1 124.5 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.343 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.09 52.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.203 0.525 . . . . 0.0 111.27 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.34 126.83 0.85 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.824 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -63.4 121.44 13.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.435 0.636 . . . . 0.0 111.558 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 3.6 t-20 -117.24 90.69 34.76 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.999 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 51.1 Cg_exo -21.37 -75.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.377 4.051 . . . . 0.0 115.926 -171.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.0 -34.44 24.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.72 -29.58 70.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.433 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.458 ' O ' HG12 ' A' ' 99' ' ' ILE . 37.9 mm -73.35 -43.69 56.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.067 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.591 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 87.4 mttt -64.26 -24.83 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.634 0.73 . . . . 0.0 109.806 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -84.09 -29.04 27.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.676 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.13 -54.35 31.27 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.98 0.419 . . . . 0.0 110.207 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -50.89 -39.79 19.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.646 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.94 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.383 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.18 41.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' HD23 ' A' ' 77' ' ' LEU . 47.5 m-80 -96.55 -15.34 21.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.968 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.791 177.022 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.957 0.408 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 41' ' ' GLU . 62.4 t -119.79 138.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 23.4 m -90.24 131.62 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.649 0.738 . . . . 0.0 112.555 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 57.9 mm-40 -69.01 137.54 53.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.939 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -83.26 170.5 14.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.798 169.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -122.7 -41.38 2.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -140.67 179.28 6.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.873 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -66.09 -27.84 68.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.513 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -59.45 -46.99 87.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.547 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -53.13 -44.2 67.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.369 172.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.743 ' O ' HG12 ' A' ' 15' ' ' ILE . 14.8 t80 -59.84 -60.91 3.07 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.85 -39.78 65.91 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.939 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -64.29 -44.8 90.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.4 75.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.144 0.497 . . . . 0.0 110.312 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.813 HG22 ' HA2' ' A' ' 81' ' ' GLY . 13.6 mm -63.49 -38.13 81.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.55 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.55 6.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HB3' ' CD ' ' A' ' 19' ' ' LYS . 96.8 mt-30 -83.69 141.95 31.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.539 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 32.23 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 111.966 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.75 178.98 6.7 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -74.58 122.32 22.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.5 t -101.15 111.2 30.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -93.54 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 176.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 11' ' ' PHE . 57.1 t -103.54 123.78 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.86 0.838 . . . . 0.0 111.188 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -95.98 96.63 9.02 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.215 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.809 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -99.29 130.63 45.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.8 p90 -157.49 -171.77 3.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.908 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -142.1 139.29 32.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -15.25 62.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -87.58 -12.74 44.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.014 0.435 . . . . 0.0 110.619 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.0 t -83.24 149.91 26.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.025 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.71 -67.89 1.58 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.791 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 41.7 Cg_endo -69.21 12.8 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.099 2.533 . . . . 0.0 114.356 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 26.5 p -63.94 -32.71 74.34 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.087 0.946 . . . . 0.0 109.879 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.673 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 44.2 mtmt -69.16 -8.86 49.43 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.009 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.31 -33.11 49.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -76.22 -24.55 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.814 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.77 -65.37 1.54 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.587 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.2 Cg_endo -82.91 -35.62 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.606 1.537 . . . . 0.0 113.238 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.41 -40.16 95.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.623 0.725 . . . . 0.0 109.936 -175.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.784 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.12 -38.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.754 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HG2' HG23 ' A' ' 2' ' ' VAL . 44.5 mt-10 -65.28 -29.57 70.35 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.525 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 13.1 mmmm -66.92 -40.2 87.57 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.444 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.0 m-30 -52.51 -62.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.781 0.324 . . . . 0.0 111.207 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.8 p -77.16 -13.29 59.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.731 0.301 . . . . 0.0 111.368 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.7 -39.68 85.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -81.84 -42.67 19.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.044 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.5 p90 -130.0 89.82 44.42 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 111.927 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.39 0.74 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.189 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -64.96 -12.11 46.14 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.207 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.32 147.13 26.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.903 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.641 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.3 p90 -91.51 116.09 28.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.142 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 3' ' ' THR . 94.9 m-85 -141.19 155.17 46.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.604 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 19.3 ptmt -149.29 151.86 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.871 -172.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.908 HD21 ' HB2' ' A' ' 60' ' ' LEU . 10.1 tt -159.55 148.34 17.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.746 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.6 p-10 -101.65 120.75 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.221 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 72' ' ' MET . 3.6 p -67.13 -16.75 21.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.611 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.85 -49.14 63.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.291 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -90.77 -42.98 10.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.819 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.908 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -105.33 73.65 1.05 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.548 0.689 . . . . 0.0 111.866 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -69.61 -43.64 67.29 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.135 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 3.7 p30 -67.63 -20.9 65.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 0.0 110.797 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 96.1 t -69.75 -51.98 35.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.31 -40.44 59.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.343 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 4.4 pt20 -68.31 -36.12 78.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.088 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.744 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.26 -28.67 68.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.777 176.097 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.744 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 10.3 m120 -102.77 -13.12 17.16 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.281 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 5.4 tp10 80.08 19.88 0.59 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.467 1.104 . . . . 0.0 111.067 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -95.09 119.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.187 0.518 . . . . 0.0 109.757 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -134.45 8.21 3.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.402 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.53 153.69 38.88 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 57' ' ' VAL . 2.2 mpt? -129.8 130.68 23.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.915 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.527 ' HB2' HG12 ' A' ' 36' ' ' ILE . 60.2 Cg_endo -86.14 165.76 51.87 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.247 -1.564 . . . . 0.0 112.377 -5.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.1 m -141.56 128.91 21.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.508 0.671 . . . . 0.0 111.09 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -97.68 123.51 41.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.044 173.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.9 mt -115.9 113.79 23.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.317 0.58 . . . . 0.0 110.742 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -99.24 127.53 45.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.04 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HB3' HG23 ' A' ' 15' ' ' ILE . 48.8 m-85 -128.08 159.14 36.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.546 0.212 . . . . 0.0 111.219 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -143.81 135.8 26.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p30 49.54 41.57 21.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.183 0.993 . . . . 0.0 113.319 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 83.39 1.49 90.29 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.576 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -122.67 161.09 24.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.5 tt0 -68.88 179.61 1.76 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 118.404 0.547 . . . . 0.0 109.77 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -149.11 -28.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.497 162.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.95 152.64 13.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.098 0.475 . . . . 0.0 111.61 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -142.92 120.11 11.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.311 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 95' ' ' ILE . 59.1 t -130.6 128.6 63.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.831 0.348 . . . . 0.0 110.978 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -99.8 52.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.126 0.488 . . . . 0.0 110.957 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.57 124.86 0.89 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.291 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.62 102.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.925 0.49 . . . . 0.0 112.131 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' CB ' HG12 ' A' ' 95' ' ' ILE . 1.5 t-20 -118.0 89.52 34.64 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.176 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 29.5 Cg_exo -32.82 -66.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.326 3.351 . . . . 0.0 115.378 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.47 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.29 68.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.67 0.271 . . . . 0.0 111.69 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 HD22 ' A' ' 75' ' ' LEU . 42.3 mm -87.66 -33.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.083 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -61.55 -32.27 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.457 0.646 . . . . 0.0 109.512 170.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -71.59 -32.84 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.17 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.3 -52.27 48.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.123 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -53.36 -36.9 27.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -30.98 60.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.098 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.86 -37.41 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.499 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -86.83 -20.15 27.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.267 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.086 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 54' ' ' LYS . 83.4 t -121.57 131.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.471 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.5 m -74.14 144.8 44.73 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -170.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -101.16 122.71 44.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.657 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.2 m-85 -84.46 160.13 20.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.652 173.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -1.76 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 166.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.0 p -140.46 159.82 41.35 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.97 -28.72 62.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.37 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.62 -42.87 93.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -54.67 -44.2 73.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.716 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 15' ' ' ILE . 18.5 t80 -57.53 -60.68 3.3 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -55.12 -40.62 70.72 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.708 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.8 t -58.77 -45.49 89.66 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.944 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.72 76.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.668 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.97 -36.09 76.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.553 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 12.73 0.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -88.11 150.84 23.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.681 0.277 . . . . 0.0 110.585 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.52 36.9 0.49 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 110.766 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 79' ' ' LYS . 19.6 ptpt -137.3 177.49 7.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.2 tm? -82.38 118.49 23.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.0 t -102.78 119.99 51.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.832 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 31.2 t -107.13 106.79 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.9 t -101.76 123.79 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.94 0.876 . . . . 0.0 110.643 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -95.39 97.61 9.95 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.106 -174.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.2 m-85 -102.57 126.67 49.71 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.552 0.692 . . . . 0.0 111.866 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.63 174.85 12.97 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -125.64 124.5 41.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.57 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -19.48 65.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.106 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -90.76 -6.98 53.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 54.1 t -93.29 152.42 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.559 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.21 -72.01 0.74 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.668 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 59.8 Cg_endo -76.39 31.58 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.904 2.402 . . . . 0.0 114.512 -172.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.19 -34.74 75.4 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.914 0.864 . . . . 0.0 110.114 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -68.1 -7.28 28.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.984 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.549 ' HG3' ' HB3' ' A' ' 90' ' ' ALA . 17.0 tpt -75.89 -35.2 59.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 109.067 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -80.19 -25.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.017 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.79 -63.04 2.58 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.764 176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 95.7 Cg_endo -82.23 -34.98 0.38 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.035 1.156 . . . . 0.0 113.652 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 3.2 tmm? -65.03 -37.89 89.07 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.187 0.518 . . . . 0.0 110.017 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD13 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -78.98 -36.26 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.798 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -63.94 -26.16 68.46 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.936 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 94.2 mttt -80.03 -34.92 37.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.5 p90 -55.51 -48.56 74.44 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.229 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 79.0 p -85.37 -14.4 46.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.51 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 9.1 tp10 -55.42 -38.69 69.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.579 172.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -90.61 -37.93 13.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.399 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 12.3 p90 -132.72 90.7 31.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.683 . . . . 0.0 112.835 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.23 0.08 6.53 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.728 2.286 . . . . 0.0 112.645 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -14.88 62.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.977 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.7 154.83 18.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.54 127.79 37.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.874 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -100.78 116.11 31.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.233 -173.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.471 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.1 m-85 -138.23 150.94 47.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.655 0.264 . . . . 0.0 111.353 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HG3' HG11 ' A' ' 2' ' ' VAL . 33.6 mtmt -134.38 158.5 43.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.755 0.822 . . . . 0.0 110.233 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.3 tt -160.43 141.61 12.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 110.79 170.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.85 117.24 29.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.9 m -65.87 -19.08 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.491 0.663 . . . . 0.0 109.672 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.83 -38.31 78.4 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.059 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -96.38 -38.79 9.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.806 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.651 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -121.1 76.11 1.2 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.095 0.474 . . . . 0.0 111.682 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.5 78.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.259 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.25 -35.54 80.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.156 0.503 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 62.1 t -64.59 -48.71 83.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.23 -39.49 60.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.195 0.522 . . . . 0.0 110.773 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -74.86 -29.3 60.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.522 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.753 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -62.37 -27.49 69.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.052 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.753 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 8.5 m120 -104.38 -13.1 16.22 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.315 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 39.7 mt-10 80.63 31.23 0.18 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.532 1.145 . . . . 0.0 111.045 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -107.94 107.71 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.552 . . . . 0.0 110.113 170.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 m -115.31 -10.59 12.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.758 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.46 142.33 36.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HE2' HG21 ' A' ' 57' ' ' VAL . 2.0 mpt? -130.87 140.99 40.35 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.74 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD3' ' HG2' ' A' ' 32' ' ' PRO . 58.9 Cg_endo -81.1 163.75 78.96 Favored 'Cis proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.858 -1.726 . . . . 0.0 113.305 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.6 m -148.78 138.22 21.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.043 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.56 130.28 54.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.305 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -120.41 114.07 21.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.016 0.436 . . . . 0.0 110.39 175.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.665 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -97.0 133.35 41.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.0 m-85 -130.31 152.85 49.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.8 tppp? -127.08 110.11 12.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.404 168.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.9 t30 57.44 56.46 5.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 111.788 167.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.668 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.86 12.27 78.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.731 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -131.42 159.23 38.63 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 178.22 4.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.48 -32.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 164.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.98 154.54 7.71 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.508 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.99 134.15 19.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.174 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.79 122.12 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.173 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.39 55.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.134 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.78 135.42 2.0 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.78 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -67.76 122.6 18.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.091 0.472 . . . . 0.0 111.523 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' H ' ' CG1' ' A' ' 95' ' ' ILE . 16.1 t30 -117.73 90.29 35.59 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.662 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 29.2 Cg_exo -21.03 -78.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.639 4.226 . . . . 0.0 116.102 -169.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.78 -31.64 25.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -63.53 -32.01 73.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.69 0.281 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.6 mm -71.35 -43.73 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.175 175.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 27.1 mmtp -61.8 -35.16 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -69.25 -37.51 77.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.459 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.6 -61.18 2.8 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -48.3 -35.3 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.956 0.785 . . . . 0.0 110.756 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.25 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.977 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -31.96 17.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 110.287 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.665 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -91.67 -13.75 31.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.728 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.86 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 47.0 ttm . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.703 0.287 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.8 t -99.65 128.26 51.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 -176.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.609 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 6.8 m -70.52 145.4 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -87.39 139.08 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.534 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.0 m-85 -102.52 148.08 25.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -129.54 1.41 5.01 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.663 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 24.0 p -142.13 156.59 45.37 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.991 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.971 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -58.32 -41.95 85.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.663 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mt-10 -56.15 -48.29 76.56 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.279 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.1 t80 -55.07 -57.98 9.52 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.12 -33.26 68.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.488 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -65.13 -49.73 68.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.54 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.72 75.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.6 mm -62.94 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.827 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 13.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.532 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -89.52 147.08 24.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.848 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.58 52.44 1.88 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.251 0.548 . . . . 0.0 112.145 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 51' ' ' ASP . 18.8 ptpt -154.86 178.49 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.59 118.86 19.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -102.78 124.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.806 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 17.2 t -113.74 111.13 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.6 t -108.29 129.08 63.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.827 0.822 . . . . 0.0 110.95 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.814 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.04 101.11 12.62 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.905 -175.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -108.48 115.65 30.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.332 0.587 . . . . 0.0 111.673 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 37.5 p90 -139.98 175.33 9.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.801 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -123.8 131.39 53.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.705 0.288 . . . . 0.0 110.572 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -26.99 69.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.419 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -81.34 -8.83 59.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.7 t -87.71 159.02 18.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.859 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.66 -67.2 1.46 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.344 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 39.8 Cg_endo -68.11 10.92 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.247 2.632 . . . . 0.0 114.219 -175.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.2 p -61.88 -34.52 76.16 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 21.8 ptmt -67.71 -8.62 36.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.61 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 21.2 ttt -82.55 -27.3 31.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -77.23 -25.16 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.064 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.83 -64.6 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.848 173.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.8 Cg_endo -82.95 -30.47 0.94 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 120.765 1.309 . . . . 0.0 114.411 -175.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.45 -33.94 71.87 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.455 0.645 . . . . 0.0 109.767 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -83.63 -34.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.932 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 37.7 mt-10 -65.64 -21.6 66.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.274 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 55.1 tttm -79.87 -36.0 37.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.886 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.4 p90 -58.87 -46.36 87.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.183 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.3 p -85.26 -14.67 45.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.476 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 6.8 tp10 -60.67 -31.67 70.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.35 -50.1 9.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.723 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.569 ' HD1' ' O ' ' A' ' 47' ' ' TYR . 3.9 p90 -134.79 92.8 18.68 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.732 0.777 . . . . 0.0 112.923 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.9 -0.26 5.97 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.198 1.932 . . . . 0.0 112.338 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 3.9 pp0? -67.11 -16.87 64.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.774 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.92 152.01 20.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -91.53 140.1 30.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.337 -175.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -113.21 115.18 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.947 -172.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -139.03 147.85 42.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.626 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 21.4 pttm -145.52 153.58 41.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.833 -174.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.0 tt -159.78 146.84 16.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.78 0.324 . . . . 0.0 110.687 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.2 m-20 -92.84 121.91 34.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.3 m -68.31 -16.6 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.248 0.547 . . . . 0.0 110.04 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.79 -39.55 91.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -79.21 -41.96 27.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 60.7 mt -136.96 83.58 2.01 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.449 0.642 . . . . 0.0 111.865 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -72.55 -38.04 57.84 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.499 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.13 -27.21 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.395 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 8' ' ' ALA . 91.1 t -67.47 -55.8 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.573 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -49.86 -41.15 44.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 111.14 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -69.2 -31.48 70.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.264 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 8.0 tptt -63.94 -25.78 68.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.31 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.687 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 5.5 m120 -102.97 -12.91 17.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 17.9 tp10 80.78 28.36 0.21 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.505 1.128 . . . . 0.0 110.645 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -106.58 116.41 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.248 0.546 . . . . 0.0 110.011 170.422 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -117.47 -30.94 5.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.22 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.46 13.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.173 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -150.0 143.5 16.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 111.016 -179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.495 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.5 Cg_endo -80.04 149.74 80.84 Favored 'Cis proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.445 -1.898 . . . . 0.0 113.036 -3.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -130.48 138.35 50.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.218 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -108.98 130.5 55.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.515 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 78' ' ' PHE . 3.1 mt -119.6 116.13 25.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.188 0.518 . . . . 0.0 110.825 176.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 85' ' ' ALA . 4.9 mp -99.08 128.33 45.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.915 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 76' ' ' LEU . 62.3 m-85 -131.13 155.9 46.19 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.941 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 40.3 ttmt -134.97 125.47 26.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.4 p-10 43.67 56.47 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.27 -1.66 69.5 Favored Glycine 0 CA--C 1.51 -0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.653 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -118.94 160.09 22.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.6 tt0 -72.94 179.12 3.87 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -153.25 -32.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.657 163.214 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.698 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.42 157.37 7.31 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.893 0.377 . . . . 0.0 111.954 177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -150.24 132.07 15.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.339 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 95' ' ' ILE . 55.2 t -133.27 132.32 58.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.308 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.67 50.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.075 0.464 . . . . 0.0 111.574 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.49 134.88 1.82 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.784 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.18 112.85 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.275 0.56 . . . . 0.0 111.421 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.97 90.2 32.11 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.424 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 32.8 Cg_exo -28.79 -68.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.933 3.755 . . . . 0.0 115.147 -170.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.21 -40.07 18.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -64.78 -30.44 71.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 87' ' ' VAL . 25.9 mm -74.59 -51.49 22.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.999 0.428 . . . . 0.0 110.226 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 99' ' ' ILE . 9.9 mtmp? -64.36 -23.3 67.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -82.98 -25.83 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.47 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.73 12.53 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.547 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 11.6 mt -50.36 -43.61 22.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.551 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.8 74.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.004 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.384 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -82.77 -17.66 43.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.373 176.165 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 tpp . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.139 0.495 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.5 t -88.78 131.39 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.225 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -72.23 144.16 48.56 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.5 tp-100 -90.65 135.85 33.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 7.6 m-85 -82.64 170.02 15.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.359 0.6 . . . . 0.0 110.773 172.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.648 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 36.8 mttp -129.71 -27.16 2.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.21 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 26.2 p -147.48 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -69.95 -26.42 64.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.93 -43.11 99.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.673 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.8 mm-40 -52.74 -45.56 67.06 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.682 ' O ' HG12 ' A' ' 15' ' ' ILE . 20.5 t80 -60.08 -62.48 1.84 Allowed 'General case' 0 N--CA 1.458 -0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.055 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.32 -37.35 74.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.112 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -61.34 -45.95 92.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.691 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.09 82.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 110.21 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.5 mm -64.16 -37.08 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.627 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 1.79 4.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.382 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 26.2 mt-30 -78.31 136.9 37.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.983 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 26.3 t0 -81.61 46.55 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.995 0.902 . . . . 0.0 110.285 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 19.8 ptpt -131.38 179.43 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.312 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 99' ' ' ILE . 1.9 tm? -83.43 113.95 21.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 3.5 t -104.51 121.33 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.88 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.7 t -108.8 114.95 48.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.55 HG11 ' CE2' ' A' ' 11' ' ' PHE . 21.9 t -107.68 129.25 62.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.853 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.23 100.96 12.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.663 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.2 m-85 -103.66 120.86 41.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.499 0.666 . . . . 0.0 111.585 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 39.6 p90 -152.23 161.24 42.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.769 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -113.5 133.55 55.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.664 0.268 . . . . 0.0 110.34 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.5 p -65.96 -21.54 66.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.418 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -77.83 -18.28 56.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.053 0.454 . . . . 0.0 110.387 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 48.1 t -82.38 147.06 29.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 -177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.58 -64.08 2.34 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.331 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 43.8 Cg_endo -68.06 10.5 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.284 2.656 . . . . 0.0 114.743 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 27.6 p -66.28 -24.79 66.62 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.833 0.825 . . . . 0.0 110.033 177.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.9 mttp -61.96 -20.64 64.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.94 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.452 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -68.16 -37.89 81.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 109.488 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.73 HD12 ' HB2' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.36 -25.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.06 -65.87 0.98 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.145 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.6 Cg_endo -83.26 -31.73 0.61 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 CA-C-N 121.066 1.416 . . . . 0.0 114.298 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.46 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.4 tmm? -67.96 -34.75 77.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.499 0.666 . . . . 0.0 109.68 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -82.18 -37.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.28 -179.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 2' ' ' VAL . 36.3 mt-10 -64.56 -23.25 67.2 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.666 171.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' NZ ' ' A' ' 96' ' ' LYS . 53.8 tptt -77.93 -36.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.995 -177.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -58.61 -41.85 86.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.995 -179.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.18 -16.92 41.69 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.961 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.52 -27.24 68.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.02 -47.45 8.11 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.306 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.606 ' OH ' ' HB ' ' A' ' 99' ' ' ILE . 8.0 p90 -137.48 93.15 12.87 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 121.645 0.736 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.66 2.52 3.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.235 1.956 . . . . 0.0 111.662 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.6 tt0 -63.04 -23.27 67.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.171 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.13 154.52 18.36 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -90.9 123.68 34.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.225 -173.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.7 p90 -96.05 116.35 28.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 99.2 m-85 -139.75 151.7 46.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.321 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.9 pttt -149.13 161.88 41.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 -175.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.9 tt -159.23 145.3 16.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.227 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t0 -90.98 116.47 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.077 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.48 -23.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -68.03 -34.37 76.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.342 0.591 . . . . 0.0 109.739 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -78.89 -42.01 28.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.056 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 63' ' ' VAL . 91.1 mt -136.3 78.48 1.71 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.537 0.684 . . . . 0.0 111.971 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -69.03 -32.69 73.34 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.455 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.44 -36.9 81.68 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.085 0.469 . . . . 0.0 110.984 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 60' ' ' LEU . 93.0 t -64.19 -49.01 83.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.892 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.06 -38.27 56.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 95.2 mt-30 -70.5 -34.21 72.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.415 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.641 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 2.7 tptp -61.76 -25.86 67.72 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.188 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.648 ' HB2' HG12 ' A' ' 69' ' ' VAL . 5.9 m120 -106.94 -13.05 15.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.272 -0.267 . . . . 0.0 111.627 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 13.3 tp10 79.82 31.26 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.378 1.049 . . . . 0.0 110.906 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.16 114.98 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.135 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.6 t -120.3 -19.12 7.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.891 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.64 156.58 16.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.731 0.301 . . . . 0.0 110.756 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mpt? -126.66 127.95 24.39 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.418 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.8 Cg_endo -89.26 164.4 37.8 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.605 -0.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.3 m -141.47 131.8 25.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.604 . . . . 0.0 111.302 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.514 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.8 mp -102.34 135.78 43.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.474 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -125.17 113.43 17.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.271 0.558 . . . . 0.0 110.58 172.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.8 mp -93.95 130.05 40.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 76' ' ' LEU . 43.4 m-85 -128.64 154.86 45.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.745 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 58.2 tttm -134.05 125.58 28.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.21 166.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.49 HD21 ' HE2' ' A' ' 82' ' ' LYS . 3.7 p-10 46.58 49.05 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.343 1.057 . . . . 0.0 113.553 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 81.53 -1.78 84.62 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.837 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HE2' HD21 ' A' ' 80' ' ' ASN . 37.8 mtmt -115.11 160.12 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -71.82 179.76 3.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.86 -32.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.478 163.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.67 140.58 1.35 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.05 136.17 41.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 95' ' ' ILE . 41.1 t -132.81 123.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 m -88.34 58.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.12 137.42 2.2 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.969 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -68.46 118.76 11.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.04 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.438 ' H ' ' CG1' ' A' ' 95' ' ' ILE . 6.6 t-20 -117.03 89.93 31.52 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 89.8 Cg_exo -22.67 -80.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 1 C-N-CA 125.449 4.1 . . . . 0.0 115.537 -169.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.09 -27.94 27.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.77 78.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.085 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' CG1' ' H ' ' A' ' 91' ' ' ASN . 32.1 mm -72.35 -46.32 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.1 mttt -64.0 -23.15 67.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.855 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -80.53 -33.64 36.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.521 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -67.46 -52.98 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.606 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.19 -42.22 25.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.571 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.13 63.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -36.45 57.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.492 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.3 m-80 -83.76 -21.91 32.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.842 178.417 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.763 0.315 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 40' ' ' ILE . 94.0 t -85.51 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.141 0.496 . . . . 0.0 111.028 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.1 m -80.02 144.29 33.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.967 -171.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.521 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.9 tp-100 -93.3 136.79 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.168 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 8.6 m-85 -83.59 170.01 14.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.715 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 42.6 mtpt -123.55 -40.6 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.527 176.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -142.48 179.95 6.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -66.46 -25.76 66.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.652 0.263 . . . . 0.0 110.393 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -58.02 -49.99 74.96 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -55.16 -41.69 72.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.692 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 23' ' ' VAL . 27.0 t80 -61.17 -59.76 4.81 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.61 -35.81 75.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.547 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -61.5 -45.03 95.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -32.7 74.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 110.342 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.84 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.1 mm -63.54 -39.26 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 5.76 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.442 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -77.77 140.83 39.5 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.63 38.57 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.382 0.611 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -145.22 176.29 9.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.95 122.45 22.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.2 t -100.54 111.24 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.047 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.42 103.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 11' ' ' PHE . 60.1 t -104.88 119.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.867 0.842 . . . . 0.0 111.166 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.05 96.79 8.72 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.74 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.8 m-85 -99.99 113.69 26.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.471 0.653 . . . . 0.0 111.791 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -140.27 163.8 31.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.616 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -115.84 134.54 54.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.5 p -60.67 -26.13 66.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.671 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -78.58 -15.47 58.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 44.7 t -80.7 144.38 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.071 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.47 -67.63 1.9 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.274 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 66.0 Cg_endo -74.22 20.73 0.4 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.942 2.428 . . . . 0.0 114.321 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.0 p -68.02 -27.92 66.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.839 0.828 . . . . 0.0 109.556 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.6 pttt -68.25 -7.65 32.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.041 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.447 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -79.67 -35.91 38.48 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.49 -25.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.039 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.31 -61.55 6.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.809 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 88.0 Cg_endo -83.41 -30.67 0.78 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.417 1.412 . . . . 0.0 114.219 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.567 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 ttp -66.15 -50.41 64.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.67 0.668 . . . . 0.0 109.199 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -65.56 -37.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.228 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 26.6 tt0 -69.02 -27.81 66.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.2 0.524 . . . . 0.0 110.057 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -74.84 -29.05 60.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.052 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 39' ' ' MET . 18.7 m-30 -51.49 -64.0 0.95 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 110.245 175.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 60.5 p -79.27 -14.11 59.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.1 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -58.38 -35.77 72.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -83.15 -47.97 11.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.2 p90 -129.3 91.34 42.0 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.204 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.57 1.5 5.56 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.707 2.271 . . . . 0.0 111.668 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.9 tt0 -63.35 -24.05 67.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.776 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.59 154.73 18.85 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.306 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -92.47 141.6 28.34 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.026 -176.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.22 115.13 28.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.99 -172.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' THR . 97.3 m-85 -140.59 152.0 45.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.8 pttt -149.92 159.44 44.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.571 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.0 tt -158.73 150.76 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.631 0.253 . . . . 0.0 110.41 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 19.8 t0 -93.81 115.78 28.21 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.743 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -61.95 -25.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.829 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -37.31 86.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.421 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -84.94 -42.19 15.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.6 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.512 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.7 mm? -121.95 73.39 1.08 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.387 0.613 . . . . 0.0 112.12 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.86 -24.59 73.79 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.196 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 16.2 t70 -66.1 -27.63 68.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.594 0.712 . . . . 0.0 110.523 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 60' ' ' LEU . 18.4 t -75.24 -52.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.202 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.629 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.05 -20.78 10.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.8 pt20 -85.82 -31.92 22.04 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.573 0.702 . . . . 0.0 110.086 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -69.12 -27.87 65.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.573 179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.629 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.0 p30 -108.76 -8.16 15.42 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 24.6 tt0 81.04 16.82 0.53 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.057 0.848 . . . . 0.0 112.095 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.628 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -93.84 109.23 21.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.374 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -108.17 -30.4 8.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.15 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.84 162.95 17.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.266 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.439 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -151.37 145.0 17.51 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.73 0.3 . . . . 0.0 110.826 177.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -79.69 148.58 80.12 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.579 -1.842 . . . . 0.0 112.853 -1.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.2 m -133.68 142.98 48.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.68 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -112.34 125.14 53.86 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.766 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.626 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -116.91 113.56 22.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 175.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.3 mp -96.55 134.35 39.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.2 m-85 -129.43 153.16 48.21 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.597 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 21.6 tptm -134.01 119.94 19.63 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 2.2 p-10 46.63 56.7 6.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.84 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 77.7 4.43 85.13 Favored Glycine 0 CA--C 1.51 -0.232 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.495 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.4 160.73 28.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 29.0 tt0 -71.53 179.69 2.9 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -150.39 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.572 164.054 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -165.26 155.56 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.587 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.5 130.6 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.38 133.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.226 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.63 47.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 0.0 111.373 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.7 130.1 1.31 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.992 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.736 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.19 112.03 3.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' CB ' HG12 ' A' ' 95' ' ' ILE . 1.5 t-20 -116.09 89.87 26.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 56.0 Cg_exo -22.49 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.357 4.038 . . . . 0.0 115.667 -171.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 -28.82 29.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.99 74.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.799 0.333 . . . . 0.0 111.222 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.68 HG21 HD22 ' A' ' 75' ' ' LEU . 45.9 mm -83.38 -32.76 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.428 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.748 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.5 mttt -57.65 -47.44 82.26 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -60.19 -32.29 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.64 61.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.2 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.4 mm -54.0 -41.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.047 0.451 . . . . 0.0 110.647 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -25.72 63.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.204 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.96 19.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.472 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -79.91 -16.93 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.069 -172.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.223 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 46.2 ttm . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.04 0.447 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.516 ' HB ' ' HD2' ' A' ' 54' ' ' LYS . 85.5 t -81.22 136.6 22.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.747 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.7 m -83.47 143.9 29.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.208 0.527 . . . . 0.0 112.335 -172.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.2 tp-100 -94.82 132.47 39.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.645 -175.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 13.0 m-85 -93.11 160.41 14.87 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.688 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.6 ptpp? -135.9 -4.45 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.817 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 18.8 p -141.89 157.29 45.16 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 111.368 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -71.41 -29.03 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.013 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -62.92 -38.15 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.688 ' OE1' ' HG2' ' A' ' 6' ' ' LYS . 24.5 mt-10 -55.44 -44.0 75.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.441 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 23' ' ' VAL . 24.1 t80 -56.21 -56.3 22.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.39 -44.16 79.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -57.38 -38.48 74.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.82 64.3 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.87 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -65.01 -40.53 89.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.63 13.51 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.048 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -85.49 140.21 30.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -79.38 47.39 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.432 0.634 . . . . 0.0 109.984 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -154.2 178.97 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.469 177.026 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 99' ' ' ILE . 1.6 tm? -75.74 123.89 26.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.076 0.465 . . . . 0.0 110.782 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -105.36 116.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.208 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.89 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 11' ' ' PHE . 40.5 t -102.82 126.06 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.741 0.781 . . . . 0.0 111.351 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.03 97.31 7.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.762 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.4 m-85 -104.35 116.82 32.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.613 0.721 . . . . 0.0 111.953 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 p90 -135.67 173.88 11.23 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.136 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -125.41 130.74 52.47 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -63.3 -19.48 64.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -92.97 -13.07 29.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.396 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 59.8 m -75.55 159.81 30.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.312 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.32 -83.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.227 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 89.0 Cg_endo -79.37 36.02 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.094 2.529 . . . . 0.0 113.858 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 p -65.3 -36.97 85.7 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 122.04 0.924 . . . . 0.0 109.814 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.855 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 7.7 ttpm? -68.05 -11.33 58.79 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.536 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.31 70.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -74.52 -24.66 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.932 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.715 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.3 -67.52 0.53 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.824 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.855 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 3.9 Cg_endo -85.32 -23.86 2.19 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 121.457 1.556 . . . . 0.0 113.621 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.677 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.7 ttp -71.74 -44.54 63.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.35 0.595 . . . . 0.0 109.733 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.825 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.36 -36.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.241 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 tp10 -63.01 -29.81 71.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.525 174.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -74.4 -33.87 63.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.474 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.647 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 19.9 m-85 -57.24 -57.72 11.39 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 p -76.91 -14.22 59.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.932 0.396 . . . . 0.0 110.805 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.3 -35.14 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -84.51 -44.56 13.48 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.595 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.4 p90 -129.7 89.54 46.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.641 0.734 . . . . 0.0 112.042 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.2 -0.69 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.219 1.946 . . . . 0.0 112.152 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.99 -3.71 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.3 163.08 12.69 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.38 139.72 30.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.237 -177.418 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.4 p90 -122.96 114.58 20.62 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.551 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.508 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 96.9 m-85 -141.06 148.4 40.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HD2' ' HB ' ' A' ' 2' ' ' VAL . 17.4 ptmt -148.48 152.58 37.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 -172.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.4 tt -160.88 149.02 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 8.1 p-10 -100.04 129.89 46.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.474 0.654 . . . . 0.0 110.831 174.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 72' ' ' MET . 2.4 m -72.6 -11.79 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.081 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.6 -44.16 74.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -79.61 -41.53 26.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.969 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.9 mm? -122.42 79.1 1.58 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.696 0.76 . . . . 0.0 112.838 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.03 -38.83 34.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.001 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -68.46 -24.69 64.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.173 0.486 . . . . 0.0 110.619 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 8' ' ' ALA . 87.3 t -68.48 -50.0 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 174.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.99 -39.29 62.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.867 175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -70.4 -28.59 65.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.84 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.733 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 9.6 tptt -67.38 -27.87 67.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.487 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.733 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 5.3 m120 -104.54 -7.91 19.4 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 -170.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 32.9 tt0 80.88 17.4 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.469 1.105 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -93.29 106.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.627 0.727 . . . . 0.0 109.918 175.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 p -114.47 -18.38 11.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.832 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 147.06 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -135.89 143.85 46.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.17 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 67.4 Cg_endo -80.78 153.19 82.77 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.287 -1.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -135.01 143.36 46.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.887 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -115.39 128.36 56.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.333 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.84 114.13 21.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 85' ' ' ALA . 6.5 mp -94.07 126.26 39.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.086 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CG ' HD12 ' A' ' 15' ' ' ILE . 52.8 m-85 -125.32 151.95 45.37 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.579 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -136.96 112.99 9.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.048 0.451 . . . . 0.0 110.475 172.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.68 55.33 4.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.115 175.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.87 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 70.53 10.38 66.68 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.248 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -127.38 159.82 33.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 84' ' ' VAL . 26.8 tt0 -73.85 179.74 4.11 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -153.65 -30.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 165.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.01 157.95 24.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 111.557 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -147.57 121.66 9.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.416 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 95' ' ' ILE . 21.3 t -131.04 135.34 60.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 -172.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.31 49.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.925 0.393 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.25 122.63 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.686 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.35 105.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.465 ' HB3' HG12 ' A' ' 95' ' ' ILE . 1.7 t-20 -118.69 88.64 35.53 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.524 175.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.7 Cg_exo -35.45 -59.08 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.414 3.409 . . . . 0.0 115.411 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -50.09 8.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -31.93 71.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.598 HG21 HD22 ' A' ' 75' ' ' LEU . 22.2 mm -84.52 -36.05 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.569 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 8.9 tmtt? -58.44 -38.98 78.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.73 -23.64 62.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.539 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -77.53 -58.06 3.48 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG23 ' CD1' ' A' ' 20' ' ' LEU . 9.4 mt -51.7 -40.7 27.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.295 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -34.15 77.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -37.02 69.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 57.5 m-80 -84.73 -19.35 32.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.316 -175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.47 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG11 ' HG3' ' A' ' 54' ' ' LYS . 87.8 t -116.86 127.67 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 120.939 0.4 . . . . 0.0 109.942 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -76.14 138.97 41.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -82.98 126.45 32.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.076 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.725 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.5 m-30 -80.02 169.78 17.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.296 0.569 . . . . 0.0 110.605 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 70.6 mmtt -128.7 -38.3 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.41 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 30.7 p -134.98 178.9 6.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.443 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.17 -28.44 64.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.07 -44.6 83.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.166 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 4.5 mm-40 -54.34 -50.53 67.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.307 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.639 ' O ' HG12 ' A' ' 15' ' ' ILE . 12.7 t80 -58.73 -59.33 5.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.14 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 24.5 t70 -63.19 -34.4 77.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.841 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -62.88 -42.87 99.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.62 0.248 . . . . 0.0 110.441 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.74 92.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.6 mm -58.12 -38.41 67.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.022 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.68 5.32 3.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.429 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -79.34 150.54 31.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.67 0.272 . . . . 0.0 110.465 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.39 45.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 111.068 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 30.6 pttt -156.91 -179.99 8.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.4 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.0 tm? -79.22 118.81 21.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 0.0 111.265 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -112.82 109.12 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.936 176.05 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -107.76 116.94 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.697 0.761 . . . . 0.0 110.039 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.527 HG11 ' CE2' ' A' ' 11' ' ' PHE . 48.1 t -103.19 128.43 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.934 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -88.22 97.73 11.18 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.895 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.71 114.43 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -178.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 17.4 p90 -140.64 -179.56 6.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.852 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.07 130.72 46.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.088 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -66.01 -19.41 65.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.118 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -86.06 -13.35 47.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.632 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 52.0 t -90.35 148.45 22.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.587 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -80.67 -62.33 2.05 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.742 -176.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.7 Cg_exo -60.24 -7.49 6.74 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.909 2.406 . . . . 0.0 113.894 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 71.5 m -63.89 -26.87 68.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.424 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 55.3 pttt -62.77 -15.96 55.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.777 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 23.9 ttt -77.46 -27.15 51.98 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.147 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.698 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -75.73 -23.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.735 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.46 -66.57 0.88 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.24 172.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 69.0 Cg_endo -82.52 -34.14 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 CA-C-N 121.055 1.412 . . . . 0.0 114.315 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.591 ' CE ' HG13 ' A' ' 40' ' ' ILE . 2.5 tmm? -66.54 -36.72 83.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.492 0.663 . . . . 0.0 110.085 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.778 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.9 mt -81.11 -34.05 13.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -66.31 -25.33 66.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.912 171.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -78.38 -33.59 48.75 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.689 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -59.57 -47.9 83.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.827 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 97.6 p -85.25 -15.69 42.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.973 -0.454 . . . . 0.0 110.981 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.4 -29.68 70.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 13.6 tp60 -89.02 -50.17 6.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.286 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 43' ' ' PHE . 10.1 p90 -124.71 91.27 49.71 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 0.94 5.07 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.066 1.844 . . . . 0.0 111.224 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.0 tt0 -63.02 -23.37 67.42 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.918 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 17.85 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.1 m-20 -91.07 126.7 36.23 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.803 0.811 . . . . 0.0 111.005 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.541 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -103.6 114.17 28.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.282 -172.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.3 m-85 -136.05 147.58 47.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.711 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 76.4 mttt -132.71 152.08 51.81 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.956 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.751 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.8 tt -159.24 149.73 19.43 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.827 0.346 . . . . 0.0 110.711 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 9.0 t0 -101.43 119.78 39.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.954 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.7 p -69.74 -21.34 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.97 -37.16 83.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.214 0.53 . . . . 0.0 109.748 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.47 -42.99 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.342 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -115.02 80.49 1.42 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.13 -40.49 34.37 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.502 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.34 -24.77 65.75 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.116 0.484 . . . . 0.0 110.703 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.634 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 95.3 t -68.0 -51.44 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.361 174.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -46.67 -42.84 17.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.042 0.448 . . . . 0.0 111.579 174.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -73.73 -25.26 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.858 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.696 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 13.5 tptt -69.37 -25.04 63.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.686 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.696 ' ND2' ' HG3' ' A' ' 66' ' ' LYS . 5.0 m120 -108.24 -13.72 14.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.664 -171.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.3 tp10 79.79 30.99 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.26 0.975 . . . . 0.0 110.999 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.649 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -107.47 120.2 58.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.873 -0.517 . . . . 0.0 110.491 171.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -115.72 -39.49 3.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.42 164.79 13.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.322 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.45 ' CE ' HG11 ' A' ' 57' ' ' VAL . 1.1 pmm? -146.01 151.57 45.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.915 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.7 Cg_endo -78.23 149.84 87.42 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.81 -3.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.4 m -132.27 133.64 44.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.793 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -103.07 124.07 47.85 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.699 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -117.57 112.36 20.46 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.427 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.8 mp -96.41 133.09 41.25 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.699 ' CE1' HD22 ' A' ' 76' ' ' LEU . 62.0 m-85 -128.65 157.11 42.22 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.522 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -139.42 116.26 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.3 t30 65.37 50.39 1.74 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.675 0.75 . . . . 0.0 111.239 171.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.747 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.9 5.15 64.13 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.011 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -126.91 160.37 31.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 28.3 tt0 -69.53 178.89 2.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -148.67 -32.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.892 163.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.31 138.22 1.56 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.929 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.54 ' HB3' HD23 ' A' ' 76' ' ' LEU . 23.0 pttm -133.31 134.95 44.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.92 173.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -131.98 122.69 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.322 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 t -91.58 62.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 110.267 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.62 125.66 0.81 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.25 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.27 111.57 1.25 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.211 0.529 . . . . 0.0 111.491 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.7 OUTLIER -116.52 88.97 25.91 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -31.76 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.723 3.615 . . . . 0.0 115.427 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.13 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.63 61.87 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.5 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.0 mm -76.58 -49.24 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.623 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 19.5 mtpp -62.58 -26.08 68.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.444 0.64 . . . . 0.0 110.21 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -80.03 -33.13 39.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.564 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.12 -52.8 57.43 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -53.23 -39.59 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.394 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 -20.42 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.249 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.26 -43.45 17.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.981 0.42 . . . . 0.0 111.047 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -80.01 -22.63 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.822 -0.608 . . . . 0.0 111.324 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 47.0 ttm . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.008 0.432 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' HG2' ' A' ' 41' ' ' GLU . 54.9 t -100.96 136.41 32.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.596 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.9 m -80.82 144.78 31.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.22 0.533 . . . . 0.0 112.377 -170.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.6 tp-100 -94.16 136.21 34.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.932 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.696 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.3 m-85 -98.57 158.6 15.5 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 14.8 ptmm? -135.01 -1.54 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.832 169.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 33.8 p -138.57 159.75 41.31 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 111.15 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.219 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.155 173.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.696 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 27.3 mt-10 -54.06 -47.26 71.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.05 173.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.1 t80 -58.74 -59.03 6.06 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.958 0.409 . . . . 0.0 109.959 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.58 -35.22 72.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.549 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -63.51 -48.43 77.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.621 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.91 73.2 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.0 110.381 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.824 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -63.39 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.065 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.33 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.81 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -84.54 142.9 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.06 74.54 9.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.26 0.552 . . . . 0.0 110.801 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -174.62 179.22 1.77 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.9 tm? -81.2 120.75 25.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.1 t -100.59 109.8 26.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.154 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 t -92.55 103.38 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 11' ' ' PHE . 22.1 t -105.65 131.08 55.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.311 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -108.21 100.45 9.76 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.939 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -103.58 115.52 30.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.514 0.673 . . . . 0.0 111.813 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 25.8 p90 -137.76 175.96 9.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB3' ' HG3' ' A' ' 72' ' ' MET . . . -126.29 133.5 51.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -15.11 63.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.359 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.436 ' HD1' ' OD2' ' A' ' 58' ' ' ASP . 51.8 p-90 -89.11 -13.47 38.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 110.794 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.8 t -84.39 143.83 29.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.056 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.03 2.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.96 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 19.5 Cg_exo -68.98 15.81 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.447 2.765 . . . . 0.0 114.531 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.01 -29.28 69.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 122.02 0.914 . . . . 0.0 108.98 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -65.62 -8.83 22.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.21 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -37.26 39.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.11 -25.2 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.751 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.78 -66.46 1.07 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.481 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 85.6 Cg_endo -83.23 -26.85 2.08 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 120.617 1.256 . . . . 0.0 114.226 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.608 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.1 ttp -69.75 -41.95 74.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.55 0.69 . . . . 0.0 109.587 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -74.72 -39.26 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.767 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.803 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.6 mt-10 -66.59 -26.69 67.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.045 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.34 -37.74 74.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.275 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.6 m-85 -52.45 -62.32 1.72 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.257 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 m -76.77 -13.76 59.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.567 0.223 . . . . 0.0 111.301 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 35.3 tt0 -60.0 -31.93 70.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.3 -46.69 8.57 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.07 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.2 p90 -127.35 90.13 49.63 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.26 0.552 . . . . 0.0 111.941 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.34 -0.72 9.6 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.444 2.096 . . . . 0.0 112.381 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -13.5 58.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.433 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.12 151.66 21.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.99 141.44 28.62 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.668 -177.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.728 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -116.25 115.38 25.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.164 -170.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 93.8 m-85 -140.69 149.1 41.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.783 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.7 pttt -149.32 157.71 43.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.665 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 60' ' ' LEU . 7.1 tt -160.61 151.88 19.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.636 0.255 . . . . 0.0 111.344 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.7 m-20 -91.72 111.74 23.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.699 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 26' ' ' TYR . 3.4 p -66.4 -19.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD2' ' HD1' ' A' ' 29' ' ' TRP . 6.4 t70 -53.21 -43.81 67.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.596 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -94.28 -42.42 8.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.994 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.1 mm? -111.67 73.25 0.81 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.5 64.75 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.129 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 22.1 m-20 -65.82 -26.5 67.71 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.428 0.632 . . . . 0.0 110.555 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 84.7 t -71.52 -52.48 25.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.634 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.78 -34.71 65.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.75 0.31 . . . . 0.0 111.369 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -68.07 -37.85 81.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 109.441 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 17.0 tptt -60.78 -22.89 64.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.964 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 69' ' ' VAL . 9.3 m120 -106.71 -13.63 15.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 34.0 tt0 79.63 27.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 124.269 0.981 . . . . 0.0 110.854 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.47 126.92 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 170.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -126.59 -40.1 1.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.307 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.25 160.67 16.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 1.3 pmm? -143.02 151.46 56.01 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.878 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' HG12 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -78.65 148.4 83.4 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 -1.907 . . . . 0.0 113.049 -3.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -131.21 135.89 47.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.731 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 40' ' ' ILE . 4.1 mp -106.02 130.79 53.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.661 177.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.656 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.6 mt -124.58 113.69 18.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.095 0.474 . . . . 0.0 110.824 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -96.97 131.06 44.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.656 ' CE1' HD22 ' A' ' 76' ' ' LEU . 59.9 m-85 -128.26 157.1 41.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 34.5 ttpt -141.73 125.14 16.59 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.9 p30 47.08 55.5 7.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.557 1.143 . . . . 0.0 113.698 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.824 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 75.34 3.55 71.09 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.704 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.41 160.81 26.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -71.0 -179.05 2.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -152.44 -29.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.707 164.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.633 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.32 150.79 4.37 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.635 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HB3' HD23 ' A' ' 76' ' ' LEU . 14.1 ptmm? -145.31 126.63 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.255 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.67 133.46 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.949 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.28 59.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 122.287 1.042 . . . . 0.0 110.189 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 129.43 1.12 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.527 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.07 106.08 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.676 0.391 . . . . 0.0 111.957 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 89.54 37.74 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.788 175.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -35.5 -61.02 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.397 3.398 . . . . 0.0 115.161 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.3 14.42 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -172.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.08 71.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.648 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 99' ' ' ILE . 46.1 mm -87.24 -32.43 6.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.229 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 10.1 ttpp -60.13 -39.57 86.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 170.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.32 -28.91 67.58 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.653 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.02 -61.65 1.93 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.55 -34.96 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.712 0.632 . . . . 0.0 110.576 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.75 -21.62 54.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.949 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.82 -35.56 15.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.062 0.458 . . . . 0.0 110.56 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.655 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -88.07 -18.26 29.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 -176.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.662 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 1.5 pmm? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 52' ' ' PHE . 59.7 t -121.7 130.24 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.544 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.3 m -75.65 145.12 41.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.251 -170.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -94.39 138.97 31.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.2 m-85 -88.73 164.0 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.199 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.13 -14.71 2.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.758 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -147.16 174.38 11.64 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.94 -23.57 62.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 t -60.02 -47.93 83.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.555 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -53.14 -42.66 66.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.94 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.728 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.2 t80 -57.35 -58.3 8.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 8.7 m-20 -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.816 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -60.24 -44.27 95.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.578 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.29 76.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.464 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.684 HG22 ' HA2' ' A' ' 81' ' ' GLY . 9.2 mm -66.99 -39.99 84.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.56 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.17 7.52 3.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -80.73 146.35 31.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.99 40.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.28 176.33 9.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.897 -176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.7 tm? -81.13 121.9 26.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 0.0 109.828 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -100.74 122.41 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.218 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.21 102.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.728 HG11 ' CE2' ' A' ' 11' ' ' PHE . 59.2 t -104.11 119.34 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.813 0.816 . . . . 0.0 111.077 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.49 96.75 8.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.67 -177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE2' HD22 ' A' ' 55' ' ' LEU . 1.9 m-85 -100.35 124.79 46.28 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.408 0.623 . . . . 0.0 111.953 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 47.9 p90 -151.5 -178.46 6.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.992 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -128.81 137.53 51.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 111.047 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 p -68.9 -21.61 64.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -84.62 -6.61 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.089 0.471 . . . . 0.0 110.633 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 41.9 t -88.28 159.9 17.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.24 -61.72 1.02 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.081 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 28.1 Cg_exo -65.49 -1.38 4.67 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.647 . . . . 0.0 114.026 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 16.9 p -62.04 -28.34 69.52 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.103 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -8.31 24.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.557 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.4 ttt -84.04 -28.87 27.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.302 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -76.93 -24.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.249 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -56.54 -64.36 2.51 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.189 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.1 Cg_endo -82.64 -31.13 0.86 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.592 1.528 . . . . 0.0 114.427 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 1.7 ttp -68.24 -41.68 80.84 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.496 0.589 . . . . 0.0 109.679 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.827 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.72 -39.39 60.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 45.4 tt0 -62.39 -36.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 22.5 ttmm -68.77 -29.47 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.707 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 23.0 m-85 -56.84 -59.22 5.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.2 m -77.25 -14.01 59.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.627 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' LYS . 40.1 tt0 -62.26 -29.51 70.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 21.4 mt-30 -89.95 -50.68 5.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.2 p90 -125.9 90.91 49.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.254 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.02 0.89 5.17 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.831 2.354 . . . . 0.0 112.361 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 5.1 tt0 -63.46 -23.67 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.936 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.68 154.65 18.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -91.53 126.07 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.64 -173.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.7 p90 -96.57 115.76 27.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.252 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.7 m-85 -141.53 149.46 40.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.723 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.8 pttp -148.79 158.82 44.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.64 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.4 tt -159.16 150.06 19.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 110.294 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.8 t0 -98.74 120.08 38.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.758 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 27' ' ' ALA . 3.1 m -66.54 -20.6 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.453 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.75 -37.79 82.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.392 0.615 . . . . 0.0 109.521 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -42.89 24.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.674 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HB3' HG23 ' A' ' 63' ' ' VAL . 93.7 mt -131.07 75.26 1.65 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.586 0.708 . . . . 0.0 112.17 -175.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -70.25 -29.05 70.61 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.792 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.3 -29.33 70.07 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.535 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 60' ' ' LEU . 22.0 t -69.57 -51.06 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.63 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.09 -20.11 9.04 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.569 0.543 . . . . 0.0 112.307 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 77.6 mm-40 -85.35 -33.75 21.97 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 0.0 110.822 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 11.1 tptt -68.31 -36.2 78.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 110.644 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.63 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.3 p30 -96.48 -13.23 23.22 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.7 mt-10 78.69 17.86 0.99 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.927 174.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.38 108.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 109.462 172.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -109.59 -19.65 13.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.002 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.97 149.52 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.53 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -133.61 133.88 23.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.116 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HB2' HG12 ' A' ' 36' ' ' ILE . 73.3 Cg_endo -82.33 153.97 76.63 Favored 'Cis proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.301 -1.541 . . . . 0.0 113.802 -0.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -137.45 142.44 41.59 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.183 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 95' ' ' ILE . 4.4 mp -109.8 126.05 53.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.693 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -117.01 113.72 22.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.052 0.453 . . . . 0.0 111.039 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.6 mp -96.84 134.96 39.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.282 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 76' ' ' LEU . 49.8 m-85 -132.04 151.08 51.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 15.9 mtpp -128.18 108.0 10.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.986 0.179 . . . . 0.0 110.743 170.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 58.2 53.8 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.682 0.753 . . . . 0.0 111.852 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.77 -6.0 79.9 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.832 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 64.7 pttt -121.45 160.74 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.7 tt0 -67.98 179.45 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -152.15 -29.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.635 163.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -160.23 155.26 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.085 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -155.17 113.69 3.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.669 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 95' ' ' ILE . 22.0 t -127.65 135.25 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.629 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.2 m -102.12 43.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.29 123.91 0.88 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.323 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -57.77 104.45 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' O ' HG12 ' A' ' 95' ' ' ILE . 1.8 t-20 -116.48 89.2 26.46 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.72 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.5 Cg_exo -31.23 -76.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.474 3.449 . . . . 0.0 115.079 -172.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.92 -41.08 68.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.12 -29.91 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.455 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.7 mm -87.55 -31.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.808 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 64.6 mttm -54.6 -44.37 72.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -65.42 -32.87 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.883 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.17 -57.82 6.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.4 mm -54.03 -35.12 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.679 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.81 -29.74 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.273 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.64 -40.89 61.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 111.011 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 46.0 m-80 -82.98 -16.28 47.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.029 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.548 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.852 0.358 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 40' ' ' ILE . 88.3 t -81.24 125.56 39.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.425 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.505 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.2 m -72.36 144.8 48.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.186 -170.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -97.3 125.07 41.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.809 -174.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.4 m-85 -75.15 170.44 16.04 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 10' ' ' GLU . 59.9 pttt -133.93 -21.62 1.89 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.288 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 178.8 9.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.365 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -70.23 -29.08 65.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.792 0.329 . . . . 0.0 110.781 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -54.56 -48.12 72.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.839 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.571 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 6.0 mp0 -55.38 -46.85 76.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.55 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.685 ' O ' HG12 ' A' ' 15' ' ' ILE . 30.9 t80 -56.45 -59.51 4.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.811 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.0 -36.78 77.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.663 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.6 m -61.79 -45.7 92.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.655 0.264 . . . . 0.0 110.991 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -34.12 77.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.877 0.37 . . . . 0.0 110.322 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.773 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.94 -40.51 87.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.312 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.41 2.16 14.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.481 -173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 63.2 tt0 -76.51 144.49 39.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.882 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 57.2 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 8.8 ptmm? -168.73 176.53 5.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.005 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.15 115.18 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.213 0.53 . . . . 0.0 110.895 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.4 t -101.22 135.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.982 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.59 115.97 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 11' ' ' PHE . 33.6 t -107.52 131.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.577 0.703 . . . . 0.0 110.9 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.88 96.6 6.94 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.469 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CD1' HG11 ' A' ' 69' ' ' VAL . 26.7 m-85 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.667 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.659 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.9 p90 -163.24 179.17 7.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.727 169.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -127.61 128.74 46.05 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 p -65.05 -18.67 65.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -88.96 -10.59 47.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.417 . . . . 0.0 110.713 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 49.7 t -97.64 148.88 22.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.831 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.22 2.86 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.411 -0.66 . . . . 0.0 114.655 -173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.3 Cg_exo -59.49 -2.56 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.17 2.58 . . . . 0.0 114.044 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 26' ' ' TYR . 69.5 m -63.19 -24.44 67.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.27 0.557 . . . . 0.0 110.929 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 57.0 mtpt -65.63 -9.36 26.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.765 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.414 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.03 -35.49 49.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 109.354 176.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -75.29 -25.82 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.408 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.13 -66.2 0.88 Allowed Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.923 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 76.4 Cg_endo -83.44 -32.72 0.45 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.319 1.346 . . . . 0.0 114.479 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.5 tmm? -69.86 -38.08 76.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.412 0.625 . . . . 0.0 109.85 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.84 -33.64 14.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.804 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 41.1 tt0 -67.87 -23.23 65.11 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.156 172.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 49.4 tptt -78.64 -37.27 42.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.584 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.1 p90 -59.05 -49.63 77.14 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.572 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 94.1 p -85.13 -14.5 46.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.673 -175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 5.5 tp10 -59.59 -33.69 71.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.02 -47.62 8.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.419 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 9.4 p90 -126.69 90.89 48.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.469 0.652 . . . . 0.0 112.489 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.05 -0.34 8.94 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.357 2.038 . . . . 0.0 112.182 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.37 29.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.225 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.47 155.58 17.98 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 5.8 m-20 -91.08 120.55 32.13 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.719 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -100.66 115.27 29.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.979 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.505 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 95.9 m-85 -139.92 141.46 36.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.088 0.471 . . . . 0.0 111.324 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 76.2 mttt -122.21 155.05 36.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.006 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 63' ' ' VAL . 8.4 tt -159.5 142.04 13.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.23 130.79 52.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.308 0.575 . . . . 0.0 111.196 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.9 m -69.42 -16.11 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.256 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.35 -41.56 84.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.216 0.532 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.46 -42.72 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.899 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -121.4 77.71 1.36 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.165 0.507 . . . . 0.0 112.282 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.06 35.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.327 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.05 -32.58 74.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 110.295 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.492 HG11 HD13 ' A' ' 55' ' ' LEU . 86.5 t -64.53 -52.16 58.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.119 176.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.48 -38.84 46.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.024 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 89.8 mm-40 -70.68 -33.5 71.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HG3' ' ND2' ' A' ' 67' ' ' ASN . 10.4 tptt -62.04 -28.45 69.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 175.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.834 ' HB2' HG12 ' A' ' 69' ' ' VAL . 6.0 m120 -100.55 -12.53 19.19 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.004 -169.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.4 tp10 79.82 26.42 0.36 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.298 0.999 . . . . 0.0 110.225 -177.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -106.61 118.23 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.425 0.631 . . . . 0.0 111.412 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.5 m -131.25 11.92 5.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.426 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.94 30.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' HG21 ' A' ' 57' ' ' VAL . 14.8 mmt -127.19 117.98 21.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.583 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.7 Cg_endo -89.52 175.21 22.44 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.561 -1.016 . . . . 0.0 111.702 -4.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 48.0 m -147.55 146.48 29.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 mp -120.88 139.64 52.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 2.3 mt -125.77 120.33 30.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.5 mp -97.96 129.26 44.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.511 ' CD2' HD12 ' A' ' 15' ' ' ILE . 35.1 m-85 -128.13 146.66 50.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -121.52 110.9 16.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.329 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p30 46.1 56.35 6.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.773 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.1 6.28 89.24 Favored Glycine 0 CA--C 1.511 -0.211 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.646 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.93 153.61 42.42 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 178.35 2.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -150.23 -32.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.437 164.313 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -161.98 150.97 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -145.11 129.2 17.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.55 126.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.638 0.256 . . . . 0.0 110.525 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -96.21 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.32 0.581 . . . . 0.0 111.177 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.64 140.15 2.8 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.571 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -70.08 108.88 4.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.057 0.456 . . . . 0.0 110.896 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 6.1 t-20 -117.23 89.04 29.71 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.261 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -28.92 -72.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.829 3.686 . . . . 0.0 115.321 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -43.34 56.86 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.667 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -61.09 -33.21 72.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.434 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.9 mm -74.78 -49.64 28.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.999 0.428 . . . . 0.0 110.211 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 18.1 mtpp -67.18 -24.2 65.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.387 0.613 . . . . 0.0 110.63 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.92 -31.97 51.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.099 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.49 -54.3 30.28 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.212 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -53.56 -36.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.14 60.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.227 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.61 -40.46 20.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.453 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' HD23 ' A' ' 77' ' ' LEU . 45.9 m-80 -83.51 -11.63 57.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.278 -175.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.699 177.26 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 ttm . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.665 HG23 ' HG2' ' A' ' 41' ' ' GLU . 69.8 t -90.88 131.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.947 0.403 . . . . 0.0 111.251 -175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -79.08 144.1 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.295 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.515 ' OE1' ' HG3' ' A' ' 54' ' ' LYS . 8.7 tp60 -91.87 131.24 37.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.974 -178.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -80.11 167.38 20.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.053 0.454 . . . . 0.0 110.847 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.45 -39.74 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -144.47 -179.94 6.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.011 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.8 67.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.902 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 t -57.81 -49.91 75.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.0 mp0 -51.17 -46.53 62.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.579 173.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.3 t80 -58.19 -58.31 9.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 -178.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.94 -36.48 84.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.732 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.5 m -65.49 -30.94 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 111.104 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.45 -35.45 58.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.091 0.472 . . . . 0.0 109.874 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.848 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.4 mm -62.72 -39.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.478 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.46 3.39 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.424 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.402 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 99.0 mt-30 -77.01 141.62 40.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.083 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.2 31.96 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.533 0.682 . . . . 0.0 111.254 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.18 179.36 6.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.549 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.7 tm? -76.01 117.13 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.631 -174.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.5 t -103.02 119.14 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.748 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 13.9 t -106.91 112.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 11' ' ' PHE . 23.8 t -106.57 122.17 60.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.807 0.813 . . . . 0.0 110.83 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.22 97.39 11.1 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.935 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.712 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.5 m-85 -96.66 124.33 40.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.697 0.761 . . . . 0.0 112.631 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -154.79 165.47 36.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.141 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -118.01 140.5 49.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.181 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 p -65.39 -19.64 66.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.663 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -80.87 -18.54 46.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.364 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 46.3 t -83.37 141.92 31.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.056 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -75.54 -55.32 5.09 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.611 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 33.4 Cg_endo -65.75 4.73 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 114.196 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 21.7 p -64.01 -29.85 70.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.691 0.757 . . . . 0.0 109.646 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -68.84 -9.21 50.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.403 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -35.12 39.36 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.0 -25.72 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.26 -65.74 1.16 Allowed Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.859 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 64.9 Cg_endo -83.03 -29.58 1.19 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.696 1.284 . . . . 0.0 114.092 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.482 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.7 tmm? -71.41 -33.4 69.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.596 0.712 . . . . 0.0 109.851 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -84.26 -34.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.973 -179.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.665 ' HG2' HG23 ' A' ' 2' ' ' VAL . 39.6 mt-10 -68.64 -20.09 64.45 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.534 171.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -76.58 -39.07 53.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.738 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.5 p90 -57.5 -47.0 83.1 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.321 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 89.7 p -84.59 -15.41 45.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.977 -0.452 . . . . 0.0 110.655 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.59 -29.15 69.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.569 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.99 -42.32 13.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.0 175.355 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 8.4 p90 -138.53 91.61 12.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 112.21 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.57 1.09 4.61 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.469 2.113 . . . . 0.0 111.744 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.2 tt0 -63.89 -22.77 67.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.332 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.16 159.99 14.67 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.1 m-20 -91.02 125.89 35.95 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.477 0.656 . . . . 0.0 111.232 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.66 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -104.4 114.68 29.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.049 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.4 m-85 -142.49 151.14 41.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 64.6 pttt -149.59 159.07 44.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.36 -175.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.8 tt -155.71 151.96 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.907 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 29.0 t0 -95.56 113.33 24.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.809 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 41.0 t -62.44 -27.12 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.183 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -66.27 -32.5 73.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 110.166 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.44 -41.97 11.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.4 mm? -118.44 65.88 0.76 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.364 0.602 . . . . 0.0 111.555 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -67.75 -31.72 76.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.625 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.12 -22.07 63.99 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 25.2 t -72.96 -50.98 28.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.701 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.82 -21.44 4.2 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 86.6 mt-30 -86.17 -28.97 23.6 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.858 -0.527 . . . . 0.0 110.801 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -70.17 -29.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.905 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 2.3 p30 -108.58 -12.55 14.97 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.023 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.2 tp10 79.23 30.1 0.32 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.052 0.845 . . . . 0.0 111.216 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.701 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -106.48 107.69 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.366 0.603 . . . . 0.0 110.611 169.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -111.35 -35.92 5.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.32 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.2 152.49 29.13 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 27' ' ' ALA . 19.7 ptp -144.49 147.32 35.99 Favored Pre-proline 0 C--N 1.321 -0.667 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.547 -174.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG12 ' A' ' 36' ' ' ILE . 59.9 Cg_endo -80.65 149.6 78.23 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.599 -1.834 . . . . 0.0 112.518 -3.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 3.3 m -133.06 133.18 42.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.295 0.569 . . . . 0.0 111.109 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.2 mp -98.79 125.77 44.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.53 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.2 mt -114.27 113.74 25.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.118 0.485 . . . . 0.0 110.473 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.1 mp -95.54 127.88 41.94 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 76' ' ' LEU . 61.4 m-85 -127.17 154.61 44.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.804 -0.18 . . . . 0.0 110.653 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -139.23 127.06 22.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 50.22 49.24 20.88 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.494 1.117 . . . . 0.0 113.453 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.848 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.46 1.09 81.2 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.238 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -118.27 160.14 22.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.19 179.69 2.74 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -151.73 -29.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 164.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.59 160.32 5.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.229 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 21.5 ptmt -153.18 134.22 14.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.029 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.04 120.87 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.646 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 62.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 122.209 1.004 . . . . 0.0 110.199 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.27 130.75 1.28 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.306 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -72.72 98.28 2.35 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.667 0.27 . . . . 0.0 110.87 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.4 OUTLIER -116.4 88.48 23.73 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.285 -179.03 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.26 -58.93 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.344 3.363 . . . . 0.0 114.903 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.56 -46.51 38.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.87 -27.57 65.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.481 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 99' ' ' ILE . 34.3 mm -76.6 -45.2 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.572 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 72.8 tttt -60.98 -28.49 69.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.404 0.621 . . . . 0.0 110.642 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -84.35 -27.3 27.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.553 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.64 -56.65 5.97 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -51.82 -41.22 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.416 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.3 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.127 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.21 60.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -80.79 -21.22 41.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.386 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.073 179.518 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' PHE . 91.2 t -79.55 127.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.348 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.599 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 14.9 m -71.03 144.35 50.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.68 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -91.51 119.57 31.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.136 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 2.2 m-30 -76.09 167.48 21.79 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.496 173.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -129.61 -40.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -142.77 179.55 6.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.558 0.218 . . . . 0.0 111.405 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -65.99 -29.81 70.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.623 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -58.13 -46.02 86.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -54.45 -43.63 71.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 172.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.614 ' O ' HG12 ' A' ' 15' ' ' ILE . 26.9 t80 -58.28 -58.72 7.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 110.495 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.606 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 47.9 m-20 -60.0 -33.91 72.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.027 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.1 m -63.48 -41.72 98.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.689 0.281 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.08 -36.73 82.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.014 0.435 . . . . 0.0 110.154 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.768 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.3 mm -63.6 -39.71 86.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.662 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.21 12.84 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.44 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.72 146.41 25.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.051 0.453 . . . . 0.0 111.082 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.6 32.27 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.723 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 7.0 ptmm? -150.63 168.94 22.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.5 tm? -72.44 118.56 15.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.185 0.517 . . . . 0.0 110.959 -171.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.1 t -100.74 120.56 50.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.892 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 18.8 t -109.61 106.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.567 HG11 ' CE2' ' A' ' 11' ' ' PHE . 15.4 t -103.0 123.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.801 0.81 . . . . 0.0 110.986 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.39 96.86 10.75 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.049 -175.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.721 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.52 106.87 17.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.58 0.705 . . . . 0.0 112.004 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 40.2 p90 -128.77 -173.61 3.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.634 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -132.66 130.69 40.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 p -66.47 -21.82 66.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -84.45 -9.76 58.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.718 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.665 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.8 t -93.42 147.31 23.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.155 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.97 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.648 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.665 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.2 Cg_exo -67.23 4.62 1.14 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.096 2.531 . . . . 0.0 114.356 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 29.7 p -62.94 -32.19 73.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.028 0.918 . . . . 0.0 109.361 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -70.76 -8.98 56.28 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.968 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.6 ttt -82.76 -28.69 30.22 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 40' ' ' ILE . 1.3 mp -75.31 -25.03 17.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.594 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.92 -65.89 1.07 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.399 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 91.7 Cg_endo -83.16 -30.71 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.264 1.31 . . . . 0.0 114.521 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -68.4 -39.48 81.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -77.42 -36.37 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.565 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.68 -20.73 65.33 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.116 -0.633 . . . . 0.0 109.563 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 22.8 ttmm -83.32 -32.67 26.17 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.277 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.2 p90 -57.51 -46.37 83.87 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.265 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 93.5 p -84.8 -15.64 44.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.506 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 38.9 tt0 -56.48 -32.72 65.27 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.24 -50.43 6.6 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.837 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.597 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.8 p90 -127.78 90.67 47.34 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.166 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.61 -0.68 7.99 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.483 2.122 . . . . 0.0 112.29 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.47 -18.05 65.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.492 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.45 157.62 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 7.6 m-20 -91.75 128.12 37.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.584 0.707 . . . . 0.0 111.473 -173.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.559 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.3 p90 -106.96 114.7 28.94 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.87 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.599 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.41 146.53 40.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.196 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 42.2 mtpt -131.2 148.81 52.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.886 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.7 tt -160.7 148.12 15.78 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.1 p-10 -105.6 131.59 52.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.383 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.5 m -69.29 -12.69 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.146 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.54 -46.05 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.184 0.516 . . . . 0.0 109.794 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.51 -41.72 17.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.43 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -122.68 75.11 1.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.433 0.635 . . . . 0.0 112.129 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.62 -34.18 54.32 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.358 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.65 -28.41 69.6 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.332 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 8' ' ' ALA . 57.8 t -70.86 -50.19 45.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.67 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.61 -40.41 52.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.059 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 91.1 mt-30 -69.17 -35.58 76.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.313 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HE3' ' OD2' ' A' ' 12' ' ' ASP . 14.4 tptp -62.57 -25.54 68.12 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.305 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.651 ' HB2' HG12 ' A' ' 69' ' ' VAL . 3.6 m120 -105.9 -9.98 16.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.233 -171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 37.4 mt-10 80.51 27.31 0.26 Allowed 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.455 1.097 . . . . 0.0 111.217 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -105.2 115.35 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 110.256 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.6 p -115.95 -23.38 8.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.166 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.84 166.24 12.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.179 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -149.63 140.88 14.5 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.015 0.436 . . . . 0.0 111.359 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 57.7 Cg_endo -80.27 151.56 82.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.475 -1.885 . . . . 0.0 113.194 -4.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -129.58 139.14 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.63 126.54 54.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.358 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -115.62 115.35 26.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.04 0.447 . . . . 0.0 110.69 176.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -96.96 131.2 43.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.099 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.3 m-85 -130.45 148.69 52.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.619 0.247 . . . . 0.0 111.229 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -127.0 108.59 11.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.619 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.9 t30 60.41 55.51 3.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 111.633 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.768 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.04 6.45 64.31 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.497 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -121.8 157.86 30.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' VAL . 33.9 tt0 -73.27 179.09 4.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -151.83 -32.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 165.001 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.78 152.54 3.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 111.722 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 134.18 30.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.909 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.1 t -131.75 123.78 52.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.12 53.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.2 0.524 . . . . 0.0 111.497 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.93 136.01 1.94 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.625 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -66.88 107.54 2.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.12 0.486 . . . . 0.0 110.964 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 7.3 t-20 -111.51 88.38 9.15 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.3 Cg_exo -31.43 -74.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 124.477 3.451 . . . . 0.0 115.319 -169.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -38.09 68.53 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.235 -0.291 . . . . 0.0 111.626 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.18 -31.3 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.383 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 99' ' ' ILE . 33.3 mm -76.41 -49.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 110.265 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 47.0 mtmt -64.37 -22.94 67.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.486 0.66 . . . . 0.0 110.152 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -80.89 -37.05 30.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.66 171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.93 -61.34 2.71 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.5 mm -47.93 -38.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.068 0.855 . . . . 0.0 110.671 -176.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.95 -22.24 59.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.615 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.5 -28.97 18.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.156 0.503 . . . . 0.0 110.443 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.628 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -95.73 -10.34 29.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.027 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.736 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 52' ' ' PHE . 71.5 t . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 14.4 m -72.71 145.0 47.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.653 0.739 . . . . 0.0 112.68 -168.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.48 139.47 30.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.237 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.546 ' HB2' HD12 ' A' ' 55' ' ' LEU . 5.9 m-85 -85.11 170.54 12.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.772 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 54.1 mttm -121.62 -39.24 2.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -148.56 -179.07 6.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.55 -27.92 69.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 m -60.01 -45.37 93.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.2 mp0 -57.99 -42.69 85.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.52 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' O ' HG12 ' A' ' 15' ' ' ILE . 13.5 t80 -60.4 -54.63 43.26 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.51 -39.12 79.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.684 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -61.65 -47.07 87.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.706 0.288 . . . . 0.0 110.565 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -63.76 -31.71 72.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.471 . . . . 0.0 110.379 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.696 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.4 mm -65.21 -40.37 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.38 2.21 9.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.297 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 25.9 mt-30 -73.95 139.62 45.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.711 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.33 40.46 0.56 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.315 0.578 . . . . 0.0 110.823 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 2.3 pttp -153.54 163.11 40.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.884 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.9 tm? -69.54 113.82 7.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.029 0.442 . . . . 0.0 110.995 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 4.4 p -110.01 118.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.957 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.605 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -110.23 119.66 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 109.85 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.498 HG11 ' CE2' ' A' ' 11' ' ' PHE . 58.0 t -102.59 127.41 56.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.243 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -87.86 97.01 10.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.443 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -107.15 110.36 22.43 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.092 0.472 . . . . 0.0 110.818 -176.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 26.3 p90 -145.31 -171.54 3.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.092 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -136.25 136.69 40.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -61.02 -24.12 65.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -88.69 -10.44 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.275 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 72' ' ' MET . 44.2 t -77.44 158.39 30.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.034 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.1 -76.57 0.6 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.217 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 6.3 Cg_exo -74.39 14.77 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.187 2.591 . . . . 0.0 113.757 -173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 27.4 p -59.92 -34.95 73.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.882 0.848 . . . . 0.0 109.916 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -70.29 -8.0 46.87 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.423 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.586 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.1 ttt -84.44 -28.99 26.47 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.098 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -77.5 -25.73 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.32 -64.98 1.46 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 94.8 Cg_endo -82.46 -30.55 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 121.192 1.261 . . . . 0.0 114.133 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.545 ' CE ' HD21 ' A' ' 75' ' ' LEU . 1.5 ttp -67.44 -42.8 82.53 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 118.508 0.595 . . . . 0.0 109.905 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.31 -37.35 51.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.432 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.9 -38.52 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.658 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 56.8 mttp -65.36 -31.37 72.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.107 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.9 m-30 -55.65 -62.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.703 0.287 . . . . 0.0 110.268 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -73.84 -14.05 61.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.678 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 tt0 -60.32 -33.4 72.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.494 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.4 -47.96 8.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 175.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.518 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.2 p90 -128.68 86.4 57.68 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.158 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 -0.68 8.95 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.475 2.116 . . . . 0.0 112.252 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -67.47 -13.35 61.96 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.17 17.27 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.453 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.2 m-20 -91.8 126.42 36.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.254 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -102.27 114.16 28.07 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.493 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 98.6 m-85 -139.89 152.65 46.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.06 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.7 pttp -148.98 153.46 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.849 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.824 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 8.0 tt -159.14 146.44 17.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.1 m-20 -99.68 125.23 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -65.21 -22.72 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.07 -35.65 73.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.454 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.67 -43.53 11.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.964 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 55' ' ' LEU . 46.0 mt -131.77 89.98 2.77 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.559 0.695 . . . . 0.0 112.445 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.06 -33.78 39.78 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.246 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.53 -30.13 68.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.151 0.501 . . . . 0.0 110.03 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.678 HG12 HD21 ' A' ' 67' ' ' ASN . 89.2 t -62.89 -50.23 80.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 69' ' ' VAL . . . -46.76 -42.42 16.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.191 0.519 . . . . 0.0 111.406 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.04 -34.72 69.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.631 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 16.0 tptt -61.1 -26.44 67.66 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.711 ' HB2' HG12 ' A' ' 69' ' ' VAL . 9.1 m-20 -105.09 -10.89 16.87 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.187 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 43.1 mt-10 80.17 26.68 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.391 1.057 . . . . 0.0 111.271 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -104.72 110.71 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.687 0.756 . . . . 0.0 111.241 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -114.0 -34.66 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.54 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.65 159.65 26.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.872 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.446 ' HG3' ' SG ' ' A' ' 30' ' ' CYS . 20.3 ptp -151.17 140.84 14.06 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.906 0.384 . . . . 0.0 110.958 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.2 Cg_endo -80.83 150.47 79.1 Favored 'Cis proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.726 -1.781 . . . . 0.0 113.154 -2.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -120.79 145.93 47.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.229 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 95' ' ' ILE . 3.6 mp -120.76 123.47 42.75 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 78' ' ' PHE . 7.1 mt -122.5 112.72 18.37 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.841 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.605 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 4.0 mp -94.46 134.8 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HB3' HG23 ' A' ' 15' ' ' ILE . 52.0 m-85 -133.45 156.73 47.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.406 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.42 122.75 19.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.47 167.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 t30 60.78 41.49 14.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.661 0.743 . . . . 0.0 111.352 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 86.16 -4.32 86.12 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.272 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -121.86 161.61 22.45 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 25.1 tt0 -66.92 178.75 1.28 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.59 -28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.047 162.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -154.81 146.39 23.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 112.073 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -135.14 115.33 13.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.665 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 95' ' ' ILE . 12.3 t -131.06 141.54 45.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -121.62 48.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.152 0.501 . . . . 0.0 110.743 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.35 129.2 1.18 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.309 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -62.63 108.21 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.122 0.487 . . . . 0.0 112.114 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.98 90.32 32.55 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -33.07 -63.15 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.659 3.573 . . . . 0.0 115.074 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 -46.02 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.969 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 75' ' ' LEU . 29.5 mm -87.36 -34.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.271 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.518 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 31.9 tttt -59.83 -37.87 80.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.595 0.712 . . . . 0.0 109.121 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.75 -30.27 69.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.466 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -56.59 8.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.441 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -51.07 -41.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.223 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.74 70.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.36 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -78.98 -21.04 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.979 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.787 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 52' ' ' PHE . 96.1 t . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.6 m -83.04 139.18 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 112.447 -170.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 55' ' ' LEU . 8.4 tp-100 -90.56 138.91 31.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.097 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.694 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 16.0 m-85 -95.69 161.4 14.05 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.622 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.8 ptpp? -134.37 -3.72 2.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.315 170.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.9 p -141.94 158.86 43.27 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.939 0.399 . . . . 0.0 111.322 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.21 -27.94 63.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.097 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -57.61 -46.4 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.344 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.694 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.1 mt-10 -55.41 -43.27 75.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.984 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.8 t80 -60.55 -58.41 8.6 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.36 -37.39 80.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.259 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -59.41 -43.22 93.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.892 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.02 -33.73 74.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.475 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.808 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.2 mm -63.01 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.279 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.93 -1.3 16.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.693 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.454 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 8.3 tt0 -72.31 141.32 48.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.791 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.32 48.16 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.501 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 5.3 ptpp? -157.9 -179.88 8.55 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -73.8 123.11 23.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 109.885 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -102.2 117.9 48.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.231 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -97.06 103.0 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 11' ' ' PHE . 38.4 t -105.34 124.17 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.973 0.892 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.806 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.17 96.76 7.2 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.733 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -101.0 128.62 46.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.778 0.799 . . . . 0.0 111.908 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 25.7 p90 -152.95 178.47 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.113 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.5 138.92 51.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.738 0.304 . . . . 0.0 110.277 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 p -66.19 -18.87 65.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.473 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -86.44 -10.75 53.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.59 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 39.4 t -84.16 152.75 24.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.597 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.59 -61.87 1.67 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.953 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.35 3.28 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.094 2.529 . . . . 0.0 113.872 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 29.0 p -60.43 -32.42 71.35 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.6 tptm -68.2 -11.88 60.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.801 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.0 ttt -79.43 -28.11 41.71 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -76.21 -22.73 15.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.616 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.57 -68.25 0.49 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.474 172.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.9 Cg_endo -84.11 -32.04 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 CA-C-N 120.941 1.372 . . . . 0.0 114.43 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.554 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.97 -48.55 73.61 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.374 0.534 . . . . 0.0 109.71 -176.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.806 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -68.19 -37.9 78.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.045 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.14 -26.52 67.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 109.499 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 50.2 tptt -77.13 -30.85 55.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.948 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.671 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 18.1 m-30 -52.65 -64.55 0.78 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.012 0.434 . . . . 0.0 109.872 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.4 m -80.03 -13.2 59.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.216 -173.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.0 -35.99 80.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.15 -39.39 14.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.212 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 10.4 p90 -131.77 90.87 35.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 111.937 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 1.87 6.12 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.792 2.328 . . . . 0.0 112.652 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.31 -23.25 67.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.542 . . . . 0.0 111.257 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.4 157.95 16.42 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.04 138.42 31.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.358 0.599 . . . . 0.0 111.23 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -110.78 115.91 30.37 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.234 -171.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.492 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 92.1 m-85 -138.89 154.25 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 111.843 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HG3' HG11 ' A' ' 2' ' ' VAL . 53.1 mttm -140.93 155.86 46.19 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.99 0.916 . . . . 0.0 109.972 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.03 147.49 16.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.937 0.398 . . . . 0.0 111.024 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.3 t0 -96.7 118.85 34.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.015 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 26' ' ' TYR . 21.7 t -66.12 -28.57 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.172 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.46 -25.47 65.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.93 -42.06 9.27 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.309 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -122.45 76.18 1.31 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.272 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.41 -40.72 91.47 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.027 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.78 -31.56 71.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.907 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.604 HG12 HD21 ' A' ' 67' ' ' ASN . 85.3 t -61.73 -52.55 59.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.132 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.33 -39.33 56.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 111.075 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.71 -33.14 72.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.417 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -22.12 66.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.969 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.624 ' HB2' HG12 ' A' ' 69' ' ' VAL . 8.9 m-20 -109.79 -11.54 14.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 -173.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 80.28 27.28 0.29 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.439 1.087 . . . . 0.0 111.381 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.624 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -106.36 126.11 62.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.957 0.408 . . . . 0.0 110.375 173.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -139.85 5.52 2.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.08 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.48 ' HG2' ' CB ' ' A' ' 27' ' ' ALA . 2.4 mpt? -124.31 121.39 26.05 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.032 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 36' ' ' ILE . 40.3 Cg_endo -90.5 162.53 32.46 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.983 -1.257 . . . . 0.0 113.162 -1.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 m -136.89 131.93 33.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.325 0.583 . . . . 0.0 111.176 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -101.93 125.25 48.57 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.47 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.664 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.1 mt -118.61 113.2 20.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.149 0.5 . . . . 0.0 110.437 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -97.19 133.32 41.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.664 ' CE1' HD22 ' A' ' 76' ' ' LEU . 55.1 m-85 -130.67 158.2 40.7 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.578 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -140.93 125.26 17.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 48.09 51.85 14.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.131 0.972 . . . . 0.0 113.508 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.808 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 76.67 3.19 78.46 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.653 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -119.03 160.93 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.4 tt0 -71.23 -179.31 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.51 -34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 164.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.85 149.96 5.57 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.569 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.61 ' HB3' HD23 ' A' ' 76' ' ' LEU . 17.8 pttm -144.54 131.36 20.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.439 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.87 123.76 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.09 55.85 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.244 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.11 128.28 0.94 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -61.11 115.98 4.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.444 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.92 90.33 32.3 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.8 Cg_exo -25.13 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 125.256 3.971 . . . . 0.0 115.68 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.96 -28.42 35.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.15 -0.344 . . . . 0.0 111.833 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.1 83.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 75' ' ' LEU . 41.0 mm -82.54 -31.0 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.818 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 33.4 mtmt -61.2 -40.07 92.55 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -64.7 -30.29 71.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.16 173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -52.54 45.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 99' ' ' ILE . 4.2 mm -51.96 -41.09 30.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.56 -31.46 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.286 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.72 66.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.605 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -86.25 -20.79 27.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.59 177.283 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' HG2' ' A' ' 41' ' ' GLU . 74.5 t . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.554 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.0 m -81.77 145.54 30.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.086 -172.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -92.37 124.62 36.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 9.0 m-85 -84.58 157.31 21.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 21.6 pttm -135.16 -3.27 2.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.239 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -140.83 164.9 28.98 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.153 0.501 . . . . 0.0 111.792 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -76.47 -31.85 58.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.284 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 m -59.28 -42.94 92.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.656 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.614 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 24.2 mt-10 -53.66 -45.61 70.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 23' ' ' VAL . 12.3 t80 -56.84 -59.49 4.96 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.244 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 62.1 m-20 -60.72 -27.83 68.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.766 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -64.42 -44.59 90.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.051 0.453 . . . . 0.0 110.055 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -69.15 -20.2 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.887 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.799 HG22 ' HA2' ' A' ' 81' ' ' GLY . 17.9 mm -77.9 -38.35 24.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.109 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.59 14.59 2.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -99.18 163.37 12.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.955 0.407 . . . . 0.0 111.05 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.62 36.47 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.075 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.5 173.67 12.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.921 0.391 . . . . 0.0 110.916 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.5 tm? -79.37 126.12 30.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.331 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG21 ' HB1' ' A' ' 14' ' ' ALA . 7.7 p -111.68 128.23 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.35 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.38 102.96 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 11' ' ' PHE . 41.6 t -96.98 129.61 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.595 0.712 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.663 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -111.62 97.46 6.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.131 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.719 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.4 m-85 -103.23 137.24 41.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.571 0.7 . . . . 0.0 112.058 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 22.6 p90 -156.48 -171.37 3.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.688 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.63 135.1 32.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 p -69.3 -19.47 63.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.981 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -84.14 -14.77 49.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.01 0.434 . . . . 0.0 110.319 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 49.7 t -88.7 141.73 28.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.855 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.03 -60.85 5.31 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.83 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 41.1 Cg_endo -67.55 8.86 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.117 2.545 . . . . 0.0 114.766 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -60.52 -30.49 69.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.81 0.814 . . . . 0.0 109.958 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.68 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 19.7 ptmt -67.25 -9.6 42.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.646 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -81.24 -34.57 32.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -75.68 -24.66 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.674 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.04 -65.89 1.5 Allowed Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.978 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.5 Cg_endo -84.32 -30.58 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.692 1.594 . . . . 0.0 113.545 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -67.26 -39.74 86.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 109.804 -176.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -75.07 -39.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.137 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 2' ' ' VAL . 33.0 mt-10 -63.13 -32.02 73.31 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 173.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 39' ' ' MET . 27.3 ttpp -64.41 -41.06 96.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.284 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.1 m-85 -53.65 -63.23 1.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.949 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -76.4 -13.54 60.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.278 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.42 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.03 -41.07 13.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.29 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.6 p90 -133.8 90.81 26.56 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.28 0.562 . . . . 0.0 112.179 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.81 1.4 5.81 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.691 2.261 . . . . 0.0 112.584 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -63.15 -19.9 64.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.123 0.487 . . . . 0.0 110.694 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.13 153.26 19.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.73 143.39 26.59 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.914 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.856 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.84 116.05 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.309 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 90.6 m-85 -141.76 137.85 31.9 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 120.987 0.423 . . . . 0.0 112.12 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HG3' HG11 ' A' ' 2' ' ' VAL . 31.1 mtmt -123.19 153.36 40.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.465 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.719 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.8 tt -161.17 144.42 12.82 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.6 p-10 -100.52 129.63 46.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.082 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.511 HG23 ' HA2' ' A' ' 61' ' ' GLY . 3.8 p -72.67 -16.63 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.488 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -57.93 -43.54 86.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.991 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -88.89 -42.32 11.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.0 mm? -111.9 76.45 0.98 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.276 0.56 . . . . 0.0 112.01 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -67.34 -47.23 64.65 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.413 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.36 -30.95 70.84 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 111.177 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 67' ' ' ASN . 89.5 t -65.53 -54.14 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.9 70.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 111.187 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.48 -30.22 69.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -66.96 -23.53 65.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.536 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB2' HG12 ' A' ' 69' ' ' VAL . 58.1 m-20 -106.63 -12.58 15.53 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.868 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 26.5 tt0 80.46 22.27 0.43 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.308 1.005 . . . . 0.0 110.938 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.25 124.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 121.818 -0.551 . . . . 0.0 109.834 173.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 m -131.63 -25.48 2.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.477 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.1 159.68 14.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.3 mpt? -128.26 142.69 45.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 121.069 0.461 . . . . 0.0 111.434 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . 7.0 Cg_exo -82.23 166.39 70.63 Favored 'Cis proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.289 -1.546 . . . . 0.0 112.009 -9.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 69' ' ' VAL . 15.6 m -140.8 136.64 32.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.539 . . . . 0.0 111.023 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.8 mp -112.18 136.45 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.445 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 78' ' ' PHE . 4.7 mt -128.8 115.94 18.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.121 0.486 . . . . 0.0 110.856 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.704 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -99.3 129.31 45.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.055 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.625 ' HB3' HG23 ' A' ' 15' ' ' ILE . 54.0 m-85 -130.15 151.32 50.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.593 0.235 . . . . 0.0 110.788 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.493 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 56.0 tttp -132.96 124.57 28.02 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.493 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.1 p30 44.8 50.37 8.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.799 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.03 -4.98 81.58 Favored Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.589 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -119.97 160.85 21.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 84' ' ' VAL . 23.4 tt0 -66.18 179.94 0.87 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -152.68 -24.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.601 164.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.631 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.99 157.63 5.35 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 111.436 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.21 133.91 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.428 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 95' ' ' ILE . 5.6 t -132.23 144.05 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 88' ' ' VAL . 9.0 p -117.1 49.04 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 122.218 1.008 . . . . 0.0 109.897 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.02 130.5 1.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.275 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.59 111.88 1.78 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.57 91.12 41.12 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.334 175.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 46.7 Cg_exo -31.69 -65.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.922 3.748 . . . . 0.0 115.359 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.65 -45.45 11.69 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.05 -30.59 71.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.3 mt -85.95 -31.61 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.308 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.557 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 15.4 ttpp -59.83 -38.77 82.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -64.4 -34.61 78.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.857 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -64.67 -60.78 2.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -50.73 -30.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.582 0.551 . . . . 0.0 110.802 -176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.5 -20.86 39.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.771 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.71 -32.11 17.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.704 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -92.19 -12.07 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.907 -178.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.942 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.556 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 4.8 m -65.03 145.03 56.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.775 -168.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.458 HE22 ' HA ' ' A' ' 55' ' ' LEU . 25.7 tp60 -96.71 123.88 40.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.807 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 12.5 m-85 -84.63 158.95 20.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.235 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -128.65 -27.25 2.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.007 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 29.6 p -127.54 162.8 25.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.409 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.09 -26.72 62.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.13 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.508 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.0 mt-10 -58.1 -41.43 83.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.522 172.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 23' ' ' VAL . 31.8 t80 -57.36 -59.72 4.72 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -56.36 -40.75 75.05 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.722 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -42.5 82.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.665 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 -36.27 71.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.364 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.7 mm -61.89 -40.73 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.8 2.24 8.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.257 -172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.85 143.15 44.02 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.56 34.43 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.563 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 172.31 13.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.153 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.56 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -68.49 123.08 19.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.488 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.6 t -103.2 114.28 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -93.64 103.61 14.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 11' ' ' PHE . 56.1 t -105.61 124.65 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.787 0.803 . . . . 0.0 111.256 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -103.43 98.37 8.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.933 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.5 121.59 44.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.482 0.658 . . . . 0.0 111.698 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 28.3 p90 -147.98 169.6 19.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.213 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -117.31 124.7 49.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -23.28 55.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -87.29 -10.17 53.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.518 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.13 158.83 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.758 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.62 -74.22 0.44 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.611 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.51 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 5.9 Cg_exo -77.91 25.66 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.315 2.677 . . . . 0.0 114.078 -171.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 p -65.65 -35.67 81.46 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.011 0.91 . . . . 0.0 109.566 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -68.31 -8.01 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.993 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -36.2 30.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -75.31 -25.58 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.864 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.36 -66.2 1.12 Allowed Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.738 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 90.0 Cg_endo -82.47 -30.05 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.263 1.309 . . . . 0.0 114.251 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -66.13 -44.97 82.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.606 0.639 . . . . 0.0 109.463 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.904 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -71.64 -37.57 63.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.219 -178.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.52 -33.19 75.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.809 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 5.0 tppp? -67.46 -34.97 78.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.331 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 20.5 m-30 -49.59 -62.99 1.24 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.267 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -76.55 -14.34 60.02 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.016 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 10.3 tp10 -59.39 -33.09 70.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 170.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.638 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.74 -45.52 10.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.567 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.3 p90 -130.49 86.67 52.54 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.143 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.4 -1.79 10.25 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.446 2.097 . . . . 0.0 112.168 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -9.98 45.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.481 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.8 16.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -92.75 135.83 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.125 0.488 . . . . 0.0 111.234 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -113.66 116.55 29.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.235 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -140.47 151.25 44.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.928 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -148.77 158.24 44.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.693 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.04 146.75 16.04 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 177.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.3 m-20 -95.83 118.33 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.183 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.653 HG21 ' HE1' ' A' ' 72' ' ' MET . 1.5 m -67.74 -16.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.43 . . . . 0.0 110.895 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.58 -40.17 96.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.03 -42.76 14.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.195 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -127.15 73.02 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 111.555 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.84 -36.89 87.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.17 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.11 -38.83 73.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 110.866 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 67' ' ' ASN . 95.4 t -63.66 -51.21 72.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.035 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.82 -39.06 62.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.884 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 30.1 mm-40 -69.27 -33.33 73.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.366 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 12.3 tptt -62.37 -30.05 70.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.815 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.696 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -102.71 -7.5 21.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.674 -170.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 45.1 mt-10 79.08 24.95 0.49 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.047 0.842 . . . . 0.0 111.043 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -100.68 112.09 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.231 0.538 . . . . 0.0 110.103 175.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.5 t -124.78 -20.83 4.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.28 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.653 ' HE1' HG21 ' A' ' 57' ' ' VAL . 19.9 mmt -129.36 121.55 20.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.056 -174.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 73.4 Cg_endo -88.01 167.71 40.26 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.005 -1.248 . . . . 0.0 113.018 -3.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 10.7 m -136.58 138.16 40.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.686 0.755 . . . . 0.0 111.555 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -109.02 127.79 54.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.569 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 78' ' ' PHE . 3.1 mt -121.5 113.6 20.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.112 0.482 . . . . 0.0 110.632 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -98.83 131.59 44.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.139 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.1 m-85 -129.69 158.34 39.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.465 0.174 . . . . 0.0 110.586 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -141.25 123.76 15.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p30 48.07 54.02 10.76 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 79.62 -1.6 76.89 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.48 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -127.62 161.33 29.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.3 tt0 -65.55 179.43 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.06 0.457 . . . . 0.0 110.907 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -151.03 -28.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 163.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -168.63 152.68 5.73 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.539 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HB3' HD23 ' A' ' 76' ' ' LEU . 21.7 pttp -145.81 129.58 17.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.866 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.17 129.89 60.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.545 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.94 50.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.018 0.437 . . . . 0.0 111.503 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.49 128.47 0.99 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.251 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.33 114.42 2.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.12 90.21 32.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.688 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 74.1 Cg_exo -21.93 -83.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 1 C-N-CA 125.512 4.141 . . . . 0.0 115.595 -171.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 96' ' ' LYS . . . -83.87 -30.51 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -173.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.66 77.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.36 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 75' ' ' LEU . 34.7 mm -83.39 -29.85 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.798 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 37.3 mtpt -59.31 -39.25 82.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -66.63 -33.03 74.76 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.516 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -61.71 -60.78 3.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.52 -36.56 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 123.831 0.707 . . . . 0.0 110.683 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.55 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.831 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -37.12 14.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.296 0.57 . . . . 0.0 109.991 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.668 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -85.42 -11.65 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.522 174.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 52' ' ' PHE . 52.8 t . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.566 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 11.2 m -71.82 144.64 49.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 0.0 112.525 -169.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -90.86 121.51 32.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.232 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 3.7 m-85 -69.75 168.5 14.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 0.0 110.418 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 16.7 mtpp -127.86 -36.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.019 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -144.6 179.28 7.39 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.51 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -65.95 -27.74 68.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -57.48 -48.5 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.787 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.503 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -55.02 -43.04 73.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.729 174.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.5 t80 -58.03 -60.08 4.29 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.7 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.01 -38.87 76.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.803 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -60.36 -47.83 84.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.695 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.24 75.0 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.844 0.354 . . . . 0.0 110.402 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.706 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -59.67 -36.81 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.308 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 14.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.469 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -83.14 153.73 24.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.65 0.262 . . . . 0.0 110.537 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -87.99 39.34 0.89 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.478 0.656 . . . . 0.0 110.36 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 17.7 ptpt -152.61 -179.8 7.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.051 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.35 121.63 23.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.629 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.1 t -96.21 116.19 37.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.051 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.41 103.16 14.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 11' ' ' PHE . 43.4 t -104.93 126.53 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.592 0.71 . . . . 0.0 111.285 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.66 101.16 10.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.847 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.699 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.6 m-85 -104.69 121.64 44.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 42.1 p90 -151.4 162.64 40.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.525 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -111.7 132.31 54.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -62.0 -24.55 67.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.687 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -84.27 -17.13 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.823 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.39 152.45 39.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.342 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.89 -75.56 0.48 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.348 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 20.85 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.156 2.571 . . . . 0.0 114.226 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.4 p -65.74 -28.57 69.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.903 0.858 . . . . 0.0 109.345 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 22.5 pttp -68.33 -8.45 39.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.501 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.542 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.0 ttt -84.92 -25.56 27.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.148 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -79.99 -24.7 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.306 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.39 -63.57 2.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.6 Cg_endo -83.91 -34.47 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.084 1.856 . . . . 0.0 114.045 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.528 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 0.5 OUTLIER -66.25 -42.99 87.81 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.426 0.631 . . . . 0.0 109.681 -176.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.51 -36.82 48.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.883 -178.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.3 mt-10 -63.43 -30.49 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.035 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 51.1 tttp -75.78 -28.91 58.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.524 -176.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.2 m-85 -56.59 -57.87 10.5 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.4 p -76.5 -13.75 60.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.496 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 34.1 tt0 -60.79 -31.9 71.27 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.34 -47.04 8.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.095 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.6 p90 -129.6 90.06 44.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.099 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -1.09 9.61 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.266 1.977 . . . . 0.0 112.174 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -10.62 51.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.964 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 154.63 18.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.1 m-20 -91.61 126.34 36.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -101.86 116.21 32.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.177 -174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.566 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.58 152.48 46.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.988 0.423 . . . . 0.0 111.029 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.5 pttt -148.91 160.92 42.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.4 tt -157.58 151.19 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 18.6 t0 -97.86 119.1 35.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.62 -26.99 42.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.809 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.19 -35.59 80.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.373 0.606 . . . . 0.0 109.98 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.53 -42.46 20.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.498 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB2' HD21 ' A' ' 55' ' ' LEU . 74.2 mt -135.09 84.01 2.07 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.91 -33.76 54.42 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.553 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.28 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.528 HG12 HD21 ' A' ' 67' ' ' ASN . 79.6 t -63.74 -51.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.911 173.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.41 -39.69 57.76 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 110.76 176.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 75.9 mt-30 -69.97 -32.56 70.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.588 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -20.73 66.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.877 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.65 ' HB2' HG12 ' A' ' 69' ' ' VAL . 15.4 m-20 -110.71 -8.75 14.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.482 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 25.7 tt0 80.69 25.85 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.102 0.876 . . . . 0.0 110.883 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -105.92 107.81 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.333 0.587 . . . . 0.0 110.668 174.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -116.76 -24.52 7.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.138 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.12 157.76 26.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.3 ptp -151.3 137.4 11.19 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.269 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.0 Cg_endo -77.88 155.82 94.87 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.768 -1.763 . . . . 0.0 113.021 -3.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.5 m -134.73 142.87 46.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.442 0.639 . . . . 0.0 111.339 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 95' ' ' ILE . 4.0 mp -114.24 129.36 56.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.768 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.592 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 mt -122.21 117.17 25.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 0.0 110.999 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -101.06 129.45 46.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.102 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.6 m-85 -127.79 161.39 29.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 4.6 ttpm? -143.55 115.45 8.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.008 168.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 64.26 55.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.762 0.791 . . . . 0.0 111.205 172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.706 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.39 2.66 60.04 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.488 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 8.5 ptpp? -133.44 160.97 35.84 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 31.6 tt0 -64.99 177.63 0.96 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 110.856 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -148.84 -35.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 160.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.99 152.96 15.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.51 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HB3' HD23 ' A' ' 76' ' ' LEU . 42.3 pttt -147.61 127.16 13.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.168 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.66 134.22 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.278 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.9 52.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.234 0.54 . . . . 0.0 110.782 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.28 129.46 1.25 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.073 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -64.69 103.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.734 0.302 . . . . 0.0 111.601 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.3 OUTLIER -117.49 88.89 30.42 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.032 175.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -35.37 -67.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.496 3.464 . . . . 0.0 115.272 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 -32.16 48.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.24 63.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.163 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 99' ' ' ILE . 40.3 mm -87.56 -34.4 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.23 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.704 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 55.0 tttt -59.48 -35.06 73.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -72.89 -31.22 64.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -68.75 -52.76 27.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.5 mm -54.43 -37.51 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.337 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.112 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -44.51 34.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.832 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.6 m-80 -79.03 -16.95 56.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.654 -172.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.628 177.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.64 HG21 HG22 ' A' ' 40' ' ' ILE . 95.2 t . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 21.3 m -81.53 144.53 31.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.513 -170.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -90.13 135.83 33.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.122 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 8.9 m-30 -88.37 167.88 13.13 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 170.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 55.7 pttt -134.67 -20.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.206 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 22.6 p -145.49 174.69 10.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -70.8 -27.48 63.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -59.27 -43.8 92.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.304 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.718 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 42.9 mm-40 -55.35 -46.62 76.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.382 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 23' ' ' VAL . 16.6 t80 -59.24 -57.73 11.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.695 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.59 -40.98 93.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.828 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -62.02 -40.09 94.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.192 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.78 -42.58 90.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.648 175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.857 HG22 ' HA2' ' A' ' 81' ' ' GLY . 4.9 mm -60.2 -40.33 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.97 7.65 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 24.3 mt-30 -83.95 148.66 26.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.53 44.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -144.26 167.87 21.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.089 177.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -78.88 117.58 20.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 14' ' ' ALA . 41.1 t -108.36 122.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.227 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 28.9 t -106.59 112.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.723 HG11 ' CE2' ' A' ' 11' ' ' PHE . 54.6 t -100.14 121.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.641 0.734 . . . . 0.0 110.87 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.765 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -85.26 96.61 9.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.659 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -96.84 126.03 41.7 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.966 0.413 . . . . 0.0 110.077 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 36' ' ' ILE . 8.6 p90 -149.8 -175.28 4.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.573 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -132.76 130.04 39.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.637 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -65.55 -19.47 65.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.959 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -84.98 -13.5 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.174 0.511 . . . . 0.0 110.552 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.648 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.2 t -90.48 136.56 32.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.37 7.67 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 113.532 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.648 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.3 Cg_exo -61.33 3.59 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.103 2.535 . . . . 0.0 114.145 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.1 t -59.03 -29.88 67.6 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.737 0.779 . . . . 0.0 110.429 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -67.97 -8.99 41.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.306 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -38.13 44.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.05 -25.46 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.861 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.65 -65.69 1.38 Allowed Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.891 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 73.2 Cg_endo -83.55 -26.87 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.72 1.613 . . . . 0.0 114.378 -175.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.539 ' HE3' HG13 ' A' ' 40' ' ' ILE . 3.3 tmm? -72.72 -37.45 67.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.291 0.567 . . . . 0.0 109.753 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.765 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.85 -33.34 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.659 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.53 -29.05 70.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -72.79 -38.77 67.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.823 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.576 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -57.12 -49.63 75.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.5 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 95.8 p -85.39 -13.97 47.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.56 -27.98 69.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 13.3 mm-40 -89.68 -40.7 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.12 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 11.5 p90 -138.85 93.11 10.8 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 112.431 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.44 2.37 2.9 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.451 2.1 . . . . 0.0 112.107 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.06 -23.74 67.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.48 157.58 16.7 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.3 135.75 33.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.904 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.5 p90 -111.52 115.46 29.24 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.249 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 3' ' ' THR . 95.8 m-85 -140.66 156.74 46.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.716 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 43.4 mtmt -137.52 149.21 46.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.155 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD22 ' CE1' ' A' ' 25' ' ' PHE . 8.8 tt -157.87 148.81 21.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.034 0.445 . . . . 0.0 110.745 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 5.3 t0 -104.38 123.35 47.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.8 p -70.29 -24.39 25.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.061 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.62 -23.96 65.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.532 0.682 . . . . 0.0 109.694 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -99.12 -42.49 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.507 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -120.22 76.16 1.15 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.276 0.56 . . . . 0.0 112.163 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.81 62.67 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.85 -25.58 65.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.914 0.388 . . . . 0.0 110.797 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.623 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 51.5 t -68.68 -50.33 56.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -52.82 -22.84 5.85 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -86.26 -27.3 24.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -75.39 -26.5 58.48 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.107 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.642 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.5 p30 -110.13 -12.6 14.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 29.3 tt0 79.84 17.35 0.75 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.85 0.718 . . . . 0.0 112.635 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -89.55 130.89 38.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 121.567 -0.708 . . . . 0.0 110.639 173.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -123.94 -27.34 3.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.98 166.36 11.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.535 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -148.09 141.71 15.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.84 0.353 . . . . 0.0 110.951 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.89 150.29 78.55 Favored 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.836 -1.735 . . . . 0.0 112.635 -2.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -132.46 136.93 47.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.552 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -107.83 123.26 48.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.689 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -116.06 116.43 27.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.573 0.701 . . . . 0.0 109.876 175.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.2 mp -95.75 128.46 42.65 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.504 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 76' ' ' LEU . 58.9 m-85 -125.96 153.26 44.55 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.493 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -135.87 125.39 25.13 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 46.8 53.82 9.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.223 1.009 . . . . 0.0 113.49 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.857 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.8 5.4 69.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.528 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -120.08 161.12 21.51 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 84' ' ' VAL . 27.0 tt0 -71.58 179.89 2.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -153.86 -33.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 164.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.58 149.76 5.78 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.423 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -146.82 127.86 14.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.032 0.444 . . . . 0.0 110.54 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 95' ' ' ILE . 4.2 m -132.44 139.42 50.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -101.69 48.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.255 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.33 131.58 1.71 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.317 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.647 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -69.72 108.13 3.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -117.28 89.75 32.06 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 12.2 Cg_exo -28.53 -67.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.79 3.66 . . . . 0.0 115.588 -171.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.9 21.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.74 71.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.739 0.304 . . . . 0.0 111.32 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 91' ' ' ASN . 35.3 mm -72.62 -49.24 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.695 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mtmp? -63.46 -28.59 70.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -38.38 68.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.038 173.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.72 68.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.498 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -52.73 -39.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.711 -178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.7 -19.85 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.175 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.9 -38.08 23.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.254 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' ND2' HD23 ' A' ' 77' ' ' LEU . 58.1 m-80 -83.95 -21.16 31.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.448 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.894 178.17 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.646 HG23 ' HG2' ' A' ' 41' ' ' GLU . 43.7 t . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.636 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 1.4 m -60.48 144.42 51.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.414 -168.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -101.52 117.43 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.224 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.4 m-85 -71.07 167.58 18.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.138 0.494 . . . . 0.0 111.755 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -125.38 -41.31 2.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.924 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -138.5 -179.96 6.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 111.443 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -67.86 -25.5 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.978 0.418 . . . . 0.0 110.186 175.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -61.2 -46.83 88.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -54.96 -42.74 72.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.448 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.801 ' CE2' HG11 ' A' ' 23' ' ' VAL . 17.6 t80 -57.37 -58.88 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.01 -36.35 74.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -63.54 -41.46 98.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.845 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.21 -35.54 78.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.037 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.763 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -62.26 -39.16 83.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.052 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.06 0.97 9.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 28.3 mt-30 -75.5 143.58 42.45 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.73 40.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 0.0 110.986 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 20.7 ptmt -142.19 167.44 22.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.381 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -70.1 126.42 29.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.0 t -106.07 120.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.2 104.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.801 HG11 ' CE2' ' A' ' 11' ' ' PHE . 39.4 t -102.72 127.18 56.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.663 0.744 . . . . 0.0 111.083 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.849 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.33 98.17 7.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.125 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.3 m-85 -103.21 123.97 47.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.439 ' O ' HG13 ' A' ' 57' ' ' VAL . 48.9 p90 -152.92 179.02 9.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.398 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -129.92 135.97 48.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.652 0.263 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.61 HG23 ' OD2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -63.96 -22.04 66.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.38 -13.26 52.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.562 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 52.9 t -81.99 148.79 28.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.706 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.39 -65.98 1.98 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 13.1 Cg_exo -71.8 18.52 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.24 2.627 . . . . 0.0 114.23 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -67.44 -29.24 68.66 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.048 0.927 . . . . 0.0 109.44 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 99.2 mttt -68.08 -7.36 28.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.133 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -38.33 58.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.659 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.22 -25.47 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.044 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.671 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.45 -65.8 1.3 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.976 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 96.2 Cg_endo -82.46 -29.75 1.36 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.456 1.437 . . . . 0.0 114.299 -173.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -66.3 -44.9 82.14 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.36 0.6 . . . . 0.0 109.456 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.849 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -69.55 -37.5 74.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.22 -179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 2' ' ' VAL . 40.8 mt-10 -62.83 -31.99 73.1 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.065 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.53 -32.74 70.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.696 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 16.8 m-30 -52.44 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -76.07 -13.4 60.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.263 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -60.55 -39.57 88.41 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.62 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -79.05 -47.61 15.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.5 p90 -133.06 89.9 32.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.214 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.28 2.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.503 2.135 . . . . 0.0 112.661 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -24.74 67.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.304 0.573 . . . . 0.0 110.716 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.48 153.29 20.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.352 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.92 150.17 21.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.162 -175.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -118.33 115.96 25.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.969 -172.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.636 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.9 m-85 -141.8 149.51 40.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 111.635 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 36.9 mtmt -131.03 160.78 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.932 0.893 . . . . 0.0 110.1 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 25' ' ' PHE . 9.0 tt -159.8 147.8 17.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -98.89 117.99 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.131 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -71.83 -17.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 0.0 110.376 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.02 -31.99 69.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' O ' HD13 ' A' ' 60' ' ' LEU . 37.2 tt0 -87.69 -42.77 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.024 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.4 mm? -124.22 80.63 1.85 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.0 -39.77 93.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.701 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.83 -33.98 76.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.58 HG12 HD21 ' A' ' 67' ' ' ASN . 86.6 t -65.56 -49.53 77.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.095 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.7 -39.26 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.713 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.6 mm100 -69.24 -38.11 78.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.12 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.54 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 5.9 tptp -59.46 -24.96 63.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.475 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HB2' HG12 ' A' ' 69' ' ' VAL . 8.7 m-20 -109.47 -8.02 15.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 122.278 -0.264 . . . . 0.0 111.366 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.2 mt-10 79.21 27.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.997 0.811 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -106.22 109.84 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.4 0.619 . . . . 0.0 110.481 175.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.0 m -117.41 -34.51 4.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.182 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.07 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.624 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 19.6 ptp -151.79 149.27 23.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.959 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.3 Cg_endo -79.63 150.82 84.38 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.525 -1.864 . . . . 0.0 112.422 -4.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.1 m -126.05 140.21 52.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.595 0.712 . . . . 0.0 111.784 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 mp -114.99 124.65 52.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.436 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.646 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -116.32 118.74 33.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.462 . . . . 0.0 110.57 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.4 mp -99.72 131.84 45.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.279 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.646 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.3 m-85 -131.23 160.31 35.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.558 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 7.0 ttpm? -144.69 131.19 19.83 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.85 52.88 11.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.763 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.45 1.6 82.39 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.46 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -125.46 160.31 29.78 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.1 tt0 -66.57 -178.36 0.69 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.12 -31.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.647 162.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.681 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -164.0 154.43 15.23 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.918 0.39 . . . . 0.0 111.736 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -145.69 126.53 14.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 75' ' ' LEU . 12.3 m -133.65 142.74 40.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.669 0.271 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.23 43.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.963 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.48 121.9 0.82 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.119 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -59.63 109.59 0.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.952 0.406 . . . . 0.0 111.566 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.466 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.14 90.66 34.24 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.2 Cg_exo -26.26 -79.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.826 3.684 . . . . 0.0 115.288 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.91 -35.31 43.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.81 76.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.417 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.7 mm -86.15 -31.61 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.633 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 22.4 mtmm -63.05 -32.93 74.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.704 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -69.96 -32.86 71.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.035 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.55 48.56 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.089 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.1 mm -54.26 -38.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.453 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.77 60.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.097 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.98 -38.14 32.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.437 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 77' ' ' LEU . 52.5 m-80 -86.67 -14.58 42.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.269 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.73 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 40' ' ' ILE . 53.6 t . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.001 0.429 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.655 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 2.7 m -72.47 146.14 47.08 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -167.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -93.54 139.06 31.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.954 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 11' ' ' PHE . 11.5 m-85 -103.67 154.87 19.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.029 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 25.3 pttm -133.85 -3.35 2.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.205 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -143.22 164.11 31.08 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.477 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -56.93 -47.66 80.11 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -53.5 -44.95 69.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.609 ' O ' HG12 ' A' ' 15' ' ' ILE . 17.0 t80 -58.89 -57.25 13.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.7 -34.86 78.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.757 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -62.35 -40.35 96.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.678 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.61 -20.78 63.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.466 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.76 HG22 ' HA2' ' A' ' 81' ' ' GLY . 12.5 mm -82.58 -36.49 13.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.335 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 12.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -101.09 148.2 25.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 120.817 0.342 . . . . 0.0 110.313 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.73 66.22 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.619 0.723 . . . . 0.0 110.747 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -154.03 174.59 14.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.44 117.16 24.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.158 0.504 . . . . 0.0 109.846 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.3 t -102.23 128.43 54.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.2 t -115.78 108.79 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 11' ' ' PHE . 14.5 t -106.31 129.58 59.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.706 0.765 . . . . 0.0 110.885 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.893 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.68 100.17 11.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.081 -175.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -105.89 108.88 20.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.492 0.663 . . . . 0.0 111.945 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.4 p90 -131.76 -174.51 3.44 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.532 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.97 139.91 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.892 0.377 . . . . 0.0 110.404 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -20.28 62.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.709 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -88.7 -15.75 34.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.36 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 33' ' ' CYS . 16.3 p -90.92 150.25 21.57 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.2 -46.99 9.55 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.912 -0.585 . . . . 0.0 114.321 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 42.0 Cg_endo -67.11 5.08 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.578 2.186 . . . . 0.0 114.307 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 24.4 p -61.98 -34.1 75.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.457 0.646 . . . . 0.0 110.383 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.4 -8.66 42.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.402 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 90' ' ' ALA . 16.9 tpt -79.7 -33.34 41.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -79.95 -26.75 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.049 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.05 -62.04 3.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.269 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 83.9 Cg_endo -80.39 -41.2 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 120.152 1.09 . . . . 0.0 113.706 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.461 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 2.8 tmm? -62.04 -36.21 80.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.246 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -82.17 -35.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.288 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -64.57 -23.43 67.26 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.189 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 27.0 mtpp -85.56 -26.05 26.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -60.69 -42.07 96.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.965 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -15.43 49.35 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 122.054 -0.404 . . . . 0.0 111.008 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 24.0 tt0 -56.53 -39.18 72.94 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.22 -50.23 8.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.908 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 14.3 p90 -134.13 91.02 24.46 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.252 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.99 0.78 8.48 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.885 1.723 . . . . 0.0 111.195 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -65.63 -9.66 29.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.779 176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.84 161.15 13.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.18 130.76 37.81 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -114.96 116.32 28.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.053 -172.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 88.2 m-85 -140.57 151.34 44.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.526 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 19.5 pttm -148.64 152.44 36.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.15 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 60' ' ' LEU . 6.7 tt -160.33 152.44 20.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.757 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.7 p-10 -99.77 128.54 45.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 111.263 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -72.42 -12.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.082 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.49 -48.6 72.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.025 0.441 . . . . 0.0 109.926 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -80.12 -41.56 25.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.832 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.748 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -116.04 71.81 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.142 0.496 . . . . 0.0 112.249 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -75.15 -36.09 46.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.966 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.98 -30.58 71.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.403 0.621 . . . . 0.0 110.79 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.618 HG12 HD21 ' A' ' 67' ' ' ASN . 60.7 t -68.99 -52.55 32.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.6 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.91 -40.9 58.08 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.23 0.331 . . . . 0.0 111.238 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 71.6 mt-30 -69.66 -32.04 70.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.8 tptt -62.98 -27.95 69.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.729 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.677 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -103.94 -10.11 18.39 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.3 tt0 80.99 19.49 0.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.201 0.938 . . . . 0.0 111.029 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.677 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -96.44 118.66 43.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 121.804 -0.56 . . . . 0.0 110.145 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 m -117.32 -31.33 5.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.618 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.11 163.87 13.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.269 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.425 ' CE ' HG21 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -144.51 138.51 14.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' CG ' HD13 ' A' ' 36' ' ' ILE . 59.3 Cg_endo -83.39 152.18 69.03 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.741 -1.775 . . . . 0.0 113.024 -0.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.7 m -131.56 135.03 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.681 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -104.9 129.93 53.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.533 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE2' ' A' ' 78' ' ' PHE . 1.3 mt -120.64 115.67 23.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.011 0.434 . . . . 0.0 110.92 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -98.81 133.15 43.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE2' HD22 ' A' ' 76' ' ' LEU . 47.9 m-85 -130.85 153.91 48.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 4.1 tppp? -132.68 118.15 18.75 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.589 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 8.8 p30 43.78 55.74 4.96 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.255 1.022 . . . . 0.0 113.735 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.76 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.34 -5.63 63.08 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.601 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.97 160.08 16.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.19 178.52 4.39 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -149.23 -34.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 163.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.655 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.01 157.17 11.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.465 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HB3' HD23 ' A' ' 76' ' ' LEU . 29.2 pttt -152.03 134.71 15.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 t -132.1 124.5 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.343 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.09 52.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.203 0.525 . . . . 0.0 111.27 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.34 126.83 0.85 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.824 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -63.4 121.44 13.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.435 0.636 . . . . 0.0 111.558 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -117.24 90.69 34.76 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.999 176.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 51.1 Cg_exo -21.37 -75.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.377 4.051 . . . . 0.0 115.926 -171.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.0 -34.44 24.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.72 -29.58 70.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.433 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.458 ' O ' HG12 ' A' ' 99' ' ' ILE . 37.9 mm -73.35 -43.69 56.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.067 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.591 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 87.4 mttt -64.26 -24.83 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.634 0.73 . . . . 0.0 109.806 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -84.09 -29.04 27.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.676 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.13 -54.35 31.27 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.98 0.419 . . . . 0.0 110.207 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -50.89 -39.79 19.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.646 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.94 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.383 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.18 41.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' HD23 ' A' ' 77' ' ' LEU . 47.5 m-80 -96.55 -15.34 21.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.968 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.791 177.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 41' ' ' GLU . 62.4 t . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 23.4 m -90.24 131.62 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.649 0.738 . . . . 0.0 112.555 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.46 ' OE1' ' HG3' ' A' ' 54' ' ' LYS . 8.5 mm100 -69.01 137.54 53.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.939 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -83.26 170.5 14.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.798 169.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -122.7 -41.38 2.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -140.67 179.28 6.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.873 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -66.09 -27.84 68.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.513 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -59.45 -46.99 87.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.547 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -53.13 -44.2 67.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.369 172.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.743 ' O ' HG12 ' A' ' 15' ' ' ILE . 14.8 t80 -59.84 -60.91 3.07 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.85 -39.78 65.91 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.939 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -64.29 -44.8 90.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.4 75.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.144 0.497 . . . . 0.0 110.312 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.813 HG22 ' HA2' ' A' ' 81' ' ' GLY . 13.6 mm -63.49 -38.13 81.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.55 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.55 6.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HB3' ' CD ' ' A' ' 19' ' ' LYS . 25.4 mt-30 -83.69 141.95 31.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.539 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 32.23 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 111.966 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.75 178.98 6.7 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -74.58 122.32 22.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.5 t -101.15 111.2 30.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -93.54 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 176.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 11' ' ' PHE . 57.1 t -103.54 123.78 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.86 0.838 . . . . 0.0 111.188 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -95.98 96.63 9.02 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.215 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.809 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -99.29 130.63 45.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.8 p90 -157.49 -171.77 3.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.908 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -142.1 139.29 32.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -15.25 62.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -87.58 -12.74 44.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.014 0.435 . . . . 0.0 110.619 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.0 t -83.24 149.91 26.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.025 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.71 -67.89 1.58 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.791 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 41.7 Cg_endo -69.21 12.8 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.099 2.533 . . . . 0.0 114.356 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 26.5 p -63.94 -32.71 74.34 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.087 0.946 . . . . 0.0 109.879 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.673 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 44.2 mtmt -69.16 -8.86 49.43 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.009 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.31 -33.11 49.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -76.22 -24.55 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.814 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.77 -65.37 1.54 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.587 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.2 Cg_endo -82.91 -35.62 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.606 1.537 . . . . 0.0 113.238 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.41 -40.16 95.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.623 0.725 . . . . 0.0 109.936 -175.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.784 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.12 -38.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.754 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HG2' HG23 ' A' ' 2' ' ' VAL . 44.5 mt-10 -65.28 -29.57 70.35 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.525 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 13.1 mmmm -66.92 -40.2 87.57 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.444 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.0 m-30 -52.51 -62.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.781 0.324 . . . . 0.0 111.207 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.8 p -77.16 -13.29 59.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.731 0.301 . . . . 0.0 111.368 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.7 -39.68 85.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -81.84 -42.67 19.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.044 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.5 p90 -130.0 89.82 44.42 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 111.927 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.39 0.74 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.189 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -64.96 -12.11 46.14 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.207 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.32 147.13 26.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.903 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.641 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.3 p90 -91.51 116.09 28.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.142 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 3' ' ' THR . 94.9 m-85 -141.19 155.17 46.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HG3' ' OE1' ' A' ' 4' ' ' GLN . 19.3 ptmt -149.29 151.86 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.871 -172.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.908 HD21 ' HB2' ' A' ' 60' ' ' LEU . 10.1 tt -159.55 148.34 17.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.746 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.6 p-10 -101.65 120.75 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.221 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 72' ' ' MET . 3.6 p -67.13 -16.75 21.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.611 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.85 -49.14 63.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.291 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -90.77 -42.98 10.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.819 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.908 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -105.33 73.65 1.05 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.548 0.689 . . . . 0.0 111.866 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -69.61 -43.64 67.29 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.135 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 3.7 p30 -67.63 -20.9 65.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 0.0 110.797 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG12 HD21 ' A' ' 67' ' ' ASN . 96.1 t -69.75 -51.98 35.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.31 -40.44 59.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.343 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.2 pt20 -68.31 -36.12 78.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.088 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.26 -28.67 68.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.777 176.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.702 ' HB2' HG12 ' A' ' 69' ' ' VAL . 39.7 m-20 -102.77 -13.12 17.16 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.281 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 5.4 tp10 80.08 19.88 0.59 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.467 1.104 . . . . 0.0 111.067 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -95.09 119.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.187 0.518 . . . . 0.0 109.757 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -134.45 8.21 3.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.402 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.53 153.69 38.88 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 57' ' ' VAL . 2.2 mpt? -129.8 130.68 23.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.915 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.527 ' HB2' HG12 ' A' ' 36' ' ' ILE . 60.2 Cg_endo -86.14 165.76 51.87 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.247 -1.564 . . . . 0.0 112.377 -5.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.1 m -141.56 128.91 21.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.508 0.671 . . . . 0.0 111.09 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -97.68 123.51 41.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.044 173.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.9 mt -115.9 113.79 23.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.317 0.58 . . . . 0.0 110.742 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -99.24 127.53 45.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.04 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HB3' HG23 ' A' ' 15' ' ' ILE . 48.8 m-85 -128.08 159.14 36.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.546 0.212 . . . . 0.0 111.219 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -143.81 135.8 26.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p30 49.54 41.57 21.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.183 0.993 . . . . 0.0 113.319 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 83.39 1.49 90.29 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.576 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -122.67 161.09 24.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.5 tt0 -68.88 179.61 1.76 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 118.404 0.547 . . . . 0.0 109.77 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -149.11 -28.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.497 162.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.95 152.64 13.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.098 0.475 . . . . 0.0 111.61 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -142.92 120.11 11.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.311 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 95' ' ' ILE . 59.1 t -130.6 128.6 63.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.831 0.348 . . . . 0.0 110.978 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -99.8 52.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.126 0.488 . . . . 0.0 110.957 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.57 124.86 0.89 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.291 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.62 102.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.925 0.49 . . . . 0.0 112.131 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.0 89.52 34.64 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.176 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 29.5 Cg_exo -32.82 -66.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.326 3.351 . . . . 0.0 115.378 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.47 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.29 68.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.67 0.271 . . . . 0.0 111.69 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 HD22 ' A' ' 75' ' ' LEU . 42.3 mm -87.66 -33.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.083 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -61.55 -32.27 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.457 0.646 . . . . 0.0 109.512 170.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -71.59 -32.84 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.17 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.3 -52.27 48.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.123 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -53.36 -36.9 27.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -30.98 60.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.098 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.86 -37.41 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.499 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -86.83 -20.15 27.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.267 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.086 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 54' ' ' LYS . 83.4 t . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.471 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.5 m -74.14 144.8 44.73 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -170.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.523 HE22 ' HA ' ' A' ' 55' ' ' LEU . 20.9 tp60 -101.16 122.71 44.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.657 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.2 m-85 -84.46 160.13 20.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.652 173.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -1.76 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 166.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.0 p -140.46 159.82 41.35 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.97 -28.72 62.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.37 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.62 -42.87 93.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -54.67 -44.2 73.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.716 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 15' ' ' ILE . 18.5 t80 -57.53 -60.68 3.3 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -55.12 -40.62 70.72 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.708 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.8 t -58.77 -45.49 89.66 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.944 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.72 76.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.668 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.97 -36.09 76.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.553 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 12.73 0.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -88.11 150.84 23.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.681 0.277 . . . . 0.0 110.585 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.52 36.9 0.49 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 110.766 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 79' ' ' LYS . 19.6 ptpt -137.3 177.49 7.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.2 tm? -82.38 118.49 23.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.0 t -102.78 119.99 51.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.832 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 31.2 t -107.13 106.79 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.9 t -101.76 123.79 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.94 0.876 . . . . 0.0 110.643 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -95.39 97.61 9.95 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.106 -174.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.2 m-85 -102.57 126.67 49.71 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.552 0.692 . . . . 0.0 111.866 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.63 174.85 12.97 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -125.64 124.5 41.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.57 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -19.48 65.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.106 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -90.76 -6.98 53.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 54.1 t -93.29 152.42 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.559 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.21 -72.01 0.74 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.668 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 59.8 Cg_endo -76.39 31.58 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.904 2.402 . . . . 0.0 114.512 -172.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.19 -34.74 75.4 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.914 0.864 . . . . 0.0 110.114 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -68.1 -7.28 28.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.984 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.549 ' HG3' ' HB3' ' A' ' 90' ' ' ALA . 17.0 tpt -75.89 -35.2 59.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 109.067 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -80.19 -25.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.017 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.79 -63.04 2.58 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.764 176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 95.7 Cg_endo -82.23 -34.98 0.38 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.035 1.156 . . . . 0.0 113.652 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 3.2 tmm? -65.03 -37.89 89.07 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.187 0.518 . . . . 0.0 110.017 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD13 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -78.98 -36.26 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.798 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -63.94 -26.16 68.46 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.936 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 94.2 mttt -80.03 -34.92 37.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.5 p90 -55.51 -48.56 74.44 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.229 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 79.0 p -85.37 -14.4 46.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.51 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 9.1 tp10 -55.42 -38.69 69.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.579 172.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -90.61 -37.93 13.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.399 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 12.3 p90 -132.72 90.7 31.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.683 . . . . 0.0 112.835 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.23 0.08 6.53 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.728 2.286 . . . . 0.0 112.645 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -14.88 62.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.977 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.7 154.83 18.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.54 127.79 37.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.874 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -100.78 116.11 31.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.233 -173.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.471 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.1 m-85 -138.23 150.94 47.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.655 0.264 . . . . 0.0 111.353 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HG3' HG11 ' A' ' 2' ' ' VAL . 33.6 mtmt -134.38 158.5 43.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.755 0.822 . . . . 0.0 110.233 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.3 tt -160.43 141.61 12.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 110.79 170.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.85 117.24 29.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.9 m -65.87 -19.08 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.491 0.663 . . . . 0.0 109.672 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.83 -38.31 78.4 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.059 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -96.38 -38.79 9.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.806 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.651 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -121.1 76.11 1.2 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.095 0.474 . . . . 0.0 111.682 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.5 78.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.259 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.25 -35.54 80.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.156 0.503 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 67' ' ' ASN . 62.1 t -64.59 -48.71 83.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.23 -39.49 60.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.195 0.522 . . . . 0.0 110.773 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -74.86 -29.3 60.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.522 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -62.37 -27.49 69.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.052 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.611 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 30.1 m-20 -104.38 -13.1 16.22 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.315 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 39.7 mt-10 80.63 31.23 0.18 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.532 1.145 . . . . 0.0 111.045 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -107.94 107.71 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.552 . . . . 0.0 110.113 170.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 m -115.31 -10.59 12.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.758 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.46 142.33 36.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HE2' HG21 ' A' ' 57' ' ' VAL . 2.0 mpt? -130.87 140.99 40.35 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.74 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 58.9 Cg_endo -81.1 163.75 78.96 Favored 'Cis proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.858 -1.726 . . . . 0.0 113.305 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.6 m -148.78 138.22 21.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.043 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.56 130.28 54.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.305 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -120.41 114.07 21.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.016 0.436 . . . . 0.0 110.39 175.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.665 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -97.0 133.35 41.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.0 m-85 -130.31 152.85 49.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.8 tppp? -127.08 110.11 12.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.404 168.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.9 t30 57.44 56.46 5.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 111.788 167.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.668 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.86 12.27 78.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.731 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -131.42 159.23 38.63 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 178.22 4.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.48 -32.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 164.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.98 154.54 7.71 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.508 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.99 134.15 19.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.174 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.79 122.12 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.173 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.39 55.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.134 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.78 135.42 2.0 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.78 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -67.76 122.6 18.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.091 0.472 . . . . 0.0 111.523 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -117.73 90.29 35.59 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.662 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 29.2 Cg_exo -21.03 -78.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.639 4.226 . . . . 0.0 116.102 -169.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.78 -31.64 25.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -63.53 -32.01 73.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.69 0.281 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.6 mm -71.35 -43.73 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.175 175.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 27.1 mmtp -61.8 -35.16 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -69.25 -37.51 77.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.459 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.6 -61.18 2.8 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -48.3 -35.3 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.956 0.785 . . . . 0.0 110.756 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.25 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.977 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -31.96 17.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 110.287 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.665 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -91.67 -13.75 31.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.728 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.86 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.8 t . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.609 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 6.8 m -70.52 145.4 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.532 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.6 mm-40 -87.39 139.08 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.534 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.0 m-85 -102.52 148.08 25.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -129.54 1.41 5.01 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.663 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 24.0 p -142.13 156.59 45.37 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.991 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.971 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -58.32 -41.95 85.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.663 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mt-10 -56.15 -48.29 76.56 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.279 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.1 t80 -55.07 -57.98 9.52 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.12 -33.26 68.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.488 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -65.13 -49.73 68.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.54 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.72 75.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.6 mm -62.94 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.827 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 13.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.532 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -89.52 147.08 24.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.848 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.58 52.44 1.88 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.251 0.548 . . . . 0.0 112.145 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 51' ' ' ASP . 18.8 ptpt -154.86 178.49 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.59 118.86 19.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -102.78 124.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.806 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 17.2 t -113.74 111.13 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.6 t -108.29 129.08 63.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.827 0.822 . . . . 0.0 110.95 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.814 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.04 101.11 12.62 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.905 -175.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -108.48 115.65 30.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.332 0.587 . . . . 0.0 111.673 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 37.5 p90 -139.98 175.33 9.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.801 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -123.8 131.39 53.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.705 0.288 . . . . 0.0 110.572 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -26.99 69.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.419 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -81.34 -8.83 59.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.7 t -87.71 159.02 18.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.859 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.66 -67.2 1.46 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.344 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 39.8 Cg_endo -68.11 10.92 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.247 2.632 . . . . 0.0 114.219 -175.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.2 p -61.88 -34.52 76.16 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 21.8 ptmt -67.71 -8.62 36.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.61 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 21.2 ttt -82.55 -27.3 31.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -77.23 -25.16 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.064 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.83 -64.6 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.848 173.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.8 Cg_endo -82.95 -30.47 0.94 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 120.765 1.309 . . . . 0.0 114.411 -175.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.45 -33.94 71.87 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.455 0.645 . . . . 0.0 109.767 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -83.63 -34.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.932 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 37.7 mt-10 -65.64 -21.6 66.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.274 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 55.1 tttm -79.87 -36.0 37.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.886 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.4 p90 -58.87 -46.36 87.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.183 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.3 p -85.26 -14.67 45.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.476 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 6.8 tp10 -60.67 -31.67 70.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.35 -50.1 9.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.723 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.569 ' O ' ' HD1' ' A' ' 47' ' ' TYR . 3.9 p90 -134.79 92.8 18.68 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.732 0.777 . . . . 0.0 112.923 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.9 -0.26 5.97 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.198 1.932 . . . . 0.0 112.338 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 3.9 pp0? -67.11 -16.87 64.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.774 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.92 152.01 20.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -91.53 140.1 30.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.337 -175.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -113.21 115.18 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.947 -172.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -139.03 147.85 42.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.626 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 21.4 pttm -145.52 153.58 41.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.833 -174.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.0 tt -159.78 146.84 16.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.78 0.324 . . . . 0.0 110.687 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.2 m-20 -92.84 121.91 34.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.3 m -68.31 -16.6 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.248 0.547 . . . . 0.0 110.04 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.79 -39.55 91.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -79.21 -41.96 27.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 60.7 mt -136.96 83.58 2.01 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.449 0.642 . . . . 0.0 111.865 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -72.55 -38.04 57.84 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.499 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.13 -27.21 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.395 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 67' ' ' ASN . 91.1 t -67.47 -55.8 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.573 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -49.86 -41.15 44.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 111.14 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -69.2 -31.48 70.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.264 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 8.0 tptt -63.94 -25.78 68.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.31 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.631 ' HB2' HG12 ' A' ' 69' ' ' VAL . 14.8 m-20 -102.97 -12.91 17.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 17.9 tp10 80.78 28.36 0.21 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.505 1.128 . . . . 0.0 110.645 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -106.58 116.41 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.248 0.546 . . . . 0.0 110.011 170.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -117.47 -30.94 5.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.22 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.46 13.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.173 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -150.0 143.5 16.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 111.016 -179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.495 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.5 Cg_endo -80.04 149.74 80.84 Favored 'Cis proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.445 -1.898 . . . . 0.0 113.036 -3.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -130.48 138.35 50.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.218 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -108.98 130.5 55.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.515 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 78' ' ' PHE . 3.1 mt -119.6 116.13 25.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.188 0.518 . . . . 0.0 110.825 176.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 85' ' ' ALA . 4.9 mp -99.08 128.33 45.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.915 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 76' ' ' LEU . 62.3 m-85 -131.13 155.9 46.19 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.941 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 40.3 ttmt -134.97 125.47 26.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.4 p-10 43.67 56.47 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.27 -1.66 69.5 Favored Glycine 0 CA--C 1.51 -0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.653 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -118.94 160.09 22.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.6 tt0 -72.94 179.12 3.87 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -153.25 -32.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.657 163.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.698 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.42 157.37 7.31 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.893 0.377 . . . . 0.0 111.954 177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -150.24 132.07 15.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.339 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 95' ' ' ILE . 55.2 t -133.27 132.32 58.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.308 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.67 50.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.075 0.464 . . . . 0.0 111.574 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.49 134.88 1.82 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.784 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.18 112.85 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.275 0.56 . . . . 0.0 111.421 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.97 90.2 32.11 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.424 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 32.8 Cg_exo -28.79 -68.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.933 3.755 . . . . 0.0 115.147 -170.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.21 -40.07 18.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -64.78 -30.44 71.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 87' ' ' VAL . 25.9 mm -74.59 -51.49 22.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.999 0.428 . . . . 0.0 110.226 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 99' ' ' ILE . 9.9 mtmp? -64.36 -23.3 67.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -82.98 -25.83 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.47 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.73 12.53 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.547 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 11.6 mt -50.36 -43.61 22.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.551 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.8 74.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.004 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.384 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -82.77 -17.66 43.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.373 176.165 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.5 t . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -72.23 144.16 48.56 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.5 tp-100 -90.65 135.85 33.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 7.6 m-85 -82.64 170.02 15.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.359 0.6 . . . . 0.0 110.773 172.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.648 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 36.8 mttp -129.71 -27.16 2.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.21 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 26.2 p -147.48 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -69.95 -26.42 64.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.93 -43.11 99.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.673 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.8 mm-40 -52.74 -45.56 67.06 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.682 ' O ' HG12 ' A' ' 15' ' ' ILE . 20.5 t80 -60.08 -62.48 1.84 Allowed 'General case' 0 N--CA 1.458 -0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.055 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.32 -37.35 74.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.112 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -61.34 -45.95 92.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.691 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.09 82.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 110.21 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.5 mm -64.16 -37.08 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.627 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 1.79 4.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.382 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 26.2 mt-30 -78.31 136.9 37.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.983 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 26.3 t0 -81.61 46.55 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.995 0.902 . . . . 0.0 110.285 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 19.8 ptpt -131.38 179.43 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.312 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 99' ' ' ILE . 1.9 tm? -83.43 113.95 21.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 3.5 t -104.51 121.33 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.88 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.7 t -108.8 114.95 48.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.55 HG11 ' CE2' ' A' ' 11' ' ' PHE . 21.9 t -107.68 129.25 62.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.853 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.23 100.96 12.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.663 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.2 m-85 -103.66 120.86 41.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.499 0.666 . . . . 0.0 111.585 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 39.6 p90 -152.23 161.24 42.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.769 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -113.5 133.55 55.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.664 0.268 . . . . 0.0 110.34 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.5 p -65.96 -21.54 66.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.418 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -77.83 -18.28 56.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.053 0.454 . . . . 0.0 110.387 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 48.1 t -82.38 147.06 29.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 -177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.58 -64.08 2.34 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.331 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 43.8 Cg_endo -68.06 10.5 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.284 2.656 . . . . 0.0 114.743 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 27.6 p -66.28 -24.79 66.62 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.833 0.825 . . . . 0.0 110.033 177.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.9 mttp -61.96 -20.64 64.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.94 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.452 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -68.16 -37.89 81.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 109.488 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.73 HD12 ' HB2' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.36 -25.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.06 -65.87 0.98 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.145 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.6 Cg_endo -83.26 -31.73 0.61 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 CA-C-N 121.066 1.416 . . . . 0.0 114.298 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.46 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.4 tmm? -67.96 -34.75 77.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.499 0.666 . . . . 0.0 109.68 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -82.18 -37.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.28 -179.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 2' ' ' VAL . 36.3 mt-10 -64.56 -23.25 67.2 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.666 171.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' NZ ' ' A' ' 96' ' ' LYS . 53.8 tptt -77.93 -36.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.995 -177.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -58.61 -41.85 86.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.995 -179.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.18 -16.92 41.69 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.961 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.52 -27.24 68.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.02 -47.45 8.11 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.306 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.606 ' OH ' ' HB ' ' A' ' 99' ' ' ILE . 8.0 p90 -137.48 93.15 12.87 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 121.645 0.736 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.66 2.52 3.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.235 1.956 . . . . 0.0 111.662 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.04 -23.27 67.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.171 179.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.13 154.52 18.36 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -90.9 123.68 34.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.225 -173.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.7 p90 -96.05 116.35 28.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 99.2 m-85 -139.75 151.7 46.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.321 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.9 pttt -149.13 161.88 41.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 -175.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.9 tt -159.23 145.3 16.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.227 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t0 -90.98 116.47 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.077 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.48 -23.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -68.03 -34.37 76.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.342 0.591 . . . . 0.0 109.739 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -78.89 -42.01 28.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.056 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 63' ' ' VAL . 91.1 mt -136.3 78.48 1.71 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.537 0.684 . . . . 0.0 111.971 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -69.03 -32.69 73.34 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.455 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.44 -36.9 81.68 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.085 0.469 . . . . 0.0 110.984 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG12 HD21 ' A' ' 67' ' ' ASN . 93.0 t -64.19 -49.01 83.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.892 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.06 -38.27 56.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 25.3 mt-30 -70.5 -34.21 72.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.415 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 2.7 tptp -61.76 -25.86 67.72 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.188 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.648 ' HB2' HG12 ' A' ' 69' ' ' VAL . 17.1 m-20 -106.94 -13.05 15.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.272 -0.267 . . . . 0.0 111.627 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 13.3 tp10 79.82 31.26 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.378 1.049 . . . . 0.0 110.906 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.16 114.98 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.135 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.6 t -120.3 -19.12 7.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.891 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.64 156.58 16.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.731 0.301 . . . . 0.0 110.756 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mpt? -126.66 127.95 24.39 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.418 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.8 Cg_endo -89.26 164.4 37.8 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.605 -0.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.3 m -141.47 131.8 25.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.604 . . . . 0.0 111.302 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.514 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.8 mp -102.34 135.78 43.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.474 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -125.17 113.43 17.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.271 0.558 . . . . 0.0 110.58 172.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.8 mp -93.95 130.05 40.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 76' ' ' LEU . 43.4 m-85 -128.64 154.86 45.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.745 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 58.2 tttm -134.05 125.58 28.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.21 166.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.49 HD21 ' HE2' ' A' ' 82' ' ' LYS . 3.7 p-10 46.58 49.05 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.343 1.057 . . . . 0.0 113.553 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 81.53 -1.78 84.62 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.837 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HE2' HD21 ' A' ' 80' ' ' ASN . 37.8 mtmt -115.11 160.12 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -71.82 179.76 3.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.86 -32.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.478 163.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.67 140.58 1.35 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.05 136.17 41.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 95' ' ' ILE . 41.1 t -132.81 123.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 m -88.34 58.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.12 137.42 2.2 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.969 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -68.46 118.76 11.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.04 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' H ' ' CG1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.03 89.93 31.52 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 89.8 Cg_exo -22.67 -80.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 1 C-N-CA 125.449 4.1 . . . . 0.0 115.537 -169.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.09 -27.94 27.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.77 78.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.085 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' CG1' ' H ' ' A' ' 91' ' ' ASN . 32.1 mm -72.35 -46.32 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.1 mttt -64.0 -23.15 67.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.855 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 97' ' ' GLN . 2.0 tt0 -80.53 -33.64 36.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.521 172.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -67.46 -52.98 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.606 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.19 -42.22 25.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.571 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.13 63.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -36.45 57.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.492 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.3 m-80 -83.76 -21.91 32.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.842 178.417 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 40' ' ' ILE . 94.0 t . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.1 m -80.02 144.29 33.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.967 -171.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.521 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.9 tp-100 -93.3 136.79 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.168 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 8.6 m-85 -83.59 170.01 14.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.715 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 42.6 mtpt -123.55 -40.6 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.527 176.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -142.48 179.95 6.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -66.46 -25.76 66.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.652 0.263 . . . . 0.0 110.393 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -58.02 -49.99 74.96 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -55.16 -41.69 72.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.692 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 23' ' ' VAL . 27.0 t80 -61.17 -59.76 4.81 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.61 -35.81 75.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.547 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -61.5 -45.03 95.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -32.7 74.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 110.342 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.84 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.1 mm -63.54 -39.26 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 5.76 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.442 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.77 140.83 39.5 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.63 38.57 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.382 0.611 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -145.22 176.29 9.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.95 122.45 22.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.2 t -100.54 111.24 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.047 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.42 103.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 11' ' ' PHE . 60.1 t -104.88 119.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.867 0.842 . . . . 0.0 111.166 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.05 96.79 8.72 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.74 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.8 m-85 -99.99 113.69 26.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.471 0.653 . . . . 0.0 111.791 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -140.27 163.8 31.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.616 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -115.84 134.54 54.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.5 p -60.67 -26.13 66.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.671 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -78.58 -15.47 58.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 44.7 t -80.7 144.38 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.071 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.47 -67.63 1.9 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.274 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 66.0 Cg_endo -74.22 20.73 0.4 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.942 2.428 . . . . 0.0 114.321 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.0 p -68.02 -27.92 66.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.839 0.828 . . . . 0.0 109.556 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.6 pttt -68.25 -7.65 32.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.041 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.447 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -79.67 -35.91 38.48 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.49 -25.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.039 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.31 -61.55 6.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.809 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 88.0 Cg_endo -83.41 -30.67 0.78 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.417 1.412 . . . . 0.0 114.219 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.567 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 ttp -66.15 -50.41 64.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.67 0.668 . . . . 0.0 109.199 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -65.56 -37.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.228 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 26.6 tt0 -69.02 -27.81 66.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.2 0.524 . . . . 0.0 110.057 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -74.84 -29.05 60.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.052 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 39' ' ' MET . 18.7 m-30 -51.49 -64.0 0.95 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 110.245 175.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 60.5 p -79.27 -14.11 59.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.1 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -58.38 -35.77 72.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -83.15 -47.97 11.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.2 p90 -129.3 91.34 42.0 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.204 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.57 1.5 5.56 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.707 2.271 . . . . 0.0 111.668 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.9 tt0 -63.35 -24.05 67.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.776 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.59 154.73 18.85 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.306 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -92.47 141.6 28.34 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.026 -176.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.22 115.13 28.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.99 -172.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' THR . 97.3 m-85 -140.59 152.0 45.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.8 pttt -149.92 159.44 44.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.571 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.0 tt -158.73 150.76 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.631 0.253 . . . . 0.0 110.41 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 19.8 t0 -93.81 115.78 28.21 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.743 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -61.95 -25.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.829 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -37.31 86.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.421 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -84.94 -42.19 15.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.6 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.512 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.7 mm? -121.95 73.39 1.08 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.387 0.613 . . . . 0.0 112.12 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.86 -24.59 73.79 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.196 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 16.2 t70 -66.1 -27.63 68.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.594 0.712 . . . . 0.0 110.523 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 60' ' ' LEU . 18.4 t -75.24 -52.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.202 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.629 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.05 -20.78 10.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.8 pt20 -85.82 -31.92 22.04 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.573 0.702 . . . . 0.0 110.086 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -69.12 -27.87 65.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.573 179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.629 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.0 p30 -108.76 -8.16 15.42 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 24.6 tt0 81.04 16.82 0.53 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.057 0.848 . . . . 0.0 112.095 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.628 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -93.84 109.23 21.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.374 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -108.17 -30.4 8.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.15 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.84 162.95 17.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.266 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.439 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -151.37 145.0 17.51 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.73 0.3 . . . . 0.0 110.826 177.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -79.69 148.58 80.12 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.579 -1.842 . . . . 0.0 112.853 -1.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.2 m -133.68 142.98 48.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.68 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -112.34 125.14 53.86 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.766 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.626 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -116.91 113.56 22.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 175.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.3 mp -96.55 134.35 39.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.2 m-85 -129.43 153.16 48.21 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.597 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 21.6 tptm -134.01 119.94 19.63 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 2.2 p-10 46.63 56.7 6.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.84 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 77.7 4.43 85.13 Favored Glycine 0 CA--C 1.51 -0.232 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.495 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.4 160.73 28.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 29.0 tt0 -71.53 179.69 2.9 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -150.39 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.572 164.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -165.26 155.56 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.587 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.5 130.6 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.38 133.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.226 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.63 47.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 0.0 111.373 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.7 130.1 1.31 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.992 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.736 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.19 112.03 3.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.406 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -116.09 89.87 26.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 56.0 Cg_exo -22.49 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.357 4.038 . . . . 0.0 115.667 -171.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 -28.82 29.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.99 74.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.799 0.333 . . . . 0.0 111.222 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.68 HG21 HD22 ' A' ' 75' ' ' LEU . 45.9 mm -83.38 -32.76 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.428 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.748 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.5 mttt -57.65 -47.44 82.26 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -60.19 -32.29 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.64 61.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.2 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.4 mm -54.0 -41.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.047 0.451 . . . . 0.0 110.647 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -25.72 63.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.204 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.96 19.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.472 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -79.91 -16.93 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.069 -172.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.223 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.516 ' HB ' ' HD2' ' A' ' 54' ' ' LYS . 85.5 t . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.806 0.336 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.7 m -83.47 143.9 29.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.208 0.527 . . . . 0.0 112.335 -172.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.2 tp-100 -94.82 132.47 39.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.645 -175.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 13.0 m-85 -93.11 160.41 14.87 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.688 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.6 ptpp? -135.9 -4.45 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.817 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 18.8 p -141.89 157.29 45.16 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 111.368 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -71.41 -29.03 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.013 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -62.92 -38.15 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.688 ' OE1' ' HG2' ' A' ' 6' ' ' LYS . 24.5 mt-10 -55.44 -44.0 75.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.441 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 23' ' ' VAL . 24.1 t80 -56.21 -56.3 22.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.39 -44.16 79.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -57.38 -38.48 74.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.82 64.3 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.87 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -65.01 -40.53 89.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.63 13.51 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.048 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -85.49 140.21 30.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -79.38 47.39 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.432 0.634 . . . . 0.0 109.984 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -154.2 178.97 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.469 177.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 99' ' ' ILE . 1.6 tm? -75.74 123.89 26.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.076 0.465 . . . . 0.0 110.782 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -105.36 116.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.208 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.89 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 11' ' ' PHE . 40.5 t -102.82 126.06 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.741 0.781 . . . . 0.0 111.351 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.03 97.31 7.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.762 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.4 m-85 -104.35 116.82 32.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.613 0.721 . . . . 0.0 111.953 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 p90 -135.67 173.88 11.23 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.136 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -125.41 130.74 52.47 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -63.3 -19.48 64.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -92.97 -13.07 29.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.396 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 59.8 m -75.55 159.81 30.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.312 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.32 -83.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.227 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 89.0 Cg_endo -79.37 36.02 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.094 2.529 . . . . 0.0 113.858 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 p -65.3 -36.97 85.7 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 122.04 0.924 . . . . 0.0 109.814 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.855 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 7.7 ttpm? -68.05 -11.33 58.79 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.536 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.31 70.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -74.52 -24.66 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.932 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.715 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.3 -67.52 0.53 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.824 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.855 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 3.9 Cg_endo -85.32 -23.86 2.19 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 121.457 1.556 . . . . 0.0 113.621 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.677 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.7 ttp -71.74 -44.54 63.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.35 0.595 . . . . 0.0 109.733 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.825 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.36 -36.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.241 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 tp10 -63.01 -29.81 71.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.525 174.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -74.4 -33.87 63.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.474 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.647 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 19.9 m-85 -57.24 -57.72 11.39 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 p -76.91 -14.22 59.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.932 0.396 . . . . 0.0 110.805 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.3 -35.14 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -84.51 -44.56 13.48 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.595 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.4 p90 -129.7 89.54 46.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.641 0.734 . . . . 0.0 112.042 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.2 -0.69 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.219 1.946 . . . . 0.0 112.152 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.99 -3.71 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.3 163.08 12.69 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.38 139.72 30.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.237 -177.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.4 p90 -122.96 114.58 20.62 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.551 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.508 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 96.9 m-85 -141.06 148.4 40.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HD2' ' HB ' ' A' ' 2' ' ' VAL . 17.4 ptmt -148.48 152.58 37.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 -172.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.4 tt -160.88 149.02 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 8.1 p-10 -100.04 129.89 46.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.474 0.654 . . . . 0.0 110.831 174.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 72' ' ' MET . 2.4 m -72.6 -11.79 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.081 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.6 -44.16 74.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -79.61 -41.53 26.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.969 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.9 mm? -122.42 79.1 1.58 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.696 0.76 . . . . 0.0 112.838 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.03 -38.83 34.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.001 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.435 ' HA ' HE21 ' A' ' 65' ' ' GLN . 3.9 p-10 -68.46 -24.69 64.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.173 0.486 . . . . 0.0 110.619 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG12 HD21 ' A' ' 67' ' ' ASN . 87.3 t -68.48 -50.0 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 174.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.99 -39.29 62.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.867 175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' A' ' 62' ' ' ASP . 49.9 mt-30 -70.4 -28.59 65.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.84 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.583 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 9.6 tptt -67.38 -27.87 67.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.487 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.713 ' HB2' HG12 ' A' ' 69' ' ' VAL . 14.1 m-20 -104.54 -7.91 19.4 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 -170.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 32.9 tt0 80.88 17.4 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.469 1.105 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -93.29 106.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.627 0.727 . . . . 0.0 109.918 175.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 p -114.47 -18.38 11.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.832 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 147.06 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -135.89 143.85 46.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.17 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 67.4 Cg_endo -80.78 153.19 82.77 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.287 -1.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -135.01 143.36 46.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.887 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -115.39 128.36 56.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.333 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.84 114.13 21.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 85' ' ' ALA . 6.5 mp -94.07 126.26 39.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.086 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CG ' HD12 ' A' ' 15' ' ' ILE . 52.8 m-85 -125.32 151.95 45.37 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.579 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -136.96 112.99 9.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.048 0.451 . . . . 0.0 110.475 172.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.68 55.33 4.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.115 175.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.87 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 70.53 10.38 66.68 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.248 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -127.38 159.82 33.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 84' ' ' VAL . 26.8 tt0 -73.85 179.74 4.11 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -153.65 -30.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 165.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.01 157.95 24.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 111.557 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -147.57 121.66 9.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.416 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 95' ' ' ILE . 21.3 t -131.04 135.34 60.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 -172.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.31 49.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.925 0.393 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.25 122.63 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.686 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.35 105.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.465 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.69 88.64 35.53 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.524 175.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.7 Cg_exo -35.45 -59.08 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.414 3.409 . . . . 0.0 115.411 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -50.09 8.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -31.93 71.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.598 HG21 HD22 ' A' ' 75' ' ' LEU . 22.2 mm -84.52 -36.05 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.569 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 8.9 tmtt? -58.44 -38.98 78.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.73 -23.64 62.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.539 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -77.53 -58.06 3.48 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG23 ' CD1' ' A' ' 20' ' ' LEU . 9.4 mt -51.7 -40.7 27.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.295 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -34.15 77.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -37.02 69.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 57.5 m-80 -84.73 -19.35 32.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.316 -175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.47 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG11 ' HG3' ' A' ' 54' ' ' LYS . 87.8 t . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.939 0.4 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -76.14 138.97 41.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.98 126.45 32.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.076 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.725 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.5 m-30 -80.02 169.78 17.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.296 0.569 . . . . 0.0 110.605 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 70.6 mmtt -128.7 -38.3 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.41 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 30.7 p -134.98 178.9 6.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.443 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.17 -28.44 64.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.07 -44.6 83.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.166 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 4.5 mm-40 -54.34 -50.53 67.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.307 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.639 ' O ' HG12 ' A' ' 15' ' ' ILE . 12.7 t80 -58.73 -59.33 5.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.14 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 24.5 t70 -63.19 -34.4 77.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.841 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -62.88 -42.87 99.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.62 0.248 . . . . 0.0 110.441 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.74 92.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.6 mm -58.12 -38.41 67.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.022 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.68 5.32 3.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.429 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -79.34 150.54 31.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.67 0.272 . . . . 0.0 110.465 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.39 45.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 111.068 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 30.6 pttt -156.91 -179.99 8.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.4 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.0 tm? -79.22 118.81 21.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 0.0 111.265 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -112.82 109.12 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.936 176.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -107.76 116.94 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.697 0.761 . . . . 0.0 110.039 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.527 HG11 ' CE2' ' A' ' 11' ' ' PHE . 48.1 t -103.19 128.43 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.934 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -88.22 97.73 11.18 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.895 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.71 114.43 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -178.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 17.4 p90 -140.64 -179.56 6.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.852 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.07 130.72 46.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.088 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -66.01 -19.41 65.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.118 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -86.06 -13.35 47.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.632 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 52.0 t -90.35 148.45 22.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.587 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -80.67 -62.33 2.05 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.742 -176.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.7 Cg_exo -60.24 -7.49 6.74 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.909 2.406 . . . . 0.0 113.894 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 71.5 m -63.89 -26.87 68.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.424 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 55.3 pttt -62.77 -15.96 55.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.777 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 23.9 ttt -77.46 -27.15 51.98 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.147 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.698 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -75.73 -23.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.735 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.46 -66.57 0.88 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.24 172.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 69.0 Cg_endo -82.52 -34.14 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 CA-C-N 121.055 1.412 . . . . 0.0 114.315 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.591 ' CE ' HG13 ' A' ' 40' ' ' ILE . 2.5 tmm? -66.54 -36.72 83.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.492 0.663 . . . . 0.0 110.085 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.778 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.9 mt -81.11 -34.05 13.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -66.31 -25.33 66.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.912 171.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -78.38 -33.59 48.75 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.689 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -59.57 -47.9 83.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.827 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 97.6 p -85.25 -15.69 42.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.973 -0.454 . . . . 0.0 110.981 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.4 -29.68 70.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 13.6 tp60 -89.02 -50.17 6.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.286 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 43' ' ' PHE . 10.1 p90 -124.71 91.27 49.71 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 0.94 5.07 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.066 1.844 . . . . 0.0 111.224 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 4.0 tt0 -63.02 -23.37 67.42 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.918 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 17.85 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.1 m-20 -91.07 126.7 36.23 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.803 0.811 . . . . 0.0 111.005 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.541 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -103.6 114.17 28.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.282 -172.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.3 m-85 -136.05 147.58 47.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.711 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 76.4 mttt -132.71 152.08 51.81 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.956 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.751 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.8 tt -159.24 149.73 19.43 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.827 0.346 . . . . 0.0 110.711 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 9.0 t0 -101.43 119.78 39.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.954 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.7 p -69.74 -21.34 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.97 -37.16 83.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.214 0.53 . . . . 0.0 109.748 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.47 -42.99 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.342 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -115.02 80.49 1.42 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.13 -40.49 34.37 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.502 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.34 -24.77 65.75 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.116 0.484 . . . . 0.0 110.703 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.634 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 95.3 t -68.0 -51.44 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.361 174.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -46.67 -42.84 17.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.042 0.448 . . . . 0.0 111.579 174.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -73.73 -25.26 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.858 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.546 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 13.5 tptt -69.37 -25.04 63.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.686 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.575 HD21 HG12 ' A' ' 63' ' ' VAL . 12.1 m-20 -108.24 -13.72 14.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.664 -171.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.3 tp10 79.79 30.99 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.26 0.975 . . . . 0.0 110.999 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.649 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -107.47 120.2 58.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.873 -0.517 . . . . 0.0 110.491 171.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -115.72 -39.49 3.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.42 164.79 13.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.322 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.45 ' CE ' HG11 ' A' ' 57' ' ' VAL . 1.1 pmm? -146.01 151.57 45.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.915 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.7 Cg_endo -78.23 149.84 87.42 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.81 -3.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.4 m -132.27 133.64 44.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.793 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -103.07 124.07 47.85 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.699 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -117.57 112.36 20.46 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.427 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.8 mp -96.41 133.09 41.25 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.699 ' CE1' HD22 ' A' ' 76' ' ' LEU . 62.0 m-85 -128.65 157.11 42.22 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.522 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -139.42 116.26 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.3 t30 65.37 50.39 1.74 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.675 0.75 . . . . 0.0 111.239 171.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.747 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.9 5.15 64.13 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.011 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -126.91 160.37 31.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 28.3 tt0 -69.53 178.89 2.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -148.67 -32.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.892 163.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.31 138.22 1.56 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.929 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.54 ' HB3' HD23 ' A' ' 76' ' ' LEU . 23.0 pttm -133.31 134.95 44.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.92 173.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -131.98 122.69 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.322 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 t -91.58 62.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 110.267 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.62 125.66 0.81 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.25 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.27 111.57 1.25 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.211 0.529 . . . . 0.0 111.491 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.7 OUTLIER -116.52 88.97 25.91 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -31.76 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.723 3.615 . . . . 0.0 115.427 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.13 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.63 61.87 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.5 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.0 mm -76.58 -49.24 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.623 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 19.5 mtpp -62.58 -26.08 68.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.444 0.64 . . . . 0.0 110.21 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -80.03 -33.13 39.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.564 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.12 -52.8 57.43 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -53.23 -39.59 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.394 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 -20.42 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.249 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.26 -43.45 17.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.981 0.42 . . . . 0.0 111.047 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -80.01 -22.63 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.822 -0.608 . . . . 0.0 111.324 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' HG2' ' A' ' 41' ' ' GLU . 54.9 t . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 120.733 0.302 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.9 m -80.82 144.78 31.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.22 0.533 . . . . 0.0 112.377 -170.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.6 tp-100 -94.16 136.21 34.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.932 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.696 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.3 m-85 -98.57 158.6 15.5 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 14.8 ptmm? -135.01 -1.54 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.832 169.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 33.8 p -138.57 159.75 41.31 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 111.15 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.219 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.155 173.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.696 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 27.3 mt-10 -54.06 -47.26 71.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.05 173.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.1 t80 -58.74 -59.03 6.06 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.958 0.409 . . . . 0.0 109.959 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.58 -35.22 72.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.549 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -63.51 -48.43 77.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.621 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.91 73.2 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.0 110.381 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.824 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -63.39 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.065 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.33 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.81 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.54 142.9 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.06 74.54 9.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.26 0.552 . . . . 0.0 110.801 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -174.62 179.22 1.77 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.9 tm? -81.2 120.75 25.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.1 t -100.59 109.8 26.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.154 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 t -92.55 103.38 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 11' ' ' PHE . 22.1 t -105.65 131.08 55.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.311 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -108.21 100.45 9.76 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.939 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -103.58 115.52 30.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.514 0.673 . . . . 0.0 111.813 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 25.8 p90 -137.76 175.96 9.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB3' ' HG3' ' A' ' 72' ' ' MET . . . -126.29 133.5 51.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -15.11 63.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.359 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.436 ' HD1' ' OD2' ' A' ' 58' ' ' ASP . 51.8 p-90 -89.11 -13.47 38.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 110.794 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.8 t -84.39 143.83 29.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.056 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.03 2.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.96 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 19.5 Cg_exo -68.98 15.81 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.447 2.765 . . . . 0.0 114.531 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.01 -29.28 69.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 122.02 0.914 . . . . 0.0 108.98 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -65.62 -8.83 22.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.21 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -37.26 39.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.11 -25.2 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.751 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.78 -66.46 1.07 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.481 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 85.6 Cg_endo -83.23 -26.85 2.08 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 120.617 1.256 . . . . 0.0 114.226 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.608 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.1 ttp -69.75 -41.95 74.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.55 0.69 . . . . 0.0 109.587 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -74.72 -39.26 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.767 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.803 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.6 mt-10 -66.59 -26.69 67.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.045 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.34 -37.74 74.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.275 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.6 m-85 -52.45 -62.32 1.72 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.257 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 m -76.77 -13.76 59.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.567 0.223 . . . . 0.0 111.301 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 35.3 tt0 -60.0 -31.93 70.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.467 HE22 ' CD ' ' A' ' 96' ' ' LYS . 20.6 mt-30 -89.3 -46.69 8.57 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.07 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.2 p90 -127.35 90.13 49.63 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.26 0.552 . . . . 0.0 111.941 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.34 -0.72 9.6 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.444 2.096 . . . . 0.0 112.381 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.4 -13.5 58.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.433 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.12 151.66 21.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.99 141.44 28.62 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.668 -177.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.728 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -116.25 115.38 25.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.164 -170.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 93.8 m-85 -140.69 149.1 41.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.783 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.7 pttt -149.32 157.71 43.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.665 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 60' ' ' LEU . 7.1 tt -160.61 151.88 19.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.636 0.255 . . . . 0.0 111.344 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.7 m-20 -91.72 111.74 23.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.699 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 26' ' ' TYR . 3.4 p -66.4 -19.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD2' ' HD1' ' A' ' 29' ' ' TRP . 6.4 t70 -53.21 -43.81 67.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.596 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -94.28 -42.42 8.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.994 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.1 mm? -111.67 73.25 0.81 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.5 64.75 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.129 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 22.1 m-20 -65.82 -26.5 67.71 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.428 0.632 . . . . 0.0 110.555 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 67' ' ' ASN . 84.7 t -71.52 -52.48 25.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.634 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.78 -34.71 65.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.75 0.31 . . . . 0.0 111.369 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -68.07 -37.85 81.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 109.441 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 17.0 tptt -60.78 -22.89 64.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.964 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 69' ' ' VAL . 33.9 m-20 -106.71 -13.63 15.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 34.0 tt0 79.63 27.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 124.269 0.981 . . . . 0.0 110.854 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.47 126.92 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 170.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -126.59 -40.1 1.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.307 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.25 160.67 16.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 1.3 pmm? -143.02 151.46 56.01 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.878 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' HG12 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -78.65 148.4 83.4 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 -1.907 . . . . 0.0 113.049 -3.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -131.21 135.89 47.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.731 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 40' ' ' ILE . 4.1 mp -106.02 130.79 53.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.661 177.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.656 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.6 mt -124.58 113.69 18.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.095 0.474 . . . . 0.0 110.824 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -96.97 131.06 44.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.656 ' CE1' HD22 ' A' ' 76' ' ' LEU . 59.9 m-85 -128.26 157.1 41.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 34.5 ttpt -141.73 125.14 16.59 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.9 p30 47.08 55.5 7.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.557 1.143 . . . . 0.0 113.698 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.824 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 75.34 3.55 71.09 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.704 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.41 160.81 26.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -71.0 -179.05 2.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -152.44 -29.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.707 164.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.633 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.32 150.79 4.37 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.635 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HB3' HD23 ' A' ' 76' ' ' LEU . 14.1 ptmm? -145.31 126.63 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.255 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.67 133.46 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.949 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.28 59.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 122.287 1.042 . . . . 0.0 110.189 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 129.43 1.12 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.527 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.07 106.08 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.676 0.391 . . . . 0.0 111.957 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 89.54 37.74 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.788 175.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -35.5 -61.02 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.397 3.398 . . . . 0.0 115.161 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.3 14.42 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -172.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.08 71.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.648 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 99' ' ' ILE . 46.1 mm -87.24 -32.43 6.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.229 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 10.1 ttpp -60.13 -39.57 86.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 170.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.32 -28.91 67.58 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.653 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.02 -61.65 1.93 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.55 -34.96 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.712 0.632 . . . . 0.0 110.576 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.75 -21.62 54.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.949 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.82 -35.56 15.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.062 0.458 . . . . 0.0 110.56 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.655 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -88.07 -18.26 29.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 -176.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.662 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 52' ' ' PHE . 59.7 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.544 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.3 m -75.65 145.12 41.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.251 -170.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -94.39 138.97 31.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.2 m-85 -88.73 164.0 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.199 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.13 -14.71 2.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.758 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -147.16 174.38 11.64 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.94 -23.57 62.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 t -60.02 -47.93 83.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.555 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -53.14 -42.66 66.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.94 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.728 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.2 t80 -57.35 -58.3 8.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 8.7 m-20 -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.816 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -60.24 -44.27 95.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.578 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.29 76.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.464 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.684 HG22 ' HA2' ' A' ' 81' ' ' GLY . 9.2 mm -66.99 -39.99 84.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.56 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.17 7.52 3.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -80.73 146.35 31.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.99 40.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.28 176.33 9.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.897 -176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.7 tm? -81.13 121.9 26.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 0.0 109.828 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -100.74 122.41 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.218 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.21 102.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.728 HG11 ' CE2' ' A' ' 11' ' ' PHE . 59.2 t -104.11 119.34 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.813 0.816 . . . . 0.0 111.077 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.49 96.75 8.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.67 -177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE2' HD22 ' A' ' 55' ' ' LEU . 1.9 m-85 -100.35 124.79 46.28 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.408 0.623 . . . . 0.0 111.953 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 47.9 p90 -151.5 -178.46 6.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.992 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -128.81 137.53 51.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 111.047 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 p -68.9 -21.61 64.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -84.62 -6.61 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.089 0.471 . . . . 0.0 110.633 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 41.9 t -88.28 159.9 17.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.24 -61.72 1.02 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.081 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 28.1 Cg_exo -65.49 -1.38 4.67 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.647 . . . . 0.0 114.026 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 16.9 p -62.04 -28.34 69.52 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.103 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -8.31 24.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.557 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.4 ttt -84.04 -28.87 27.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.302 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -76.93 -24.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.249 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -56.54 -64.36 2.51 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.189 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.1 Cg_endo -82.64 -31.13 0.86 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.592 1.528 . . . . 0.0 114.427 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 1.7 ttp -68.24 -41.68 80.84 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.496 0.589 . . . . 0.0 109.679 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.827 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.72 -39.39 60.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.39 -36.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 22.5 ttmm -68.77 -29.47 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.707 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 23.0 m-85 -56.84 -59.22 5.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.2 m -77.25 -14.01 59.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.627 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' LYS . 40.1 tt0 -62.26 -29.51 70.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 21.4 mt-30 -89.95 -50.68 5.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.2 p90 -125.9 90.91 49.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.254 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.02 0.89 5.17 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.831 2.354 . . . . 0.0 112.361 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 5.1 tt0 -63.46 -23.67 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.936 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.68 154.65 18.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -91.53 126.07 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.64 -173.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.7 p90 -96.57 115.76 27.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.252 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.7 m-85 -141.53 149.46 40.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.723 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.8 pttp -148.79 158.82 44.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.64 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.7 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.4 tt -159.16 150.06 19.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 110.294 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.8 t0 -98.74 120.08 38.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.758 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 27' ' ' ALA . 3.1 m -66.54 -20.6 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.453 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.75 -37.79 82.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.392 0.615 . . . . 0.0 109.521 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -42.89 24.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.674 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HB3' HG23 ' A' ' 63' ' ' VAL . 93.7 mt -131.07 75.26 1.65 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.586 0.708 . . . . 0.0 112.17 -175.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -70.25 -29.05 70.61 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.792 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.3 -29.33 70.07 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.535 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 60' ' ' LEU . 22.0 t -69.57 -51.06 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.63 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.09 -20.11 9.04 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.569 0.543 . . . . 0.0 112.307 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 77.6 mm-40 -85.35 -33.75 21.97 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 0.0 110.822 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 11.1 tptt -68.31 -36.2 78.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 110.644 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.63 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.3 p30 -96.48 -13.23 23.22 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.7 mt-10 78.69 17.86 0.99 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.927 174.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.38 108.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 109.462 172.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -109.59 -19.65 13.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.002 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.97 149.52 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.53 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -133.61 133.88 23.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.116 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HB2' HG12 ' A' ' 36' ' ' ILE . 73.3 Cg_endo -82.33 153.97 76.63 Favored 'Cis proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.301 -1.541 . . . . 0.0 113.802 -0.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -137.45 142.44 41.59 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.183 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 95' ' ' ILE . 4.4 mp -109.8 126.05 53.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.693 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -117.01 113.72 22.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.052 0.453 . . . . 0.0 111.039 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.6 mp -96.84 134.96 39.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.282 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 76' ' ' LEU . 49.8 m-85 -132.04 151.08 51.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 15.9 mtpp -128.18 108.0 10.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.986 0.179 . . . . 0.0 110.743 170.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 58.2 53.8 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.682 0.753 . . . . 0.0 111.852 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.77 -6.0 79.9 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.832 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 64.7 pttt -121.45 160.74 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.7 tt0 -67.98 179.45 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -152.15 -29.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.635 163.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -160.23 155.26 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.085 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -155.17 113.69 3.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.669 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 95' ' ' ILE . 22.0 t -127.65 135.25 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.629 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.2 m -102.12 43.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.29 123.91 0.88 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.323 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -57.77 104.45 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.467 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.48 89.2 26.46 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.72 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.5 Cg_exo -31.23 -76.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.474 3.449 . . . . 0.0 115.079 -172.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.92 -41.08 68.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.12 -29.91 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.455 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.7 mm -87.55 -31.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.808 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 64.6 mttm -54.6 -44.37 72.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -65.42 -32.87 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.883 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.17 -57.82 6.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.4 mm -54.03 -35.12 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.679 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.81 -29.74 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.273 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.64 -40.89 61.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 111.011 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 46.0 m-80 -82.98 -16.28 47.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.029 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.548 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 40' ' ' ILE . 88.3 t . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.505 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.2 m -72.36 144.8 48.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.186 -170.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -97.3 125.07 41.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.809 -174.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.4 m-85 -75.15 170.44 16.04 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 10' ' ' GLU . 59.9 pttt -133.93 -21.62 1.89 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.288 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 178.8 9.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.365 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -70.23 -29.08 65.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.792 0.329 . . . . 0.0 110.781 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -54.56 -48.12 72.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.839 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.571 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 6.0 mp0 -55.38 -46.85 76.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.55 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.685 ' O ' HG12 ' A' ' 15' ' ' ILE . 30.9 t80 -56.45 -59.51 4.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.811 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.0 -36.78 77.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.663 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.6 m -61.79 -45.7 92.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.655 0.264 . . . . 0.0 110.991 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -34.12 77.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.877 0.37 . . . . 0.0 110.322 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.773 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.94 -40.51 87.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.312 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.41 2.16 14.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.481 -173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 9.9 tt0 -76.51 144.49 39.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.882 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 57.2 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 8.8 ptmm? -168.73 176.53 5.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.005 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.15 115.18 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.213 0.53 . . . . 0.0 110.895 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.4 t -101.22 135.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.982 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.59 115.97 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 11' ' ' PHE . 33.6 t -107.52 131.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.577 0.703 . . . . 0.0 110.9 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.88 96.6 6.94 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.469 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CD1' HG11 ' A' ' 69' ' ' VAL . 26.7 m-85 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.667 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.659 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.9 p90 -163.24 179.17 7.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.727 169.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -127.61 128.74 46.05 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 p -65.05 -18.67 65.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -88.96 -10.59 47.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.417 . . . . 0.0 110.713 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 49.7 t -97.64 148.88 22.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.831 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.22 2.86 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.411 -0.66 . . . . 0.0 114.655 -173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.3 Cg_exo -59.49 -2.56 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.17 2.58 . . . . 0.0 114.044 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 26' ' ' TYR . 69.5 m -63.19 -24.44 67.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.27 0.557 . . . . 0.0 110.929 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 57.0 mtpt -65.63 -9.36 26.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.765 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.414 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.03 -35.49 49.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 109.354 176.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -75.29 -25.82 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.408 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.13 -66.2 0.88 Allowed Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.923 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 76.4 Cg_endo -83.44 -32.72 0.45 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.319 1.346 . . . . 0.0 114.479 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.5 tmm? -69.86 -38.08 76.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.412 0.625 . . . . 0.0 109.85 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.84 -33.64 14.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.804 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 41.1 tt0 -67.87 -23.23 65.11 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.156 172.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 49.4 tptt -78.64 -37.27 42.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.584 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.1 p90 -59.05 -49.63 77.14 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.572 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 94.1 p -85.13 -14.5 46.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.673 -175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 5.5 tp10 -59.59 -33.69 71.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.02 -47.62 8.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.419 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 9.4 p90 -126.69 90.89 48.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.469 0.652 . . . . 0.0 112.489 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.05 -0.34 8.94 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.357 2.038 . . . . 0.0 112.182 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.02 -9.37 29.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.225 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.47 155.58 17.98 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 5.8 m-20 -91.08 120.55 32.13 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.719 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -100.66 115.27 29.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.979 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.505 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 95.9 m-85 -139.92 141.46 36.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.088 0.471 . . . . 0.0 111.324 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 76.2 mttt -122.21 155.05 36.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.006 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 63' ' ' VAL . 8.4 tt -159.5 142.04 13.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.23 130.79 52.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.308 0.575 . . . . 0.0 111.196 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.9 m -69.42 -16.11 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.256 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.35 -41.56 84.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.216 0.532 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.46 -42.72 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.899 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -121.4 77.71 1.36 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.165 0.507 . . . . 0.0 112.282 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.06 35.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.327 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.05 -32.58 74.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 110.295 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 67' ' ' ASN . 86.5 t -64.53 -52.16 58.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.119 176.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.48 -38.84 46.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.024 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 17.8 mm100 -70.68 -33.5 71.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.4 tptt -62.04 -28.45 69.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 175.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.834 ' HB2' HG12 ' A' ' 69' ' ' VAL . 17.7 m-20 -100.55 -12.53 19.19 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.004 -169.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.4 tp10 79.82 26.42 0.36 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.298 0.999 . . . . 0.0 110.225 -177.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -106.61 118.23 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.425 0.631 . . . . 0.0 111.412 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.5 m -131.25 11.92 5.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.426 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.94 30.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' HG21 ' A' ' 57' ' ' VAL . 14.8 mmt -127.19 117.98 21.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.583 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.7 Cg_endo -89.52 175.21 22.44 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.561 -1.016 . . . . 0.0 111.702 -4.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 48.0 m -147.55 146.48 29.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 mp -120.88 139.64 52.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 2.3 mt -125.77 120.33 30.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.5 mp -97.96 129.26 44.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.511 ' CD2' HD12 ' A' ' 15' ' ' ILE . 35.1 m-85 -128.13 146.66 50.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -121.52 110.9 16.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.329 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p30 46.1 56.35 6.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.773 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.1 6.28 89.24 Favored Glycine 0 CA--C 1.511 -0.211 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.646 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.93 153.61 42.42 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 178.35 2.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -150.23 -32.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.437 164.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -161.98 150.97 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -145.11 129.2 17.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.55 126.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.638 0.256 . . . . 0.0 110.525 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -96.21 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.32 0.581 . . . . 0.0 111.177 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.64 140.15 2.8 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.571 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -70.08 108.88 4.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.057 0.456 . . . . 0.0 110.896 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -117.23 89.04 29.71 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.261 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -28.92 -72.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.829 3.686 . . . . 0.0 115.321 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -43.34 56.86 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.667 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -61.09 -33.21 72.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.434 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.9 mm -74.78 -49.64 28.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.999 0.428 . . . . 0.0 110.211 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 18.1 mtpp -67.18 -24.2 65.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.387 0.613 . . . . 0.0 110.63 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.92 -31.97 51.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.099 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.49 -54.3 30.28 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.212 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -53.56 -36.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.14 60.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.227 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.61 -40.46 20.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.453 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' HD23 ' A' ' 77' ' ' LEU . 45.9 m-80 -83.51 -11.63 57.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.278 -175.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.699 177.26 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.665 HG23 ' HG2' ' A' ' 41' ' ' GLU . 69.8 t . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -79.08 144.1 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.295 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.668 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.87 131.24 37.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.974 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -80.11 167.38 20.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.053 0.454 . . . . 0.0 110.847 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.45 -39.74 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -144.47 -179.94 6.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.011 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.8 67.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.902 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 t -57.81 -49.91 75.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.0 mp0 -51.17 -46.53 62.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.579 173.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.3 t80 -58.19 -58.31 9.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 -178.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.94 -36.48 84.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.732 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.5 m -65.49 -30.94 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 111.104 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.45 -35.45 58.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.091 0.472 . . . . 0.0 109.874 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.848 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.4 mm -62.72 -39.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.478 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.46 3.39 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.424 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.402 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 26.1 mt-30 -77.01 141.62 40.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.083 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.2 31.96 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.533 0.682 . . . . 0.0 111.254 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.18 179.36 6.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.549 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.7 tm? -76.01 117.13 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.631 -174.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.5 t -103.02 119.14 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.748 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 13.9 t -106.91 112.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 11' ' ' PHE . 23.8 t -106.57 122.17 60.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.807 0.813 . . . . 0.0 110.83 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.22 97.39 11.1 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.935 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.712 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.5 m-85 -96.66 124.33 40.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.697 0.761 . . . . 0.0 112.631 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -154.79 165.47 36.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.141 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -118.01 140.5 49.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.181 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 p -65.39 -19.64 66.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.663 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -80.87 -18.54 46.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.364 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 46.3 t -83.37 141.92 31.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.056 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -75.54 -55.32 5.09 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.611 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 33.4 Cg_endo -65.75 4.73 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 114.196 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 21.7 p -64.01 -29.85 70.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.691 0.757 . . . . 0.0 109.646 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -68.84 -9.21 50.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.403 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -35.12 39.36 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.0 -25.72 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.26 -65.74 1.16 Allowed Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.859 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 64.9 Cg_endo -83.03 -29.58 1.19 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.696 1.284 . . . . 0.0 114.092 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.482 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.7 tmm? -71.41 -33.4 69.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.596 0.712 . . . . 0.0 109.851 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -84.26 -34.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.973 -179.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.665 ' HG2' HG23 ' A' ' 2' ' ' VAL . 39.6 mt-10 -68.64 -20.09 64.45 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.534 171.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -76.58 -39.07 53.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.738 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.5 p90 -57.5 -47.0 83.1 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.321 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.463 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 89.7 p -84.59 -15.41 45.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.977 -0.452 . . . . 0.0 110.655 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.59 -29.15 69.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.569 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.99 -42.32 13.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.0 175.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 8.4 p90 -138.53 91.61 12.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 112.21 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.57 1.09 4.61 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.469 2.113 . . . . 0.0 111.744 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.89 -22.77 67.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.332 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.16 159.99 14.67 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.1 m-20 -91.02 125.89 35.95 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.477 0.656 . . . . 0.0 111.232 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.66 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -104.4 114.68 29.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.049 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.4 m-85 -142.49 151.14 41.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.668 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.6 pttt -149.59 159.07 44.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.36 -175.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.8 tt -155.71 151.96 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.907 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 29.0 t0 -95.56 113.33 24.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.809 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 41.0 t -62.44 -27.12 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.183 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -66.27 -32.5 73.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 110.166 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.44 -41.97 11.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.4 mm? -118.44 65.88 0.76 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.364 0.602 . . . . 0.0 111.555 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -67.75 -31.72 76.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.625 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.12 -22.07 63.99 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 25.2 t -72.96 -50.98 28.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.701 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.82 -21.44 4.2 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 21.5 mt-30 -86.17 -28.97 23.6 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.858 -0.527 . . . . 0.0 110.801 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -70.17 -29.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.905 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 2.3 p30 -108.58 -12.55 14.97 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.023 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.2 tp10 79.23 30.1 0.32 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.052 0.845 . . . . 0.0 111.216 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.701 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -106.48 107.69 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.366 0.603 . . . . 0.0 110.611 169.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -111.35 -35.92 5.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.32 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.2 152.49 29.13 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 27' ' ' ALA . 19.7 ptp -144.49 147.32 35.99 Favored Pre-proline 0 C--N 1.321 -0.667 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.547 -174.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG12 ' A' ' 36' ' ' ILE . 59.9 Cg_endo -80.65 149.6 78.23 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.599 -1.834 . . . . 0.0 112.518 -3.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 3.3 m -133.06 133.18 42.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.295 0.569 . . . . 0.0 111.109 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.2 mp -98.79 125.77 44.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.53 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.2 mt -114.27 113.74 25.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.118 0.485 . . . . 0.0 110.473 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.1 mp -95.54 127.88 41.94 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 76' ' ' LEU . 61.4 m-85 -127.17 154.61 44.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.804 -0.18 . . . . 0.0 110.653 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' HD22 ' A' ' 80' ' ' ASN . 81.8 tttt -139.23 127.06 22.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 168.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.483 HD22 ' HG2' ' A' ' 79' ' ' LYS . 9.3 p30 50.22 49.24 20.88 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.494 1.117 . . . . 0.0 113.453 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.848 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.46 1.09 81.2 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.238 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -118.27 160.14 22.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.19 179.69 2.74 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -151.73 -29.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 164.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.59 160.32 5.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.229 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 21.5 ptmt -153.18 134.22 14.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.029 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.04 120.87 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.646 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 62.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 122.209 1.004 . . . . 0.0 110.199 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.27 130.75 1.28 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.306 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -72.72 98.28 2.35 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.667 0.27 . . . . 0.0 110.87 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.4 OUTLIER -116.4 88.48 23.73 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.285 -179.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.26 -58.93 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.344 3.363 . . . . 0.0 114.903 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.56 -46.51 38.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.87 -27.57 65.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.481 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 99' ' ' ILE . 34.3 mm -76.6 -45.2 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.572 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 72.8 tttt -60.98 -28.49 69.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.404 0.621 . . . . 0.0 110.642 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -84.35 -27.3 27.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.553 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.64 -56.65 5.97 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -51.82 -41.22 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.416 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.3 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.127 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.21 60.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -80.79 -21.22 41.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.386 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.073 179.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' PHE . 91.2 t . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.599 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 14.9 m -71.03 144.35 50.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.68 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -91.51 119.57 31.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.136 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 2.2 m-30 -76.09 167.48 21.79 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.496 173.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -129.61 -40.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -142.77 179.55 6.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.558 0.218 . . . . 0.0 111.405 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -65.99 -29.81 70.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.623 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -58.13 -46.02 86.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -54.45 -43.63 71.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 172.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.614 ' O ' HG12 ' A' ' 15' ' ' ILE . 26.9 t80 -58.28 -58.72 7.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 110.495 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.606 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 47.9 m-20 -60.0 -33.91 72.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.027 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.1 m -63.48 -41.72 98.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.689 0.281 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.08 -36.73 82.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.014 0.435 . . . . 0.0 110.154 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.768 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.3 mm -63.6 -39.71 86.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.662 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.21 12.84 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.44 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -87.72 146.41 25.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.051 0.453 . . . . 0.0 111.082 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.6 32.27 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.723 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 7.0 ptmm? -150.63 168.94 22.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.5 tm? -72.44 118.56 15.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.185 0.517 . . . . 0.0 110.959 -171.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.1 t -100.74 120.56 50.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.892 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 18.8 t -109.61 106.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.567 HG11 ' CE2' ' A' ' 11' ' ' PHE . 15.4 t -103.0 123.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.801 0.81 . . . . 0.0 110.986 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.39 96.86 10.75 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.049 -175.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.721 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.52 106.87 17.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.58 0.705 . . . . 0.0 112.004 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 40.2 p90 -128.77 -173.61 3.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.634 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -132.66 130.69 40.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 p -66.47 -21.82 66.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -84.45 -9.76 58.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.718 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.665 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.8 t -93.42 147.31 23.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.155 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.97 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.648 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.665 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.2 Cg_exo -67.23 4.62 1.14 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.096 2.531 . . . . 0.0 114.356 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 29.7 p -62.94 -32.19 73.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.028 0.918 . . . . 0.0 109.361 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -70.76 -8.98 56.28 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.968 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.6 ttt -82.76 -28.69 30.22 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 40' ' ' ILE . 1.3 mp -75.31 -25.03 17.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.594 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.92 -65.89 1.07 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.399 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 91.7 Cg_endo -83.16 -30.71 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.264 1.31 . . . . 0.0 114.521 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -68.4 -39.48 81.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -77.42 -36.37 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.565 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.68 -20.73 65.33 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.116 -0.633 . . . . 0.0 109.563 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 22.8 ttmm -83.32 -32.67 26.17 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.277 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.2 p90 -57.51 -46.37 83.87 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.265 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 93.5 p -84.8 -15.64 44.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.506 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 38.9 tt0 -56.48 -32.72 65.27 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.476 ' NE2' ' HD2' ' A' ' 96' ' ' LYS . 39.8 mt-30 -87.24 -50.43 6.6 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.837 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.597 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.8 p90 -127.78 90.67 47.34 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.166 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.61 -0.68 7.99 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.483 2.122 . . . . 0.0 112.29 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.47 -18.05 65.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.492 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.45 157.62 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 7.6 m-20 -91.75 128.12 37.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.584 0.707 . . . . 0.0 111.473 -173.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.559 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.3 p90 -106.96 114.7 28.94 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.87 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.599 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.41 146.53 40.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.196 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 42.2 mtpt -131.2 148.81 52.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.886 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.7 tt -160.7 148.12 15.78 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.1 p-10 -105.6 131.59 52.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.383 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.5 m -69.29 -12.69 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.146 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.54 -46.05 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.184 0.516 . . . . 0.0 109.794 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.51 -41.72 17.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.43 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -122.68 75.11 1.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.433 0.635 . . . . 0.0 112.129 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.62 -34.18 54.32 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.358 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.65 -28.41 69.6 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.332 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.682 HG12 HD21 ' A' ' 67' ' ' ASN . 57.8 t -70.86 -50.19 45.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.67 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.61 -40.41 52.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.059 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 mt-30 -69.17 -35.58 76.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.313 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HE3' ' OD2' ' A' ' 12' ' ' ASP . 14.4 tptp -62.57 -25.54 68.12 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.305 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.682 HD21 HG12 ' A' ' 63' ' ' VAL . 7.3 m-20 -105.9 -9.98 16.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.233 -171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 37.4 mt-10 80.51 27.31 0.26 Allowed 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.455 1.097 . . . . 0.0 111.217 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -105.2 115.35 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 110.256 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.6 p -115.95 -23.38 8.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.166 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.84 166.24 12.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.179 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -149.63 140.88 14.5 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.015 0.436 . . . . 0.0 111.359 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 57.7 Cg_endo -80.27 151.56 82.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.475 -1.885 . . . . 0.0 113.194 -4.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -129.58 139.14 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.63 126.54 54.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.358 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -115.62 115.35 26.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.04 0.447 . . . . 0.0 110.69 176.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -96.96 131.2 43.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.099 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.3 m-85 -130.45 148.69 52.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.619 0.247 . . . . 0.0 111.229 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -127.0 108.59 11.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.619 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.9 t30 60.41 55.51 3.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 111.633 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.768 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.04 6.45 64.31 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.497 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -121.8 157.86 30.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' VAL . 33.9 tt0 -73.27 179.09 4.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -151.83 -32.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 165.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.78 152.54 3.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 111.722 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 134.18 30.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.909 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.1 t -131.75 123.78 52.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.12 53.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.2 0.524 . . . . 0.0 111.497 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.93 136.01 1.94 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.625 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -66.88 107.54 2.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.12 0.486 . . . . 0.0 110.964 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -111.51 88.38 9.15 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.3 Cg_exo -31.43 -74.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 124.477 3.451 . . . . 0.0 115.319 -169.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -38.09 68.53 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.235 -0.291 . . . . 0.0 111.626 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.18 -31.3 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.383 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 99' ' ' ILE . 33.3 mm -76.41 -49.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 110.265 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 47.0 mtmt -64.37 -22.94 67.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.486 0.66 . . . . 0.0 110.152 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -80.89 -37.05 30.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.66 171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.93 -61.34 2.71 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.5 mm -47.93 -38.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.068 0.855 . . . . 0.0 110.671 -176.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.95 -22.24 59.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.615 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.5 -28.97 18.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.156 0.503 . . . . 0.0 110.443 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.628 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -95.73 -10.34 29.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.027 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.736 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.104 0.478 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 52' ' ' PHE . 71.5 t -103.74 125.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.759 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 14.4 m -72.71 145.0 47.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.653 0.739 . . . . 0.0 112.68 -168.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.48 139.47 30.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.237 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.546 ' HB2' HD12 ' A' ' 55' ' ' LEU . 5.9 m-85 -85.11 170.54 12.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.772 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 54.1 mttm -121.62 -39.24 2.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -148.56 -179.07 6.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.55 -27.92 69.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 m -60.01 -45.37 93.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.2 mp0 -57.99 -42.69 85.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.52 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' O ' HG12 ' A' ' 15' ' ' ILE . 13.5 t80 -60.4 -54.63 43.26 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.51 -39.12 79.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.684 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -61.65 -47.07 87.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.706 0.288 . . . . 0.0 110.565 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -63.76 -31.71 72.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.471 . . . . 0.0 110.379 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.696 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.4 mm -65.21 -40.37 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.38 2.21 9.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.297 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 25.9 mt-30 -73.95 139.62 45.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.711 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.33 40.46 0.56 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.315 0.578 . . . . 0.0 110.823 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 2.3 pttp -153.54 163.11 40.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.884 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.9 tm? -69.54 113.82 7.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.029 0.442 . . . . 0.0 110.995 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 4.4 p -110.01 118.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.957 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.605 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -110.23 119.66 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 109.85 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.498 HG11 ' CE2' ' A' ' 11' ' ' PHE . 58.0 t -102.59 127.41 56.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.243 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -87.86 97.01 10.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.443 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -107.15 110.36 22.43 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.092 0.472 . . . . 0.0 110.818 -176.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 26.3 p90 -145.31 -171.54 3.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.092 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -136.25 136.69 40.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -61.02 -24.12 65.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -88.69 -10.44 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.275 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 72' ' ' MET . 44.2 t -77.44 158.39 30.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.034 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.1 -76.57 0.6 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.217 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 6.3 Cg_exo -74.39 14.77 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.187 2.591 . . . . 0.0 113.757 -173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 27.4 p -59.92 -34.95 73.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.882 0.848 . . . . 0.0 109.916 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -70.29 -8.0 46.87 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.423 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.586 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.1 ttt -84.44 -28.99 26.47 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.098 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -77.5 -25.73 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.32 -64.98 1.46 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 94.8 Cg_endo -82.46 -30.55 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 121.192 1.261 . . . . 0.0 114.133 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.545 ' CE ' HD21 ' A' ' 75' ' ' LEU . 1.5 ttp -67.44 -42.8 82.53 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 118.508 0.595 . . . . 0.0 109.905 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.31 -37.35 51.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.432 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.9 -38.52 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.658 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 56.8 mttp -65.36 -31.37 72.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.107 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.9 m-30 -55.65 -62.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.703 0.287 . . . . 0.0 110.268 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -73.84 -14.05 61.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.678 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 tt0 -60.32 -33.4 72.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.494 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.4 -47.96 8.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 175.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.518 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.2 p90 -128.68 86.4 57.68 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.158 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 -0.68 8.95 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.475 2.116 . . . . 0.0 112.252 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -67.47 -13.35 61.96 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.17 17.27 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.453 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.2 m-20 -91.8 126.42 36.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.254 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -102.27 114.16 28.07 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.493 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 98.6 m-85 -139.89 152.65 46.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.06 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.7 pttp -148.98 153.46 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.849 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.824 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 8.0 tt -159.14 146.44 17.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.1 m-20 -99.68 125.23 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -65.21 -22.72 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.07 -35.65 73.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.454 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.67 -43.53 11.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.964 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 55' ' ' LEU . 46.0 mt -131.77 89.98 2.77 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.559 0.695 . . . . 0.0 112.445 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.06 -33.78 39.78 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.246 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.53 -30.13 68.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.151 0.501 . . . . 0.0 110.03 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.678 HG12 HD21 ' A' ' 67' ' ' ASN . 89.2 t -62.89 -50.23 80.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 69' ' ' VAL . . . -46.76 -42.42 16.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.191 0.519 . . . . 0.0 111.406 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.04 -34.72 69.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.631 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 16.0 tptt -61.1 -26.44 67.66 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.711 ' HB2' HG12 ' A' ' 69' ' ' VAL . 9.1 m-20 -105.09 -10.89 16.87 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.187 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 43.1 mt-10 80.17 26.68 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.391 1.057 . . . . 0.0 111.271 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -104.72 110.71 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.687 0.756 . . . . 0.0 111.241 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -114.0 -34.66 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.54 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.65 159.65 26.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.872 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.446 ' HG3' ' SG ' ' A' ' 30' ' ' CYS . 20.3 ptp -151.17 140.84 14.06 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.906 0.384 . . . . 0.0 110.958 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.2 Cg_endo -80.83 150.47 79.1 Favored 'Cis proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.726 -1.781 . . . . 0.0 113.154 -2.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -120.79 145.93 47.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.229 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 95' ' ' ILE . 3.6 mp -120.76 123.47 42.75 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 78' ' ' PHE . 7.1 mt -122.5 112.72 18.37 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.841 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.605 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 4.0 mp -94.46 134.8 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HB3' HG23 ' A' ' 15' ' ' ILE . 52.0 m-85 -133.45 156.73 47.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.406 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.42 122.75 19.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.47 167.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 t30 60.78 41.49 14.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.661 0.743 . . . . 0.0 111.352 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 86.16 -4.32 86.12 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.272 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -121.86 161.61 22.45 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 78' ' ' PHE . 25.1 tt0 -66.92 178.75 1.28 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.59 -28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.047 162.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -154.81 146.39 23.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 112.073 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -135.14 115.33 13.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.665 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 95' ' ' ILE . 12.3 t -131.06 141.54 45.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -121.62 48.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.152 0.501 . . . . 0.0 110.743 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.35 129.2 1.18 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.309 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -62.63 108.21 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.122 0.487 . . . . 0.0 112.114 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.98 90.32 32.55 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -33.07 -63.15 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.659 3.573 . . . . 0.0 115.074 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 -46.02 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.72 71.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.969 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 75' ' ' LEU . 29.5 mm -87.36 -34.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.271 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.518 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 31.9 tttt -59.83 -37.87 80.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.595 0.712 . . . . 0.0 109.121 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.75 -30.27 69.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.466 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -56.59 8.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.441 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -51.07 -41.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.223 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.74 70.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.36 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -78.98 -21.04 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.979 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.787 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.584 0.23 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 52' ' ' PHE . 96.1 t -87.65 131.93 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.193 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.6 m -83.04 139.18 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 112.447 -170.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 55' ' ' LEU . 8.4 tp-100 -90.56 138.91 31.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.097 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 16.0 m-85 -95.69 161.4 14.05 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.622 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.8 ptpp? -134.37 -3.72 2.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.315 170.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.9 p -141.94 158.86 43.27 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.939 0.399 . . . . 0.0 111.322 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.21 -27.94 63.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.097 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -57.61 -46.4 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.344 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.694 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.1 mt-10 -55.41 -43.27 75.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.984 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.8 t80 -60.55 -58.41 8.6 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.36 -37.39 80.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.259 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -59.41 -43.22 93.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.892 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.02 -33.73 74.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.475 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.808 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.2 mm -63.01 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.279 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.93 -1.3 16.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.693 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.454 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 8.3 tt0 -72.31 141.32 48.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.791 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.32 48.16 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.501 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 5.3 ptpp? -157.9 -179.88 8.55 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -73.8 123.11 23.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 109.885 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -102.2 117.9 48.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.231 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -97.06 103.0 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 11' ' ' PHE . 38.4 t -105.34 124.17 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.973 0.892 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.806 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.17 96.76 7.2 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.733 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -101.0 128.62 46.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.778 0.799 . . . . 0.0 111.908 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 25.7 p90 -152.95 178.47 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.113 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.5 138.92 51.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.738 0.304 . . . . 0.0 110.277 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 p -66.19 -18.87 65.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.473 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -86.44 -10.75 53.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.59 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 39.4 t -84.16 152.75 24.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.597 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.59 -61.87 1.67 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.953 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.35 3.28 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.094 2.529 . . . . 0.0 113.872 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 29.0 p -60.43 -32.42 71.35 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.6 tptm -68.2 -11.88 60.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.801 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 24.0 ttt -79.43 -28.11 41.71 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -76.21 -22.73 15.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.616 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.57 -68.25 0.49 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.474 172.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.9 Cg_endo -84.11 -32.04 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 CA-C-N 120.941 1.372 . . . . 0.0 114.43 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.554 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.97 -48.55 73.61 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.374 0.534 . . . . 0.0 109.71 -176.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.806 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -68.19 -37.9 78.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.045 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.14 -26.52 67.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 109.499 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 50.2 tptt -77.13 -30.85 55.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.948 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.671 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 18.1 m-30 -52.65 -64.55 0.78 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.012 0.434 . . . . 0.0 109.872 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.4 m -80.03 -13.2 59.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.216 -173.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.0 -35.99 80.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.15 -39.39 14.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.212 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 10.4 p90 -131.77 90.87 35.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 111.937 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 1.87 6.12 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.792 2.328 . . . . 0.0 112.652 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.31 -23.25 67.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.542 . . . . 0.0 111.257 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.4 157.95 16.42 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.04 138.42 31.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.358 0.599 . . . . 0.0 111.23 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -110.78 115.91 30.37 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.234 -171.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.492 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 92.1 m-85 -138.89 154.25 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 111.843 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HG3' HG11 ' A' ' 2' ' ' VAL . 53.1 mttm -140.93 155.86 46.19 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.99 0.916 . . . . 0.0 109.972 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.03 147.49 16.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.937 0.398 . . . . 0.0 111.024 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.3 t0 -96.7 118.85 34.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.015 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 26' ' ' TYR . 21.7 t -66.12 -28.57 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.172 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.46 -25.47 65.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.93 -42.06 9.27 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.309 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -122.45 76.18 1.31 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.272 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.41 -40.72 91.47 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.027 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.78 -31.56 71.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.907 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.604 HG12 HD21 ' A' ' 67' ' ' ASN . 85.3 t -61.73 -52.55 59.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.132 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.33 -39.33 56.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 111.075 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.71 -33.14 72.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.417 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -22.12 66.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.969 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.624 ' HB2' HG12 ' A' ' 69' ' ' VAL . 8.9 m-20 -109.79 -11.54 14.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 -173.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 80.28 27.28 0.29 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.439 1.087 . . . . 0.0 111.381 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.624 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -106.36 126.11 62.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.957 0.408 . . . . 0.0 110.375 173.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -139.85 5.52 2.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.08 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.48 ' HG2' ' CB ' ' A' ' 27' ' ' ALA . 2.4 mpt? -124.31 121.39 26.05 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.032 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 36' ' ' ILE . 40.3 Cg_endo -90.5 162.53 32.46 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.983 -1.257 . . . . 0.0 113.162 -1.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 m -136.89 131.93 33.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.325 0.583 . . . . 0.0 111.176 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -101.93 125.25 48.57 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.47 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.664 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.1 mt -118.61 113.2 20.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.149 0.5 . . . . 0.0 110.437 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -97.19 133.32 41.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.664 ' CE1' HD22 ' A' ' 76' ' ' LEU . 55.1 m-85 -130.67 158.2 40.7 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.578 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -140.93 125.26 17.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 48.09 51.85 14.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.131 0.972 . . . . 0.0 113.508 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.808 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 76.67 3.19 78.46 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.653 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -119.03 160.93 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.4 tt0 -71.23 -179.31 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.51 -34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 164.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.85 149.96 5.57 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.569 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.61 ' HB3' HD23 ' A' ' 76' ' ' LEU . 17.8 pttm -144.54 131.36 20.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.439 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.87 123.76 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.09 55.85 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.244 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.11 128.28 0.94 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB3' ' SD ' ' A' ' 35' ' ' MET . . . -61.11 115.98 4.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.444 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.92 90.33 32.3 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.8 Cg_exo -25.13 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 125.256 3.971 . . . . 0.0 115.68 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.96 -28.42 35.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.15 -0.344 . . . . 0.0 111.833 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.1 83.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 75' ' ' LEU . 41.0 mm -82.54 -31.0 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.818 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 33.4 mtmt -61.2 -40.07 92.55 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -64.7 -30.29 71.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.16 173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -52.54 45.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 99' ' ' ILE . 4.2 mm -51.96 -41.09 30.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.56 -31.46 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.286 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.72 66.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.605 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -86.25 -20.79 27.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.59 177.283 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttm . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.77 0.319 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' HG2' ' A' ' 41' ' ' GLU . 74.5 t -87.99 136.69 22.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.629 -175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.554 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.0 m -81.77 145.54 30.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.086 -172.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -92.37 124.62 36.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 9.0 m-85 -84.58 157.31 21.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 21.6 pttm -135.16 -3.27 2.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.239 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -140.83 164.9 28.98 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.153 0.501 . . . . 0.0 111.792 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -76.47 -31.85 58.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.284 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 m -59.28 -42.94 92.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.656 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.614 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 24.2 mt-10 -53.66 -45.61 70.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 23' ' ' VAL . 12.3 t80 -56.84 -59.49 4.96 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.244 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 62.1 m-20 -60.72 -27.83 68.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.766 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -64.42 -44.59 90.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.051 0.453 . . . . 0.0 110.055 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 21' ' ' VAL . . . -69.15 -20.2 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.887 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.799 HG22 ' HA2' ' A' ' 81' ' ' GLY . 17.9 mm -77.9 -38.35 24.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.109 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.59 14.59 2.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -99.18 163.37 12.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.955 0.407 . . . . 0.0 111.05 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.62 36.47 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.075 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.5 173.67 12.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.921 0.391 . . . . 0.0 110.916 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.5 tm? -79.37 126.12 30.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.331 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG21 ' HB1' ' A' ' 14' ' ' ALA . 7.7 p -111.68 128.23 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.35 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.38 102.96 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 11' ' ' PHE . 41.6 t -96.98 129.61 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.595 0.712 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.663 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -111.62 97.46 6.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.131 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.719 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.4 m-85 -103.23 137.24 41.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.571 0.7 . . . . 0.0 112.058 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 22.6 p90 -156.48 -171.37 3.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.688 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.63 135.1 32.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 p -69.3 -19.47 63.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.981 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -84.14 -14.77 49.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.01 0.434 . . . . 0.0 110.319 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 49.7 t -88.7 141.73 28.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.855 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.03 -60.85 5.31 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.83 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 41.1 Cg_endo -67.55 8.86 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.117 2.545 . . . . 0.0 114.766 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -60.52 -30.49 69.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.81 0.814 . . . . 0.0 109.958 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.68 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 19.7 ptmt -67.25 -9.6 42.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.646 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -81.24 -34.57 32.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -75.68 -24.66 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.674 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.04 -65.89 1.5 Allowed Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.978 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.5 Cg_endo -84.32 -30.58 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.692 1.594 . . . . 0.0 113.545 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -67.26 -39.74 86.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 109.804 -176.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -75.07 -39.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.137 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 2' ' ' VAL . 33.0 mt-10 -63.13 -32.02 73.31 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 173.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 39' ' ' MET . 27.3 ttpp -64.41 -41.06 96.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.284 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.1 m-85 -53.65 -63.23 1.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.949 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -76.4 -13.54 60.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.278 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.42 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.03 -41.07 13.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.29 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.6 p90 -133.8 90.81 26.56 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.28 0.562 . . . . 0.0 112.179 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.81 1.4 5.81 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.691 2.261 . . . . 0.0 112.584 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -63.15 -19.9 64.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.123 0.487 . . . . 0.0 110.694 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.13 153.26 19.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.73 143.39 26.59 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.914 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.856 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.84 116.05 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.309 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 90.6 m-85 -141.76 137.85 31.9 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 120.987 0.423 . . . . 0.0 112.12 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HG3' HG11 ' A' ' 2' ' ' VAL . 31.1 mtmt -123.19 153.36 40.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.465 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.719 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.8 tt -161.17 144.42 12.82 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.6 p-10 -100.52 129.63 46.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.082 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.511 HG23 ' HA2' ' A' ' 61' ' ' GLY . 3.8 p -72.67 -16.63 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.488 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -57.93 -43.54 86.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.991 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -88.89 -42.32 11.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.0 mm? -111.9 76.45 0.98 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.276 0.56 . . . . 0.0 112.01 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -67.34 -47.23 64.65 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.413 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.36 -30.95 70.84 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 111.177 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 67' ' ' ASN . 89.5 t -65.53 -54.14 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.9 70.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 111.187 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.48 -30.22 69.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -66.96 -23.53 65.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.536 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB2' HG12 ' A' ' 69' ' ' VAL . 58.1 m-20 -106.63 -12.58 15.53 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.868 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 26.5 tt0 80.46 22.27 0.43 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.308 1.005 . . . . 0.0 110.938 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.25 124.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 121.818 -0.551 . . . . 0.0 109.834 173.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 m -131.63 -25.48 2.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.477 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.1 159.68 14.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.3 mpt? -128.26 142.69 45.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 121.069 0.461 . . . . 0.0 111.434 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . 7.0 Cg_exo -82.23 166.39 70.63 Favored 'Cis proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.289 -1.546 . . . . 0.0 112.009 -9.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 69' ' ' VAL . 15.6 m -140.8 136.64 32.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.539 . . . . 0.0 111.023 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.8 mp -112.18 136.45 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.445 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 78' ' ' PHE . 4.7 mt -128.8 115.94 18.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.121 0.486 . . . . 0.0 110.856 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.704 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -99.3 129.31 45.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.055 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.625 ' HB3' HG23 ' A' ' 15' ' ' ILE . 54.0 m-85 -130.15 151.32 50.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.593 0.235 . . . . 0.0 110.788 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.493 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 56.0 tttp -132.96 124.57 28.02 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.493 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.1 p30 44.8 50.37 8.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.799 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.03 -4.98 81.58 Favored Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.589 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -119.97 160.85 21.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 84' ' ' VAL . 23.4 tt0 -66.18 179.94 0.87 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -152.68 -24.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.601 164.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.631 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.99 157.63 5.35 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 111.436 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.21 133.91 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.428 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 95' ' ' ILE . 5.6 t -132.23 144.05 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 88' ' ' VAL . 9.0 p -117.1 49.04 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 122.218 1.008 . . . . 0.0 109.897 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.02 130.5 1.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.275 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.59 111.88 1.78 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.57 91.12 41.12 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.334 175.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 46.7 Cg_exo -31.69 -65.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.922 3.748 . . . . 0.0 115.359 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.65 -45.45 11.69 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.05 -30.59 71.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.3 mt -85.95 -31.61 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.308 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.557 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 15.4 ttpp -59.83 -38.77 82.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -64.4 -34.61 78.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.857 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -64.67 -60.78 2.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -50.73 -30.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.582 0.551 . . . . 0.0 110.802 -176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.5 -20.86 39.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.771 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.71 -32.11 17.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.704 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -92.19 -12.07 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.907 -178.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.942 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptm . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.688 0.28 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.6 t -103.12 128.33 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.9 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.556 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 4.8 m -65.03 145.03 56.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.775 -168.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.458 HE22 ' HA ' ' A' ' 55' ' ' LEU . 25.7 tp60 -96.71 123.88 40.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.807 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 12.5 m-85 -84.63 158.95 20.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.235 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -128.65 -27.25 2.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.007 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 29.6 p -127.54 162.8 25.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.409 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.09 -26.72 62.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.13 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.508 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 28.0 mt-10 -58.1 -41.43 83.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.522 172.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 23' ' ' VAL . 31.8 t80 -57.36 -59.72 4.72 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -56.36 -40.75 75.05 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.722 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -42.5 82.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.665 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 -36.27 71.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.364 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.7 mm -61.89 -40.73 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.8 2.24 8.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.257 -172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.85 143.15 44.02 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.56 34.43 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.563 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 172.31 13.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.153 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.56 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -68.49 123.08 19.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.488 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.6 t -103.2 114.28 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -93.64 103.61 14.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 11' ' ' PHE . 56.1 t -105.61 124.65 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.787 0.803 . . . . 0.0 111.256 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -103.43 98.37 8.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.933 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.5 121.59 44.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.482 0.658 . . . . 0.0 111.698 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 28.3 p90 -147.98 169.6 19.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.213 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -117.31 124.7 49.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -23.28 55.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -87.29 -10.17 53.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.518 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.13 158.83 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.758 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.62 -74.22 0.44 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.611 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.51 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 5.9 Cg_exo -77.91 25.66 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.315 2.677 . . . . 0.0 114.078 -171.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 p -65.65 -35.67 81.46 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.011 0.91 . . . . 0.0 109.566 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -68.31 -8.01 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.993 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -36.2 30.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -75.31 -25.58 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.864 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.36 -66.2 1.12 Allowed Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.738 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 90.0 Cg_endo -82.47 -30.05 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.263 1.309 . . . . 0.0 114.251 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -66.13 -44.97 82.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.606 0.639 . . . . 0.0 109.463 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.904 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -71.64 -37.57 63.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.219 -178.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.52 -33.19 75.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.809 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 5.0 tppp? -67.46 -34.97 78.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.331 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 20.5 m-30 -49.59 -62.99 1.24 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.267 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -76.55 -14.34 60.02 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.016 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 10.3 tp10 -59.39 -33.09 70.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 170.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.638 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.74 -45.52 10.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.567 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.3 p90 -130.49 86.67 52.54 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.143 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.4 -1.79 10.25 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.446 2.097 . . . . 0.0 112.168 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -9.98 45.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.481 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.8 16.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -92.75 135.83 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.125 0.488 . . . . 0.0 111.234 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -113.66 116.55 29.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.235 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -140.47 151.25 44.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.928 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -148.77 158.24 44.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.693 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.7 tt -160.04 146.75 16.04 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 177.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.3 m-20 -95.83 118.33 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.183 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.653 HG21 ' HE1' ' A' ' 72' ' ' MET . 1.5 m -67.74 -16.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.43 . . . . 0.0 110.895 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.58 -40.17 96.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.03 -42.76 14.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.195 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -127.15 73.02 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 111.555 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.84 -36.89 87.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.17 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.11 -38.83 73.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 110.866 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 67' ' ' ASN . 95.4 t -63.66 -51.21 72.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.035 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.82 -39.06 62.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.884 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 30.1 mm-40 -69.27 -33.33 73.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.366 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 12.3 tptt -62.37 -30.05 70.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.815 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.696 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -102.71 -7.5 21.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.674 -170.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 45.1 mt-10 79.08 24.95 0.49 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.047 0.842 . . . . 0.0 111.043 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -100.68 112.09 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.231 0.538 . . . . 0.0 110.103 175.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.5 t -124.78 -20.83 4.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.28 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.653 ' HE1' HG21 ' A' ' 57' ' ' VAL . 19.9 mmt -129.36 121.55 20.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.056 -174.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 73.4 Cg_endo -88.01 167.71 40.26 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.005 -1.248 . . . . 0.0 113.018 -3.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 10.7 m -136.58 138.16 40.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.686 0.755 . . . . 0.0 111.555 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -109.02 127.79 54.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.569 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 78' ' ' PHE . 3.1 mt -121.5 113.6 20.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.112 0.482 . . . . 0.0 110.632 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -98.83 131.59 44.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.139 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.1 m-85 -129.69 158.34 39.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.465 0.174 . . . . 0.0 110.586 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -141.25 123.76 15.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p30 48.07 54.02 10.76 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 79.62 -1.6 76.89 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.48 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -127.62 161.33 29.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.3 tt0 -65.55 179.43 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.06 0.457 . . . . 0.0 110.907 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -151.03 -28.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 163.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -168.63 152.68 5.73 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.539 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HB3' HD23 ' A' ' 76' ' ' LEU . 21.7 pttp -145.81 129.58 17.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.866 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.17 129.89 60.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.545 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.94 50.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.018 0.437 . . . . 0.0 111.503 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.49 128.47 0.99 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.251 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -60.33 114.42 2.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.12 90.21 32.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.688 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 74.1 Cg_exo -21.93 -83.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 1 C-N-CA 125.512 4.141 . . . . 0.0 115.595 -171.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 96' ' ' LYS . . . -83.87 -30.51 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -173.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.66 77.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.36 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 75' ' ' LEU . 34.7 mm -83.39 -29.85 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.798 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 37.3 mtpt -59.31 -39.25 82.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -66.63 -33.03 74.76 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.516 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -61.71 -60.78 3.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.52 -36.56 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 123.831 0.707 . . . . 0.0 110.683 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.09 -18.55 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.831 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -37.12 14.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.296 0.57 . . . . 0.0 109.991 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.668 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -85.42 -11.65 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.522 174.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptm . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 52' ' ' PHE . 52.8 t -122.01 129.39 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.86 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.566 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 11.2 m -71.82 144.64 49.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 0.0 112.525 -169.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -90.86 121.51 32.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.232 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 3.7 m-85 -69.75 168.5 14.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 0.0 110.418 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 16.7 mtpp -127.86 -36.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.019 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -144.6 179.28 7.39 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.51 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -65.95 -27.74 68.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -57.48 -48.5 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.787 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.503 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -55.02 -43.04 73.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.729 174.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.5 t80 -58.03 -60.08 4.29 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.7 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.01 -38.87 76.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.803 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -60.36 -47.83 84.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.695 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.24 75.0 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.844 0.354 . . . . 0.0 110.402 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.706 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -59.67 -36.81 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.308 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 14.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.469 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -83.14 153.73 24.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.65 0.262 . . . . 0.0 110.537 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -87.99 39.34 0.89 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.478 0.656 . . . . 0.0 110.36 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 17.7 ptpt -152.61 -179.8 7.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.051 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.35 121.63 23.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.629 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.1 t -96.21 116.19 37.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.051 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.41 103.16 14.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 11' ' ' PHE . 43.4 t -104.93 126.53 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.592 0.71 . . . . 0.0 111.285 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.66 101.16 10.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.847 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.699 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.6 m-85 -104.69 121.64 44.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 42.1 p90 -151.4 162.64 40.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.525 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -111.7 132.31 54.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -62.0 -24.55 67.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.687 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -84.27 -17.13 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.823 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.39 152.45 39.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.342 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.89 -75.56 0.48 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.348 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 20.85 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.156 2.571 . . . . 0.0 114.226 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.4 p -65.74 -28.57 69.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.903 0.858 . . . . 0.0 109.345 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 22.5 pttp -68.33 -8.45 39.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.501 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.542 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.0 ttt -84.92 -25.56 27.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.148 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.4 mp -79.99 -24.7 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.306 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.39 -63.57 2.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.6 Cg_endo -83.91 -34.47 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.084 1.856 . . . . 0.0 114.045 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.528 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 0.5 OUTLIER -66.25 -42.99 87.81 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.426 0.631 . . . . 0.0 109.681 -176.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.51 -36.82 48.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.883 -178.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.3 mt-10 -63.43 -30.49 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.035 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 51.1 tttp -75.78 -28.91 58.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.524 -176.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 22.2 m-85 -56.59 -57.87 10.5 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.4 p -76.5 -13.75 60.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.496 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 34.1 tt0 -60.79 -31.9 71.27 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.34 -47.04 8.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.095 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 4.6 p90 -129.6 90.06 44.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.099 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -1.09 9.61 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.266 1.977 . . . . 0.0 112.174 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -10.62 51.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.964 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 154.63 18.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.1 m-20 -91.61 126.34 36.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -101.86 116.21 32.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.177 -174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.566 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.58 152.48 46.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.988 0.423 . . . . 0.0 111.029 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.5 pttt -148.91 160.92 42.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.4 tt -157.58 151.19 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 18.6 t0 -97.86 119.1 35.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.62 -26.99 42.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.809 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.19 -35.59 80.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.373 0.606 . . . . 0.0 109.98 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.53 -42.46 20.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.498 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB2' HD21 ' A' ' 55' ' ' LEU . 74.2 mt -135.09 84.01 2.07 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.91 -33.76 54.42 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.553 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.28 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.528 HG12 HD21 ' A' ' 67' ' ' ASN . 79.6 t -63.74 -51.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.911 173.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.41 -39.69 57.76 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 110.76 176.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 75.9 mt-30 -69.97 -32.56 70.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.588 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -20.73 66.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.877 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.65 ' HB2' HG12 ' A' ' 69' ' ' VAL . 15.4 m-20 -110.71 -8.75 14.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.482 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 25.7 tt0 80.69 25.85 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.102 0.876 . . . . 0.0 110.883 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -105.92 107.81 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.333 0.587 . . . . 0.0 110.668 174.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -116.76 -24.52 7.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.138 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.12 157.76 26.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.3 ptp -151.3 137.4 11.19 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.269 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.0 Cg_endo -77.88 155.82 94.87 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.768 -1.763 . . . . 0.0 113.021 -3.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.5 m -134.73 142.87 46.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.442 0.639 . . . . 0.0 111.339 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 95' ' ' ILE . 4.0 mp -114.24 129.36 56.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.768 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.592 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 mt -122.21 117.17 25.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 0.0 110.999 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.8 mp -101.06 129.45 46.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.102 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.6 m-85 -127.79 161.39 29.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 4.6 ttpm? -143.55 115.45 8.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.008 168.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 64.26 55.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.762 0.791 . . . . 0.0 111.205 172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.706 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.39 2.66 60.04 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.488 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 8.5 ptpp? -133.44 160.97 35.84 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 31.6 tt0 -64.99 177.63 0.96 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 110.856 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -148.84 -35.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 160.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.99 152.96 15.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.51 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HB3' HD23 ' A' ' 76' ' ' LEU . 42.3 pttt -147.61 127.16 13.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.168 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.66 134.22 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.278 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.9 52.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.234 0.54 . . . . 0.0 110.782 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.28 129.46 1.25 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.073 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -64.69 103.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.734 0.302 . . . . 0.0 111.601 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.3 OUTLIER -117.49 88.89 30.42 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.032 175.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -35.37 -67.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.496 3.464 . . . . 0.0 115.272 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 -32.16 48.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.24 63.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.163 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 99' ' ' ILE . 40.3 mm -87.56 -34.4 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.23 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.704 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 55.0 tttt -59.48 -35.06 73.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -72.89 -31.22 64.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -68.75 -52.76 27.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.5 mm -54.43 -37.51 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.337 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.112 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -44.51 34.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.832 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.6 m-80 -79.03 -16.95 56.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.654 -172.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.628 177.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptp . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.541 0.21 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG21 HG22 ' A' ' 40' ' ' ILE . 95.2 t -122.6 130.88 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.992 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 21.3 m -81.53 144.53 31.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.513 -170.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -90.13 135.83 33.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.122 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 8.9 m-30 -88.37 167.88 13.13 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 170.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 55.7 pttt -134.67 -20.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.206 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 22.6 p -145.49 174.69 10.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -70.8 -27.48 63.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -59.27 -43.8 92.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.304 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.718 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 42.9 mm-40 -55.35 -46.62 76.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.382 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 23' ' ' VAL . 16.6 t80 -59.24 -57.73 11.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.695 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.59 -40.98 93.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.828 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -62.02 -40.09 94.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.192 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.78 -42.58 90.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.648 175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.857 HG22 ' HA2' ' A' ' 81' ' ' GLY . 4.9 mm -60.2 -40.33 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.97 7.65 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 24.3 mt-30 -83.95 148.66 26.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.53 44.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -144.26 167.87 21.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.089 177.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.3 tm? -78.88 117.58 20.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 14' ' ' ALA . 41.1 t -108.36 122.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.227 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 28.9 t -106.59 112.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.723 HG11 ' CE2' ' A' ' 11' ' ' PHE . 54.6 t -100.14 121.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.641 0.734 . . . . 0.0 110.87 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.765 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -85.26 96.61 9.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.659 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -96.84 126.03 41.7 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.966 0.413 . . . . 0.0 110.077 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 36' ' ' ILE . 8.6 p90 -149.8 -175.28 4.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.573 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -132.76 130.04 39.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.637 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -65.55 -19.47 65.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.959 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -84.98 -13.5 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.174 0.511 . . . . 0.0 110.552 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.648 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.2 t -90.48 136.56 32.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.37 7.67 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 113.532 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.648 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.3 Cg_exo -61.33 3.59 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.103 2.535 . . . . 0.0 114.145 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.1 t -59.03 -29.88 67.6 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.737 0.779 . . . . 0.0 110.429 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -67.97 -8.99 41.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.306 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -38.13 44.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.05 -25.46 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.861 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.65 -65.69 1.38 Allowed Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.891 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 73.2 Cg_endo -83.55 -26.87 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.72 1.613 . . . . 0.0 114.378 -175.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.539 ' HE3' HG13 ' A' ' 40' ' ' ILE . 3.3 tmm? -72.72 -37.45 67.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.291 0.567 . . . . 0.0 109.753 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.765 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.85 -33.34 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.659 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.53 -29.05 70.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -72.79 -38.77 67.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.823 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.576 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -57.12 -49.63 75.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.5 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 95.8 p -85.39 -13.97 47.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.56 -27.98 69.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 13.3 mm-40 -89.68 -40.7 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.12 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 11.5 p90 -138.85 93.11 10.8 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 112.431 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.44 2.37 2.9 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.451 2.1 . . . . 0.0 112.107 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 3.9 tt0 -63.06 -23.74 67.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.48 157.58 16.7 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.3 135.75 33.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.904 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.5 p90 -111.52 115.46 29.24 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.249 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 3' ' ' THR . 95.8 m-85 -140.66 156.74 46.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.716 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 43.4 mtmt -137.52 149.21 46.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.155 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD22 ' CE1' ' A' ' 25' ' ' PHE . 8.8 tt -157.87 148.81 21.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.034 0.445 . . . . 0.0 110.745 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 5.3 t0 -104.38 123.35 47.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.8 p -70.29 -24.39 25.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.061 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.62 -23.96 65.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.532 0.682 . . . . 0.0 109.694 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -99.12 -42.49 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.507 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -120.22 76.16 1.15 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.276 0.56 . . . . 0.0 112.163 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.81 62.67 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.85 -25.58 65.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.914 0.388 . . . . 0.0 110.797 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.623 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 51.5 t -68.68 -50.33 56.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -52.82 -22.84 5.85 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -86.26 -27.3 24.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -75.39 -26.5 58.48 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.107 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.642 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.5 p30 -110.13 -12.6 14.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 29.3 tt0 79.84 17.35 0.75 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.85 0.718 . . . . 0.0 112.635 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -89.55 130.89 38.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 121.567 -0.708 . . . . 0.0 110.639 173.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -123.94 -27.34 3.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.98 166.36 11.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.535 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -148.09 141.71 15.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.84 0.353 . . . . 0.0 110.951 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.89 150.29 78.55 Favored 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.836 -1.735 . . . . 0.0 112.635 -2.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -132.46 136.93 47.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.552 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -107.83 123.26 48.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.689 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -116.06 116.43 27.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.573 0.701 . . . . 0.0 109.876 175.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.2 mp -95.75 128.46 42.65 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.504 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 76' ' ' LEU . 58.9 m-85 -125.96 153.26 44.55 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.493 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -135.87 125.39 25.13 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 46.8 53.82 9.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.223 1.009 . . . . 0.0 113.49 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.857 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 73.8 5.4 69.28 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.528 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -120.08 161.12 21.51 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 84' ' ' VAL . 27.0 tt0 -71.58 179.89 2.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -153.86 -33.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 164.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.58 149.76 5.78 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.423 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -146.82 127.86 14.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.032 0.444 . . . . 0.0 110.54 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 95' ' ' ILE . 4.2 m -132.44 139.42 50.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -101.69 48.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.255 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.33 131.58 1.71 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.317 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.647 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -69.72 108.13 3.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -117.28 89.75 32.06 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 12.2 Cg_exo -28.53 -67.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.79 3.66 . . . . 0.0 115.588 -171.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.9 21.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.74 71.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.739 0.304 . . . . 0.0 111.32 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 91' ' ' ASN . 35.3 mm -72.62 -49.24 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.695 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mtmp? -63.46 -28.59 70.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -38.38 68.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.038 173.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.72 68.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.498 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -52.73 -39.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.711 -178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.7 -19.85 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.175 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.9 -38.08 23.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.254 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' ND2' HD23 ' A' ' 77' ' ' LEU . 58.1 m-80 -83.95 -21.16 31.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.448 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.894 178.17 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 7.1 ptp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.017 0.437 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.646 HG23 ' HG2' ' A' ' 41' ' ' GLU . 43.7 t -112.76 124.79 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.384 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.636 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 1.4 m -60.48 144.42 51.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.414 -168.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -101.52 117.43 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.224 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.4 m-85 -71.07 167.58 18.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.138 0.494 . . . . 0.0 111.755 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -125.38 -41.31 2.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.924 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -138.5 -179.96 6.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 111.443 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -67.86 -25.5 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.978 0.418 . . . . 0.0 110.186 175.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -61.2 -46.83 88.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -54.96 -42.74 72.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.448 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.801 ' CE2' HG11 ' A' ' 23' ' ' VAL . 17.6 t80 -57.37 -58.88 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.01 -36.35 74.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -63.54 -41.46 98.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.845 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.21 -35.54 78.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.037 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.763 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -62.26 -39.16 83.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.052 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.06 0.97 9.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 28.3 mt-30 -75.5 143.58 42.45 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.73 40.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 0.0 110.986 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 20.7 ptmt -142.19 167.44 22.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.381 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' HG21 ' A' ' 84' ' ' VAL . 2.7 tm? -70.1 126.42 29.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.0 t -106.07 120.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.2 104.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.801 HG11 ' CE2' ' A' ' 11' ' ' PHE . 39.4 t -102.72 127.18 56.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.663 0.744 . . . . 0.0 111.083 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.849 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.33 98.17 7.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.125 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.3 m-85 -103.21 123.97 47.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.439 ' O ' HG13 ' A' ' 57' ' ' VAL . 48.9 p90 -152.92 179.02 9.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.398 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -129.92 135.97 48.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.652 0.263 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.61 HG23 ' OD2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -63.96 -22.04 66.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.38 -13.26 52.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.562 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 52.9 t -81.99 148.79 28.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.706 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.39 -65.98 1.98 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 13.1 Cg_exo -71.8 18.52 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.24 2.627 . . . . 0.0 114.23 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -67.44 -29.24 68.66 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.048 0.927 . . . . 0.0 109.44 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 99.2 mttt -68.08 -7.36 28.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.133 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -38.33 58.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.659 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.1 mp -75.22 -25.47 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.044 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.671 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.45 -65.8 1.3 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.976 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 96.2 Cg_endo -82.46 -29.75 1.36 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.456 1.437 . . . . 0.0 114.299 -173.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -66.3 -44.9 82.14 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.36 0.6 . . . . 0.0 109.456 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.849 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -69.55 -37.5 74.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.22 -179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 2' ' ' VAL . 40.8 mt-10 -62.83 -31.99 73.1 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.065 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.53 -32.74 70.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.696 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 16.8 m-30 -52.44 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -76.07 -13.4 60.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.263 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -60.55 -39.57 88.41 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.62 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -79.05 -47.61 15.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.5 p90 -133.06 89.9 32.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.214 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.28 2.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.503 2.135 . . . . 0.0 112.661 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -24.74 67.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.304 0.573 . . . . 0.0 110.716 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.48 153.29 20.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.352 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.92 150.17 21.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.162 -175.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -118.33 115.96 25.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.969 -172.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.636 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.9 m-85 -141.8 149.51 40.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 111.635 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 36.9 mtmt -131.03 160.78 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.932 0.893 . . . . 0.0 110.1 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 25' ' ' PHE . 9.0 tt -159.8 147.8 17.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -98.89 117.99 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.131 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -71.83 -17.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 0.0 110.376 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.02 -31.99 69.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' O ' HD13 ' A' ' 60' ' ' LEU . 37.2 tt0 -87.69 -42.77 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.024 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.4 mm? -124.22 80.63 1.85 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -67.0 -39.77 93.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.701 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.83 -33.98 76.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.58 HG12 HD21 ' A' ' 67' ' ' ASN . 86.6 t -65.56 -49.53 77.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.095 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.7 -39.26 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.713 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.6 mm100 -69.24 -38.11 78.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.12 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.54 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 5.9 tptp -59.46 -24.96 63.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.475 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HB2' HG12 ' A' ' 69' ' ' VAL . 8.7 m-20 -109.47 -8.02 15.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 122.278 -0.264 . . . . 0.0 111.366 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.2 mt-10 79.21 27.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.997 0.811 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -106.22 109.84 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.4 0.619 . . . . 0.0 110.481 175.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.0 m -117.41 -34.51 4.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.182 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.07 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.624 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 19.6 ptp -151.79 149.27 23.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.959 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.3 Cg_endo -79.63 150.82 84.38 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.525 -1.864 . . . . 0.0 112.422 -4.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.1 m -126.05 140.21 52.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.595 0.712 . . . . 0.0 111.784 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 mp -114.99 124.65 52.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.436 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.646 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -116.32 118.74 33.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.462 . . . . 0.0 110.57 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.4 mp -99.72 131.84 45.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.279 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.646 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.3 m-85 -131.23 160.31 35.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.558 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 7.0 ttpm? -144.69 131.19 19.83 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.85 52.88 11.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.763 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.45 1.6 82.39 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.46 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -125.46 160.31 29.78 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.1 tt0 -66.57 -178.36 0.69 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -151.12 -31.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.647 162.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.681 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -164.0 154.43 15.23 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.918 0.39 . . . . 0.0 111.736 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -145.69 126.53 14.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 75' ' ' LEU . 12.3 m -133.65 142.74 40.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.669 0.271 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.23 43.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.963 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.48 121.9 0.82 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.119 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -59.63 109.59 0.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.952 0.406 . . . . 0.0 111.566 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.466 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.14 90.66 34.24 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.711 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 21.2 Cg_exo -26.26 -79.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.826 3.684 . . . . 0.0 115.288 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.91 -35.31 43.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.81 76.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.417 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 99' ' ' ILE . 42.7 mm -86.15 -31.61 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.633 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 22.4 mtmm -63.05 -32.93 74.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.704 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -69.96 -32.86 71.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.035 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.55 48.56 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.089 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.1 mm -54.26 -38.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.453 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.77 60.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.097 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.98 -38.14 32.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.437 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 77' ' ' LEU . 52.5 m-80 -86.67 -14.58 42.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.269 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.73 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 40' ' ' ILE . 53.6 t -121.46 124.32 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.655 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 2.7 m -72.47 146.14 47.08 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -167.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -93.54 139.06 31.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.954 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 11' ' ' PHE . 11.5 m-85 -103.67 154.87 19.05 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.029 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HG2' ' OE2' ' A' ' 10' ' ' GLU . 25.3 pttm -133.85 -3.35 2.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.205 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -143.22 164.11 31.08 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.477 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -56.93 -47.66 80.11 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -53.5 -44.95 69.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.609 ' O ' HG12 ' A' ' 15' ' ' ILE . 17.0 t80 -58.89 -57.25 13.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.7 -34.86 78.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.757 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -62.35 -40.35 96.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.678 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.61 -20.78 63.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.466 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.76 HG22 ' HA2' ' A' ' 81' ' ' GLY . 12.5 mm -82.58 -36.49 13.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.335 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 12.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -101.09 148.2 25.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 120.817 0.342 . . . . 0.0 110.313 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -82.73 66.22 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.619 0.723 . . . . 0.0 110.747 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -154.03 174.59 14.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.44 117.16 24.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.158 0.504 . . . . 0.0 109.846 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.3 t -102.23 128.43 54.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.2 t -115.78 108.79 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 11' ' ' PHE . 14.5 t -106.31 129.58 59.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.706 0.765 . . . . 0.0 110.885 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.893 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.68 100.17 11.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.081 -175.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -105.89 108.88 20.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.492 0.663 . . . . 0.0 111.945 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.4 p90 -131.76 -174.51 3.44 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.532 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.97 139.91 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.892 0.377 . . . . 0.0 110.404 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -20.28 62.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.709 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -88.7 -15.75 34.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.36 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 33' ' ' CYS . 16.3 p -90.92 150.25 21.57 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.2 -46.99 9.55 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.912 -0.585 . . . . 0.0 114.321 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 42.0 Cg_endo -67.11 5.08 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.578 2.186 . . . . 0.0 114.307 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 24.4 p -61.98 -34.1 75.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.457 0.646 . . . . 0.0 110.383 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.4 -8.66 42.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.402 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 90' ' ' ALA . 16.9 tpt -79.7 -33.34 41.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -79.95 -26.75 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.049 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.05 -62.04 3.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.269 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 83.9 Cg_endo -80.39 -41.2 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 120.152 1.09 . . . . 0.0 113.706 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.461 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 2.8 tmm? -62.04 -36.21 80.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.246 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -82.17 -35.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.288 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -64.57 -23.43 67.26 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.189 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 27.0 mtpp -85.56 -26.05 26.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.1 p90 -60.69 -42.07 96.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.965 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -15.43 49.35 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 122.054 -0.404 . . . . 0.0 111.008 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 24.0 tt0 -56.53 -39.18 72.94 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.22 -50.23 8.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.908 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 14.3 p90 -134.13 91.02 24.46 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.252 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.99 0.78 8.48 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.885 1.723 . . . . 0.0 111.195 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -65.63 -9.66 29.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.779 176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.84 161.15 13.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -92.18 130.76 37.81 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -114.96 116.32 28.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.053 -172.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 88.2 m-85 -140.57 151.34 44.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.526 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 19.5 pttm -148.64 152.44 36.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.15 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 60' ' ' LEU . 6.7 tt -160.33 152.44 20.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.757 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.7 p-10 -99.77 128.54 45.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 111.263 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.5 m -72.42 -12.11 15.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.082 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.49 -48.6 72.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.025 0.441 . . . . 0.0 109.926 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -80.12 -41.56 25.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.832 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.748 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -116.04 71.81 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.142 0.496 . . . . 0.0 112.249 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -75.15 -36.09 46.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.966 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.98 -30.58 71.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.403 0.621 . . . . 0.0 110.79 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.618 HG12 HD21 ' A' ' 67' ' ' ASN . 60.7 t -68.99 -52.55 32.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.6 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -50.91 -40.9 58.08 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.23 0.331 . . . . 0.0 111.238 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 71.6 mt-30 -69.66 -32.04 70.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.8 tptt -62.98 -27.95 69.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.729 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.677 ' HB2' HG12 ' A' ' 69' ' ' VAL . 10.5 m-20 -103.94 -10.11 18.39 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.3 tt0 80.99 19.49 0.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.201 0.938 . . . . 0.0 111.029 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.677 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -96.44 118.66 43.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 121.804 -0.56 . . . . 0.0 110.145 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 m -117.32 -31.33 5.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.618 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.11 163.87 13.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.269 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.425 ' CE ' HG21 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -144.51 138.51 14.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' CG ' HD13 ' A' ' 36' ' ' ILE . 59.3 Cg_endo -83.39 152.18 69.03 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.741 -1.775 . . . . 0.0 113.024 -0.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.7 m -131.56 135.03 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.681 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -104.9 129.93 53.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.533 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE2' ' A' ' 78' ' ' PHE . 1.3 mt -120.64 115.67 23.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.011 0.434 . . . . 0.0 110.92 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -98.81 133.15 43.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE2' HD22 ' A' ' 76' ' ' LEU . 47.9 m-85 -130.85 153.91 48.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 4.1 tppp? -132.68 118.15 18.75 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.589 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 8.8 p30 43.78 55.74 4.96 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.255 1.022 . . . . 0.0 113.735 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.76 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.34 -5.63 63.08 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.601 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.97 160.08 16.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.19 178.52 4.39 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -149.23 -34.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 163.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.655 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.01 157.17 11.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.465 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HB3' HD23 ' A' ' 76' ' ' LEU . 29.2 pttt -152.03 134.71 15.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 t -132.1 124.5 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.343 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.09 52.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.203 0.525 . . . . 0.0 111.27 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.34 126.83 0.85 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.824 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -63.4 121.44 13.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.435 0.636 . . . . 0.0 111.558 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -117.24 90.69 34.76 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.999 176.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 51.1 Cg_exo -21.37 -75.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.377 4.051 . . . . 0.0 115.926 -171.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.0 -34.44 24.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.72 -29.58 70.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.433 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.458 ' O ' HG12 ' A' ' 99' ' ' ILE . 37.9 mm -73.35 -43.69 56.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.067 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.591 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 87.4 mttt -64.26 -24.83 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.634 0.73 . . . . 0.0 109.806 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -84.09 -29.04 27.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.676 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.13 -54.35 31.27 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.98 0.419 . . . . 0.0 110.207 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -50.89 -39.79 19.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.646 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.94 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.383 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.18 41.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' HD23 ' A' ' 77' ' ' LEU . 47.5 m-80 -96.55 -15.34 21.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.968 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.791 177.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.957 0.408 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 41' ' ' GLU . 62.4 t -119.79 138.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 23.4 m -90.24 131.62 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.649 0.738 . . . . 0.0 112.555 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.46 ' OE1' ' HG3' ' A' ' 54' ' ' LYS . 8.5 mm100 -69.01 137.54 53.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.939 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -83.26 170.5 14.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.798 169.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -122.7 -41.38 2.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -140.67 179.28 6.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.873 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -66.09 -27.84 68.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.513 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -59.45 -46.99 87.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.547 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -53.13 -44.2 67.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.369 172.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.743 ' O ' HG12 ' A' ' 15' ' ' ILE . 14.8 t80 -59.84 -60.91 3.07 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.85 -39.78 65.91 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.939 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -64.29 -44.8 90.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.4 75.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.144 0.497 . . . . 0.0 110.312 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.813 HG22 ' HA2' ' A' ' 81' ' ' GLY . 13.6 mm -63.49 -38.13 81.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.55 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.55 6.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HB3' ' CD ' ' A' ' 19' ' ' LYS . 25.4 mt-30 -83.69 141.95 31.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.539 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 32.23 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 111.966 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.75 178.98 6.7 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -74.58 122.32 22.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.5 t -101.15 111.2 30.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -93.54 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 176.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 11' ' ' PHE . 57.1 t -103.54 123.78 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.86 0.838 . . . . 0.0 111.188 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -95.98 96.63 9.02 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.215 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.809 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -99.29 130.63 45.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 38.8 p90 -157.49 -171.77 3.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.908 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -142.1 139.29 32.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -15.25 62.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -87.58 -12.74 44.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.014 0.435 . . . . 0.0 110.619 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.0 t -83.24 149.91 26.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.025 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.71 -67.89 1.58 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.791 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 41.7 Cg_endo -69.21 12.8 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.099 2.533 . . . . 0.0 114.356 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 26.5 p -63.94 -32.71 74.34 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.087 0.946 . . . . 0.0 109.879 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.673 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 44.2 mtmt -69.16 -8.86 49.43 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.009 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.31 -33.11 49.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -76.22 -24.55 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.814 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.77 -65.37 1.54 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.587 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.2 Cg_endo -82.91 -35.62 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.606 1.537 . . . . 0.0 113.238 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.41 -40.16 95.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.623 0.725 . . . . 0.0 109.936 -175.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.784 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.12 -38.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.754 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HG2' HG23 ' A' ' 2' ' ' VAL . 44.5 mt-10 -65.28 -29.57 70.35 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.525 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 13.1 mmmm -66.92 -40.2 87.57 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.444 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.0 m-30 -52.51 -62.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.781 0.324 . . . . 0.0 111.207 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.8 p -77.16 -13.29 59.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.731 0.301 . . . . 0.0 111.368 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.7 -39.68 85.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -81.84 -42.67 19.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.044 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.5 p90 -130.0 89.82 44.42 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 111.927 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.39 0.74 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.189 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -64.96 -12.11 46.14 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.207 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.32 147.13 26.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.903 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.641 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.3 p90 -91.51 116.09 28.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.142 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 3' ' ' THR . 94.9 m-85 -141.19 155.17 46.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HG3' ' OE1' ' A' ' 4' ' ' GLN . 19.3 ptmt -149.29 151.86 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.871 -172.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.908 HD21 ' HB2' ' A' ' 60' ' ' LEU . 10.1 tt -159.55 148.34 17.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.746 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 3.6 p-10 -101.65 120.75 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.221 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 72' ' ' MET . 3.6 p -67.13 -16.75 21.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.611 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.85 -49.14 63.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.291 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -90.77 -42.98 10.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.819 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.908 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -105.33 73.65 1.05 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.548 0.689 . . . . 0.0 111.866 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' HG23 ' A' ' 57' ' ' VAL . . . -69.61 -43.64 67.29 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.135 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 3.7 p30 -67.63 -20.9 65.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 0.0 110.797 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG12 HD21 ' A' ' 67' ' ' ASN . 96.1 t -69.75 -51.98 35.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -51.31 -40.44 59.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.343 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.2 pt20 -68.31 -36.12 78.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.088 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.26 -28.67 68.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.777 176.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.702 ' HB2' HG12 ' A' ' 69' ' ' VAL . 39.7 m-20 -102.77 -13.12 17.16 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.281 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 5.4 tp10 80.08 19.88 0.59 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.467 1.104 . . . . 0.0 111.067 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -95.09 119.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.187 0.518 . . . . 0.0 109.757 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -134.45 8.21 3.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.402 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.53 153.69 38.88 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.445 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 57' ' ' VAL . 2.2 mpt? -129.8 130.68 23.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.915 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.527 ' HB2' HG12 ' A' ' 36' ' ' ILE . 60.2 Cg_endo -86.14 165.76 51.87 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.247 -1.564 . . . . 0.0 112.377 -5.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.1 m -141.56 128.91 21.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.508 0.671 . . . . 0.0 111.09 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 95' ' ' ILE . 4.1 mp -97.68 123.51 41.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.044 173.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 78' ' ' PHE . 2.9 mt -115.9 113.79 23.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.317 0.58 . . . . 0.0 110.742 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -99.24 127.53 45.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.04 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HB3' HG23 ' A' ' 15' ' ' ILE . 48.8 m-85 -128.08 159.14 36.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.546 0.212 . . . . 0.0 111.219 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -143.81 135.8 26.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p30 49.54 41.57 21.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.183 0.993 . . . . 0.0 113.319 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 83.39 1.49 90.29 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.576 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -122.67 161.09 24.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.5 tt0 -68.88 179.61 1.76 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 118.404 0.547 . . . . 0.0 109.77 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -149.11 -28.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.497 162.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.95 152.64 13.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.098 0.475 . . . . 0.0 111.61 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -142.92 120.11 11.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.311 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 95' ' ' ILE . 59.1 t -130.6 128.6 63.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.831 0.348 . . . . 0.0 110.978 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -99.8 52.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.126 0.488 . . . . 0.0 110.957 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.57 124.86 0.89 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.291 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.62 102.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.925 0.49 . . . . 0.0 112.131 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.0 89.52 34.64 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.176 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 29.5 Cg_exo -32.82 -66.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.326 3.351 . . . . 0.0 115.378 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.47 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.29 68.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.67 0.271 . . . . 0.0 111.69 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 HD22 ' A' ' 75' ' ' LEU . 42.3 mm -87.66 -33.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.083 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -61.55 -32.27 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.457 0.646 . . . . 0.0 109.512 170.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -71.59 -32.84 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.17 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.3 -52.27 48.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.123 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -53.36 -36.9 27.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -30.98 60.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.098 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.86 -37.41 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.499 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -86.83 -20.15 27.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.267 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.086 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 54' ' ' LYS . 83.4 t -121.57 131.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.471 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.5 m -74.14 144.8 44.73 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -170.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.523 HE22 ' HA ' ' A' ' 55' ' ' LEU . 20.9 tp60 -101.16 122.71 44.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.657 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.2 m-85 -84.46 160.13 20.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.652 173.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -1.76 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 166.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 14.0 p -140.46 159.82 41.35 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -72.97 -28.72 62.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.37 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.62 -42.87 93.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 26.5 mt-10 -54.67 -44.2 73.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.716 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 15' ' ' ILE . 18.5 t80 -57.53 -60.68 3.3 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -55.12 -40.62 70.72 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.708 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.8 t -58.77 -45.49 89.66 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.944 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.72 76.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.668 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.97 -36.09 76.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.553 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 12.73 0.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -88.11 150.84 23.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.681 0.277 . . . . 0.0 110.585 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.52 36.9 0.49 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 110.766 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 79' ' ' LYS . 19.6 ptpt -137.3 177.49 7.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.2 tm? -82.38 118.49 23.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.0 t -102.78 119.99 51.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.832 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 31.2 t -107.13 106.79 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.9 t -101.76 123.79 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.94 0.876 . . . . 0.0 110.643 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -95.39 97.61 9.95 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.106 -174.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.2 m-85 -102.57 126.67 49.71 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.552 0.692 . . . . 0.0 111.866 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.63 174.85 12.97 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -125.64 124.5 41.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.57 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -19.48 65.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.106 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -90.76 -6.98 53.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 54.1 t -93.29 152.42 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.559 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.21 -72.01 0.74 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.668 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 59.8 Cg_endo -76.39 31.58 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.904 2.402 . . . . 0.0 114.512 -172.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.19 -34.74 75.4 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.914 0.864 . . . . 0.0 110.114 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -68.1 -7.28 28.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.984 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.549 ' HG3' ' HB3' ' A' ' 90' ' ' ALA . 17.0 tpt -75.89 -35.2 59.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 109.067 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -80.19 -25.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.017 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.79 -63.04 2.58 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.764 176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 95.7 Cg_endo -82.23 -34.98 0.38 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.035 1.156 . . . . 0.0 113.652 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 39' ' ' MET . 3.2 tmm? -65.03 -37.89 89.07 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.187 0.518 . . . . 0.0 110.017 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD13 ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -78.98 -36.26 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.798 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -63.94 -26.16 68.46 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.936 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 94.2 mttt -80.03 -34.92 37.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.5 p90 -55.51 -48.56 74.44 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.229 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 79.0 p -85.37 -14.4 46.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.51 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 9.1 tp10 -55.42 -38.69 69.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.579 172.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -90.61 -37.93 13.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.399 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 12.3 p90 -132.72 90.7 31.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.683 . . . . 0.0 112.835 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.23 0.08 6.53 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.728 2.286 . . . . 0.0 112.645 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -14.88 62.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.977 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.7 154.83 18.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.54 127.79 37.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.874 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -100.78 116.11 31.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.233 -173.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.471 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.1 m-85 -138.23 150.94 47.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.655 0.264 . . . . 0.0 111.353 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HG3' HG11 ' A' ' 2' ' ' VAL . 33.6 mtmt -134.38 158.5 43.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.755 0.822 . . . . 0.0 110.233 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.3 tt -160.43 141.61 12.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 110.79 170.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.85 117.24 29.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.9 m -65.87 -19.08 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.491 0.663 . . . . 0.0 109.672 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.83 -38.31 78.4 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.059 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -96.38 -38.79 9.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.806 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.651 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.7 mm? -121.1 76.11 1.2 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.095 0.474 . . . . 0.0 111.682 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.5 78.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.259 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.25 -35.54 80.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.156 0.503 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 67' ' ' ASN . 62.1 t -64.59 -48.71 83.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.23 -39.49 60.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.195 0.522 . . . . 0.0 110.773 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -74.86 -29.3 60.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.522 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -62.37 -27.49 69.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.052 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.611 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 30.1 m-20 -104.38 -13.1 16.22 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.315 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 39.7 mt-10 80.63 31.23 0.18 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.532 1.145 . . . . 0.0 111.045 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -107.94 107.71 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.552 . . . . 0.0 110.113 170.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 m -115.31 -10.59 12.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.758 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.46 142.33 36.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HE2' HG21 ' A' ' 57' ' ' VAL . 2.0 mpt? -130.87 140.99 40.35 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.74 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 58.9 Cg_endo -81.1 163.75 78.96 Favored 'Cis proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.858 -1.726 . . . . 0.0 113.305 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.6 m -148.78 138.22 21.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.043 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.56 130.28 54.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.305 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -120.41 114.07 21.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.016 0.436 . . . . 0.0 110.39 175.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.665 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -97.0 133.35 41.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 76' ' ' LEU . 54.0 m-85 -130.31 152.85 49.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.8 tppp? -127.08 110.11 12.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.404 168.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.9 t30 57.44 56.46 5.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 111.788 167.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.668 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.86 12.27 78.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.731 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -131.42 159.23 38.63 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 178.22 4.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.48 -32.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 164.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -167.98 154.54 7.71 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.508 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.99 134.15 19.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.174 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.79 122.12 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.173 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.39 55.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.134 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.78 135.42 2.0 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.78 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -67.76 122.6 18.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.091 0.472 . . . . 0.0 111.523 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -117.73 90.29 35.59 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.662 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 29.2 Cg_exo -21.03 -78.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.639 4.226 . . . . 0.0 116.102 -169.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.78 -31.64 25.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -63.53 -32.01 73.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.69 0.281 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.6 mm -71.35 -43.73 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.175 175.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 27.1 mmtp -61.8 -35.16 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -69.25 -37.51 77.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.459 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.6 -61.18 2.8 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.9 mm -48.3 -35.3 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.956 0.785 . . . . 0.0 110.756 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.25 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.977 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -31.96 17.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 110.287 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.665 ' ND2' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -91.67 -13.75 31.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.728 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.86 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 47.0 ttm . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.703 0.287 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.8 t -99.65 128.26 51.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 -176.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.609 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 6.8 m -70.52 145.4 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.532 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.6 mm-40 -87.39 139.08 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.534 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.0 m-85 -102.52 148.08 25.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -129.54 1.41 5.01 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.663 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 24.0 p -142.13 156.59 45.37 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.991 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.971 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -58.32 -41.95 85.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.663 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mt-10 -56.15 -48.29 76.56 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.279 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.1 t80 -55.07 -57.98 9.52 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.12 -33.26 68.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.488 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -65.13 -49.73 68.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.54 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.72 75.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.6 mm -62.94 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.827 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 13.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.532 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -89.52 147.08 24.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.848 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.58 52.44 1.88 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.251 0.548 . . . . 0.0 112.145 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 51' ' ' ASP . 18.8 ptpt -154.86 178.49 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 99' ' ' ILE . 2.0 tm? -76.59 118.86 19.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -102.78 124.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.806 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 17.2 t -113.74 111.13 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 11' ' ' PHE . 11.6 t -108.29 129.08 63.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.827 0.822 . . . . 0.0 110.95 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.814 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.04 101.11 12.62 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.905 -175.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.7 m-85 -108.48 115.65 30.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.332 0.587 . . . . 0.0 111.673 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 37.5 p90 -139.98 175.33 9.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.801 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -123.8 131.39 53.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.705 0.288 . . . . 0.0 110.572 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -26.99 69.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.419 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -81.34 -8.83 59.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.7 t -87.71 159.02 18.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.859 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.66 -67.2 1.46 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.344 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 39.8 Cg_endo -68.11 10.92 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.247 2.632 . . . . 0.0 114.219 -175.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.2 p -61.88 -34.52 76.16 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 21.8 ptmt -67.71 -8.62 36.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.61 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 21.2 ttt -82.55 -27.3 31.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -77.23 -25.16 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.064 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.83 -64.6 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.848 173.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.8 Cg_endo -82.95 -30.47 0.94 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 120.765 1.309 . . . . 0.0 114.411 -175.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.45 -33.94 71.87 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.455 0.645 . . . . 0.0 109.767 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -83.63 -34.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.932 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 37.7 mt-10 -65.64 -21.6 66.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.274 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 55.1 tttm -79.87 -36.0 37.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.886 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.4 p90 -58.87 -46.36 87.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.183 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.3 p -85.26 -14.67 45.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.476 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 6.8 tp10 -60.67 -31.67 70.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.35 -50.1 9.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.723 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.569 ' O ' ' HD1' ' A' ' 47' ' ' TYR . 3.9 p90 -134.79 92.8 18.68 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.732 0.777 . . . . 0.0 112.923 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.9 -0.26 5.97 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.198 1.932 . . . . 0.0 112.338 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 47' ' ' TYR . 3.9 pp0? -67.11 -16.87 64.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.774 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.92 152.01 20.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -91.53 140.1 30.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.337 -175.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -113.21 115.18 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.947 -172.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 98.4 m-85 -139.03 147.85 42.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.626 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 21.4 pttm -145.52 153.58 41.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.833 -174.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.0 tt -159.78 146.84 16.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.78 0.324 . . . . 0.0 110.687 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.2 m-20 -92.84 121.91 34.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.3 m -68.31 -16.6 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.248 0.547 . . . . 0.0 110.04 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.79 -39.55 91.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.635 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -79.21 -41.96 27.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 60.7 mt -136.96 83.58 2.01 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.449 0.642 . . . . 0.0 111.865 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -72.55 -38.04 57.84 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.499 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.13 -27.21 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.395 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 67' ' ' ASN . 91.1 t -67.47 -55.8 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.573 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -49.86 -41.15 44.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 111.14 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -69.2 -31.48 70.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.264 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 8.0 tptt -63.94 -25.78 68.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.31 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.631 ' HB2' HG12 ' A' ' 69' ' ' VAL . 14.8 m-20 -102.97 -12.91 17.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 17.9 tp10 80.78 28.36 0.21 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.505 1.128 . . . . 0.0 110.645 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -106.58 116.41 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.248 0.546 . . . . 0.0 110.011 170.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -117.47 -30.94 5.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.22 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.46 13.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.173 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -150.0 143.5 16.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 111.016 -179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.495 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.5 Cg_endo -80.04 149.74 80.84 Favored 'Cis proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.445 -1.898 . . . . 0.0 113.036 -3.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -130.48 138.35 50.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.218 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -108.98 130.5 55.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.515 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 78' ' ' PHE . 3.1 mt -119.6 116.13 25.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.188 0.518 . . . . 0.0 110.825 176.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 85' ' ' ALA . 4.9 mp -99.08 128.33 45.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.915 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 76' ' ' LEU . 62.3 m-85 -131.13 155.9 46.19 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.941 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 40.3 ttmt -134.97 125.47 26.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.4 p-10 43.67 56.47 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.27 -1.66 69.5 Favored Glycine 0 CA--C 1.51 -0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.653 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -118.94 160.09 22.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.6 tt0 -72.94 179.12 3.87 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -153.25 -32.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.657 163.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.698 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.42 157.37 7.31 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.893 0.377 . . . . 0.0 111.954 177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -150.24 132.07 15.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.339 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 95' ' ' ILE . 55.2 t -133.27 132.32 58.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.308 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.67 50.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.075 0.464 . . . . 0.0 111.574 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.49 134.88 1.82 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.784 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.18 112.85 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.275 0.56 . . . . 0.0 111.421 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -116.97 90.2 32.11 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.424 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 32.8 Cg_exo -28.79 -68.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.933 3.755 . . . . 0.0 115.147 -170.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.21 -40.07 18.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -64.78 -30.44 71.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 87' ' ' VAL . 25.9 mm -74.59 -51.49 22.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.999 0.428 . . . . 0.0 110.226 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 99' ' ' ILE . 9.9 mtmp? -64.36 -23.3 67.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -82.98 -25.83 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.47 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.73 12.53 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.547 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 11.6 mt -50.36 -43.61 22.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.551 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.8 74.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.004 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.98 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.384 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -82.77 -17.66 43.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.373 176.165 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 tpp . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.139 0.495 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' PHE . 53.5 t -88.78 131.39 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.225 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -72.23 144.16 48.56 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.5 tp-100 -90.65 135.85 33.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 7.6 m-85 -82.64 170.02 15.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.359 0.6 . . . . 0.0 110.773 172.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.648 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 36.8 mttp -129.71 -27.16 2.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.21 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 26.2 p -147.48 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -69.95 -26.42 64.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.93 -43.11 99.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.673 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.8 mm-40 -52.74 -45.56 67.06 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.682 ' O ' HG12 ' A' ' 15' ' ' ILE . 20.5 t80 -60.08 -62.48 1.84 Allowed 'General case' 0 N--CA 1.458 -0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.055 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.32 -37.35 74.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.112 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -61.34 -45.95 92.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.691 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.09 82.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 110.21 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.5 mm -64.16 -37.08 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.627 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 1.79 4.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.382 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 26.2 mt-30 -78.31 136.9 37.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.983 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 26.3 t0 -81.61 46.55 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.995 0.902 . . . . 0.0 110.285 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 17' ' ' GLN . 19.8 ptpt -131.38 179.43 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.312 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 99' ' ' ILE . 1.9 tm? -83.43 113.95 21.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 3.5 t -104.51 121.33 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.88 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 21.7 t -108.8 114.95 48.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.55 HG11 ' CE2' ' A' ' 11' ' ' PHE . 21.9 t -107.68 129.25 62.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.853 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -98.23 100.96 12.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.663 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.2 m-85 -103.66 120.86 41.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.499 0.666 . . . . 0.0 111.585 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 39.6 p90 -152.23 161.24 42.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.769 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -113.5 133.55 55.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.664 0.268 . . . . 0.0 110.34 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.5 p -65.96 -21.54 66.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.418 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -77.83 -18.28 56.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.053 0.454 . . . . 0.0 110.387 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 48.1 t -82.38 147.06 29.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 -177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.58 -64.08 2.34 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.331 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 43.8 Cg_endo -68.06 10.5 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.284 2.656 . . . . 0.0 114.743 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 27.6 p -66.28 -24.79 66.62 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.833 0.825 . . . . 0.0 110.033 177.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.9 mttp -61.96 -20.64 64.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.94 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.452 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -68.16 -37.89 81.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 109.488 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.73 HD12 ' HB2' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.36 -25.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.06 -65.87 0.98 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.145 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 75.6 Cg_endo -83.26 -31.73 0.61 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 CA-C-N 121.066 1.416 . . . . 0.0 114.298 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.46 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.4 tmm? -67.96 -34.75 77.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.499 0.666 . . . . 0.0 109.68 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -82.18 -37.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.28 -179.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 2' ' ' VAL . 36.3 mt-10 -64.56 -23.25 67.2 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.666 171.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' NZ ' ' A' ' 96' ' ' LYS . 53.8 tptt -77.93 -36.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.995 -177.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -58.61 -41.85 86.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.995 -179.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.18 -16.92 41.69 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.961 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.52 -27.24 68.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.02 -47.45 8.11 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.306 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.606 ' OH ' ' HB ' ' A' ' 99' ' ' ILE . 8.0 p90 -137.48 93.15 12.87 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 121.645 0.736 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.66 2.52 3.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.235 1.956 . . . . 0.0 111.662 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.04 -23.27 67.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.171 179.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.13 154.52 18.36 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -90.9 123.68 34.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.225 -173.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.7 p90 -96.05 116.35 28.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 99.2 m-85 -139.75 151.7 46.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.321 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.9 pttt -149.13 161.88 41.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 -175.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.9 tt -159.23 145.3 16.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.227 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t0 -90.98 116.47 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.077 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.48 -23.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -68.03 -34.37 76.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.342 0.591 . . . . 0.0 109.739 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -78.89 -42.01 28.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.056 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 63' ' ' VAL . 91.1 mt -136.3 78.48 1.71 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.537 0.684 . . . . 0.0 111.971 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -69.03 -32.69 73.34 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.455 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.44 -36.9 81.68 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.085 0.469 . . . . 0.0 110.984 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG12 HD21 ' A' ' 67' ' ' ASN . 93.0 t -64.19 -49.01 83.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.892 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.06 -38.27 56.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 25.3 mt-30 -70.5 -34.21 72.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.415 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 2.7 tptp -61.76 -25.86 67.72 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.188 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.648 ' HB2' HG12 ' A' ' 69' ' ' VAL . 17.1 m-20 -106.94 -13.05 15.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.272 -0.267 . . . . 0.0 111.627 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 13.3 tp10 79.82 31.26 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.378 1.049 . . . . 0.0 110.906 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.16 114.98 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.135 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.6 t -120.3 -19.12 7.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.891 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.64 156.58 16.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.731 0.301 . . . . 0.0 110.756 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mpt? -126.66 127.95 24.39 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.418 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.8 Cg_endo -89.26 164.4 37.8 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.605 -0.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.3 m -141.47 131.8 25.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.604 . . . . 0.0 111.302 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.514 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.8 mp -102.34 135.78 43.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.474 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -125.17 113.43 17.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.271 0.558 . . . . 0.0 110.58 172.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.8 mp -93.95 130.05 40.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 76' ' ' LEU . 43.4 m-85 -128.64 154.86 45.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.745 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 58.2 tttm -134.05 125.58 28.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.21 166.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.49 HD21 ' HE2' ' A' ' 82' ' ' LYS . 3.7 p-10 46.58 49.05 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.343 1.057 . . . . 0.0 113.553 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 81.53 -1.78 84.62 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.837 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HE2' HD21 ' A' ' 80' ' ' ASN . 37.8 mtmt -115.11 160.12 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -71.82 179.76 3.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -150.86 -32.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.478 163.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.67 140.58 1.35 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.05 136.17 41.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 95' ' ' ILE . 41.1 t -132.81 123.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 m -88.34 58.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.12 137.42 2.2 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.969 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -68.46 118.76 11.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.04 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.438 ' H ' ' CG1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -117.03 89.93 31.52 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 89.8 Cg_exo -22.67 -80.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 1 C-N-CA 125.449 4.1 . . . . 0.0 115.537 -169.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.09 -27.94 27.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.77 78.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.085 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' CG1' ' H ' ' A' ' 91' ' ' ASN . 32.1 mm -72.35 -46.32 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.1 mttt -64.0 -23.15 67.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.855 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 97' ' ' GLN . 2.0 tt0 -80.53 -33.64 36.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.521 172.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -67.46 -52.98 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.606 ' HB ' ' OH ' ' A' ' 47' ' ' TYR . 9.4 mt -51.19 -42.22 25.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.571 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.13 63.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.54 -36.45 57.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.492 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 55.3 m-80 -83.76 -21.91 32.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.842 178.417 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.763 0.315 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 40' ' ' ILE . 94.0 t -85.51 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.141 0.496 . . . . 0.0 111.028 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.1 m -80.02 144.29 33.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.967 -171.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.521 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 7.9 tp-100 -93.3 136.79 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.168 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 8.6 m-85 -83.59 170.01 14.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.715 173.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 10' ' ' GLU . 42.6 mtpt -123.55 -40.6 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.527 176.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -142.48 179.95 6.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -66.46 -25.76 66.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.652 0.263 . . . . 0.0 110.393 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -58.02 -49.99 74.96 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.6 mp0 -55.16 -41.69 72.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.692 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 23' ' ' VAL . 27.0 t80 -61.17 -59.76 4.81 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.61 -35.81 75.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.547 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -61.5 -45.03 95.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -32.7 74.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 110.342 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.84 HG22 ' HA2' ' A' ' 81' ' ' GLY . 10.1 mm -63.54 -39.26 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 5.76 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.442 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.77 140.83 39.5 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.63 38.57 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.382 0.611 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -145.22 176.29 9.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.95 122.45 22.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 15' ' ' ILE . 2.2 t -100.54 111.24 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.047 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.42 103.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 11' ' ' PHE . 60.1 t -104.88 119.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.867 0.842 . . . . 0.0 111.166 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.05 96.79 8.72 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.74 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.8 m-85 -99.99 113.69 26.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.471 0.653 . . . . 0.0 111.791 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -140.27 163.8 31.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.616 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -115.84 134.54 54.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.5 p -60.67 -26.13 66.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.671 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -78.58 -15.47 58.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 44.7 t -80.7 144.38 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.071 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.47 -67.63 1.9 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.274 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 66.0 Cg_endo -74.22 20.73 0.4 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.942 2.428 . . . . 0.0 114.321 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.0 p -68.02 -27.92 66.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.839 0.828 . . . . 0.0 109.556 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 59.6 pttt -68.25 -7.65 32.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.041 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.447 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -79.67 -35.91 38.48 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.49 -25.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.039 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.31 -61.55 6.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.809 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 88.0 Cg_endo -83.41 -30.67 0.78 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.417 1.412 . . . . 0.0 114.219 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.567 ' HG2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 ttp -66.15 -50.41 64.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.67 0.668 . . . . 0.0 109.199 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -65.56 -37.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.228 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 26.6 tt0 -69.02 -27.81 66.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.2 0.524 . . . . 0.0 110.057 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -74.84 -29.05 60.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.052 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 39' ' ' MET . 18.7 m-30 -51.49 -64.0 0.95 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 110.245 175.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 60.5 p -79.27 -14.11 59.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.1 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -58.38 -35.77 72.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -83.15 -47.97 11.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 6.2 p90 -129.3 91.34 42.0 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.204 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.57 1.5 5.56 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.707 2.271 . . . . 0.0 111.668 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 4.9 tt0 -63.35 -24.05 67.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.776 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.59 154.73 18.85 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.306 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -92.47 141.6 28.34 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.026 -176.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -111.22 115.13 28.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.99 -172.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' THR . 97.3 m-85 -140.59 152.0 45.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 63.8 pttt -149.92 159.44 44.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.571 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.0 tt -158.73 150.76 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.631 0.253 . . . . 0.0 110.41 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 19.8 t0 -93.81 115.78 28.21 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.743 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -61.95 -25.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.829 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -37.31 86.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.421 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -84.94 -42.19 15.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.6 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.512 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.7 mm? -121.95 73.39 1.08 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.387 0.613 . . . . 0.0 112.12 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.86 -24.59 73.79 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.196 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 16.2 t70 -66.1 -27.63 68.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.594 0.712 . . . . 0.0 110.523 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 60' ' ' LEU . 18.4 t -75.24 -52.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.202 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.629 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.05 -20.78 10.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 2.8 pt20 -85.82 -31.92 22.04 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.573 0.702 . . . . 0.0 110.086 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -69.12 -27.87 65.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.573 179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.629 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.0 p30 -108.76 -8.16 15.42 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 24.6 tt0 81.04 16.82 0.53 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.057 0.848 . . . . 0.0 112.095 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.628 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -93.84 109.23 21.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.374 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -108.17 -30.4 8.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.15 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.84 162.95 17.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.266 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.439 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -151.37 145.0 17.51 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.73 0.3 . . . . 0.0 110.826 177.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -79.69 148.58 80.12 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.579 -1.842 . . . . 0.0 112.853 -1.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.2 m -133.68 142.98 48.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.68 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -112.34 125.14 53.86 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.766 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.626 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -116.91 113.56 22.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 175.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 85' ' ' ALA . 1.3 mp -96.55 134.35 39.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 76' ' ' LEU . 60.2 m-85 -129.43 153.16 48.21 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.597 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 21.6 tptm -134.01 119.94 19.63 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 2.2 p-10 46.63 56.7 6.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.84 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 77.7 4.43 85.13 Favored Glycine 0 CA--C 1.51 -0.232 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.495 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.4 160.73 28.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 29.0 tt0 -71.53 179.69 2.9 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -150.39 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.572 164.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -165.26 155.56 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.587 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HB3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.5 130.6 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.38 133.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.226 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.63 47.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 0.0 111.373 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.7 130.1 1.31 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.992 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.736 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.19 112.03 3.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' CB ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -116.09 89.87 26.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 56.0 Cg_exo -22.49 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.357 4.038 . . . . 0.0 115.667 -171.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 -28.82 29.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.99 74.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.799 0.333 . . . . 0.0 111.222 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.68 HG21 HD22 ' A' ' 75' ' ' LEU . 45.9 mm -83.38 -32.76 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.428 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.748 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 78.5 mttt -57.65 -47.44 82.26 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -60.19 -32.29 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.64 61.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.2 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.4 mm -54.0 -41.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.047 0.451 . . . . 0.0 110.647 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -25.72 63.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.204 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.96 19.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.472 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -79.91 -16.93 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.069 -172.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.223 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 46.2 ttm . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.04 0.447 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.516 ' HB ' ' HD2' ' A' ' 54' ' ' LYS . 85.5 t -81.22 136.6 22.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.747 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 25.7 m -83.47 143.9 29.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.208 0.527 . . . . 0.0 112.335 -172.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.2 tp-100 -94.82 132.47 39.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.645 -175.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 13.0 m-85 -93.11 160.41 14.87 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.688 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 5.6 ptpp? -135.9 -4.45 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.817 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 18.8 p -141.89 157.29 45.16 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 111.368 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -71.41 -29.03 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.013 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -62.92 -38.15 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.688 ' OE1' ' HG2' ' A' ' 6' ' ' LYS . 24.5 mt-10 -55.44 -44.0 75.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.441 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 23' ' ' VAL . 24.1 t80 -56.21 -56.3 22.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.39 -44.16 79.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -57.38 -38.48 74.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.82 64.3 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.87 HG22 ' HA2' ' A' ' 81' ' ' GLY . 14.3 mm -65.01 -40.53 89.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.63 13.51 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.048 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -85.49 140.21 30.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -79.38 47.39 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.432 0.634 . . . . 0.0 109.984 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -154.2 178.97 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.469 177.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 99' ' ' ILE . 1.6 tm? -75.74 123.89 26.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.076 0.465 . . . . 0.0 110.782 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -105.36 116.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.208 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.89 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 11' ' ' PHE . 40.5 t -102.82 126.06 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.741 0.781 . . . . 0.0 111.351 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -105.03 97.31 7.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.762 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.4 m-85 -104.35 116.82 32.81 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.613 0.721 . . . . 0.0 111.953 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 p90 -135.67 173.88 11.23 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.136 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -125.41 130.74 52.47 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -63.3 -19.48 64.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -92.97 -13.07 29.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.396 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 59.8 m -75.55 159.81 30.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.312 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.32 -83.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.227 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 73' ' ' PRO . 89.0 Cg_endo -79.37 36.02 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.094 2.529 . . . . 0.0 113.858 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 p -65.3 -36.97 85.7 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 122.04 0.924 . . . . 0.0 109.814 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.855 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 7.7 ttpm? -68.05 -11.33 58.79 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.536 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.31 70.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -74.52 -24.66 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.932 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.715 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -52.3 -67.52 0.53 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.824 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.855 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 3.9 Cg_endo -85.32 -23.86 2.19 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 121.457 1.556 . . . . 0.0 113.621 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.677 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.7 ttp -71.74 -44.54 63.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.35 0.595 . . . . 0.0 109.733 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.825 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -73.36 -36.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.241 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 tp10 -63.01 -29.81 71.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.525 174.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -74.4 -33.87 63.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.474 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.647 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 19.9 m-85 -57.24 -57.72 11.39 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 p -76.91 -14.22 59.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.932 0.396 . . . . 0.0 110.805 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.3 -35.14 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -84.51 -44.56 13.48 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.595 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 3.4 p90 -129.7 89.54 46.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.641 0.734 . . . . 0.0 112.042 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.2 -0.69 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.219 1.946 . . . . 0.0 112.152 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.99 -3.71 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.3 163.08 12.69 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.38 139.72 30.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.237 -177.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.4 p90 -122.96 114.58 20.62 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.551 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.508 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 96.9 m-85 -141.06 148.4 40.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HD2' ' HB ' ' A' ' 2' ' ' VAL . 17.4 ptmt -148.48 152.58 37.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 -172.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.4 tt -160.88 149.02 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 8.1 p-10 -100.04 129.89 46.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.474 0.654 . . . . 0.0 110.831 174.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 72' ' ' MET . 2.4 m -72.6 -11.79 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.081 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.6 -44.16 74.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -79.61 -41.53 26.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.969 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.9 mm? -122.42 79.1 1.58 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.696 0.76 . . . . 0.0 112.838 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.03 -38.83 34.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.001 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.435 ' HA ' HE21 ' A' ' 65' ' ' GLN . 3.9 p-10 -68.46 -24.69 64.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.173 0.486 . . . . 0.0 110.619 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG12 HD21 ' A' ' 67' ' ' ASN . 87.3 t -68.48 -50.0 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 174.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.99 -39.29 62.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.867 175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' A' ' 62' ' ' ASP . 49.9 mt-30 -70.4 -28.59 65.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.84 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.583 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 9.6 tptt -67.38 -27.87 67.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.487 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.713 ' HB2' HG12 ' A' ' 69' ' ' VAL . 14.1 m-20 -104.54 -7.91 19.4 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 -170.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 32.9 tt0 80.88 17.4 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.469 1.105 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -93.29 106.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.627 0.727 . . . . 0.0 109.918 175.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 p -114.47 -18.38 11.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.832 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 147.06 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -135.89 143.85 46.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.17 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 67.4 Cg_endo -80.78 153.19 82.77 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.287 -1.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -135.01 143.36 46.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.887 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 95' ' ' ILE . 3.9 mp -115.39 128.36 56.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.333 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.84 114.13 21.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 85' ' ' ALA . 6.5 mp -94.07 126.26 39.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.086 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CG ' HD12 ' A' ' 15' ' ' ILE . 52.8 m-85 -125.32 151.95 45.37 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.579 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -136.96 112.99 9.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.048 0.451 . . . . 0.0 110.475 172.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.68 55.33 4.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.115 175.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.87 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 70.53 10.38 66.68 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.248 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -127.38 159.82 33.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 84' ' ' VAL . 26.8 tt0 -73.85 179.74 4.11 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -153.65 -30.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 165.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -162.01 157.95 24.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 111.557 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -147.57 121.66 9.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.416 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 95' ' ' ILE . 21.3 t -131.04 135.34 60.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 -172.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.31 49.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.925 0.393 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.25 122.63 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.686 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.35 105.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.465 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -118.69 88.64 35.53 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.524 175.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 39' ' ' MET . 34.7 Cg_exo -35.45 -59.08 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.414 3.409 . . . . 0.0 115.411 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -50.09 8.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -31.93 71.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.598 HG21 HD22 ' A' ' 75' ' ' LEU . 22.2 mm -84.52 -36.05 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.569 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 8.9 tmtt? -58.44 -38.98 78.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.73 -23.64 62.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.539 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -77.53 -58.06 3.48 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG23 ' CD1' ' A' ' 20' ' ' LEU . 9.4 mt -51.7 -40.7 27.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.295 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -34.15 77.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -37.02 69.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 98' ' ' ALA . 57.5 m-80 -84.73 -19.35 32.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.316 -175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.47 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG11 ' HG3' ' A' ' 54' ' ' LYS . 87.8 t -116.86 127.67 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 120.939 0.4 . . . . 0.0 109.942 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -76.14 138.97 41.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.98 126.45 32.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.076 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.725 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.5 m-30 -80.02 169.78 17.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.296 0.569 . . . . 0.0 110.605 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 70.6 mmtt -128.7 -38.3 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.41 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 30.7 p -134.98 178.9 6.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.443 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 63' ' ' VAL . . . -71.17 -28.44 64.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.07 -44.6 83.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.166 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 4.5 mm-40 -54.34 -50.53 67.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.307 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.639 ' O ' HG12 ' A' ' 15' ' ' ILE . 12.7 t80 -58.73 -59.33 5.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.14 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 24.5 t70 -63.19 -34.4 77.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.841 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -62.88 -42.87 99.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.62 0.248 . . . . 0.0 110.441 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.74 92.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.6 mm -58.12 -38.41 67.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.022 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.68 5.32 3.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.429 ' OE1' ' HG3' ' A' ' 19' ' ' LYS . 3.3 pt20 -79.34 150.54 31.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.67 0.272 . . . . 0.0 110.465 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.39 45.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 111.068 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 30.6 pttt -156.91 -179.99 8.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.4 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.0 tm? -79.22 118.81 21.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 0.0 111.265 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -112.82 109.12 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.936 176.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -107.76 116.94 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.697 0.761 . . . . 0.0 110.039 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.527 HG11 ' CE2' ' A' ' 11' ' ' PHE . 48.1 t -103.19 128.43 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.934 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -88.22 97.73 11.18 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.895 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.71 114.43 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -178.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 17.4 p90 -140.64 -179.56 6.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.852 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -129.07 130.72 46.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.088 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -66.01 -19.41 65.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.118 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -86.06 -13.35 47.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.632 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 52.0 t -90.35 148.45 22.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.587 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -80.67 -62.33 2.05 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.742 -176.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.7 Cg_exo -60.24 -7.49 6.74 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.909 2.406 . . . . 0.0 113.894 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 30' ' ' CYS . 71.5 m -63.89 -26.87 68.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.424 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 55.3 pttt -62.77 -15.96 55.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.777 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 23.9 ttt -77.46 -27.15 51.98 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.147 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.698 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.3 mp -75.73 -23.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.735 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.46 -66.57 0.88 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.24 172.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 69.0 Cg_endo -82.52 -34.14 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 CA-C-N 121.055 1.412 . . . . 0.0 114.315 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.591 ' CE ' HG13 ' A' ' 40' ' ' ILE . 2.5 tmm? -66.54 -36.72 83.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.492 0.663 . . . . 0.0 110.085 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.778 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.9 mt -81.11 -34.05 13.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -66.31 -25.33 66.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.912 171.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -78.38 -33.59 48.75 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.689 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -59.57 -47.9 83.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.827 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 97.6 p -85.25 -15.69 42.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.973 -0.454 . . . . 0.0 110.981 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.4 -29.68 70.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 13.6 tp60 -89.02 -50.17 6.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.286 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 43' ' ' PHE . 10.1 p90 -124.71 91.27 49.71 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.96 0.94 5.07 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.066 1.844 . . . . 0.0 111.224 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 4.0 tt0 -63.02 -23.37 67.42 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.918 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 17.85 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.1 m-20 -91.07 126.7 36.23 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.803 0.811 . . . . 0.0 111.005 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.541 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -103.6 114.17 28.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.282 -172.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.3 m-85 -136.05 147.58 47.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.711 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 76.4 mttt -132.71 152.08 51.81 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.956 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.751 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 7.8 tt -159.24 149.73 19.43 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.827 0.346 . . . . 0.0 110.711 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 9.0 t0 -101.43 119.78 39.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.954 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG11 ' CE ' ' A' ' 72' ' ' MET . 7.7 p -69.74 -21.34 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.97 -37.16 83.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.214 0.53 . . . . 0.0 109.748 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.47 -42.99 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.342 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -115.02 80.49 1.42 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.13 -40.49 34.37 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.502 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.34 -24.77 65.75 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.116 0.484 . . . . 0.0 110.703 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.634 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 95.3 t -68.0 -51.44 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.361 174.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -46.67 -42.84 17.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.042 0.448 . . . . 0.0 111.579 174.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -73.73 -25.26 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.858 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.546 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 13.5 tptt -69.37 -25.04 63.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.686 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.575 HD21 HG12 ' A' ' 63' ' ' VAL . 12.1 m-20 -108.24 -13.72 14.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.664 -171.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.3 tp10 79.79 30.99 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.26 0.975 . . . . 0.0 110.999 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.649 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -107.47 120.2 58.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.873 -0.517 . . . . 0.0 110.491 171.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -115.72 -39.49 3.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.42 164.79 13.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.322 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.45 ' CE ' HG11 ' A' ' 57' ' ' VAL . 1.1 pmm? -146.01 151.57 45.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.915 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HB2' HG12 ' A' ' 36' ' ' ILE . 58.7 Cg_endo -78.23 149.84 87.42 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.81 -3.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.4 m -132.27 133.64 44.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.793 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.1 mp -103.07 124.07 47.85 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.699 HD22 ' CE1' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -117.57 112.36 20.46 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.427 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.8 mp -96.41 133.09 41.25 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.699 ' CE1' HD22 ' A' ' 76' ' ' LEU . 62.0 m-85 -128.65 157.11 42.22 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.522 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -139.42 116.26 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.3 t30 65.37 50.39 1.74 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.675 0.75 . . . . 0.0 111.239 171.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.747 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.9 5.15 64.13 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.011 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -126.91 160.37 31.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 28.3 tt0 -69.53 178.89 2.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -148.67 -32.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.892 163.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.31 138.22 1.56 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.929 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.54 ' HB3' HD23 ' A' ' 76' ' ' LEU . 23.0 pttm -133.31 134.95 44.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.92 173.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -131.98 122.69 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.322 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 t -91.58 62.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 110.267 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.62 125.66 0.81 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.25 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -58.27 111.57 1.25 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.211 0.529 . . . . 0.0 111.491 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 91' ' ' ASN . 0.7 OUTLIER -116.52 88.97 25.91 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -31.76 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.723 3.615 . . . . 0.0 115.427 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.13 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.63 61.87 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.5 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.0 mm -76.58 -49.24 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.623 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 19.5 mtpp -62.58 -26.08 68.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.444 0.64 . . . . 0.0 110.21 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -80.03 -33.13 39.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.564 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.12 -52.8 57.43 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.8 mm -53.23 -39.59 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.394 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 -20.42 54.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.249 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.26 -43.45 17.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.981 0.42 . . . . 0.0 111.047 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -80.01 -22.63 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.822 -0.608 . . . . 0.0 111.324 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 47.0 ttm . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.008 0.432 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' HG2' ' A' ' 41' ' ' GLU . 54.9 t -100.96 136.41 32.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.596 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.9 m -80.82 144.78 31.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.22 0.533 . . . . 0.0 112.377 -170.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 8.6 tp-100 -94.16 136.21 34.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.932 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.696 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 14.3 m-85 -98.57 158.6 15.5 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HG2' ' OE1' ' A' ' 10' ' ' GLU . 14.8 ptmm? -135.01 -1.54 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.832 169.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 33.8 p -138.57 159.75 41.31 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 111.15 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.219 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.155 173.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.696 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 27.3 mt-10 -54.06 -47.26 71.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.05 173.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 23' ' ' VAL . 15.1 t80 -58.74 -59.03 6.06 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.958 0.409 . . . . 0.0 109.959 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.58 -35.22 72.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.549 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -63.51 -48.43 77.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.621 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.91 73.2 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.0 110.381 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.824 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.1 mm -63.39 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.065 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.33 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.81 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.54 142.9 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.06 74.54 9.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.26 0.552 . . . . 0.0 110.801 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -174.62 179.22 1.77 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.9 tm? -81.2 120.75 25.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 2.1 t -100.59 109.8 26.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.154 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 t -92.55 103.38 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 11' ' ' PHE . 22.1 t -105.65 131.08 55.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.311 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -108.21 100.45 9.76 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.939 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE2' HD22 ' A' ' 55' ' ' LEU . 2.1 m-85 -103.58 115.52 30.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.514 0.673 . . . . 0.0 111.813 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 25.8 p90 -137.76 175.96 9.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB3' ' HG3' ' A' ' 72' ' ' MET . . . -126.29 133.5 51.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -15.11 63.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.359 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.436 ' HD1' ' OD2' ' A' ' 58' ' ' ASP . 51.8 p-90 -89.11 -13.47 38.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 110.794 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 51.8 t -84.39 143.83 29.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.056 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.03 2.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.96 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 19.5 Cg_exo -68.98 15.81 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.447 2.765 . . . . 0.0 114.531 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.01 -29.28 69.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 122.02 0.914 . . . . 0.0 108.98 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -65.62 -8.83 22.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.21 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -37.26 39.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -75.11 -25.2 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.751 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.78 -66.46 1.07 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.481 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 85.6 Cg_endo -83.23 -26.85 2.08 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 120.617 1.256 . . . . 0.0 114.226 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.608 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 2.1 ttp -69.75 -41.95 74.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.55 0.69 . . . . 0.0 109.587 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -74.72 -39.26 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.767 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.803 ' HG2' HG23 ' A' ' 2' ' ' VAL . 38.6 mt-10 -66.59 -26.69 67.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.045 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.34 -37.74 74.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.275 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 21.6 m-85 -52.45 -62.32 1.72 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.257 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 m -76.77 -13.76 59.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.567 0.223 . . . . 0.0 111.301 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 35.3 tt0 -60.0 -31.93 70.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.467 HE22 ' CD ' ' A' ' 96' ' ' LYS . 20.6 mt-30 -89.3 -46.69 8.57 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.07 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 7.2 p90 -127.35 90.13 49.63 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.26 0.552 . . . . 0.0 111.941 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.34 -0.72 9.6 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.444 2.096 . . . . 0.0 112.381 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.4 -13.5 58.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.433 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.12 151.66 21.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.99 141.44 28.62 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.668 -177.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.728 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -116.25 115.38 25.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.164 -170.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 93.8 m-85 -140.69 149.1 41.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.783 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.7 pttt -149.32 157.71 43.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.665 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 60' ' ' LEU . 7.1 tt -160.61 151.88 19.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.636 0.255 . . . . 0.0 111.344 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 9.7 m-20 -91.72 111.74 23.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.699 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 26' ' ' TYR . 3.4 p -66.4 -19.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD2' ' HD1' ' A' ' 29' ' ' TRP . 6.4 t70 -53.21 -43.81 67.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.596 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -94.28 -42.42 8.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.994 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.1 mm? -111.67 73.25 0.81 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.5 64.75 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.129 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 22.1 m-20 -65.82 -26.5 67.71 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.428 0.632 . . . . 0.0 110.555 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 67' ' ' ASN . 84.7 t -71.52 -52.48 25.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.634 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -55.78 -34.71 65.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.75 0.31 . . . . 0.0 111.369 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -68.07 -37.85 81.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 109.441 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 17.0 tptt -60.78 -22.89 64.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.964 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 69' ' ' VAL . 33.9 m-20 -106.71 -13.63 15.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 34.0 tt0 79.63 27.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 124.269 0.981 . . . . 0.0 110.854 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -106.47 126.92 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 170.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -126.59 -40.1 1.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.307 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.25 160.67 16.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 1.3 pmm? -143.02 151.46 56.01 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.878 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' HG12 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -78.65 148.4 83.4 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 -1.907 . . . . 0.0 113.049 -3.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -131.21 135.89 47.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.731 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 40' ' ' ILE . 4.1 mp -106.02 130.79 53.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.661 177.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.656 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.6 mt -124.58 113.69 18.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.095 0.474 . . . . 0.0 110.824 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD23 ' ND2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -96.97 131.06 44.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.656 ' CE1' HD22 ' A' ' 76' ' ' LEU . 59.9 m-85 -128.26 157.1 41.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 34.5 ttpt -141.73 125.14 16.59 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.9 p30 47.08 55.5 7.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.557 1.143 . . . . 0.0 113.698 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.824 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 75.34 3.55 71.09 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.704 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.41 160.81 26.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -71.0 -179.05 2.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -152.44 -29.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.707 164.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.633 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -169.32 150.79 4.37 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.635 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HB3' HD23 ' A' ' 76' ' ' LEU . 14.1 ptmm? -145.31 126.63 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.255 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.67 133.46 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.949 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.28 59.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 122.287 1.042 . . . . 0.0 110.189 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 129.43 1.12 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.527 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -65.07 106.08 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.676 0.391 . . . . 0.0 111.957 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 89.54 37.74 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.788 175.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -35.5 -61.02 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.397 3.398 . . . . 0.0 115.161 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.3 14.42 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -172.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.08 71.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.648 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 99' ' ' ILE . 46.1 mm -87.24 -32.43 6.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.229 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 10.1 ttpp -60.13 -39.57 86.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 170.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.32 -28.91 67.58 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.653 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.02 -61.65 1.93 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.0 mm -49.55 -34.96 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.712 0.632 . . . . 0.0 110.576 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.75 -21.62 54.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.949 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.82 -35.56 15.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.062 0.458 . . . . 0.0 110.56 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.655 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -88.07 -18.26 29.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 -176.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.662 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 1.5 pmm? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 52' ' ' PHE . 59.7 t -121.7 130.24 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.544 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 7.3 m -75.65 145.12 41.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.251 -170.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -94.39 138.97 31.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 10.2 m-85 -88.73 164.0 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.199 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.13 -14.71 2.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.758 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -147.16 174.38 11.64 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.94 -23.57 62.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 t -60.02 -47.93 83.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.555 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -53.14 -42.66 66.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.94 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.728 ' CE2' HG11 ' A' ' 23' ' ' VAL . 28.2 t80 -57.35 -58.3 8.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 8.7 m-20 -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.816 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -60.24 -44.27 95.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.578 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.29 76.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.464 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.684 HG22 ' HA2' ' A' ' 81' ' ' GLY . 9.2 mm -66.99 -39.99 84.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.56 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.17 7.52 3.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -80.73 146.35 31.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.99 40.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.28 176.33 9.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.897 -176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 2.7 tm? -81.13 121.9 26.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 0.0 109.828 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 15' ' ' ILE . 1.9 t -100.74 122.41 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.218 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.21 102.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.728 HG11 ' CE2' ' A' ' 11' ' ' PHE . 59.2 t -104.11 119.34 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.813 0.816 . . . . 0.0 111.077 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -97.49 96.75 8.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.67 -177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE2' HD22 ' A' ' 55' ' ' LEU . 1.9 m-85 -100.35 124.79 46.28 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.408 0.623 . . . . 0.0 111.953 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 47.9 p90 -151.5 -178.46 6.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.992 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -128.81 137.53 51.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 111.047 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 p -68.9 -21.61 64.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -84.62 -6.61 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.089 0.471 . . . . 0.0 110.633 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 41.9 t -88.28 159.9 17.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.24 -61.72 1.02 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.081 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 28.1 Cg_exo -65.49 -1.38 4.67 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.647 . . . . 0.0 114.026 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 16.9 p -62.04 -28.34 69.52 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.103 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -8.31 24.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.557 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.4 ttt -84.04 -28.87 27.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.302 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 90' ' ' ALA . 1.4 mp -76.93 -24.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.249 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -56.54 -64.36 2.51 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.189 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 78.1 Cg_endo -82.64 -31.13 0.86 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.592 1.528 . . . . 0.0 114.427 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 1.7 ttp -68.24 -41.68 80.84 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.496 0.589 . . . . 0.0 109.679 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.827 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -72.72 -39.39 60.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 45.4 tt0 -62.39 -36.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 22.5 ttmm -68.77 -29.47 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.707 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CD2' ' HA ' ' A' ' 40' ' ' ILE . 23.0 m-85 -56.84 -59.22 5.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 5.2 m -77.25 -14.01 59.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.627 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' LYS . 40.1 tt0 -62.26 -29.51 70.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 21.4 mt-30 -89.95 -50.68 5.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.2 p90 -125.9 90.91 49.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.254 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.02 0.89 5.17 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.831 2.354 . . . . 0.0 112.361 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 5.1 tt0 -63.46 -23.67 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.936 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.68 154.65 18.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -91.53 126.07 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.64 -173.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HB2' HG22 ' A' ' 2' ' ' VAL . 2.7 p90 -96.57 115.76 27.97 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.252 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.7 m-85 -141.53 149.46 40.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.723 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . 20.8 pttp -148.79 158.82 44.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.64 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.4 tt -159.16 150.06 19.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 110.294 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 6.8 t0 -98.74 120.08 38.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.758 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 27' ' ' ALA . 3.1 m -66.54 -20.6 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.453 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.75 -37.79 82.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.392 0.615 . . . . 0.0 109.521 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -42.89 24.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.674 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HB3' HG23 ' A' ' 63' ' ' VAL . 93.7 mt -131.07 75.26 1.65 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.586 0.708 . . . . 0.0 112.17 -175.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -70.25 -29.05 70.61 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.792 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.3 -29.33 70.07 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.535 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 60' ' ' LEU . 22.0 t -69.57 -51.06 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.63 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . . . -55.09 -20.11 9.04 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.569 0.543 . . . . 0.0 112.307 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 77.6 mm-40 -85.35 -33.75 21.97 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 0.0 110.822 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 11.1 tptt -68.31 -36.2 78.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 110.644 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.63 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 3.3 p30 -96.48 -13.23 23.22 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 42.7 mt-10 78.69 17.86 0.99 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.927 174.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.38 108.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 109.462 172.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -109.59 -19.65 13.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.002 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.97 149.52 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.53 ' HE2' HG21 ' A' ' 57' ' ' VAL . 1.9 mpt? -133.61 133.88 23.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.116 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HB2' HG12 ' A' ' 36' ' ' ILE . 73.3 Cg_endo -82.33 153.97 76.63 Favored 'Cis proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.301 -1.541 . . . . 0.0 113.802 -0.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -137.45 142.44 41.59 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.183 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 95' ' ' ILE . 4.4 mp -109.8 126.05 53.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.693 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -117.01 113.72 22.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.052 0.453 . . . . 0.0 111.039 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.6 mp -96.84 134.96 39.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.282 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 76' ' ' LEU . 49.8 m-85 -132.04 151.08 51.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 15.9 mtpp -128.18 108.0 10.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.986 0.179 . . . . 0.0 110.743 170.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 58.2 53.8 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.682 0.753 . . . . 0.0 111.852 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 84.77 -6.0 79.9 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.832 174.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 64.7 pttt -121.45 160.74 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 30.7 tt0 -67.98 179.45 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -152.15 -29.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.635 163.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -160.23 155.26 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.085 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -155.17 113.69 3.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.669 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 95' ' ' ILE . 22.0 t -127.65 135.25 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.629 -173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.2 m -102.12 43.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.29 123.91 0.88 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.323 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -57.77 104.45 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -116.48 89.2 26.46 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.72 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.5 Cg_exo -31.23 -76.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.474 3.449 . . . . 0.0 115.079 -172.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.92 -41.08 68.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.12 -29.91 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.455 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' O ' HG12 ' A' ' 99' ' ' ILE . 45.7 mm -87.55 -31.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.808 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 64.6 mttm -54.6 -44.37 72.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -65.42 -32.87 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.883 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -66.17 -57.82 6.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.4 mm -54.03 -35.12 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.679 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.81 -29.74 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.273 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.64 -40.89 61.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 111.011 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 46.0 m-80 -82.98 -16.28 47.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.029 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.548 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.852 0.358 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 40' ' ' ILE . 88.3 t -81.24 125.56 39.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.425 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.505 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 15.2 m -72.36 144.8 48.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.186 -170.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -97.3 125.07 41.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.809 -174.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 6.4 m-85 -75.15 170.44 16.04 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 10' ' ' GLU . 59.9 pttt -133.93 -21.62 1.89 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.288 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 178.8 9.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.365 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -70.23 -29.08 65.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.792 0.329 . . . . 0.0 110.781 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -54.56 -48.12 72.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.839 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.571 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 6.0 mp0 -55.38 -46.85 76.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.55 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.685 ' O ' HG12 ' A' ' 15' ' ' ILE . 30.9 t80 -56.45 -59.51 4.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.811 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.0 -36.78 77.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.663 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.6 m -61.79 -45.7 92.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.655 0.264 . . . . 0.0 110.991 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -34.12 77.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.877 0.37 . . . . 0.0 110.322 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.773 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.5 mm -65.94 -40.51 87.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.312 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.41 2.16 14.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.481 -173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 19' ' ' LYS . 9.9 tt0 -76.51 144.49 39.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.882 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 57.2 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 8.8 ptmm? -168.73 176.53 5.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.005 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.15 115.18 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.213 0.53 . . . . 0.0 110.895 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.4 t -101.22 135.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.982 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.59 115.97 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 11' ' ' PHE . 33.6 t -107.52 131.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.577 0.703 . . . . 0.0 110.9 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -102.88 96.6 6.94 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.469 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CD1' HG11 ' A' ' 69' ' ' VAL . 26.7 m-85 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.667 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.659 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.9 p90 -163.24 179.17 7.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.727 169.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -127.61 128.74 46.05 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 p -65.05 -18.67 65.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -88.96 -10.59 47.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.417 . . . . 0.0 110.713 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 49.7 t -97.64 148.88 22.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.831 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.22 2.86 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.411 -0.66 . . . . 0.0 114.655 -173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.3 Cg_exo -59.49 -2.56 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.17 2.58 . . . . 0.0 114.044 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 26' ' ' TYR . 69.5 m -63.19 -24.44 67.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.27 0.557 . . . . 0.0 110.929 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 57.0 mtpt -65.63 -9.36 26.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.765 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.414 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -78.03 -35.49 49.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 109.354 176.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -75.29 -25.82 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.408 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.13 -66.2 0.88 Allowed Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.923 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 76.4 Cg_endo -83.44 -32.72 0.45 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.319 1.346 . . . . 0.0 114.479 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.5 tmm? -69.86 -38.08 76.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.412 0.625 . . . . 0.0 109.85 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.6 mt -79.84 -33.64 14.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.804 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 41.1 tt0 -67.87 -23.23 65.11 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.156 172.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 49.4 tptt -78.64 -37.27 42.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.584 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 44' ' ' SER . 1.1 p90 -59.05 -49.63 77.14 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.572 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 94.1 p -85.13 -14.5 46.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.673 -175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 5.5 tp10 -59.59 -33.69 71.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.02 -47.62 8.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.419 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 9.4 p90 -126.69 90.89 48.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.469 0.652 . . . . 0.0 112.489 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.05 -0.34 8.94 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.357 2.038 . . . . 0.0 112.182 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.02 -9.37 29.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.225 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.47 155.58 17.98 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 5.8 m-20 -91.08 120.55 32.13 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.719 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.2 p90 -100.66 115.27 29.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.979 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.505 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 95.9 m-85 -139.92 141.46 36.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.088 0.471 . . . . 0.0 111.324 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 76.2 mttt -122.21 155.05 36.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.006 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 63' ' ' VAL . 8.4 tt -159.5 142.04 13.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.23 130.79 52.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.308 0.575 . . . . 0.0 111.196 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CE ' ' A' ' 72' ' ' MET . 1.9 m -69.42 -16.11 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.256 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.35 -41.56 84.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.216 0.532 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.46 -42.72 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.899 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 2.8 mm? -121.4 77.71 1.36 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.165 0.507 . . . . 0.0 112.282 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.06 35.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.327 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.05 -32.58 74.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 110.295 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 67' ' ' ASN . 86.5 t -64.53 -52.16 58.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.119 176.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.48 -38.84 46.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.024 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 17.8 mm100 -70.68 -33.5 71.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HG3' ' OD1' ' A' ' 67' ' ' ASN . 10.4 tptt -62.04 -28.45 69.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 175.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.834 ' HB2' HG12 ' A' ' 69' ' ' VAL . 17.7 m-20 -100.55 -12.53 19.19 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.004 -169.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.4 tp10 79.82 26.42 0.36 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.298 0.999 . . . . 0.0 110.225 -177.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 67' ' ' ASN . 1.2 p -106.61 118.23 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.425 0.631 . . . . 0.0 111.412 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.5 m -131.25 11.92 5.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.426 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.94 30.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' HG21 ' A' ' 57' ' ' VAL . 14.8 mmt -127.19 117.98 21.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.583 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HG2' HD13 ' A' ' 36' ' ' ILE . 17.7 Cg_endo -89.52 175.21 22.44 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.561 -1.016 . . . . 0.0 111.702 -4.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 48.0 m -147.55 146.48 29.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 mp -120.88 139.64 52.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 2.3 mt -125.77 120.33 30.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.5 mp -97.96 129.26 44.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.511 ' CD2' HD12 ' A' ' 15' ' ' ILE . 35.1 m-85 -128.13 146.66 50.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -121.52 110.9 16.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.329 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p30 46.1 56.35 6.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.773 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 80.1 6.28 89.24 Favored Glycine 0 CA--C 1.511 -0.211 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.646 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.93 153.61 42.42 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 178.35 2.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -150.23 -32.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.437 164.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -161.98 150.97 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -145.11 129.2 17.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.55 126.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.638 0.256 . . . . 0.0 110.525 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -96.21 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.32 0.581 . . . . 0.0 111.177 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.64 140.15 2.8 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.571 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . . . -70.08 108.88 4.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.057 0.456 . . . . 0.0 110.896 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -117.23 89.04 29.71 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.261 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -28.92 -72.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.829 3.686 . . . . 0.0 115.321 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -43.34 56.86 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.667 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -61.09 -33.21 72.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.434 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 99' ' ' ILE . 35.9 mm -74.78 -49.64 28.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.999 0.428 . . . . 0.0 110.211 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 18.1 mtpp -67.18 -24.2 65.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.387 0.613 . . . . 0.0 110.63 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.92 -31.97 51.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.099 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.49 -54.3 30.28 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.212 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 77' ' ' LEU . 3.0 mm -53.56 -36.56 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.096 0.474 . . . . 0.0 110.348 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.14 60.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.227 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.61 -40.46 20.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.453 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' HD23 ' A' ' 77' ' ' LEU . 45.9 m-80 -83.51 -11.63 57.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.278 -175.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.699 177.26 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 ttm . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.665 HG23 ' HG2' ' A' ' 41' ' ' GLU . 69.8 t -90.88 131.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.947 0.403 . . . . 0.0 111.251 -175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -79.08 144.1 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.295 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.668 ' NE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.87 131.24 37.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.974 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 5.0 m-85 -80.11 167.38 20.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.053 0.454 . . . . 0.0 110.847 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.45 -39.74 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -144.47 -179.94 6.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.011 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.8 67.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.902 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 t -57.81 -49.91 75.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 2.0 mp0 -51.17 -46.53 62.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.579 173.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.3 t80 -58.19 -58.31 9.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 -178.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.94 -36.48 84.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.732 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.5 m -65.49 -30.94 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 111.104 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.45 -35.45 58.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.091 0.472 . . . . 0.0 109.874 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.848 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.4 mm -62.72 -39.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.478 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.46 3.39 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.424 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.402 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 26.1 mt-30 -77.01 141.62 40.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.083 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.2 31.96 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.533 0.682 . . . . 0.0 111.254 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -137.18 179.36 6.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.549 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' HG21 ' A' ' 84' ' ' VAL . 1.7 tm? -76.01 117.13 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.631 -174.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.5 t -103.02 119.14 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.748 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 13.9 t -106.91 112.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 11' ' ' PHE . 23.8 t -106.57 122.17 60.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.807 0.813 . . . . 0.0 110.83 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.22 97.39 11.1 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.935 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.712 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 1.5 m-85 -96.66 124.33 40.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.697 0.761 . . . . 0.0 112.631 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 44.1 p90 -154.79 165.47 36.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.141 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -118.01 140.5 49.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.181 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 p -65.39 -19.64 66.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.663 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -80.87 -18.54 46.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.364 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 46.3 t -83.37 141.92 31.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.056 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -75.54 -55.32 5.09 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.611 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 33.4 Cg_endo -65.75 4.73 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 114.196 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 21.7 p -64.01 -29.85 70.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.691 0.757 . . . . 0.0 109.646 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -68.84 -9.21 50.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.403 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -35.12 39.36 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -75.0 -25.72 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -54.26 -65.74 1.16 Allowed Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.859 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 64.9 Cg_endo -83.03 -29.58 1.19 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.696 1.284 . . . . 0.0 114.092 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.482 ' CE ' HG13 ' A' ' 40' ' ' ILE . 3.7 tmm? -71.41 -33.4 69.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.596 0.712 . . . . 0.0 109.851 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -84.26 -34.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.973 -179.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.665 ' HG2' HG23 ' A' ' 2' ' ' VAL . 39.6 mt-10 -68.64 -20.09 64.45 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.534 171.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -76.58 -39.07 53.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.738 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 1.5 p90 -57.5 -47.0 83.1 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.321 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 89.7 p -84.59 -15.41 45.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.977 -0.452 . . . . 0.0 110.655 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.59 -29.15 69.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.569 HE21 ' HA ' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -86.99 -42.32 13.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.0 175.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 8.4 p90 -138.53 91.61 12.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 112.21 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.57 1.09 4.61 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.469 2.113 . . . . 0.0 111.744 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -63.89 -22.77 67.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.332 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.16 159.99 14.67 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 3.1 m-20 -91.02 125.89 35.95 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.477 0.656 . . . . 0.0 111.232 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.66 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -104.4 114.68 29.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.049 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 95.4 m-85 -142.49 151.14 41.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.668 ' HG3' ' NE2' ' A' ' 4' ' ' GLN . 64.6 pttt -149.59 159.07 44.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.36 -175.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.8 tt -155.71 151.96 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.907 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 29.0 t0 -95.56 113.33 24.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.809 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 41.0 t -62.44 -27.12 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.183 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -66.27 -32.5 73.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 110.166 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.44 -41.97 11.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 3.4 mm? -118.44 65.88 0.76 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.364 0.602 . . . . 0.0 111.555 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -67.75 -31.72 76.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.625 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.12 -22.07 63.99 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 60' ' ' LEU . 25.2 t -72.96 -50.98 28.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.701 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -52.82 -21.44 4.2 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 21.5 mt-30 -86.17 -28.97 23.6 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.858 -0.527 . . . . 0.0 110.801 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -70.17 -29.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.905 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 64' ' ' ALA . 2.3 p30 -108.58 -12.55 14.97 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.023 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 9.2 tp10 79.23 30.1 0.32 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.052 0.845 . . . . 0.0 111.216 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.701 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -106.48 107.69 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.366 0.603 . . . . 0.0 110.611 169.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -111.35 -35.92 5.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.32 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.2 152.49 29.13 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 27' ' ' ALA . 19.7 ptp -144.49 147.32 35.99 Favored Pre-proline 0 C--N 1.321 -0.667 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.547 -174.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG12 ' A' ' 36' ' ' ILE . 59.9 Cg_endo -80.65 149.6 78.23 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.599 -1.834 . . . . 0.0 112.518 -3.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 3.3 m -133.06 133.18 42.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.295 0.569 . . . . 0.0 111.109 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.2 mp -98.79 125.77 44.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.53 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.2 mt -114.27 113.74 25.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.118 0.485 . . . . 0.0 110.473 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 85' ' ' ALA . 3.1 mp -95.54 127.88 41.94 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 76' ' ' LEU . 61.4 m-85 -127.17 154.61 44.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.804 -0.18 . . . . 0.0 110.653 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' HD22 ' A' ' 80' ' ' ASN . 81.8 tttt -139.23 127.06 22.09 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 168.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.483 HD22 ' HG2' ' A' ' 79' ' ' LYS . 9.3 p30 50.22 49.24 20.88 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.494 1.117 . . . . 0.0 113.453 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.848 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 78.46 1.09 81.2 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.238 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -118.27 160.14 22.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.19 179.69 2.74 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -151.73 -29.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 164.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -171.59 160.32 5.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.229 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 21.5 ptmt -153.18 134.22 14.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.029 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.04 120.87 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.646 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 62.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 122.209 1.004 . . . . 0.0 110.199 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.27 130.75 1.28 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.306 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -72.72 98.28 2.35 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.667 0.27 . . . . 0.0 110.87 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 91' ' ' ASN . 0.4 OUTLIER -116.4 88.48 23.73 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.285 -179.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.26 -58.93 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.344 3.363 . . . . 0.0 114.903 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.56 -46.51 38.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.87 -27.57 65.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.481 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 99' ' ' ILE . 34.3 mm -76.6 -45.2 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.572 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 72.8 tttt -60.98 -28.49 69.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.404 0.621 . . . . 0.0 110.642 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -84.35 -27.3 27.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.553 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.64 -56.65 5.97 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 95' ' ' ILE . 4.2 mm -51.82 -41.22 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.416 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.3 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.127 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.21 60.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -80.79 -21.22 41.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.386 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.073 179.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' PHE . 91.2 t -79.55 127.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.348 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.599 ' HB ' ' CD1' ' A' ' 53' ' ' TYR . 14.9 m -71.03 144.35 50.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.68 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -91.51 119.57 31.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.136 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 2.2 m-30 -76.09 167.48 21.79 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.496 173.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -129.61 -40.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -142.77 179.55 6.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.558 0.218 . . . . 0.0 111.405 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -65.99 -29.81 70.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.623 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -58.13 -46.02 86.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -54.45 -43.63 71.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 172.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.614 ' O ' HG12 ' A' ' 15' ' ' ILE . 26.9 t80 -58.28 -58.72 7.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 110.495 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.606 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 47.9 m-20 -60.0 -33.91 72.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.027 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.1 m -63.48 -41.72 98.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.689 0.281 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.08 -36.73 82.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.014 0.435 . . . . 0.0 110.154 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.768 HG22 ' HA2' ' A' ' 81' ' ' GLY . 11.3 mm -63.6 -39.71 86.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.662 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.21 12.84 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.44 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -87.72 146.41 25.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.051 0.453 . . . . 0.0 111.082 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.6 32.27 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.723 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 51' ' ' ASP . 7.0 ptmm? -150.63 168.94 22.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 103' ' ' ALA . 1.5 tm? -72.44 118.56 15.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.185 0.517 . . . . 0.0 110.959 -171.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 1.1 t -100.74 120.56 50.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.892 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 43' ' ' PHE . 18.8 t -109.61 106.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.567 HG11 ' CE2' ' A' ' 11' ' ' PHE . 15.4 t -103.0 123.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.801 0.81 . . . . 0.0 110.986 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.873 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -91.39 96.86 10.75 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.049 -175.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.721 ' CE2' HD22 ' A' ' 55' ' ' LEU . 3.0 m-85 -105.52 106.87 17.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.58 0.705 . . . . 0.0 112.004 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 40.2 p90 -128.77 -173.61 3.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.634 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -132.66 130.69 40.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 p -66.47 -21.82 66.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -84.45 -9.76 58.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.718 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.665 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 47.8 t -93.42 147.31 23.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.155 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.97 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.648 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.665 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.2 Cg_exo -67.23 4.62 1.14 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.096 2.531 . . . . 0.0 114.356 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 29.7 p -62.94 -32.19 73.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.028 0.918 . . . . 0.0 109.361 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -70.76 -8.98 56.28 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.968 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 90' ' ' ALA . 25.6 ttt -82.76 -28.69 30.22 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 40' ' ' ILE . 1.3 mp -75.31 -25.03 17.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.594 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -53.92 -65.89 1.07 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.399 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 91.7 Cg_endo -83.16 -30.71 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.264 1.31 . . . . 0.0 114.521 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -68.4 -39.48 81.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.873 HD13 ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -77.42 -36.37 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.565 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.68 -20.73 65.33 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.116 -0.633 . . . . 0.0 109.563 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 22.8 ttmm -83.32 -32.67 26.17 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.277 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 1.2 p90 -57.51 -46.37 83.87 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.265 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 93.5 p -84.8 -15.64 44.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.506 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 38.9 tt0 -56.48 -32.72 65.27 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.476 ' NE2' ' HD2' ' A' ' 96' ' ' LYS . 39.8 mt-30 -87.24 -50.43 6.6 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.837 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.597 ' OH ' ' HA ' ' A' ' 96' ' ' LYS . 5.8 p90 -127.78 90.67 47.34 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.166 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.61 -0.68 7.99 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.483 2.122 . . . . 0.0 112.29 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.47 -18.05 65.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.492 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.45 157.62 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' OD1' ' HG3' ' A' ' 19' ' ' LYS . 7.6 m-20 -91.75 128.12 37.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.584 0.707 . . . . 0.0 111.473 -173.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.559 ' HB2' HG22 ' A' ' 2' ' ' VAL . 1.3 p90 -106.96 114.7 28.94 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.87 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.599 ' CD1' ' HB ' ' A' ' 3' ' ' THR . 97.2 m-85 -139.41 146.53 40.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.196 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 42.2 mtpt -131.2 148.81 52.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.886 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.7 tt -160.7 148.12 15.78 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 6.1 p-10 -105.6 131.59 52.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.383 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 27' ' ' ALA . 1.5 m -69.29 -12.69 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.146 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.54 -46.05 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.184 0.516 . . . . 0.0 109.794 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.51 -41.72 17.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.43 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.8 mm? -122.68 75.11 1.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.433 0.635 . . . . 0.0 112.129 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -74.62 -34.18 54.32 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.358 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.65 -28.41 69.6 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.332 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.682 HG12 HD21 ' A' ' 67' ' ' ASN . 57.8 t -70.86 -50.19 45.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.67 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.61 -40.41 52.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.059 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 mt-30 -69.17 -35.58 76.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.313 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HE3' ' OD2' ' A' ' 12' ' ' ASP . 14.4 tptp -62.57 -25.54 68.12 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.305 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.682 HD21 HG12 ' A' ' 63' ' ' VAL . 7.3 m-20 -105.9 -9.98 16.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.233 -171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 37.4 mt-10 80.51 27.31 0.26 Allowed 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.455 1.097 . . . . 0.0 111.217 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -105.2 115.35 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 110.256 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.6 p -115.95 -23.38 8.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.166 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.84 166.24 12.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.179 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -149.63 140.88 14.5 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.015 0.436 . . . . 0.0 111.359 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 57.7 Cg_endo -80.27 151.56 82.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.475 -1.885 . . . . 0.0 113.194 -4.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -129.58 139.14 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.63 126.54 54.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.358 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' CE1' ' A' ' 78' ' ' PHE . 1.4 mt -115.62 115.35 26.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.04 0.447 . . . . 0.0 110.69 176.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 mp -96.96 131.2 43.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.099 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 76' ' ' LEU . 57.3 m-85 -130.45 148.69 52.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.619 0.247 . . . . 0.0 111.229 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -127.0 108.59 11.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.619 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.9 t30 60.41 55.51 3.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 111.633 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.768 ' HA2' HG22 ' A' ' 15' ' ' ILE . . . 72.04 6.45 64.31 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.497 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -121.8 157.86 30.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' VAL . 33.9 tt0 -73.27 179.09 4.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -151.83 -32.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 165.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -170.78 152.54 3.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 111.722 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 134.18 30.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.909 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.1 t -131.75 123.78 52.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.12 53.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.2 0.524 . . . . 0.0 111.497 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.93 136.01 1.94 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.625 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -66.88 107.54 2.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.12 0.486 . . . . 0.0 110.964 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -111.51 88.38 9.15 Favored Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.3 Cg_exo -31.43 -74.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 124.477 3.451 . . . . 0.0 115.319 -169.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -38.09 68.53 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.235 -0.291 . . . . 0.0 111.626 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -65.18 -31.3 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.383 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 99' ' ' ILE . 33.3 mm -76.41 -49.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 110.265 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' OH ' ' A' ' 47' ' ' TYR . 47.0 mtmt -64.37 -22.94 67.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.486 0.66 . . . . 0.0 110.152 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -80.89 -37.05 30.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.66 171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -58.93 -61.34 2.71 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 95' ' ' ILE . 3.5 mm -47.93 -38.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.068 0.855 . . . . 0.0 110.671 -176.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.95 -22.24 59.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.615 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.5 -28.97 18.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.156 0.503 . . . . 0.0 110.443 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.628 ' ND2' HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -95.73 -10.34 29.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.027 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.736 176.327 . . . . . . . . 1 1 . 1 stop_ save_